<SEC-DOCUMENT>0001206774-16-007477.txt : 20161102
<SEC-HEADER>0001206774-16-007477.hdr.sgml : 20161102
<ACCEPTANCE-DATETIME>20161102161532
ACCESSION NUMBER:		0001206774-16-007477
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		59
CONFORMED PERIOD OF REPORT:	20160930
FILED AS OF DATE:		20161102
DATE AS OF CHANGE:		20161102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CLOROX CO /DE/
		CENTRAL INDEX KEY:			0000021076
		STANDARD INDUSTRIAL CLASSIFICATION:	SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
		IRS NUMBER:				310595760
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07151
		FILM NUMBER:		161967996

	BUSINESS ADDRESS:	
		STREET 1:		THE CLOROX COMPANY
		STREET 2:		1221 BROADWAY
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1888
		BUSINESS PHONE:		5102717000

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 24305
		CITY:			OAKLAND
		STATE:			CA
		ZIP:			94612-1305
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>clorox3118958-10q.htm
<DESCRIPTION>QUARTERLY REPORT
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">
<BR>

<HR style="MARGIN-TOP: -2px" color=black SIZE=4>

<HR style="MARGIN-TOP: -10px" color=black SIZE=1>

<DIV style="MARGIN-TOP: -6pt; MARGIN-BOTTOM: -6pt" align=center><FONT face="Times New Roman">UNITED STATES<BR></FONT><FONT face="Times New Roman">SECURITIES AND EXCHANGE COMMISSION<BR></FONT><FONT face="Times New Roman" size=2>Washington, D.C. 20549</FONT></DIV>
<P style="MARGIN-BOTTOM: 6pt" align=center><FONT face="Times New Roman" size=4>FORM 10-Q</FONT><FONT face="Times New Roman"> </FONT></P>
<TABLE style="FONT-SIZE: 7pt; WIDTH: 100%; LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR vAlign=bottom>
    <TD COLSPAN="3" STYLE="text-align: left; vertical-align: top"><FONT face="Times New Roman" size=2>(Mark One)</FONT></TD></TR>
  <TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="vertical-align: top; width: 1%; text-align: left"><FONT face="Times New Roman" size=3>&#9746;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: left"><FONT face="Times New Roman" size=3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT></TD>
    <TD STYLE="vertical-align: top; width: 97%; text-align: left; padding-top: 1pt">
      <P align=left><FONT face="Times New Roman" size=3>QUARTERLY REPORT
      PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
      </FONT></P></TD></TR>
  <TR style="LINE-HEIGHT: 9pt" vAlign=bottom>
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: left; vertical-align: top"></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT face="Times New Roman" size=1>&nbsp;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD COLSPAN="3" STYLE="text-align: left; vertical-align: top">
      <P align=left><FONT face="Times New Roman" size=2>For the quarterly period
      ended September 30, 2016.</FONT></P></TD></TR>
  <TR style="LINE-HEIGHT: 10pt">
    <TD STYLE="text-align: left; vertical-align: top"></TD>
    <TD COLSPAN="2" STYLE="text-align: left; vertical-align: top"><FONT face="Times New Roman" size=1>&nbsp;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD STYLE="text-align: left; vertical-align: top"></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: top"><FONT face="Times New Roman" size=2>OR</FONT></TD></TR>
  <TR style="LINE-HEIGHT: 9pt">
    <TD STYLE="text-align: left; vertical-align: top"></TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; text-align: left"><FONT face="Times New Roman" size=1>&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="vertical-align: top; text-align: left"><FONT face="Times New Roman" size=3>&#9744;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT face=monospace size=4></FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; padding-top: 1pt">
      <P align=left><FONT face="Times New Roman" size=3>TRANSITION REPORT
      PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
      </FONT></P></TD></TR></TABLE>
<P style="MARGIN-TOP: 4pt" align=left><FONT face="Times New Roman" size=2>For
the transition period
from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
to</FONT><FONT face="Times New Roman"> </FONT></P>
<P style="MARGIN-TOP: -3pt" align=center><FONT face="Times New Roman" size=2></FONT></P>
<DIV align=center><FONT face="Times New Roman" size=2>Commission File
Number:</FONT><FONT face="Times New Roman"> </FONT><B><FONT face="Times New Roman" size=2>1-07151 <BR></FONT></B><FONT face="Times New Roman" size=1>_________________________</FONT></DIV>
<DIV align=left><FONT face="Times New Roman" size=2></FONT>&nbsp;</DIV>
<DIV style="MARGIN-TOP: -3pt" align=center><B><FONT face="Times New Roman" size=4>THE CLOROX COMPANY<BR></FONT></B><FONT face="Times New Roman" size=2>(Exact name of registrant as specified in its charter)</FONT></DIV>
<DIV align=left><FONT face="Times New Roman" size=2></FONT>&nbsp;</DIV>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="49%"><B><FONT face="Times New Roman" size=2>Delaware</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="50%"><B><FONT face="Times New Roman" size=2>31-0595760</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="49%"><FONT face="Times New Roman" size=2>(State or other jurisdiction of</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="50%"><FONT face="Times New Roman" size=2>(I.R.S. Employer Identification
    No.)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="49%"><FONT face="Times New Roman" size=2>incorporation or organization)</FONT></TD>
    <TD noWrap align=left width="50%"></TD></TR>
  <TR>
    <TD width="99%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="49%"><B><FONT face="Times New Roman" size=2>1221 Broadway</FONT></B></TD>
    <TD noWrap align=left width="50%"></TD></TR>
  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="49%"><B><FONT face="Times New Roman" size=2>Oakland, California</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="50%"><B><FONT face="Times New Roman" size=2>94612-1888</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="49%"><FONT face="Times New Roman" size=2>(Address of principal executive
      offices)</FONT></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="50%"><FONT face="Times New Roman" size=2>(Zip code)</FONT></TD></TR></TABLE><BR>
<DIV align=center>
<TABLE style="BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="90%" border=0>

  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="100%"><B><FONT face="Times New Roman" size=2>(510) 271-7000</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" width="100%"><FONT face="Times New Roman" size=2>(Registrant's telephone number, including area code)</FONT></TD></TR>
  <TR style="LINE-HEIGHT: 8pt">
    <TD style="BORDER-BOTTOM: #000000 1pt solid" align=center width="100%"><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD style="TEXT-ALIGN: center" noWrap width="100%"><FONT face="Times New Roman" size=2>(Former name, former address and former
      fiscal year, if changed since last report)</FONT></TD></TR>
  <TR>
    <TD style="TEXT-ALIGN: center" noWrap width="100%"><FONT face="Times New Roman" size=1>_________________________</FONT></TD></TR></TABLE></DIV>
<DIV align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</DIV>
<DIV style="MARGIN-BOTTOM: -2pt" align=left><FONT face="Times New Roman" size=2>Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes&nbsp;&#9745;&nbsp;</FONT><FONT face="Times New Roman" size=2>No &#9744;</FONT></DIV>
<DIV align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</DIV>
<DIV style="MARGIN-BOTTOM: -2pt" align=left><FONT face=monospace size=2></FONT><FONT face="Times New Roman"></FONT><FONT face="Times New Roman" size=2>Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation
S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files).
Yes&nbsp;&#9745;&nbsp;</FONT><FONT face="Times New Roman" size=2>No&nbsp;&#9744;</FONT></DIV>
<DIV align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</DIV>
<DIV style="MARGIN-BOTTOM: -2pt" align=left><FONT face=monospace size=2></FONT><FONT face="Times New Roman"></FONT><FONT face="Times New Roman" size=2>Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer or a smaller reporting
company. See definitions of &#147;large accelerated filer&#148; &#147;accelerated filer&#148; and
&#147;smaller reporting company&#148; in Rule 12b-2 of the Exchange Act:</FONT></DIV>
<DIV align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</DIV>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="25%"><FONT face="Times New Roman" size=2>Large accelerated filer&nbsp;&#9745;</FONT></TD>
    <TD noWrap align=left width="27%"><FONT face="Times New Roman" size=2>Accelerated filer&nbsp;&#9744;</FONT><FONT face=monospace size=2></FONT></TD>
    <TD noWrap align=left width="27%"><FONT face="Times New Roman" size=2>Non-accelerated filer&nbsp;&#9744;</FONT><FONT face=monospace size=2></FONT></TD>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>Smaller Reporting Company&nbsp;&#9744;</FONT><FONT face=monospace size=2></FONT></TD></TR></TABLE>
<DIV align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</DIV>
<DIV style="MARGIN-BOTTOM: -2pt" align=left><FONT face="Times New Roman" size=2>Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act).
Yes&nbsp;&#9744;&nbsp;No&nbsp;&#9745;</FONT></DIV>
<DIV align=left><FONT face="Times New Roman" size=1></FONT>&nbsp;</DIV>
<DIV style="MARGIN-BOTTOM: -2pt" align=left><FONT face="Times New Roman" size=2>As of October 19, 2016, there were 128,743,698 shares outstanding of the
registrant&#146;s common stock ($1.00 &#150; par value). </FONT><FONT face="Times New Roman"></FONT></DIV>

<div>&nbsp;</div>
<HR style="MARGIN-TOP: -1pt; MARGIN-BOTTOM: -1pt" color=black SIZE=1>
<div style="line-height: 12pt">&nbsp;</div>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=center><B><FONT face="Times New Roman" size=2>PART I &#150; FINANCIAL
INFORMATION </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Item 1. Financial
Statements </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>The Clorox
Company<BR></FONT><FONT face="Times New Roman" size=2>Condensed Consolidated
Statements of Earnings and Comprehensive Income (Unaudited) <BR>(Dollars in
millions, except share and per share data) </FONT><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=7><B><FONT face="Times New Roman" size=2 >Three Months
    Ended</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=2 >9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=2 >9/30/2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Net
      sales</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >1,443</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >1,390</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >Cost of products sold</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >803</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >765</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Gross
      profit</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >640</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >625</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >Selling and administrative
    expenses</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >200</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >186</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Advertising
      costs</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >128</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >123</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >Research and development costs</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >31</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >30</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Interest
      expense</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >22</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >23</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >Other (income) expense, net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >(5</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Earnings
      from continuing operations before income taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >264</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >264</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >Income taxes on continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >85</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >91</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Earnings
      from continuing operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >179</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >173</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >Earnings (losses) from discontinued
      operations, net of tax</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Net
      earnings</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >179</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >172</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >Net earnings (losses) per share</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing
      operations</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >1.39</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >1.34</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued
      operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(0.01</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic net earnings per
      share</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >1.39</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >1.33</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD width="100%" colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing
      operations</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >1.36</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >1.32</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued
      operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(0.01</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted net earnings per
      share</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >1.36</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >1.31</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD width="100%" colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Weighted
      average shares outstanding (in thousands)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >129,449</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >129,155</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >132,193</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >131,220</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >Dividend declared per share</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >0.80</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >0.77</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD width="100%" bgColor=#ffffff colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Comprehensive income</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >182</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >133</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>See Notes to Condensed
Consolidated Financial Statements (Unaudited) </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>2</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=center><FONT face="Times New Roman" size=2>The Clorox
Company<BR></FONT><FONT face="Times New Roman" size=2>Condensed Consolidated
Balance Sheets (Unaudited) <BR>(Dollars in millions, except share and per share
data) </FONT><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=2 >9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=2 >6/30/2016</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2 >ASSETS</FONT></B></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >Current
      assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash
      and cash equivalents</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >408</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >401</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables,
      net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >494</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >569</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories,
      net</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >465</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >443</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
      current assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >49</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >72</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total
      current assets</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >1,416</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >1,485</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >Property,
      plant and equipment, net of accumulated depreciation</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and
      amortization of $1,944 and $1,911, respectively</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >917</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >906</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Goodwill</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >1,196</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >1,197</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >Trademarks,
      net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >657</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >657</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Other
      intangible assets, net</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >76</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >78</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >Other
      assets</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >204</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >187</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Total
      assets</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >4,466</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >4,510</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR>
    <TD align=left width="106%" bgColor=#c0c0c0 colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><B><FONT face="Times New Roman" size=2 >LIABILITIES AND STOCKHOLDERS&#146;
    EQUITY</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Current
      liabilities</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes
      and loans payable</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >618</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >523</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current
      maturities of long-term debt</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts
      payable and accrued liabilities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >874</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >1,035</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income
      taxes payable</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >30</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total
      current liabilities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >1,522</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >1,558</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Long-term
      debt</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >1,789</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >1,789</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >Other
      liabilities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >783</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >784</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Deferred
      income taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >83</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >82</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total
      liabilities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >4,177</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >4,213</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD align=left width="106%" colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Commitments
      and contingencies</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR>
    <TD align=left width="106%" bgColor=#c0c0c0 colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >Stockholders&#146; equity</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Preferred
      stock: $1.00 par value; 5,000,000 shares authorized; none</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;issued
      or outstanding</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >Common
      stock: $1.00 par value; 750,000,000 shares authorized; 158,741,461
      shares</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;issued
      as of September 30, 2016 and June 30, 2016; and 128,707,796 and
      129,355,263</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares
      outstanding as of September 30, 2016 and June 30, 2016,
    respectively</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >159</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >159</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Additional
      paid-in capital</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >881</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >868</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >Retained
      earnings</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >2,238</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >2,163</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Treasury
      shares, at cost: 30,033,665 and 29,386,198 shares</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as of
      September 30, 2016 and June 30, 2016, respectively</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(2,422</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(2,323</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >Accumulated
      other comprehensive net (losses) income</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >(567</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >(570</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Stockholders&#146; equity</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >289</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >297</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2 >Total
      liabilities and stockholders&#146; equity</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >4,466</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >4,510</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>See Notes to Condensed
Consolidated Financial Statements (Unaudited) </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=center style = "margin-bottom: 10pt"><FONT face="Times New Roman" size=2>3</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>


<P align=center><FONT face="Times New Roman" size=2>The Clorox
Company<BR></FONT><FONT face="Times New Roman" size=2>Condensed Consolidated
Statements of Cash Flows (Unaudited)<BR>(Dollars in millions) </FONT><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=7><B><FONT face="Times New Roman" size=2 >Three Months
    Ended</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=2 >9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=2 >9/30/2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Operating
      activities:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net earnings</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >179</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >172</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deduct: Losses from
      discontinued operations, net of tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings from continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >179</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >173</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile
      earnings from continuing operations to net cash</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman"></FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provided
      by continuing operations:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation
      and amortization</FONT></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >41</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >41</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based
      compensation</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >12</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >9</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred
      income taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(2</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(5</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(14</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(5</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes
      in:</FONT></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables,
      net</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >74</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >39</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories,
      net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(23</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(30</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
      current assets</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(10</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts
      payable and accrued liabilities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(153</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(95</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income
      taxes payable</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >62</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >18</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >Net cash
      provided by continuing operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >170</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >135</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Net cash
      provided by discontinued operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >12</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >Net cash
      provided by operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >170</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >147</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR>
    <TD align=left width="100%" colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Investing
      activities:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital
    expenditures</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(59</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(28</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >12</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >Net cash
      used for investing activities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(58</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(16</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR>
    <TD align=left width="100%" colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Financing
      activities:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes and loans payable,
      net</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >95</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >36</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock
      purchased</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(110</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(103</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash dividends
    paid</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(104</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(99</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock
      for employee stock plans and other</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >15</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >46</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >Net cash
      used for financing activities</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(104</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(120</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Effect of
      exchange rate changes on cash and cash equivalents</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(10</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >Net increase
      in cash and cash equivalents</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >7</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Cash and
      cash equivalents:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2 >Beginning of
      period</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >401</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >382</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >End of
      period</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >408</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >383</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>See Notes to Condensed
Consolidated Financial Statements (Unaudited) </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>4</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><FONT face="Times New Roman" size=2>The Clorox Company
<BR></FONT><FONT face="Times New Roman" size=2>Notes to Condensed Consolidated
Financial Statements (Unaudited)<BR>(Dollars in millions, except share and per
share data)</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 1. SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES</FONT></B><FONT face="Times New Roman" size=2>
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Basis of
Presentation</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The unaudited interim
condensed consolidated financial statements for the three months ended September
30, 2016 and 2015, in the opinion of management, reflect all adjustments
(consisting of normal recurring accruals) necessary for a fair presentation of
the consolidated results of operations, financial position and cash flows of The
Clorox Company and its subsidiaries (the Company) for the periods presented.
However, the financial results for interim periods are not necessarily
indicative of the results that may be expected for a full fiscal year or for any
other future period. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Effective September 22, 2014,
the Company&#146;s Venezuela affiliate, Corporaci&#243;n Clorox de Venezuela S.A. (Clorox
Venezuela), discontinued its operations. Consequently, the Company reclassified
the financial results of Clorox Venezuela as a discontinued operation in the
condensed consolidated financial statements for all periods presented herein.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Certain information and
footnote disclosures normally included in financial statements prepared in
accordance with generally accepted accounting principles in the United States
(U.S. GAAP) have been omitted or condensed pursuant to the rules and regulations
of the U.S. Securities and Exchange Commission (SEC). The information in this
report should be read in conjunction with the Company&#146;s Annual Report on Form
10-K filed with the SEC for the fiscal year ended June 30, 2016, which includes
a complete set of footnote disclosures including the Company&#146;s significant
accounting policies. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Recently Issued Accounting
Standards </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In March 2016, the Financial
Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No.
2016-09, &#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee
Share-Based Payment Accounting,&#148; which simplifies several aspects of the
accounting for share-based payment transactions, including requiring excess tax
benefits and tax deficiencies to be recognized as income tax expense or benefit
in the consolidated statement of earnings. Additionally, the standard requires
cash flows from excess tax benefits and deficiencies, previously classified as a
financing activity, to be classified as an operating activity in the
consolidated statement of cash flows. The Company adopted this guidance in the
first quarter of fiscal year 2017. Excess tax benefits of $6 were recognized in
the consolidated statement of earnings and classified as an operating activity
in the consolidated statement of cash flows during the three months ended
September 30, 2016. The prior period consolidated statement of cash flows has
not been adjusted as permitted. The adoption resulted in approximately a 2
percentage point benefit to the Company&#146;s effective tax rate for the first
quarter of fiscal year 2017. The guidance allows for a policy election to
account for forfeitures as they occur rather than on an estimated basis. The
Company did not make this election and will continue to account for forfeitures
on an estimated basis.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In February 2016, the FASB
issued ASU No. 2016-02, &#147;Leases (Topic 842),&#148; which requires lessees to
recognize a right-of-use asset and a lease liability for all leases with terms
of more than 12 months. Recognition, measurement and presentation will depend on
the classification of the lease as either a finance or an operating lease. ASU
2016-02 also requires expanded disclosures about leasing arrangements. The new
guidance is effective for the Company beginning in the first quarter of fiscal
year 2020, with early adoption permitted. The Company is currently evaluating
the impact that the adoption of this guidance will have on its consolidated
financial statements. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In April 2015, the FASB issued
ASU No. 2015-03, &#147;Simplifying the Presentation of Debt Issuance Cost,&#148; which
requires that debt issuance costs related to a recognized debt liability be
presented in the balance sheet as a direct deduction from the carrying amount of
that debt liability, consistent with debt discounts. The Company adopted this
standard in the first quarter of fiscal year 2017 and retrospectively applied
the standard to the June 30, 2016 consolidated balance sheet, resulting in an $8
reduction in Other assets and Long-term debt. The adoption had no impact on the
Company&#146;s consolidated statement of earnings or consolidated statement of cash
flows.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In February 2015, the FASB
issued ASU No. 2015-02, &#147;Amendments to the Consolidation Analysis,&#148; which
changes the guidance for evaluating whether to consolidate certain legal
entities. The amendments modify the evaluation of whether limited partnerships
and similar legal entities are variable interest entities or voting interest
entities. The Company adopted this standard in the first quarter of fiscal year
2017. The adoption did not have an impact on the Company&#146;s consolidated
financial statements. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>5</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P style="margin-bottom:-2pt" align=left><B><FONT face="Times New Roman" size=2>NOTE 1. SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES (Continued)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P style="margin-bottom:-2pt" align=left ><FONT face="Times New Roman" size=2>In May 2014, the FASB issued
ASU No. 2014-09, &#147;Revenue from Contracts with Customers (Topic 606),&#148; which
replaces most existing U.S. GAAP revenue recognition guidance and is intended to
improve and converge with international standards the financial reporting
requirements for revenue from contracts with customers. The core principle of
ASU 2014-09 is that an entity should recognize revenue for the transfer of goods
or services equal to the amount that it expects to be entitled to receive for
those goods or services. ASU 2014-09 also requires additional disclosures about
the nature, timing and uncertainty of revenue and cash flows arising from
contracts with customers, including information about significant judgments and
changes in judgments. The new guidance is effective for the Company beginning in
the first quarter of fiscal year 2019, with the option to early adopt in the
first quarter of fiscal year 2018. The Company is currently evaluating the
impact that the adoption of this guidance will have on its consolidated
financial statements. </FONT></P>
<P style="margin-bottom:-2pt" align=left ><B><FONT face="Times New Roman" size=2>NOTE 2. DISCONTINUED
OPERATIONS</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P style="margin-bottom:-2pt" align=left ><FONT face="Times New Roman" size=2>On September 22, 2014, Clorox
Venezuela announced that it was discontinuing its operations, effective
immediately, and seeking to sell its assets. Since fiscal year 2012, Clorox
Venezuela was required to sell more than two thirds of its products at prices
frozen by the Venezuelan government. During this same period, Clorox Venezuela
experienced successive years of hyperinflation resulting in significant
sustained increases in its input costs, including packaging, raw materials,
transportation and wages. As a result, Clorox Venezuela had been selling its
products at a loss, resulting in ongoing operating losses. Clorox Venezuela
repeatedly met with government authorities in an effort to help them understand
the rapidly declining state of the business, including the need for immediate,
significant and ongoing price increases and other critical remedial actions to
address these adverse impacts. Based on the Venezuelan government&#146;s
representations, Clorox Venezuela had expected significant price increases would
be forthcoming much earlier; however, the price increases subsequently approved
were insufficient and would have caused Clorox Venezuela to continue operating
at a significant loss into the foreseeable future. As such, Clorox Venezuela was
no longer financially viable and was forced to discontinue its
operations.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P style="margin-bottom:-2pt" align=left ><FONT face="Times New Roman" size=2>On September 26, 2014, the
Company reported that Venezuelan Vice President Jorge Arreaza announced, with
endorsement by President Nicol&#225;s Maduro, that the Venezuelan government had
occupied the Santa Luc&#237;a and Guacara production facilities of Clorox Venezuela.
On November 6, 2014, the Company reported that the Venezuelan government had
published a resolution granting a government-sponsored Special Administrative
Board full authority to restart and operate the business of Clorox Venezuela,
thereby reaffirming the government's expropriation of Clorox Venezuela&#146;s assets.
Further, President Nicol&#225;s Maduro announced the government's intention to
facilitate the resumed production of bleach and other cleaning products at
Clorox Venezuela plants. He also announced his approval of a financial credit to
invest in raw materials and production at the plants. These actions by the
Venezuelan government were taken without the consent or involvement of Clorox
Venezuela, its parent Clorox Spain S.L. (Clorox Spain) or any of their
affiliates. Clorox Venezuela, Clorox Spain and their affiliates reserved their
rights under all applicable laws and treaties. </FONT></P>

<P style="margin-bottom:-2pt" STYLE="text-align: left"><FONT face="Times New Roman" size=2>With
this exit, the financial results of Clorox Venezuela are reflected as
discontinued operations in the Company&#146;s condensed consolidated financial
statements for all periods presented. The results of Clorox Venezuela had
historically been part of the International reportable segment.</FONT></P>
<P align=left style="margin-bottom:-2pt"><FONT face="Times New Roman" size=2>Net sales for Clorox Venezuela
were $0 for each of the three months ended September 30, 2016 and 2015.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left ><FONT face="Times New Roman" size=2>The following table provides a
summary of earnings (losses) from discontinued operations for Clorox Venezuela
and earnings (losses) from discontinued operations other than Clorox Venezuela
for the periods indicated:</FONT><B><FONT face="Times New Roman" size=2>
</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="1%" colSpan=6><STRONG><FONT size=2 face="Times New Roman">Three Months
      Ended</FONT></STRONG></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="1%" colSpan=2><STRONG><FONT size=2 face="Times New Roman">9/30/2016</FONT></STRONG></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="1%" colSpan=3><STRONG><FONT size=2 face="Times New Roman">9/30/2015</FONT></STRONG>&nbsp; &nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Operating
      losses from Clorox Venezuela before income taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2 >Exit costs
      and other related expenses for Clorox Venezuela</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Total losses
      from Clorox Venezuela before income taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2 >Income tax
      benefit attributable to Clorox Venezuela</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Total losses
      from Clorox Venezuela, net of tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=8>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2 >Gains
      (losses) from discontinued operations</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2 >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;other than Clorox
      Venezuela, net of tax</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Losses from
      discontinued operations, net of tax</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >)</FONT></TD></TR></TABLE><BR>
<P align=center style = "margin-bottom: 6pt; margin-top: 6pt"><FONT face="Times New Roman" size=2>6</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><B><FONT face="Times New Roman" size=2>NOTE 3. BUSINESSES ACQUIRED
</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>On May 2, 2016, the Company
acquired 100 percent of ReNew Life Holdings Corporation (RenewLife), a leading
brand in digestive health. The amount paid was $290 funded through commercial
paper. The amount paid of $290 represents the aggregate purchase price less cash
acquired. The purchase of the RenewLife business reflects the Company&#146;s strategy
to acquire leading brands with attractive margins in growth categories. Results
for RenewLife&#146;s U.S. business are reflected in the Household reportable segment
and results for RenewLife&#146;s international business are reflected in the
International reportable segment.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The assets and liabilities of
RenewLife were recorded at their respective estimated fair value as of the date
of the acquisition using U.S. GAAP for business combinations. The excess of the
purchase price over the fair value of the net identifiable assets acquired was
allocated to goodwill. Goodwill recorded primarily reflects the value of
expanding the Company&#146;s portfolio further into the health and wellness
arena.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The following table summarizes
the estimated fair value of RenewLife&#146;s assets acquired and liabilities assumed
and related deferred income taxes as of the acquisition date. Due to the timing
of the acquisition, the fair value of the assets acquired and liabilities
assumed are based on a preliminary valuation and the Company&#146;s estimates and
assumptions are subject to change within the measurement period. The primary
areas of the purchase price that are not yet finalized are related to goodwill
and income taxes. The weighted-average estimated useful life of intangible
assets subject to amortization is 15 years. </FONT></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="98%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><STRONG><FONT size=2 face="Times New Roman">RenewLife</FONT></STRONG></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="98%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Goodwill</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >137</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="98%"><FONT face="Times New Roman" size=2 >Trademarks</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >134</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="98%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Customer
      relationships</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >36</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="98%"><FONT face="Times New Roman" size=2 >Property,
      plant and equipment</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >3</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="98%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Working
      capital, net</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >41</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="98%"><FONT face="Times New Roman" size=2 >Deferred
      income taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(61</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="98%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Purchase
      Price</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >290</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>Pro forma results reflecting
the acquisition were not presented because the acquisition did not meet the
threshold requirements for additional disclosure. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 4. INVENTORIES,
NET</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Inventories, net, consisted of
the following as of: </FONT><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="5%" colSpan=3><B><FONT face="Times New Roman" size=2 >9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=2 >6/30/2016</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Finished
      goods</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >374</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >361</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >Raw materials and packaging</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >114</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >111</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Work in
      process</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%"><FONT face="Times New Roman" size=2 >LIFO allowances</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2 >(26</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2 >(32</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="90%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >Total</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >465</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2 >443</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>7</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><B><FONT face="Times New Roman" size=2>NOTE 5. FINANCIAL
INSTRUMENTS AND FAIR VALUE MEASUREMENTS </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Financial assets and
liabilities measured at fair value on a recurring basis in the condensed
consolidated balance sheets are required to be classified and disclosed in one
of the following three categories of the fair value hierarchy: </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Level 1: Quoted market prices
in active markets for identical assets or liabilities.<BR></FONT><FONT face="Times New Roman" size=2>Level 2: Observable market-based inputs or
unobservable inputs that are corroborated by market data. <BR>Level 3:
Unobservable inputs reflecting the reporting entity&#146;s own assumptions.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of September 30, 2016 and
June 30, 2016, the Company&#146;s financial assets and liabilities that were measured
at fair value on a recurring basis during the applicable periods included
derivative financial instruments, which were classified as either Level 1 or
Level 2, and trust assets to fund certain of the Company&#146;s nonqualified deferred
compensation plans, which were classified as Level 1.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Financial Risk Management
and Derivative Instruments</FONT></B><FONT face="Times New Roman" size=2>
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is exposed to
certain commodity, interest rate, foreign currency and counterparty risks
related to its ongoing business operations and uses derivative instruments to
mitigate its exposure to these risks. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Commodity Price Risk
Management </FONT></I></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company may use commodity
exchange traded futures and over-the-counter swap contracts to fix the price of
a portion of its forecasted raw material requirements. Contract maturities,
which are generally no longer than 2 years, are matched to the length of the raw
material purchase contracts. Commodity purchase contracts are measured at fair
value using market quotations obtained from commodity futures exchanges or
commodity derivative dealers. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of September 30, 2016, the
notional amount of commodity derivatives was $24, of which $14 related to jet
fuel swaps and $10 related to soybean oil futures. As of June 30, 2016, the
notional amount of commodity derivatives was $30, of which $16 related to jet
fuel swaps and $14 related to soybean oil futures. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Foreign Currency Risk
Management </FONT></I></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company may also enter
into certain over-the-counter derivative contracts to manage a portion of the
Company&#146;s forecasted foreign currency exposure associated with the purchase of
inventory. These foreign currency contracts generally have durations of no
longer than 2 years. The foreign exchange contracts are measured at fair value
using information quoted by foreign exchange dealers. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The notional amounts of
outstanding foreign currency forward contracts used by the Company&#146;s
subsidiaries to hedge forecasted purchases of inventory were $57 as of September
30, 2016, and $84 as of June 30, 2016.</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Interest Rate Risk
Management </FONT></I></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company may also enter
into over-the-counter interest rate derivative instruments to fix a portion of
the benchmark interest rate prior to an anticipated issuance of fixed rate debt
or to manage the Company&#146;s level of fixed and floating rate debt. The interest
rate derivative instruments are measured at fair value using information quoted
by U.S. government bond dealers. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of both September 30, 2016
and June 30, 2016, the Company had no interest rate derivative
instruments.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>8</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><B><FONT face="Times New Roman" size=2>NOTE 5. FINANCIAL
INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Counterparty Risk
Management and Derivative Contract Requirements </FONT></I></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company utilizes a variety
of financial institutions as counterparties for <FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">over-the-counter</font> derivative
instruments. The Company enters into agreements governing the use of
over-the-counter derivative instruments and sets internal limits on the
aggregate over-the-counter derivative instrument positions held with each
counterparty. Certain terms of these agreements require the Company or the
counterparty to post collateral when the fair value of the derivative instrument
exceeds contractually defined counterparty liability position limits. Of the
derivative instruments of $3 and $5 reflected in Accounts payable and accrued
liabilities as of September 30, 2016 and June 30, 2016, respectively, $2 and $4,
respectively, contained such terms. As of both September 30, 2016 and June 30,
2016, neither the Company nor any counterparty was required to post any
collateral as no counterparty liability position limits were exceeded.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Certain terms of the
agreements governing the Company&#146;s over-the-counter derivative instruments
require the credit ratings, as assigned by Standard &amp; Poor&#146;s and Moody&#146;s to
the Company and its counterparties, to remain at a level equal to or better than
the minimum of an investment grade credit rating. If the Company&#146;s credit
ratings were to fall below investment grade, the counterparties to the
derivative instruments could request full collateralization on derivative
instruments in net liability positions. As of both September 30, 2016 and June
30, 2016, the Company and each of its counterparties had been assigned
investment grade credit ratings by both Standard &amp; Poor&#146;s and Moody&#146;s.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Certain of the Company&#146;s
exchange-traded futures contracts used for commodity price risk management
include requirements for the Company to post collateral in the form of a cash
margin account held by the Company&#146;s broker for trades conducted on that
exchange. As of September 30, 2016 and June 30, 2016, the Company maintained
cash margin balances related to exchange-traded futures contracts of $1, which
are classified as <FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">Other</font> current assets on the condensed consolidated balance
sheets.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Trust Assets
</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company has held interests
in mutual funds and cash equivalents as part of trust assets related to certain
of its nonqualified deferred compensation plans. The participants in the
deferred compensation plans, who are the Company&#146;s current and former employees,
may select among certain mutual funds in which their compensation deferrals are
invested in accordance with the terms of the plans and within the confines of
the trusts, which hold the marketable securities. These trusts represent
variable interest entities for which the Company is considered the primary
beneficiary, and therefore, trust assets are consolidated and included in Other
assets in the condensed consolidated balance sheets. The interests in mutual
funds are measured at fair value using quoted market prices. The Company has
designated these marketable</FONT><B><FONT face="Times New Roman" size=2>
</FONT></B><FONT face="Times New Roman" size=2>securities as trading
investments.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>9</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><B><FONT face="Times New Roman" size=2>NOTE 5. FINANCIAL
INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Fair Value of Financial
Instruments </FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>The following table summarizes
the fair value of the Company&#146;s assets and liabilities for which disclosure of
fair value is required: </FONT><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom style="line-height: normal">
    <TD noWrap align=left width="80%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="3%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="6%" colSpan=5><B><FONT face="Times New Roman" size=2 >9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="6%" colSpan=5><B><FONT face="Times New Roman" size=2 >6/30/2016</FONT></B></TD></TR>

  <TR vAlign=bottom style="line-height: normal">
    <TD noWrap align=left width="80%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="1%"><B><FONT face="Times New Roman" size=2 >Balance sheet</FONT></B><BR>
<B><FONT face="Times New Roman" size=2 >classification</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%"><B><FONT face="Times New Roman" size=2 >Fair value<BR>
hierarchy<BR>
level</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2 >Carrying<BR>
Amount</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=2 >Estimated<BR>
Fair<BR>
Value</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2 >Carrying<BR>
Amount</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=2 >Estimated<BR>
Fair<BR>
Value</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"><B><FONT face="Times New Roman" size=2 >Assets</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 3%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%"><FONT face="Times New Roman" size=2 >Investments
      including money market</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"><FONT face="Times New Roman" size=2 >Cash and cash</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 3%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 2%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 2%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%"><FONT face="Times New Roman" size=2 >funds</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"><FONT face="Times New Roman" size=2 >equivalents </FONT><FONT face="Times New Roman" size=2 ><SUP>(a)</SUP></FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >253</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >253</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >234</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >234</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"><FONT size=2 face="Times New Roman">Time
      deposits</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"><FONT size=2 face="Times New Roman">Cash
      and cash</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 3%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"><FONT size=2 face="Times New Roman">equivalents <FONT face="Times New Roman" ><SUP>(a)</SUP></FONT></FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%; background-color: Silver"><FONT face="Times New Roman" size=2 >2</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"><FONT face="Times New Roman" size=2 >76</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"><FONT face="Times New Roman" size=2 >76</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"><FONT face="Times New Roman" size=2 >79</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"><FONT face="Times New Roman" size=2 >79</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%"><FONT face="Times New Roman" size=2 >Commodity
      purchase derivative contracts</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"><FONT face="Times New Roman" size=2 >Other current assets</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >1</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"><FONT face="Times New Roman" size=2 >Foreign
      exchange derivative contracts</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"><FONT face="Times New Roman" size=2 >Other
      current assets</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%; background-color: Silver"><FONT face="Times New Roman" size=2 >2</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"><FONT face="Times New Roman" size=2 >1</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%"><FONT face="Times New Roman" size=2 >Commodity
      purchase derivative contracts</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"><FONT face="Times New Roman" size=2 >Other assets</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%"><FONT face="Times New Roman" size=2 >2</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >1</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"><FONT face="Times New Roman" size=2 >Trust assets
      for nonqualified deferred</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"><FONT face="Times New Roman" size=2 >Other
      assets</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"><FONT face="Times New Roman" size=2 >compensation
      plans</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 3%; text-align: center; background-color: Silver"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 2%; background-color: Silver"><FONT size=2 face="Times New Roman">62</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 1%; background-color: Silver"><FONT size=2 face="Times New Roman">62</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 2%; background-color: Silver"><FONT size=2 face="Times New Roman">52</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 1%; background-color: Silver"><FONT size=2 face="Times New Roman">52</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%">&nbsp;</TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 3%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >394</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >394</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >368</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >368</FONT></TD></TR>
  <TR>
    <TD COLSPAN="17" STYLE="width: 100%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"><B><FONT face="Times New Roman" size=2 >Liabilities</FONT></B></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 3%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%"><FONT size=2 face="Times New Roman">Notes and loans payable</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT size=2 face="Times New Roman">Notes and loans payable <SUP>(b)</SUP></FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%"><FONT face="Times New Roman" size=2 >2</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >618</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >618</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >523</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >523</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"><FONT size=2 face="Times New Roman">Commodity purchase derivative contracts</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"><FONT size=2 face="Times New Roman">Accounts payable and</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"><FONT size=2 face="Times New Roman">accrued
      liabilities</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%; background-color: Silver"><FONT face="Times New Roman" size=2 >2</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"><FONT face="Times New Roman" size=2 >1</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"><FONT face="Times New Roman" size=2 >1</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="text-align: left; width: 80%"><FONT size=2 face="Times New Roman">Foreign exchange derivative
    contracts</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"><FONT size=2 face="Times New Roman">Accounts payable and</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"><FONT size=2 face="Times New Roman">accrued liabilities</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%"><FONT face="Times New Roman" size=2 >2</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >2</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >2</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >4</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >4</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"><FONT face="Times New Roman" size=2 >Current
      maturities of long-term debt</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"><FONT face="Times New Roman" size=2 >Current
      maturities of long-</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 3%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"><FONT face="Times New Roman" size=2 >and
      Long-term debt</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"><FONT face="Times New Roman" size=2 >term debt
      and Long-term</FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 2%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"><FONT face="Times New Roman" size=2 >debt
      </FONT><FONT face="Times New Roman" size=2 ><SUP>(c)</SUP></FONT></TD>
    <TD NOWRAP STYLE="text-align: center; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="text-align: center; width: 3%; background-color: Silver"><FONT size=2 face="Times New Roman">2</FONT></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: left; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 2%; background-color: Silver"><FONT size=2 face="Times New Roman">1,789</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 1%; background-color: Silver"><FONT size=2 face="Times New Roman">1,911</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 2%; background-color: Silver"><FONT size=2 face="Times New Roman">1,789</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 1%; background-color: Silver"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: right; width: 1%; background-color: Silver"><FONT size=2 face="Times New Roman">1,922</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 80%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 3%"></TD>
    <TD NOWRAP STYLE="text-align: left; width: 1%"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >2,410</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >2,532</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: right; width: 2%"><FONT face="Times New Roman" size=2 >2,317</FONT></TD>
    <TD NOWRAP STYLE="text-align: right; width: 1%"></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: left; width: 1%"><FONT face="Times New Roman" size=2 >$</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 2pt double; text-align: right; width: 1%"><FONT face="Times New Roman" size=2 >2,450</FONT></TD></TR></TABLE>
<DIV>____________________</DIV><BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(a)</FONT></TD>
    <TD vAlign=top noWrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Cash and cash
      equivalents are composed of time deposits and other interest bearing
      investments including money market funds with original maturity dates of
      90 days or less. Cash and cash equivalents are recorded at cost, which
      approximates fair value.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(b)</FONT></TD>
    <TD vAlign=top noWrap></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Notes and loans
      payable is composed of U.S. commercial paper and/or other similar
      short-term debts issued by non-U.S. subsidiaries, all of which are
      recorded at cost, which approximates fair value.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(c)</FONT></TD>
    <TD vAlign=top noWrap></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Current maturities of
      long-term debt and Long-term debt are recorded at cost. The fair value of
      Long-term debt, including current maturities, is determined using
      secondary market prices quoted by corporate bond dealers, and is
      classified as Level 2.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>10</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">


<!-- PAT 02-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 5. FINANCIAL
INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Continued) </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Derivatives</FONT></I></B><FONT face="Times New Roman" size=2>
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company designates its
commodity forward and future contracts for forecasted purchases of raw
materials, interest rate forward contracts for forecasted interest payments, and
foreign currency forward contracts for forecasted purchases of inventory as cash
flow hedges. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The effects of derivative
instruments designated as hedging instruments on Comprehensive income and Net
earnings were as follows: </FONT><FONT face="Times New Roman" size=2></FONT></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=7><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD></TR>
  <TR style="line-height:normal" vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=7><B><FONT face="Times New Roman" size=2>Gains (losses) recognized
      in<BR>Other comprehensive income</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><STRONG><FONT size=2 face="Times New Roman">9/30/2016</FONT></STRONG></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><STRONG><FONT size=2 face="Times New Roman">9/30/2015</FONT></STRONG></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Commodity
      purchase derivative contracts</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(7</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Interest
      rate derivative contracts</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Foreign
      exchange derivative contracts</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=9>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=7><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD></TR>
  <TR style="line-height:normal" vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=7><B><FONT face="Times New Roman" size=2>Gains (losses) reclassified
      from<BR>Accumulated other comprehensive loss and<BR>recognized in Net
      earnings</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><STRONG><FONT size=2 face="Times New Roman">9/30/2016</FONT></STRONG></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><STRONG><FONT size=2 face="Times New Roman">9/30/2015</FONT></STRONG></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Commodity
      purchase derivative contracts</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Interest
      rate derivative contracts</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Foreign
      exchange derivative contracts</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"></TD></TR></TABLE></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>The gains (losses)
reclassified from Accumulated other comprehensive losses and recognized in Net
earnings during the three months ended September 30, 2016 and 2015, for
commodity purchase and foreign exchange contracts were included in Cost of
products sold, and for interest rate contracts were included in Interest
expense. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The estimated amount of the
existing net gain (loss) in Accumulated other comprehensive losses as of
September 30, 2016, that is expected to be reclassified into Net earnings within
the next twelve months is $8. Gains and losses on derivative instruments
representing either hedge ineffectiveness or hedge components excluded from the
assessment of effectiveness are recognized in Net earnings. During the three
months ended September 30, 2016 and 2015, hedge ineffectiveness was not
significant.</FONT><B><FONT face="Times New Roman" size=2> </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 6. INCOME
TAXES</FONT></B></P>
<P align=left><FONT face="Times New Roman" size=2>In determining its quarterly
provision for income taxes, the Company uses an estimated annual effective tax
rate, which is based on expected annual income, statutory tax rates and tax
planning opportunities available in the various jurisdictions in which the
Company operates. Certain significant or unusual items are separately recognized
in the quarter in which they occur and can be a source of variability in the
effective tax rates from quarter to quarter. The effective tax rate on earnings
from continuing operations was 32.0% for the three months ended September 30,
2016, and 34.5% for the three months ended September 30, 2015. This decrease was
primarily due to the recognition of excess tax benefits from share-based
compensation upon the adoption of ASU No. 2016-09 in the first quarter of fiscal
year 2017. Refer to Note 1 for further details.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>11</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><B><FONT face="Times New Roman" size=2>NOTE 7. NET EARNINGS PER
SHARE (EPS)</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The following is a
reconciliation of the weighted average number of shares outstanding (in
thousands) used to calculate basic net EPS to those used to calculate diluted
net EPS: </FONT><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=3><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=right width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%"><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%"><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Basic</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>129,449</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>129,155</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Dilutive
      effect of stock options and other</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2,744</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2,065</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Diluted</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>132,193</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>131,220</FONT></TD></TR>
  <TR>
    <TD width="100%" bgColor=#c0c0c0 colSpan=5>&nbsp;&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Antidilutive
      stock options and other</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1,271</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The Company has two share
repurchase programs: an open-market purchase program with an authorized
aggregate purchase amount of up to $750, all of which was available for share
repurchases as of September 30, 2016, and a program to offset the anticipated
impact of share dilution related to share-based awards (the Evergreen Program),
which has no authorization limit as to amount or timing of
repurchases.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Share repurchases under
authorized programs were as follows during the three months ended September 30:
</FONT></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="17%" colSpan=9><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="8%" colSpan=4><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="8%" colSpan=4><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD></TR>
  <TR style="line-height:normal" vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=2>Amount</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%"><B><FONT face="Times New Roman" size=2>Shares<BR>(in
      000's)</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=2><B><FONT face="Times New Roman" size=2>Amount</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%"><B><FONT face="Times New Roman" size=2>Shares<BR>(in
      000's)</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Open-market
      purchase programs</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Evergreen
      Program</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>113</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>883</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>112</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>1,006</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>113</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>883</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>112</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,006</FONT></TD></TR></TABLE></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 8. COMPREHENSIVE
INCOME </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Comprehensive income was as
follows for the periods indicated: </FONT><FONT face="Times New Roman" size=2></FONT></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=7><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Earnings
      from continuing operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>179</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>173</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Earnings
      (losses) from discontinued operations, net of tax</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net
      earnings</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>179</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>172</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Other
      comprehensive income (loss), net of tax:</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency
      translation adjustments</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(43</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net unrealized gains
      (losses) on derivatives</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and postretirement
      benefit adjustments</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Total other
      comprehensive income (loss), net of tax</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>(39</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Comprehensive income</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>182</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>133</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE></DIV><BR>
<P align=center><FONT face="Times New Roman" size=2>12</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><B><FONT face="Times New Roman" size=2>NOTE 8. COMPREHENSIVE
INCOME (Continued)</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Changes in Accumulated other
comprehensive net (losses) income by component were as follows for the three
months ended September 30:</FONT><FONT face="Times New Roman" size=2>
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="line-height:normal" vAlign=bottom>
    <TD noWrap align=left width="80%"></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=2>Foreign<BR>currency<BR>translation<BR>adjustments</FONT></B></TD>
    <TD style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=2>Net unrealized<BR>gains
      (losses) on<BR>derivatives</FONT></B></TD>
    <TD style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=2>Pension
      and<BR>postretirement<BR>benefit<BR>adjustments</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=2>Accumulated<BR>other<BR>comprehensive<BR>(losses)
      income</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>Balance as of June 30,
      2015</FONT></B></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(300</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(53</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(149</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(502</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive (loss)
      income before</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;reclassifications</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(41</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(41</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from
      accumulated other</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;comprehensive net
      losses</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit
      (expense)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net current
      period other comprehensive income (loss)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(43</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(39</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"><B><FONT face="Times New Roman" size=2>Balance as of September 30, 2015</FONT></B></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(343</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(50</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(148</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(541</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=17>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%" bgColor=#c0c0c0><B><FONT face="Times New Roman" size=2>Balance as of June 30,
      2016</FONT></B></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(353</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(44</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(173</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(570</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive (loss)
      income before</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;reclassifications</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from
      accumulated other</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;comprehensive net
      losses</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>6</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit
      (expense)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net current
      period other comprehensive income (loss)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"><B><FONT face="Times New Roman" size=2>Balance as of September 30, 2016</FONT></B></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(354</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(41</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(172</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>(567</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>Included in foreign currency
translation adjustments are re-measurement losses on long-term intercompany
loans where settlement is not planned or anticipated in the foreseeable future.
For the three months ended September 30, 2016 and 2015, Other comprehensive
income (loss) on these loans totaled $0 and $(5), respectively, and there were
no amounts reclassified from Accumulated other comprehensive net (losses)
income. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTE 9. EMPLOYEE BENEFIT
PLANS </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The following table summarizes
the components of net periodic benefit cost for the Company&#146;s retirement income
plans: </FONT><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=7><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Service
      cost</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Interest
      cost</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>5</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>7</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Expected
      return on plan assets</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(5</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%"><FONT face="Times New Roman" size=2>Amortization
      of unrecognized items</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="1%"><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="92%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>5</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>The net periodic benefit cost
for the Company&#146;s retirement health care plans was $0 for each of the three
months ended September 30, 2016 and 2015.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>During the three months ended
September 30, 2016, the Company made $15 in discretionary contributions to the
domestic qualified retirement income plan.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>13</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><B><FONT face="Times New Roman" size=2>NOTE 10. OTHER
CONTINGENCIES AND GUARANTEES</FONT></B><FONT face="Times New Roman" size=2>
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Contingencies</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is involved in
certain environmental matters, including response actions at various locations.
The Company had a recorded liability of $13 and $14 as of September 30, 2016 and
June 30, 2016, respectively, for its share of aggregate future remediation costs
related to these matters. One matter in Dickinson County, Michigan, for which
the Company is jointly and severally liable, accounted for a substantial
majority of the recorded liability as of both September 30, 2016 and June 30,
2016. The Company has agreed to be liable for 24.3% of the aggregate remediation
and associated costs for this matter pursuant to a cost-sharing arrangement with
a third party. With the assistance of environmental consultants, the Company
maintains an undiscounted liability representing its current best estimate of
its share of the capital expenditures, maintenance and other costs that may be
incurred over an estimated 30-year remediation period. Currently, the Company
cannot accurately predict the timing of future payments that may be made under
this obligation. In addition, the Company&#146;s estimated loss exposure is sensitive
to a variety of uncertain factors, including the efficacy of remediation
efforts, changes in remediation requirements and the future availability of
alternative clean-up technologies. Although it is reasonably possible that the
Company&#146;s exposure may exceed the amount recorded, any amount of such additional
exposures, or range of exposures, is not estimable at this time. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is subject to
various legal proceedings, claims and other loss contingencies, including,
without limitation, loss contingencies relating to contractual arrangements,
product liability, patents and trademarks, advertising, labor and employment,
environmental, health and safety and other matters. With respect to these
proceedings, claims and other loss contingencies, while considerable uncertainty
exists, in the opinion of management at this time, the ultimate disposition of
these matters, to the extent not previously provided for, will not have a
material adverse effect, either individually or in the aggregate, on the
Company&#146;s condensed consolidated financial statements taken as a whole.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Guarantees </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In conjunction with
divestitures and other transactions, the Company may provide typical
indemnifications (e.g., indemnifications for representations and warranties and
retention of previously existing environmental, tax and employee liabilities)
that have terms that vary in duration and in the potential amount of the total
obligation and, in many circumstances, are not explicitly defined. The Company
has not made, nor does it believe that it is probable that it will make, any
material payments relating to its indemnifications, and believes that any
reasonably possible payments would not have a material adverse effect, either
individually or in the aggregate, on the Company&#146;s condensed consolidated
financial statements taken as a whole.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company had not recorded
any liabilities on the aforementioned guarantees as of September 30, 2016.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of September 30, 2016, the
Company was a party to letters of credit of $10 primarily related to one of its
insurance carriers, of which $0 had been drawn upon. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>14</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><B><FONT face="Times New Roman" size=2>NOTE 11. SEGMENT
RESULTS</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company operates through
strategic business units that are aggregated into four reportable segments based
on the economics and nature of the products sold: Cleaning, Household, Lifestyle
and International. As a result of Clorox Venezuela being reported as
discontinued operations, the results of Clorox Venezuela are no longer included
in the International reportable segment.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Certain non-allocated
administrative costs, interest income, interest expense and various other
non-operating income and expenses are reflected in Corporate. Corporate assets
include cash and cash equivalents, other current assets, property and equipment,
other investments and deferred taxes.</FONT><B><FONT face="Times New Roman" size=2> </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The table below presents
reportable segment information and a reconciliation of the segment information
to the Company&#146;s consolidated net sales and earnings from continuing operations
before income taxes, with amounts that are not allocated to the reportable
segments reflected in Corporate.</FONT><FONT face="Times New Roman" size=2>
</FONT></P>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR style="line-height:normal" vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=5><B><FONT face="Times New Roman" size=2>Net sales</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=7><B><FONT face="Times New Roman" size=2>Earnings (losses) from
      continuing<BR>operations before income taxes</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=5><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="9%" colSpan=7><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="4%" colSpan=3><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Cleaning</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>534</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>497</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>164</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap style="text-align: center" width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>149</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Household</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>422</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>411</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>69</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>82</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Lifestyle</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>236</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>231</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>62</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>59</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>International</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>251</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>251</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>27</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>32</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Corporate</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(58</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(58</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="82%"><FONT face="Times New Roman" size=2>Total</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>1,443</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>1,390</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>264</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%"><FONT face="Times New Roman" size=2>264</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD></TR></TABLE><BR>
<P align=left><FONT face="Times New Roman" size=2>All intersegment sales are
eliminated and are not included in the Company&#146;s reportable segments&#146; net
sales.</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Net sales to the Company&#146;s
largest customer, Wal-Mart Stores, Inc. and its affiliates, as a percentage of
consolidated net sales, were 26% and 27% for the three months ended September
30, 2016 and 2015, respectively. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>15</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P style="margin-bottom:-4pt" align=left><B><FONT face="Times New Roman" size=2>Item 2. Management&#146;s
Discussion and Analysis of Financial Condition and Results of Operations
</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P style="margin-bottom:-4pt" align=center><FONT face="Times New Roman" size=2>The Clorox
Company<BR></FONT><FONT face="Times New Roman" size=2>(Dollars in millions,
except share and per share data) </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P style="margin-bottom:-4pt" align=left><FONT face="Times New Roman" size=2>Management&#146;s Discussion and
Analysis of Financial Condition and Results of Operations (MD&amp;A) is designed
to provide a reader of The Clorox Company&#146;s (the Company or Clorox) financial
statements with a narrative from the perspective of management on the Company&#146;s
financial condition, results of operations, liquidity and certain other factors
that may affect future results. The following discussion of the Company&#146;s
financial condition and results of operations should be read in conjunction with
MD&amp;A and the consolidated financial statements and related notes included in
the Company&#146;s Annual Report on Form 10-K for the fiscal year ended June 30,
2016, which was filed with the Securities and Exchange Commission (SEC) on
August 16, 2016, and the unaudited condensed consolidated financial statements
and related notes contained in this Quarterly Report on Form 10-Q (this Report).
Unless otherwise noted, MD&amp;A compares the three-month period ended September
30, 2016 (the current period) to the three-month period ended September 30, 2015
(the prior period), with percentage and basis point calculations based on
rounded numbers, except for per share data and the effective tax rate.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P style="margin-bottom:-4pt" align=left><FONT face="Times New Roman" size=2>Effective September 22, 2014,
the Company&#146;s Venezuela affiliate, Corporaci&#243;n Clorox de Venezuela S.A. (Clorox
Venezuela), discontinued its operations. Consequently, for all periods presented
herein, Clorox Venezuela is reflected as a discontinued operation. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P style="margin-bottom:-4pt" align=left><B><FONT face="Times New Roman" size=2>OVERVIEW </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P style="margin-bottom:-4pt" align=left><FONT face="Times New Roman" size=2>Clorox is a leading
multinational manufacturer and marketer of consumer and professional products
with approximately 8,000 employees worldwide. Clorox sells its products
primarily through grocery and mass retail outlets, e-commerce channels,
wholesale distributors and medical supply distributors. Clorox markets some of
the most trusted and recognized consumer brand names, including its namesake
bleach and cleaning products, Pine-Sol<SUP>&#174;</SUP> cleaners,
Liquid-Plumr<SUP>&#174;</SUP> clog removers, Poett<SUP>&#174;</SUP> home care products,
Fresh Step<SUP>&#174;</SUP> cat litter, Glad<SUP>&#174;</SUP> bags, wraps and container
products, Kingsford<SUP>&#174;</SUP> charcoal, RenewLife<SUP>&#174;</SUP> digestive health
products, Hidden Valley<SUP>&#174;</SUP> dressings and sauces, Brita<SUP>&#174;</SUP>
water-filtration products and Burt&#146;s Bees<SUP>&#174;</SUP> natural personal care
products. The Company also markets brands through professional services
channels, including infection control products for the healthcare industry under
Clorox Healthcare<SUP>&#174;</SUP>, HealthLink<SUP>&#174;</SUP>, Aplicare<SUP>&#174;</SUP>, and
Dispatch<SUP>&#174;</SUP> brands. The Company manufactures products in more than a
dozen countries and sells them in more than 100 markets. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P style="margin-bottom:-4pt" align=left><FONT face="Times New Roman" size=2>The Company primarily markets
its leading brands in midsized categories considered to be financially
attractive. Most of the Company&#146;s products compete with other nationally
advertised brands within each category and with &#147;private label&#148; brands.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P  align=left><FONT face="Times New Roman" size=2>The Company operates through
strategic business units that are aggregated into the following four reportable
segments based on the economics and nature of the products sold: </FONT><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD STYLE="padding-right: 8pt; padding-left: 15pt; vertical-align: top; width: 1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 99%">
      <P align=left><I><FONT face="Times New Roman" size=2>Cleaning</FONT></I><FONT face="Times New Roman" size=2> consists of
      laundry, home care and professional products marketed and sold in the
      United States. Products within this segment include laundry additives,
      including bleach products under the Clorox<SUP>&#174;</SUP> brand and Clorox
      2<SUP>&#174;</SUP> stain fighter and color booster; home care products,
      primarily under the Clorox<SUP>&#174;</SUP>, Formula 409<SUP>&#174;</SUP>,
      Liquid-Plumr<SUP>&#174;</SUP>, Pine-Sol<SUP>&#174;</SUP>, S.O.S<SUP>&#174;</SUP> and
      Tilex<SUP>&#174;</SUP> brands; naturally derived products under the Green
      Works<SUP>&#174;</SUP> brand; and professional cleaning and disinfecting
      products under the Clorox<SUP>&#174;</SUP>, Dispatch<SUP>&#174;</SUP>,
      Aplicare<SUP>&#174;</SUP>, HealthLink<SUP>&#174;</SUP> and Clorox
      Healthcare<SUP>&#174;</SUP> brands.</FONT></P></TD></TR>
  <TR>
    <TD STYLE="padding-right: 8pt; padding-left: 15pt; vertical-align: top; width: 1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 99%">
      <P align=left><I><FONT face="Times New Roman" size=2>Household</FONT></I><FONT face="Times New Roman" size=2> consists
      of charcoal, cat litter, digestive health products and bags, wraps and
      container products marketed and sold in the United States. Products within
      this segment include charcoal products under the Kingsford<SUP>&#174;</SUP> and
      Match Light<SUP>&#174;</SUP> brands; cat litter products under the Fresh
      Step<SUP>&#174;</SUP>, Scoop Away<SUP>&#174;</SUP> and Ever Clean<SUP>&#174;</SUP>
      brands; digestive health products under the RenewLife<SUP>&#174;</SUP> brand;
      and bags, wraps and containers under the Glad<SUP>&#174;</SUP>
      brand.</FONT></P></TD></TR>
  <TR>
    <TD STYLE="padding-right: 8pt; padding-left: 15pt; vertical-align: top; width: 1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 99%">
      <P align=left><I><FONT face="Times New Roman" size=2>Lifestyle</FONT></I><FONT face="Times New Roman" size=2> consists
      of food products, water-filtration systems and filters and natural
      personal care products marketed and sold in the United States. Products
      within this segment include dressings and sauces, primarily under the
      Hidden Valley<SUP>&#174;</SUP>, KC Masterpiece<SUP>&#174;</SUP> and Soy
      Vay<SUP>&#174;</SUP> brands; water-filtration systems and filters under the
      Brita<SUP>&#174;</SUP> brand; and natural personal care products under the
      Burt&#146;s Bees<SUP>&#174;</SUP> brand.</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><I><FONT face="Times New Roman" size=2>International</FONT></I><FONT face="Times New Roman" size=2>
      consists of products sold outside the United States. This segment includes
      laundry, home care, water-filtration, digestive health products, charcoal
      and cat litter products, dressings and sauces, bags, wraps and containers
      and natural personal care products, primarily under the
      Clorox<SUP>&#174;</SUP>, Glad<SUP>&#174;</SUP>, PinoLuz<SUP>&#174;</SUP>,
      Ayudin<SUP>&#174;</SUP>, Limpido<SUP>&#174;</SUP>, Clorinda<SUP>&#174;</SUP>,
      Poett<SUP>&#174;</SUP>, Mistolin<SUP>&#174;</SUP>, Lestoil<SUP>&#174;</SUP>, Bon
      Bril<SUP>&#174;</SUP>, Brita<SUP>&#174;</SUP>, Green Works<SUP>&#174;</SUP>,
      Pine-Sol<SUP>&#174;</SUP>, Agua Jane<SUP>&#174;</SUP>, Chux<SUP>&#174;</SUP>,
      RenewLife<SUP>&#174;</SUP>, Kingsford<SUP>&#174;</SUP>, Fresh Step<SUP>&#174;</SUP>,
      Scoop Away<SUP>&#174;</SUP>, Ever Clean<SUP>&#174;</SUP>, KC
      Masterpiece<SUP>&#174;</SUP>, Hidden Valley<SUP>&#174;</SUP> and Burt&#146;s
      Bees<SUP>&#174;</SUP> brands.</FONT></P></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>16</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><B><FONT face="Times New Roman" size=2>RESULTS OF
OPERATIONS</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>CONSOLIDATED RESULTS
FROM CONTINUING OPERATIONS </FONT></I></B><FONT face="Times New Roman" size=2></FONT></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="79%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=5><B><FONT face="Times New Roman" size=2>Three Months
      Ended</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="3%" colSpan=2></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=5><B><FONT face="Times New Roman" size=2>% of Net
    Sales</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="79%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>% Change</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="79%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Diluted net earnings per share</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="79%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;from continuing
      operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1.36</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1.32</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2>%</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="2%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="79%"><FONT face="Times New Roman" size=2>Net
      sales</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>1,443</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>1,390</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>%</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100</FONT></TD>
    <TD noWrap align=right width="1%"><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="79%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Gross profit</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>640</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>625</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>44.4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>45.0</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="79%"><FONT face="Times New Roman" size=2>Selling and administrative expenses</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>200</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>186</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>8</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>13.9</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>13.4</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="79%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Advertising costs</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>128</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>123</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8.9</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>8.8</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="79%"><FONT face="Times New Roman" size=2>Research and development costs</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>31</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>30</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>2.1</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>2.2</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="79%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Interest expense</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>22</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>23</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1.5</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1.7</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD></TR></TABLE>
</DIV><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Diluted net earnings per
share from continuing operations</FONT></I></B><FONT face="Times New Roman" size=2> increased $0.04, or 3%, in the current period. Diluted net earnings per
share increased primarily due to higher net sales and cost savings, partially
offset by increased manufacturing and logistics costs and unfavorable foreign
currency exchange rates. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Net
sales</FONT></I></B><FONT face="Times New Roman" size=2> in the current <FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">period</font>
increased 4%. Volume increased 8% reflecting higher shipments in all reportable
segments, including the benefit from the acquisition of RenewLife. Volume
outpaced net sales primarily due to unfavorable product mix and foreign currency
exchange rates, partially offset by the benefit of price increases.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Gross
margin</FONT></I></B><I><FONT face="Times New Roman" size=2>,</FONT></I><FONT face="Times New Roman" size=2> defined as gross profit as a percentage of net
sales, decreased 60 basis points in the current period. The decrease was driven
by higher manufacturing and logistics costs and unfavorable product mix and
foreign currency exchange rates, partially offset by strong cost savings,
favorable commodity costs and the benefit of price increases.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Selling and
administrative expenses, </FONT></I></B><FONT face="Times New Roman" size=2>as a
percentage of net sales, increased 50 basis points in the current period,
primarily due to the impact of RenewLife and increased performance-based
compensation costs. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Advertising
costs</FONT></I></B><FONT face="Times New Roman" size=2>, as a percentage of net
sales, remained essentially flat in the current period. The Company&#146;s U.S.
retail advertising spend in the current period and prior period was
approximately 10% of net sales.</FONT><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Research and development
costs</FONT></I></B><B><FONT face="Times New Roman" size=2> </FONT></B><FONT face="Times New Roman" size=2>remained essentially flat in the current period,
reflecting the Company&#146;s continued support of its new products and established
brands with an emphasis on innovation. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Interest
expense</FONT></I></B><FONT face="Times New Roman" size=2> remained essentially
flat in the current period. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>The effective tax rate
on earnings from continuing operations</FONT></I></B><FONT face="Times New Roman" size=2> was 32.0% and 34.5% for the current and prior
period, respectively. This decrease was primarily due to the recognition of
excess tax benefits from share-based compensation upon the adoption of
Accounting Standards Update No. 2016-09 in the first quarter of fiscal year
2017. See Notes to the Condensed Consolidated Financial Statements for more
information. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>DISCONTINUED OPERATIONS
</FONT></I></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Since the exit of Clorox
Venezuela in the first quarter of fiscal year 2015, the Company has recognized
$49 in after-tax exit costs and other related expenses within discontinued
operations related to the exit of Clorox Venezuela. The Company believes it is
reasonably possible that it will recognize an additional $1 to $11 in after-tax
exit costs and other related expenses within discontinued operations related to
the exit of Clorox Venezuela during the remainder of fiscal year 2017 and fiscal
years 2018 through 2019, for a total of $50 to $60 over the entire five-year
period. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>See Notes to the Condensed
Consolidated Financial Statements for more information regarding discontinued
operations of Clorox Venezuela. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>17</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><B><I><FONT face="Times New Roman" size=2>SEGMENT RESULTS FROM
CONTINUING OPERATIONS</FONT></I></B><I><FONT face="Times New Roman" size=2>
</FONT></I><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The following sections present
the results from operations of the Company&#146;s reportable segments and certain
unallocated costs reflected in Corporate: </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Cleaning
</FONT></I></B><FONT face="Times New Roman" size=2></FONT></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=5><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="3%" colSpan=2></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>% Change</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net
      sales</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>534</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>497</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>7</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Earnings
      from continuing operations before income taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>164</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>149</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR></TABLE></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>Volume, net sales and earnings
from continuing operations before income taxes increased by 13%, 7% and 10%,
respectively, in the current period. Both volume and net sales growth were
driven mainly by higher shipments across several Clorox<SUP>&#174;</SUP> branded
products within Home Care, primarily Clorox<SUP>&#174;</SUP> disinfecting wipes
resulting from expanded club-channel distribution and increased merchandising
support, and in Professional Products across cleaning products. Volume outpaced
net sales due to unfavorable product mix. The increase in earnings from
continuing operations before income taxes was mainly due to net sales growth and
strong cost savings. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Household
</FONT></I></B><FONT face="Times New Roman" size=2></FONT></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD NOWRAP ALIGN="LEFT" WIDTH="7%" COLSPAN="5" STYLE="border-bottom: #000000 1pt solid; text-align: center"><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%" colSpan=2></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>% Change</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net
      sales</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>422</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>411</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>3</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Earnings
      from continuing operations before income taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>69</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>82</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>Volume and net sales increased
by 6% and 3%, respectively, while earnings from continuing operations before
income taxes decreased 16% in the current period. Both volume growth and net
sales growth were driven by the acquisition of RenewLife, partially offset by
lower shipments of Charcoal. Volume outpaced net sales, primarily due to higher
trade promotion spending. The decrease in earnings from continuing operations
before income taxes was mainly due to lower volume in Charcoal, higher trade
promotion <FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">spending and</font> higher manufacturing and
logistics costs, partially offset by the benefit of favorable commodity costs.
</FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Lifestyle&nbsp;</FONT></I></B></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=5><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="3%" colSpan=2></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>% Change</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net
      sales</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>236</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>231</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>2</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Earnings
      from continuing operations before income taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>62</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>59</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5</FONT></TD>
    <TD noWrap align=left width="1%"></TD></TR></TABLE></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>Volume, net sales, and
earnings from continuing operations before income taxes increased by 1%, 2% and
5%, respectively, in the current period. Both volume growth and net sales growth
were primarily driven by higher shipments in the Burt&#146;s Bees Natural Personal
Care business largely due to innovation in lip color. Net sales growth outpaced
volume, primarily due to decreased trade promotion spending. The increase in
earnings from continuing operations before income taxes was primarily due to net
sales growth, cost savings and favorable commodity costs, partially offset by
higher manufacturing and logistics costs. </FONT></P>

<P align=center><FONT face="Times New Roman" size=2>18</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>International
</FONT></I></B><FONT face="Times New Roman" size=2></FONT></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=5><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="3%" colSpan=2></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=2><B><FONT face="Times New Roman" size=2>% Change</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Net
      sales</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>251</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>251</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">%</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="88%"><FONT face="Times New Roman" size=2>Earnings
      from continuing operations before income taxes</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>27</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>32</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(16</FONT></TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>)</FONT></TD></TR></TABLE></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>Volume increased 4%, net sales
were flat and earnings from continuing operations before income taxes decreased
by 16% in the current period. Volume grew due to higher shipments, mainly in
Canada, which included the benefit from the RenewLife acquisition and in the
Burt&#146;s Bees<SUP> </SUP></FONT><FONT face="Times New Roman" size=2>Natural
Personal Care Asia business, partially offset by lower shipments in certain
Latin American countries, including Argentina. Volume outpaced net sales due to
unfavorable foreign exchange rates, partially offset by the benefit of price
increases. The decrease in earnings from continuing operations before income
taxes was primarily due to unfavorable foreign currency exchange rates,
inflationary pressure on manufacturing and logistics costs, partially offset by
the benefit of price increases. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Argentina </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company operates in
Argentina through certain wholly owned subsidiaries (collectively, &#147;Clorox
Argentina&#148;). Net sales from Clorox Argentina represented approximately 3% of the
Company&#146;s consolidated net sales for each of the three months ended September
30, 2016 and the <FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">fiscal</font> year ended June 30, 2016. The operating environment in
Argentina continues to present business challenges, including significant
devaluing of Argentina&#146;s currency and inflation.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Clorox Argentina manufactures
products at three plants that it owns and operates across Argentina and markets
those products to consumers throughout the country. Products are advertised
nationally and sold to consumers through wholesalers and retail outlets located
throughout Argentina. Sales are made primarily through the use of Clorox
Argentina&#146;s sales force. Small amounts of products produced in Argentina are
exported each year, including sales to the Company&#146;s other subsidiaries located
primarily in Latin America. Clorox Argentina obtains its raw materials almost
entirely from local sources. The Company also conducts research and development
activities at its owned facility in Buenos Aires, Argentina. Additionally,
Clorox Argentina performs marketing, legal, and various other shared service
activities to support the Company&#146;s Latin American operations. Clorox Argentina
in turn benefits from shared service activities performed within other
geographic locations, such as information technology support and manufacturing
technical assistance. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>For the three months ended
September 30, 2016 and the year ended June 30, 2016, the value of the Argentine
peso (ARS) declined 3% and 39%, respectively. As of September 30, 2016, using
the exchange rate of 15.4 ARS per USD, Clorox Argentina had total assets of $74,
including cash and cash equivalents of $10, net receivables of $19, inventories
of $19, net property, plant and equipment of $17 and intangible assets excluding
goodwill of $3. Although Argentina is not currently designated as a highly
inflationary economy for accounting purposes, further volatility and declines in
the exchange rate are expected in the future, which would have an additional
adverse impact on Clorox Argentina&#146;s net sales, net earnings, and net monetary
asset position. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company is closely
monitoring developments in Argentina and is taking steps intended to mitigate
the adverse conditions, but there can be no assurances that the Company will be
able to mitigate these conditions. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Corporate</FONT></I></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Certain non-allocated
administrative costs, interest income, interest expense and various other
non-operating income and expenses are reflected in Corporate. Corporate assets
include cash and cash equivalents, other current assets, property and equipment,
other investments and deferred taxes. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="7%" colSpan=7><B><FONT face="Times New Roman" size=2>Three Months
    Ended</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="2%" colSpan=2></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="3%" colSpan=3><B><FONT face="Times New Roman" size=2>9/30/2015</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=center width="2%" colSpan=2><B><FONT face="Times New Roman" size=2>% Change</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="89%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Losses from
      continuing operations before income taxes</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(58</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>(58</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>)</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT size=2 face="Times New Roman">%</FONT></TD></TR></TABLE></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>There was no significant
change in losses from continuing operations before income taxes in the current
period.</FONT></P>
<P align=center><FONT face="Times New Roman" size=2>19</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><B><FONT face="Times New Roman" size=2>FINANCIAL POSITION AND
LIQUIDITY </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Operating
Activities</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s financial
condition and liquidity remained strong as of September 30, 2016. Net cash
provided by continuing operations was $170 in the current period, compared with
$135 in the prior period. The year-over-year increase was primarily related to
higher tax payments in the prior period.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Investing Activities
</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Capital expenditures were $59
in the current period, compared with $28 in the prior period. Capital spending
as a percentage of net sales was approximately 4% and 2% in the three months
ended September 30, 2016 and 2015, respectively. The year-over-year increase was
due to additional capital spending for manufacturing efficiencies and
information technology infrastructure in the current period. Prior period
investing activities also included proceeds from the sale of the Company&#146;s
corporate jet. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Financing Activities
</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Net cash used for financing
activities was $104 in the current period, compared with $120 in the prior
period. The change was primarily due to an increase in cash sourced from notes
and loan payable borrowings, partially offset by a decline in proceeds from the
issuance of stock for employee stock plans. </FONT></P>
<P align=left><B><I><FONT face="Times New Roman" size=2>Credit
Arrangements</FONT></I></B><B><FONT face="Times New Roman" size=2>
</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>As of September 30, 2016, the
Company had a $1,100 revolving credit agreement (the Credit Agreement) that
expires in October 2019. As of September 30, 2016, there were no borrowings
under the Credit Agreement, and the Company believes that borrowings under the
Credit Agreement are and will continue to be available for general corporate
purposes. The Credit Agreement includes certain restrictive covenants and
limitations. The primary restrictive covenant is a maximum ratio of total debt
to earnings before interest, taxes, depreciation and amortization and intangible
asset impairment (Consolidated EBITDA) for the trailing four quarters
(Consolidated Leverage ratio), as defined and described in the Credit Agreement,
of 3.50.</FONT><FONT face="Times New Roman" size=2> </FONT></P>

<P align=left><FONT face="Times New Roman" size=2>The following table sets forth
the calculation of the Consolidated Leverage ratio as of September 30, 2016,
using Consolidated EBITDA for the trailing four quarters, as contractually
defined: </FONT><FONT face="Times New Roman" size=2></FONT></P>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="60%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"></TD>
    <TD noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="4%" colSpan=2><B><FONT face="Times New Roman" size=2>9/30/2016</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Earnings
      from continuing operations</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>654</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Add
      back:</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="3%"></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>87</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax
expense</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>329</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and
      amortization</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>165</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncash intangible asset
      impairment charges</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2>9</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Deduct:</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="3%" bgColor=#c0c0c0></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest income</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>5</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Consolidated
      EBITDA</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1,239</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%"><FONT face="Times New Roman" size=2>Total
      debt</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%"><FONT face="Times New Roman" size=2>$</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%"><FONT face="Times New Roman" size=2>2,407</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="96%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>Consolidated
      Leverage ratio</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 2pt double" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2>1.94</FONT></TD></TR></TABLE></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>The Company was in compliance
with all restrictive covenants and limitations in the Credit Agreement as of
September 30, 2016, and anticipates being in compliance with all restrictive
covenants for the foreseeable future. The Company continues to monitor the
financial markets and assess its ability to fully draw on its revolving credit
agreement, and currently expects that any drawing on the agreement will be fully
funded.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Of the $29 of foreign and
other credit lines as of September 30, 2016, $4 was outstanding and the
remainder of $25 was available for borrowing. </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>20</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">


<!-- PAT 03-->
<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><I><FONT face="Times New Roman" size=2>Share repurchases and
dividends </FONT></I></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company has two share
repurchase programs: an open-market purchase program with an authorized
aggregate purchase amount of up to $750, all of which was available for share
repurchases as of September 30, 2016, and a program to offset the anticipated
impact of share dilution related to share-based awards (the Evergreen Program),
which has no authorization limit as to amount or timing of repurchases.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>During the three months ended
September 30, 2016 and 2015, the Company repurchased approximately 0.9 million
and 1.0 million shares, respectively, under its Evergreen Program, for an
aggregate amount of $113 and $112, respectively. The Company did not repurchase
any shares under the open-market purchase program during the three months ended
September 30, 2016 and 2015.</FONT><FONT face="Times New Roman" size=2>
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>During the three months ended
September 30, 2016 and 2015, the Company paid dividends per share of $0.80 and
$0.77, respectively, aggregating to $104 and $99, respectively. </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>CONTINGENCIES</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>See Notes to Condensed
Consolidated Financial Statements for information on the Company&#146;s
contingencies. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>RECENTLY ISSUED ACCOUNTING
STANDARDS</FONT></B><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>See Notes to Condensed
Consolidated Financial Statements for a summary of recently issued accounting
standards relevant to the Company. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=center><FONT face="Times New Roman" size=2>21</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><U><FONT face="Times New Roman" size=2>Cautionary
Statement</FONT></U></P>
<P align=left><FONT face="Times New Roman" size=2>This Quarterly Report on Form
10-Q (the Report), including the exhibits hereto and the information
incorporated by reference herein, contains &#147;forward-looking statements&#148; within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, and such
forward-looking statements involve risks and uncertainties. Except for
historical information, statements about future volume, sales, foreign
currencies, costs, cost savings, margin, earnings, earnings per share, diluted
earnings per share, foreign currency exchange rates, cash flows, plans,
objectives, expectations, growth or profitability are forward-looking statements
based on management&#146;s estimates, assumptions and projections. Words such as
&#147;could,&#148; &#147;may,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;targets,&#148; &#147;goals,&#148; &#147;projects,&#148;
&#147;intends,&#148; &#147;plans,&#148; &#147;believes,&#148; &#147;seeks,&#148; &#147;estimates,&#148; &#147;predicts,&#148; and variations
on such words, and similar expressions that reflect our current views with
respect to future events and operational and financial performance, are intended
to identify such forward-looking statements. These forward-looking statements
are only predictions, subject to risks and uncertainties, and actual results
could differ materially from those discussed herein. Important factors that
could affect performance and cause results to differ materially from
management&#146;s expectations are described in the sections entitled &#147;Risk Factors&#148;
and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations&#148; in the Annual Report on Form 10-K for the fiscal year ended June 30,
2016, as updated from time to time in the Company&#146;s Securities and Exchange
Commission filings. These factors include, but are not limited to: </FONT></P>
<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>intense competition in the Company&#146;s
      markets; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>worldwide, regional and local economic
      conditions and financial market volatility; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the ability of the Company to drive sales
      growth, increase price and market share, grow its product categories and
      achieve favorable product and geographic mix; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>volatility and increases in commodity costs
      such as resin, sodium hypochlorite and agricultural commodities, and
      increases in energy, transportation or other costs; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>dependence on key customers and risks
      related to customer consolidation and ordering patterns;</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>risks related to
      reliance on information technology systems, including potential security
      breaches, cyber-attacks, privacy breaches or data breaches that result in
      the unauthorized disclosure of consumer, customer, employee or Company
      information, or service interruptions; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>costs resulting from government regulations;
      </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the ability of the Company to successfully
      manage global political, legal, tax and regulatory risks, including
      changes in regulatory or administrative activity; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>risks related to international operations,
      including political instability; </FONT><FONT face="Times New Roman" size=2>government-imposed price controls or other regulations;
      </FONT><FONT face="Times New Roman" size=2>foreign currency exchange rate
      controls, including periodic changes in such controls, fluctuations and
      devaluations; </FONT><FONT face="Times New Roman" size=2>labor claims,
      labor unrest and inflationary pressures, particularly in Argentina;
      </FONT><FONT face="Times New Roman" size=2>and </FONT><FONT face="Times New Roman" size=2>potential harm and liabilities from the use,
      storage and transportation of chlorine in certain international markets
      where chlorine is used in the production of bleach; and the possibility of
      nationalization, expropriation of assets or other government action;
      </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>risks relating to acquisitions, new ventures
      and divestitures, and associated costs, including the potential for asset
      impairment charges related to, among others, intangible assets and
      goodwill; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the ability of the Company to develop and
      introduce commercially successful products; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>supply disruptions and other risks inherent
      in reliance on a limited base of suppliers; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the impact of product liability claims,
      labor claims and other legal proceedings, including in foreign
      jurisdictions </FONT><FONT face="Times New Roman" size=2></FONT></P></TD></TR>
      <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2>the success of the Company&#146;s business strategies;</FONT></P></TD></TR>

<TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the ability of the Company to implement and
      generate anticipated cost savings and efficiencies; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the Company&#146;s ability to attract and retain
      key personnel; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the Company&#146;s ability to maintain its
      business reputation and the reputation of its brands; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>environmental matters, including costs
      associated with the remediation of past contamination and the handling
      and/or transportation of hazardous substances; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the impact of natural disasters, terrorism
      and other events beyond the Company&#146;s control; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the Company&#146;s ability to maximize, assert
      and defend its intellectual property rights; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>any infringement or claimed infringement by
      the Company of third-party intellectual property rights; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>risks related to the potential increase in
      the Company&#146;s purchase price for P&amp;G&#146;s interest in the <FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">Glad<sup>&#174;</sup></font> business
      and the impact from the decision on whether or not to extend the term of
      the related agreement with P&amp;G; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the effect of the Company&#146;s indebtedness and
      credit rating on its business operations and financial results;
    </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>risks related to the Company&#146;s
      discontinuation of operations in Venezuela; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the Company&#146;s ability to pay and declare
      dividends or repurchase its stock in the future; </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">
      <P align=left><FONT face="Times New Roman" size=2></FONT><FONT face="Times New Roman" size=2>the Company&#146;s ability to maintain an
      effective system of internal controls, including after completing
      acquisitions; </FONT><FONT face="Times New Roman" size=2></FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%"><FONT face="Times New Roman" size=2>uncertainties relating to tax positions, tax
      disputes and changes in the Company&#146;s tax rate;</FONT></TD></TR>  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">the accuracy of the Company&#146;s estimates and
      assumptions on which its financial projections are based; and</TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 8pt; PADDING-LEFT: 15pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>
    <TD vAlign=top width="99%">the impacts of potential stockholder activism.
    </TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>22</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s forward-looking
statements in this Report are based on management&#146;s current views and
assumptions regarding future events and speak only as of their dates. The
Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise, except as required by the federal securities laws.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>In this Report, unless the
context requires otherwise, the terms &#147;the Company&#148; and &#147;Clorox&#148; refer to The
Clorox Company and its subsidiaries.</FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Item 3. Quantitative and
Qualitative Disclosures About Market Risk</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>There have not been any
material changes to the Company&#146;s market risk since June 30, 2016. For
additional information, refer to &#147;Management&#146;s Discussion and Analysis of
Financial Condition and Results of Operations&#148; included in Exhibit 99.1 of the
Company&#146;s Annual Report on Form 10-K for the fiscal year ended June 30,
2016.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Item 4. Controls and
Procedures </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Company&#146;s management, with
the participation of the Company&#146;s Chief Executive Officer and Chief Financial
Officer, evaluated the effectiveness of the Company&#146;s disclosure controls and
procedures as of the end of the period covered by this Report. Based on that
evaluation, the Chief Executive Officer and Chief Financial Officer concluded
that the Company&#146;s disclosure controls and procedures, as of the end of the
period covered by this Report, were effective such that the information required
to be disclosed by the Company in reports filed under the Exchange Act is (i)
recorded, processed, summarized and reported within the time periods specified
in the SEC&#146;s rules and forms and (ii) accumulated and communicated to
management, including the Chief Executive Officer and Chief Financial Officer,
as appropriate to allow timely decisions regarding required
disclosure.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>No change in the Company&#146;s
internal control over financial reporting occurred during the first fiscal
quarter of the fiscal year ending June 30, 2017, that has materially affected,
or is reasonably likely to materially affect, the Company&#146;s internal control
over financial reporting.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=center><FONT face="Times New Roman" size=2>23</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><B><FONT face="Times New Roman" size=2>PART II &#150; OTHER
INFORMATION </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Item 1.A. Risk Factors
</FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>For information regarding Risk
Factors, please refer to Item 1.A. in the Company&#146;s Annual Report on Form 10-K
for the fiscal year ended June 30, 2016, and the information in &#147;Cautionary
Statement&#148; included in this Report. </FONT><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>Item 2. Unregistered Sales
of Equity Securities and Use of Proceeds </FONT></B><FONT face="Times New Roman" size=2></FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The following table sets forth
the purchases of the Company&#146;s securities by the Company and any affiliated
purchasers within the meaning of Rule 10b-18(a)(3) (17 CFR 240.10b-18(a)(3))
during the first quarter of fiscal year 2017.</FONT><FONT face="Times New Roman" size=2> </FONT><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="84%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="3%"><B><FONT face="Times New Roman" size=2  >[a]</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="2%"><B><FONT face="Times New Roman" size=2  >[b]</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD noWrap style="text-align: center" width="3%"><B><FONT face="Times New Roman" size=2  >[c]</FONT></B></TD>
    <TD noWrap style="text-align: center" width="1%"></TD>
    <TD NOWRAP WIDTH="2%" STYLE="text-align: center"><B><FONT face="Times New Roman" size=2  >[d]</FONT></B></TD></TR>
  <TR style = "line-height: normal" vAlign=bottom>
    <TD NOWRAP STYLE="text-align: left; width: 84%; border-bottom: #000000 1pt solid; text-align: center; padding-top: 0in; padding-bottom: 0in"><B><FONT face="Times New Roman" size=2  >Period</FONT></B></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: left; width: 1%; padding-top: 0in; padding-bottom: 0in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 3%; padding-top: 0in; padding-bottom: 0in"><B><FONT face="Times New Roman" size=2  >Total Number of<BR>Shares
      Purchased<BR>(1)</FONT></B></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 1%; padding-top: 0in; padding-bottom: 0in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 3%; padding-top: 0in; padding-bottom: 0in"><B><FONT face="Times New Roman" size=2  >Average Price Paid<BR>per
      Share</FONT></B></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 1%; padding-top: 0in; padding-bottom: 0in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 3%; padding-top: 0in; padding-bottom: 0in"><B><FONT face="Times New Roman" size=2  >Total Number of<BR>Shares Purchased
      as<BR>Part of Publicly<BR>Announced Plans or<BR>Programs</FONT></B></TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 1%; padding-top: 0in; padding-bottom: 0in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: #000000 1pt solid; text-align: center; width: 2%; padding-top: 0in; padding-bottom: 0in"><B><FONT face="Times New Roman" size=2  >Maximum Number (or<BR>Approximate
      Dollar<BR>Value) of Shares that<BR>May Yet Be Purchased<BR>Under the Plans
      or<BR>Programs</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="84%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2  >July 1 to
      31, 2016</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD NOWRAP ALIGN="LEFT" WIDTH="3%" BGCOLOR="#c0c0c0" STYLE="text-align: right"><FONT face="Times New Roman" size=2  >-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2  >$</FONT></TD>
    <TD NOWRAP ALIGN="LEFT" WIDTH="2%" BGCOLOR="#c0c0c0" STYLE="text-align: right"><FONT face="Times New Roman" size=2  >-</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2  >-</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD NOWRAP ALIGN="RIGHT" WIDTH="2%" BGCOLOR="#c0c0c0" STYLE="text-align: center"><FONT face="Times New Roman" size=2  >(2)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="84%"><FONT face="Times New Roman" size=2  >August 1 to
      31, 2016</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2  >405,154</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=right width="2%"><FONT face="Times New Roman" size=2  >131.34</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD noWrap align=right width="3%"><FONT face="Times New Roman" size=2  >405,154</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD NOWRAP ALIGN="RIGHT" WIDTH="2%" STYLE="text-align: center"><FONT face="Times New Roman" size=2  >(2)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="84%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2  >September 1
      to 30, 2016</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2  >477,586</FONT></TD>
    <TD noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="2%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2  >125.84</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=right width="3%" bgColor=#c0c0c0><FONT face="Times New Roman" size=2  >477,586</FONT></TD>
    <TD noWrap align=right width="1%" bgColor=#c0c0c0></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt none; text-align: center; width: 2%; background-color: #c0c0c0"><FONT face="Times New Roman" size=2  >(2)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="84%"><FONT face="Times New Roman" size=2  >Total</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD NOWRAP STYLE="border-bottom: Black 2pt double; text-align: right; width: 3%"><FONT face="Times New Roman" size=2  >882,740</FONT></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD NOWRAP STYLE="border-bottom: Black 2pt double; text-align: left; width: 1%"><FONT face="Times New Roman" size=2  >$</FONT></TD>
    <TD NOWRAP STYLE="border-bottom: Black 2pt double; text-align: right; width: 2%"><FONT face="Times New Roman" size=2  >128.36</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD NOWRAP STYLE="border-bottom: Black 2pt double; text-align: right; width: 3%"><FONT face="Times New Roman" size=2  >882,740</FONT></TD>
    <TD noWrap align=right width="1%"></TD>
    <TD NOWRAP STYLE="border-bottom: Black 1pt none; text-align: center; width: 2%"><FONT face="Times New Roman" size=2  >(2)</FONT></TD></TR></TABLE><DIV>____________________</div><BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(1)</FONT></TD>
    <TD vAlign=top noWrap>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Shares purchased in
      July, August and September 2016 were acquired pursuant to the Company&#146;s
      share repurchase program to offset the impact of share dilution related to
      share-based awards (the Evergreen Program).</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>(2)</FONT></TD>
    <TD vAlign=top noWrap></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>The Company has two
      share repurchase programs: an open-market purchase program with an
      authorized aggregate purchase amount of up to $750 million, all of which
      was available for share repurchases as of September 30, 2016, and the
      Evergreen Program, the purpose of which is to offset the impact of
      anticipated share dilution related to share-based awards and which has no
      authorization limit as to the amount or timing of
  repurchases.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>24</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><B><FONT face="Times New Roman" size=2>Item 6.
Exhibits</FONT></B><FONT face="Times New Roman" size=2> </FONT></P>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>3.2</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>The
      Clorox Company Amended and Restated Bylaws (filed as Exhibit 3.2 to the
      Current Report on Form 8-K, filed September 15, 2016, incorporated herein
      by reference).<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>10.1</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>Form of Performance
      Share Award Agreement under the Company&#146;s 2005 Stock Incentive Plan for
      awards made in 2016.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>10.2</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>Form
      of Nonqualified Stock Option Award Agreement under the Company&#146;s 2005
      Stock Incentive Plan.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>31.1</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>Certification by the
      Chief Executive Officer of the Company Pursuant to Section 302 of the
      Sarbanes-Oxley Act of 2002.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>31.2</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>Certification by the Chief Financial Officer of the Company
      Pursuant to Section 302 of the Sarbanes-Oxley Act of
    2002.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>32</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>Certification by the
      Chief Executive Officer and Chief Financial Officer of the Company
      Pursuant to Section 906 of the Sarbanes-Oxley Act of
    2002.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>101</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>The
      following materials from The Clorox Company&#146;s Quarterly Report on Form
      10-Q for the period ended September 30, 2016, are formatted in eXtensible
      Business Reporting Language (XBRL): (i) the Condensed Consolidated
      Statements of Earnings and Comprehensive Income, (ii) the Condensed
      Consolidated Balance Sheets, (iii) the Condensed Consolidated Statements
      of Cash Flows, and (iv) Notes to Condensed Consolidated Financial
      Statements.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>25</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><FONT face="Times New Roman" size=2>SIGNATURE </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned thereunto duly authorized.
</FONT><FONT face="Times New Roman" size=2></FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2  >THE CLOROX
      COMPANY</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2  >(Registrant)</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD width="100%" colSpan=3>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2  >DATE:
      November 2, 2016</FONT></TD>
    <TD noWrap align=left width="1%"><FONT size=2 face="Times New Roman">BY &nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="49%"><FONT face="Times New Roman" size=2  >/s/ Thomas D. Johnson</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2  >Thomas D.
      Johnson</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="50%">&nbsp;</TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2  >Vice
      President &#150; Global Business Services and</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="50%"></TD>
    <TD noWrap align=left width="1%">&nbsp;</TD>
    <TD noWrap align=left width="49%"><FONT face="Times New Roman" size=2  >Chief
      Accounting Officer</FONT></TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>26</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=center><FONT face="Times New Roman" size=2>EXHIBIT INDEX</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>Exhibit No.</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>3.2</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>The
      Clorox Company Amended and Restated Bylaws (filed as Exhibit 3.2 to the
      Current Report on Form 8-K, filed September 15, 2016, incorporated herein
      by reference).<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>10.1</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>Form of Performance
      Share Award Agreement under the Company&#146;s 2005 Stock Incentive Plan for
      awards made in 2016.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>10.2</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>Form
      of Nonqualified Stock Option Award Agreement under the Company&#146;s 2005
      Stock Incentive Plan.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>31.1</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>Certification by the
      Chief Executive Officer of the Company Pursuant to Section 302 of the
      Sarbanes-Oxley Act of 2002.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>31.2</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>Certification by the Chief Financial Officer of the Company
      Pursuant to Section 302 of the Sarbanes-Oxley Act of
    2002.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>32</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>Certification by the
      Chief Executive Officer and Chief Financial Officer of the Company
      Pursuant to Section 906 of the Sarbanes-Oxley Act of
    2002.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD NOWRAP STYLE="vertical-align: top"><FONT face="Times New Roman" size=2>101</FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top"></TD>
    <TD STYLE="width: 100%"><FONT face="Times New Roman" size=2>The
      following materials from The Clorox Company&#146;s Quarterly Report on Form
      10-Q for the period ended September 30, 2016, are formatted in eXtensible
      Business Reporting Language (XBRL): (i) the Condensed Consolidated
      Statements of Earnings and Comprehensive Income, (ii) the Condensed
      Consolidated Balance Sheets, (iii) the Condensed Consolidated Statements
      of Cash Flows, and (iv) Notes to Condensed Consolidated Financial
      Statements.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>27</FONT><FONT face="Times New Roman" size=2> </FONT></P>
<HR align=center width="100%" noShade size="2">


</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>clorox3118958-ex101.htm
<DESCRIPTION>2016 US PSU AGREEMENT CEC GL32
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT">Exhibit
10.1</FONT></font></B></P>
<P align=center><FONT face="Times New Roman" size=4>THE CLOROX COMPANY<BR>2005
STOCK INCENTIVE PLAN<BR>PERFORMANCE
SHARE AWARD AGREEMENT </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTICE OF PERFORMANCE SHARE
GRANT<BR></FONT></B><FONT face="Times New Roman" size=2>The Clorox Company, a
Delaware company (the &#147;Company&#148;), grants to the Grantee named below, in
accordance with the terms of The Clorox Company 2005 Stock Incentive Plan (the
&#147;Plan&#148;) and this performance share award agreement (the &#147;Agreement&#148;), the
following number of Performance Shares on the terms set forth below:</FONT></P>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="39%"><B><FONT face="Times New Roman" size=2>GRANTEE:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top align=left width="59%"><FONT face="Times New Roman" size=2>(refer to
      UBS Financial Services Inc. (&#147;UBS&#148;) account for details)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="39%"><B><FONT face="Times New Roman" size=2>TARGET AWARD:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="59%"><FONT face="Times New Roman" size=2>(refer to
      UBS account for details)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="39%"><B><FONT face="Times New Roman" size=2>GRANT ID:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="59%"><FONT face="Times New Roman" size=2>(refer to
      UBS account for details)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="39%"><B><FONT face="Times New Roman" size=2>PERFORMANCE PERIOD:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="59%"><FONT face="Times New Roman" size=2>July 1, 2016
      through June 30, 2019</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="39%"><B><FONT face="Times New Roman" size=2>DATE OF GRANT:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="59%"></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="39%"><B><FONT face="Times New Roman" size=2>SETTLEMENT DATE:</FONT></B></TD>
    <TD vAlign=top align=left width="1%"></TD>
    <TD vAlign=top align=left width="59%"><FONT face="Times New Roman" size=2>Within 75
      days following the last day of the Performance Period, provided the
      Grantee has remained in the employment or service of the Company or its
      Subsidiaries through such date (except for a termination of employment or
      service due to death, Disability or Retirement, as provided
    below)</FONT></TD></TR></TABLE><BR>
<P align=left><B><FONT face="Times New Roman" size=2>AGREEMENT </FONT></B></P>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>1.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Grant of
      Performance Shares</FONT></U><FONT face="Times New Roman" size=2>. The
      Company hereby grants to the Grantee the Target Award set forth above,
      payment of which is dependent upon the achievement of certain performance
      goals more fully described in Section 3 of this Agreement. This Award is
      subject to the terms, definitions and provisions of the Plan and this
      Agreement. All terms, provisions, and conditions applicable to the
      Performance Shares set forth in the Plan and not set forth herein are
      incorporated by reference. To the extent any provision hereof is
      inconsistent with a provision of the Plan, the provisions of the Plan will
      govern. All capitalized terms that are used in this Agreement and not
      otherwise defined herein shall have the meanings ascribed to them in the
      Plan.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>2.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Nature and
      Settlement of Award</FONT></U><FONT face="Times New Roman" size=2>. The
      Performance Shares awarded pursuant to this Agreement represent the
      opportunity to receive Shares of the Company and Dividend Equivalents on
      such Shares (as described in Section 4 below). The Company shall issue to
      the Participant one Share for each vested Performance Share (plus any
      Dividend Equivalents accrued with respect to such vested Performance
      Shares), rounded down to the nearest whole share, less any Shares withheld
      in accordance with the provisions of Section 7 of this Agreement.
      Settlement shall occur on a date chosen by the Committee, which date shall
      be within seventy-five (75) days following the last day of the Performance
      Period, or any deferred settlement date established pursuant to Section 6
      of this Agreement, whichever is later (the &#147;Settlement Date&#148;), and except
      as specifically provided in Section 5 of this Agreement, provided the
      Grantee has remained in the employment or service of the Company or its
      Subsidiaries through the Settlement Date. Although vested within the
      meaning of Section 83 of the Internal Revenue Code since no substantial
      risk of forfeiture exists at the Settlement Date, the Performance Shares
      (and any associated Dividend Equivalents) will not be earned until the
      Grantee has fulfilled all of the conditions precedent set forth in this
      Agreement, including, but not limited to, the obligations set forth in
      Sections 9(b), 9(c), 9(d), 9(e) and Section 10, and the Grantee shall have
      no right to retain the Shares or the value thereof upon vesting or
      settlement of the Performance Shares until all such conditions precedent
      have been satisfied.</FONT></TD></TR>
  </TABLE>
<P align=center><FONT face="Times New Roman" size=2>- 1 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>3.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Determination of Number of Performance
      Shares Vested</FONT></U><FONT face="Times New Roman" size=2>.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>The number of Performance Shares vested, if
      any, for the Performance Period shall be determined in accordance with the
      following formula:</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD width="100%" colSpan=3>
      <P align=center><B><FONT face="Times New Roman" size=2># of Performance
      Shares = Payout Percentage x Target Award </FONT></B></P></TD></TR>
  <TR>
    <TD width="100%" colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD width="100%">
      <P align=left><FONT face="Times New Roman" size=2>The &#147;Payout Percentage&#148;
      is based on cumulative economic profit (&#147;EP&#148;), calculated as described in
      the paragraph below, at the end of the Performance Period, determined in
      accordance with the following table:</FONT></P></TD></TR></TABLE><BR>
<DIV align=center>
<TABLE style="LINE-HEIGHT: 13pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=bottom>
    <TD NOWRAP STYLE="border: #000000 1pt solid; text-align: left; width: 69%; padding-right: 6pt; padding-left: 6pt"><B><FONT face="Times New Roman" size=2>FY17 &#150; FY19</FONT></B></TD>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; border-top: #000000 1pt solid; text-align: center; width: 30%; padding-right: 6pt; padding-left: 6pt"><B><FONT face="Times New Roman" size=2>Payout</FONT></B></TD></TR>
  <TR>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; border-left: #000000 1pt solid; text-align: left; width: 69%; padding-right: 6pt; padding-left: 6pt">&nbsp;</TD>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; text-align: left; width: 30%; padding-right: 6pt; padding-left: 6pt"></TD></TR>
  <TR>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; border-left: #000000 1pt solid; text-align: left; width: 69%; padding-right: 6pt; padding-left: 6pt">&nbsp;</TD>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; text-align: left; width: 30%; padding-right: 6pt; padding-left: 6pt"></TD></TR>
  <TR>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; border-left: #000000 1pt solid; text-align: left; width: 69%; padding-right: 6pt; padding-left: 6pt">&nbsp;</TD>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; text-align: left; width: 30%; padding-right: 6pt; padding-left: 6pt"></TD></TR>
  <TR>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; border-left: #000000 1pt solid; text-align: left; width: 69%; padding-right: 6pt; padding-left: 6pt">&nbsp;</TD>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; text-align: left; width: 30%; padding-right: 6pt; padding-left: 6pt"></TD></TR>
  <TR>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; border-left: #000000 1pt solid; text-align: left; width: 69%; padding-right: 6pt; padding-left: 6pt">&nbsp;</TD>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; text-align: left; width: 30%; padding-right: 6pt; padding-left: 6pt"></TD></TR>
  <TR>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; border-left: #000000 1pt solid; text-align: left; width: 69%; padding-right: 6pt; padding-left: 6pt">&nbsp;</TD>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; text-align: left; width: 30%; padding-right: 6pt; padding-left: 6pt"></TD></TR>
  <TR>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; border-left: #000000 1pt solid; text-align: left; width: 69%; padding-right: 6pt; padding-left: 6pt">&nbsp;</TD>
    <TD NOWRAP STYLE="border-right: #000000 1pt solid; border-bottom: #000000 1pt solid; text-align: left; width: 30%; padding-right: 6pt; padding-left: 6pt"></TD></TR>
  <TR vAlign=bottom>
    <TD style="line-height:normal" noWrap align=left width="99%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performance
      Period is FY17-FY19</FONT></TD></TR>
  <TR style="line-height:normal" vAlign=bottom>
    <TD noWrap align=left width="99%" colSpan=2><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interim
      percentages to be interpolated</FONT></TD></TR></TABLE></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Cumulative
      EP will be the sum of annual EP results over the Performance Period.
      Annual EP is defined as Earnings Before Interest &amp; Taxes (&#147;EBIT&#148;),
      adjusted for non-cash restructuring charges, times one minus the tax rate,
      less capital charge.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Notwithstanding the above, the EP levels in the preceding table
      shall be adjusted, fairly and appropriately, in accordance with the Plan
      and, as provided in this Agreement, to reflect accurately the direct and
      measurable effect of the impact of each of the following events not
      otherwise reflected in the determination of the initial EP levels (each,
      an &#147;Event&#148;) including, without limitation, the financial statement impact
      on the Company on account of the occurrence or potential occurrence of an
      Event: (1) the acquisition or divestiture of a business, (2) a Change in
      Control, (3) U.S Federal changes in tax statutes or the addition or
      deletion of taxes to which the Company or any Affiliated Company is
      subject, (4) force majeure (including events known as &#147;Acts of God&#148;), (5)
      the adoption of new or revised accounting pronouncements or changes to
      application of accounting pronouncements, and (6) any extraordinary,
      unusual or non-recurring item not previously listed. Notwithstanding the foregoing, an event listed in the preceding
      sentence shall not qualify as an Event, and therefore no adjustment shall
      be made to the EP levels, unless the impact of the occurrence or potential
      occurrence of such an event listed in the preceding sentence exceeds $2
      million in EP. The purpose of any adjustments on account of the occurrence
      of an Event is to keep the probability of achieving the EP levels the same
      as if the Event triggering such adjustment had either not occurred or had
      not resulted in any financial statement impact. The determination of any
      adjustments shall be based on the Company&#146;s accounting as set forth in its
      books and records (including business projections) and/or in the annual
      budget and/or long range plan of the Company pursuant to which the EP
      levels were originally established. The amount of any such adjustment
      shall be approved by the Committee in its good faith determination in
      accordance with the provisions of this paragraph. To the extent
      applicable, the Committee shall condition the determination of the number
      of Performance Shares vested under this Section 3 upon the satisfaction of
      the adjusted EP levels. All Performance Shares that are not vested for the
      Performance Period shall be forfeited as of the last day of the
      Performance Period.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>4.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Dividend
      Equivalent Rights.</FONT></U><FONT face="Times New Roman" size=2> No
      Dividend Equivalents shall be paid to the Grantee prior to the settlement
      of the award. Rather, such Dividend Equivalent payments will accrue and be
      notionally credited to the Grantee&#146;s Performance Share account and paid
      out at the Payout Percentage in the form of additional Shares (the
      &#147;Dividend Equivalent Shares&#148;) upon settlement of the award, as described
      in Section 2 above.</FONT></TD></TR>
  </TABLE>
<P align=center><FONT face="Times New Roman" size=2>- 2 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 border=0>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>5.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%" colSpan=3><U><FONT face="Times New Roman" size=2>Termination of Continuous Service</FONT></U><FONT face="Times New Roman" size=2>. Except as otherwise provided below, if the
      Grantee&#146;s employment or service with the Company and its Subsidiaries is
      terminated for any reason prior to the Settlement Date, all Performance
      Shares and Dividend Equivalents subject to this Agreement shall be
      immediately forfeited.</FONT></TD></TR>

<TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>

<TR>
    <TD noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>a.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Termination due to
      Death or Disability</FONT></U><FONT face="Times New Roman" size=2>. If the
      Grantee&#146;s termination of employment or service is due to death or
      Disability, all Performance Shares and Dividend Equivalents shall
      immediately vest and will be paid upon completion of the Performance
      Period based on the level of performance achieved as of the end of such
      Performance Period.</FONT></TD></TR>

<TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>

  <TR>
    <TD noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>b.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Termination due to
      Retirement</FONT></U><FONT face="Times New Roman" size=2>. If the
      Grantee&#146;s termination of employment or service is due to Retirement and is
      more than twelve (12) months from the Date of Grant set forth in this
      Agreement, the Performance Shares shall vest on a pro rata monthly basis,
      including full credit for partial months elapsed, and will be paid upon
      completion of the Performance Period based on the level of performance
      achieved as of the end of such Performance Period; provided, however, that
      this provision shall not apply in the event the Grantee&#146;s employment or
      service is terminated for Cause. The amount of the vested Award may be
      computed under the following formula: Target Award times (number of full
      months elapsed in Performance Period divided by number of full months in
      Performance Period) times percent performance level achieved as of the end
      of the Performance Period. Dividend Equivalents accrued through the
      Grantee&#146;s date of termination due to Retirement shall be paid at the same
      time as the settlement of the vested Performance Shares.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>c.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Definition of &#147;Retirement.</FONT></U><FONT face="Times New Roman" size=2>&#148; For purposes of this Agreement, the term
      &#147;Retirement&#148; shall mean termination of employment or service as an
      Employee after (1) twenty (20) or more years of &#147;vesting service,&#148; which
      solely for purposes of this Agreement, shall be calculated under Article
      III of The Clorox Company 401(k) Plan (the &#147;401(k) Plan&#148;) entitled
      &#147;Service&#148; along with any other relevant provisions of the 401(k) Plan
      necessary or desirable to give full effect thereto, or any successor
      provisions, regardless of the status of the Grantee with respect to the
      401(k) Plan (&#147;Vesting Service&#148;), or (2) attaining age fifty-five with ten
      (10) or more years of Vesting Service.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>d.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Definition of &#147;Disability.</FONT></U><FONT face="Times New Roman" size=2>&#148; For purposes of this Agreement, the
      Grantee&#146;s employment shall be deemed to have terminated due to the
      Grantee&#146;s Disability if the Grantee is entitled to long-term disability
      benefits under the Company&#146;s long-term disability plan or policy, as in
      effect on the date of termination of the Grantee&#146;s
employment.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>6.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%" colSpan=3><U><FONT face="Times New Roman" size=2>Election to Defer
      Settlement</FONT></U><FONT face="Times New Roman" size=2>. Prior to the
      commencement of the last year of the Performance Period, the Grantee may
      elect to defer the settlement of the Performance Shares from the last day
      of the Performance Period until a date at least two years following such
      date, or until the Grantee&#146;s later termination of employment or service.
      If the Grantee makes such an election, it will become irrevocable on the
      date of such election. If the Grantee makes such an election, any Dividend
      Equivalents awarded with respect to such deferred Performance Shares shall
      also be deferred under the same terms. If the Grantee makes such an
      election, but a transaction occurs that subjects the Grantee&#146;s Performance
      Shares to Section 19 of the Plan prior to the settlement date, the
      Grantee&#146;s deferral election will terminate and the Grantee&#146;s Performance
      Shares and Dividend Equivalents will be settled as of the date of that
      transaction. The Company may terminate any deferral hereunder if a change
      in law requires such termination.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>7.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%" colSpan=3><U><FONT face="Times New Roman" size=2>Taxes</FONT></U><FONT face="Times New Roman" size=2>. Pursuant to Section 16 of the Plan, the
      Committee shall have the power and the right to deduct or withhold, or
      require the Grantee to remit to the Company, an amount sufficient to
      satisfy any applicable tax withholding requirements applicable to this
      Award. The Committee may condition the issuance of Shares upon the
      Grantee&#146;s satisfaction of such withholding obligations. The Grantee may
      elect to satisfy all or part of such withholding requirement by tendering
      previously-owned Shares or by having the Company withhold Shares having a
      Fair Market Value equal to the minimum statutory withholding rate that
      could be imposed on the transaction (or such other rate that will not
      result in a negative accounting impact) or in such other manner as is
      acceptable to the Company. Such election shall be irrevocable, made in
      writing, signed by the Grantee, and shall be subject to any restriction or
      limitations that the Committee, in its sole discretion, deems
      appropriate.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>8.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%" colSpan=3><U><FONT face="Times New Roman" size=2>Transferability of
      Performance Shares</FONT></U><FONT face="Times New Roman" size=2>.
      Performance Shares shall not be transferable by the Grantee other than by
      will or by the laws of descent or distribution. For avoidance of doubt,
      Shares issued to the Grantee in settlement of Performance Shares pursuant
      to Section 2 of this Agreement shall not be subject to any of the
      foregoing transferability restrictions.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>- 3 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">9.</FONT></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top width="100%" colSpan=5><U><FONT size=2 face="Times New Roman">Protection of Trade Secrets
      and Limitations on Retention.</FONT></U></TD></TR>
  <TR>
    <TD vAlign=top width="100%" colSpan=7>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>a.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%" colSpan=3><U><FONT face="Times New Roman" size=2>Definitions.</FONT></U></TD></TR>
  <TR>
    <TD width="100%" colSpan=7>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD vAlign=top noWrap align=right></TD>
    <TD vAlign=top noWrap align=right><FONT face="Times New Roman" size=2>i.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Affiliated Company</FONT></U><FONT face="Times New Roman" size=2>&#148;
      means any organization controlling, controlled by or under common control
      with the Company.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=7>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD vAlign=top noWrap align=right></TD>
    <TD vAlign=top noWrap align=right><FONT face="Times New Roman" size=2>ii.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Confidential Information</FONT></U><FONT face="Times New Roman" size=2>&#148; means the Company&#146;s technical or business or personnel
      information not readily available to the public or generally known in the
      trade, including inventions, developments, trade secrets and other
      confidential information, knowledge, data and know-how of the Company or
      any Affiliated Company, whether or not they originated with the Grantee,
      or information which the Company or any Affiliated Company received from
      third parties under an obligation of confidentiality.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=7>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD vAlign=top noWrap align=right></TD>
    <TD vAlign=top noWrap align=right><FONT face="Times New Roman" size=2>iii.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Conflicting Product</FONT></U><FONT face="Times New Roman" size=2>&#148;
      means any product, process, machine, or service of any person or
      organization, other than the Company or any Affiliated Company, in
      existence or under development that (1) resembles or competes with a
      product, process, machine, or service upon or with which the Grantee shall
      have worked during the two years prior to the Grantee&#146;s termination of
      employment with the Company or any Affiliated Company or (2) with respect
      to which during that period of time the Grantee, as a result of his/her
      job performance and duties, shall have acquired knowledge of Confidential
      Information, and whose use or marketability could be enhanced by
      application to it of Confidential Information. For purposes of this
      section, it shall be conclusively presumed that the Grantee has knowledge
      of information to which s/he has been directly exposed through actual
      receipt or review of memorandum or documents containing such information
      or through actual attendance at meetings at which such information was
      discussed or disclosed.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=7>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD vAlign=top noWrap align=right></TD>
    <TD vAlign=top noWrap align=right><FONT face="Times New Roman" size=2>iv.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>&#147;</FONT><U><FONT face="Times New Roman" size=2>Conflicting Organization</FONT></U><FONT face="Times New Roman" size=2>&#148; means any person or organization that is engaged in or about to
      become engaged in research on or development, production, marketing or
      selling of a Conflicting Product.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=7>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">b.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%" colSpan=3><U><FONT face="Times New Roman" size=2>Right to Retain
      Shares Contingent on Protection of Confidential
      Information</FONT></U><FONT face="Times New Roman" size=2>. In partial
      consideration for the award of these Performance Shares, the Grantee
      agrees that at all times, both during and after the term of the Grantee&#146;s
      employment with the Company or any Affiliated Company, to hold in the
      strictest confidence, and not to use (except for the benefit of the
      Company at the Company&#146;s direction) or disclose (except for the benefit of
      the Company at the Company&#146;s direction), regardless of when disclosed to
      the Grantee, any and all Confidential Information of the Company or any
      Affiliated Company. The Grantee understands that for purposes of this
      Section 9(b), Confidential Information further includes, but is not
      limited to, information pertaining to any aspect of the business of the
      Company or any Affiliated Company which is either information not known
      (or known as a result of a wrongful act of the Grantee or of others who
      were under confidentiality obligations as to the item or items involved)
      by actual or potential competitors of the Company or other third parties
      not under confidentiality obligations to the Company. If, prior to the
      expiration of the Performance Period or at any time within one (1) year
      after the Settlement Date, the Grantee discloses or uses, or threatens to
      disclose or use, any Confidential Information other than in the course of
      performing authorized services for the Company (or any Affiliated
      Company), the Performance Shares, whether vested or not, will be
      immediately forfeited and cancelled, and the Grantee shall immediately
      return to the Company the Shares or the pre-tax income derived from any
      disposition of the Shares.</FONT></TD></TR>
  </TABLE>
<P align=center><FONT face="Times New Roman" size=2>- 4 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 border=0>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">c.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%" colSpan=3><U><FONT face="Times New Roman" size=2>No Interference with
      Customers or Suppliers</FONT></U><FONT face="Times New Roman" size=2>. In
      partial consideration for the award of these Performance Shares, in order
      to forestall the disclosure or use of Confidential Information as well as
      to deter the Grantee&#146;s intentional interference with the contractual
      relations of the Company or any Affiliated Company, the Grantee&#146;s
      intentional interference with prospective economic advantage of the
      Company or any Affiliated Company and to promote fair competition, the
      Grantee agrees that the Grantee&#146;s right to the Shares upon settlement of
      the Performance Shares is contingent upon the Grantee refraining, for a
      period of one (1) year after the date of settlement of the Performance
      Shares, for himself/herself or any third party, directly or indirectly,
      from using Confidential Information to (1) divert or attempt to divert
      from the Company (or any Affiliated Company) any business of any kind in
      which it is engaged, or (2) intentionally solicit its customers with which
      it has a contractual relationship as to Conflicting Products, or to
      interfere with the contractual relationship with any of its suppliers or
      customers (collectively, &#147;Interfere&#148;). If, during the term of the
      Performance Period or at any time within one (1) year after the Settlement
      Date, the Grantee breaches his/her obligation not to Interfere, the
      Grantee&#146;s right to the Shares upon settlement of the Performance Shares
      shall not have been earned and the Performance Shares, whether vested or
      not, will be immediately cancelled, and the Grantee shall immediately
      return to the Company the Shares or the pre-tax income derived from any
      disposition of the Shares. For avoidance of doubt, the term &#147;Interfere&#148;
      shall not include any advertisement of Conflicting Products through the
      use of media intended to reach a broad public audience (such as
      television, cable or radio broadcasts, or newspapers or magazines) or the
      broad distribution of coupons through the use of direct mail or through
      independent retail outlets. <U><FONT face="Times New Roman" size=2>THE
      GRANTEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT
      PROHIBIT THE CONDUCT DESCRIBED, BUT PROVIDES FOR THE CANCELLATION OF THE
      PERFORMANCE SHARES AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS
      TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO VIOLATE
      THIS &#147;NO INTERFERENCE WITH CUSTOMERS OR SUPPLIERS&#148; PROVISION DURING THE
      TERM OF THE PERFORMANCE PERIOD OR WITHIN ONE (1) YEAR AFTER THE SETTLEMENT
      DATE. </FONT></U></FONT></TD></TR>
   <TR>
    <TD width="100%" colSpan=7>&nbsp;</TD></TR>

  <TR>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>d.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>No Solicitation of Employees</FONT></U><FONT face="Times New Roman" size=2>. In partial consideration for the award of
      these Performance Shares, in order to forestall the disclosure or use of
      Confidential Information, as well as to deter the Grantee&#146;s intentional
      interference with the contractual relations of the Company or any
      Affiliated Company, the Grantee&#146;s intentional interference with
      prospective economic advantage of the Company or any Affiliated Company,
      and to promote fair competition, the Grantee agrees that the Grantee&#146;s
      right to the Shares upon settlement of the Performance Shares is
      contingent upon the Grantee refraining, for a period of one (1) year after
      the date of settlement of the Performance Shares, for himself/herself or
      any third party, directly or indirectly, from soliciting for employment
      any person employed by the Company, or by any Affiliated Company, during
      the period of the solicited person&#146;s employment and for a period of one
      (1) year after the termination of the solicited person&#146;s employment with
      the Company or any Affiliated Company (collectively &#147;Solicit&#148;). If, during
      the term of the Performance Period or at any time within one (1) year
      after the Settlement Date, the Grantee breaches his/her obligation not to
      Solicit, the Grantee&#146;s right to the Shares upon settlement of the
      Performance Shares shall not have been earned and the Performance Shares,
      whether vested or not, will be immediately cancelled, and the Grantee
      shall immediately return to the Company the Shares or the pre-tax income
      derived from any disposition of the Shares. <U><FONT face="Times New Roman" size=2>THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH
      IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT
      PROVIDES FOR THE CANCELLATION OF THE PERFORMANCE SHARES AND A RETURN TO
      THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF THE SHARES IF
      THE GRANTEE SHOULD CHOOSE TO VIOLATE THIS NON-SOLICITATION OF EMPLOYEES
      PROVISION DURING THE TERM OF THE PERFORMANCE PERIOD OR WITHIN ONE (1) YEAR
      AFTER THE SETTLEMENT DATE.</FONT></U></FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>e.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Injunctive and Other Available
      Relief</FONT></U><FONT face="Times New Roman" size=2>. By acceptance of
      these Performance Shares, the Grantee acknowledges that, if the Grantee
      were to breach or threaten to breach his/her obligation hereunder not to
      Interfere or Solicit or not to disclose or use any Confidential
      Information other than in the course of performing authorized services for
      the Company (or any Affiliated Company), the harm caused to the Company by
      such breach or threatened breach would be, by its nature, irreparable
      because, among other things, damages would be significant and the monetary
      harm that would ensue would not be able to be readily proven, and that the
      Company would be entitled to injunctive and other appropriate relief to
      prevent threatened or continued breach and to such other remedies as may
      be available at law or in equity. To the extent not prohibited by law, any
      cancellation of the Performance Shares pursuant to any of Sections 9(b)
      through 9(d) above shall not restrict, abridge or otherwise limit in any
      fashion the types and scope of injunctive and other available relief to
      the Company. Notwithstanding any provision of this Agreement to the
      contrary, nothing under this Agreement shall limit, abridge, modify or
      otherwise restrict the Company (or any Affiliated Company) from pursuing
      any or all legal, equitable or other appropriate remedies to which the
      Company may be entitled under any other agreement with the Grantee, any
      other plan, program, policy or arrangement of the Company (or any
      Affiliated Company) under which the Grantee is covered or participates, or
      any applicable law, all to the fullest extent not prohibited under
      applicable law.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>- 5 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 border=0 style="line-height: normal">

  <TR>
    <TD noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>f.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Permitted
      Reporting and Disclosure</FONT></U><FONT face="Times  New Roman" size=2>.
      Notwithstanding any language in this Agreement to the contrary, nothing in
      this Agreement prohibits Grantee from reporting possible violations of
      federal law or regulation to any governmental agency or governmental
      entity, or making other disclosures that are protected under federal law
      or regulation; provided, that, in each case such communications and
      disclosures are consistent with applicable law. Notwithstanding the
      foregoing, under no circumstance is Grantee authorized to disclose any
      information covered by the Company&#146;s attorney-client privilege or attorney
      work product or the Company&#146;s trade secrets without prior written consent
      of the Company&#146;s General Counsel. Any reporting or disclosure permitted
      under this Section 9(f) shall not result in the cancellation of
      Performance Shares. Grantee is entitled to certain immunities from
      liability under state and federal law for disclosing trade secrets if the
      disclosure was made to report or investigate an alleged violation of law,
      subject to certain conditions. Please see the Company&#146;s Confidential
      Information Policy for further details.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>10.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%" colSpan=3><U><FONT face="Times New Roman" size=2>Right to
      Retain Shares Contingent on Continuing Non-Conflicting
      Employment</FONT></U><FONT face="Times New Roman" size=2>. In partial
      consideration for the award of these Performance Shares, in order to
      forestall the disclosure or use of Confidential Information, as well as to
      deter the Grantee&#146;s intentional interference with the contractual
      relations of the Company or any Affiliated Company, the Grantee&#146;s
      intentional interference with prospective economic advantage of the
      Company or any Affiliated Company, and to promote fair competition, the
      Grantee agrees that the Grantee&#146;s right to the Shares upon settlement of
      the Performance Shares is contingent upon the Grantee refraining, during
      the term of the Performance Period and for a period of one (1) year after
      the Settlement Date, from rendering services, directly or indirectly, as
      director, officer, employee, agent, consultant or otherwise, to any
      Conflicting Organization except a Conflicting Organization whose business
      is diversified and that, as to that part of its business to which the
      Grantee renders services, is not a Conflicting Organization, provided that
      the Company shall receive separate written assurances satisfactory to the
      Company from the Grantee and the Conflicting Organization that the Grantee
      shall not render services during such period with respect to a Conflicting
      Product. If, prior to the expiration of the Performance Period or at any
      time within one (1) year after the Settlement Date, the Grantee shall
      render services to any Conflicting Organization other than as expressly
      permitted herein, the Grantee&#146;s right to the Shares upon settlement of the
      Performance Shares shall not have been earned and the Performance Shares,
      whether vested or not, will be immediately cancelled, and the Grantee
      shall immediately return to the Company the Shares or the pre-tax income
      derived from any disposition of the Shares. <U><FONT face="Times New Roman" size=2>THE GRANTEE UNDERSTANDS THAT THIS PARAGRAPH
      IS NOT INTENDED TO AND DOES NOT PROHIBIT THE GRANTEE FROM RENDERING
      SERVICES TO A CONFLICTING ORGANIZATION, BUT PROVIDES FOR THE CANCELLATION
      OF THE PERFORMANCE SHARES AND A RETURN TO THE COMPANY OF THE SHARES OR THE
      GROSS TAXABLE PROCEEDS OF THE SHARES IF THE GRANTEE SHOULD CHOOSE TO
      RENDER SUCH SERVICES DURING THE TERM OF THE PERFORMANCE PERIOD OR WITHIN
      ONE (1) YEAR AFTER THE SETTLEMENT DATE.</FONT></U></FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>11.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%" colSpan=3><U><FONT face="Times New Roman" size=2>Repayment Obligation</FONT></U><FONT face="Times New Roman" size=2>. In the event that (1) the Company issues a restatement of
      financial results to correct a material error and (2) the Committee
      determines, in good faith, that the Grantee&#146;s fraud or willful misconduct
      was a significant contributing factor to the need to issue such
      restatement and (3) some or all of the Performance Shares that were
      granted and/or vested prior to such restatement would not have been
      granted and/or vested, as applicable, based upon the restated financial
      results, the Grantee shall immediately return to the Company the
      Performance Shares or any Shares or the pre-tax income derived from any
      disposition of the Shares previously received in settlement of the
      Performance Shares that would not have been granted and/or vested based
      upon the restated financial results (the &#147;Repayment Obligation&#148;). The
      Company shall be able to enforce the Repayment Obligation by all legal
      means available, including, without limitation, by withholding such amount
      from other sums owed by the Company to the Grantee.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>12.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%" colSpan=3><U><FONT face="Times New Roman" size=2>Miscellaneous Provisions</FONT></U><FONT face="Times New Roman" size=2>.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>a.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Rights as a
      Stockholder</FONT></U><FONT face="Times New Roman" size=2>. Neither the
      Grantee nor the Grantee&#146;s transferee or representative shall have any
      rights as a stockholder with respect to any Shares subject to this Award
      until the Performance Shares have been settled and Share certificates have
      been issued to the Grantee, transferee or representative, as the case may
      be.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>b.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Choice of Law,
      Exclusive Jurisdiction and Venue</FONT></U><FONT face="Times New Roman" size=2>. This Agreement shall be governed by, and construed in accordance
      with, the laws of the State of Delaware, excluding any conflicts or choice
      of law rule or principle that might otherwise refer construction or
      interpretation of this Agreement to the substantive law of another
      jurisdiction. <B><U><FONT face="Times New Roman" size=2>The courts of the
      State of Delaware shall have exclusive jurisdiction over any disputes or
      other proceedings relating to this Agreement, and venue shall reside with
      the courts in New Castle County, Delaware, including if jurisdiction shall
      so permit, the U.S. District Court for the District of Delaware.</FONT></U></B><FONT face="Times New Roman" size=2> Accordingly, the
      Grantee agrees that any claim of any type relating to this Agreement must
      be brought and maintained in the appropriate court located in New Castle
      County, Delaware, including if jurisdiction will so permit, in the U.S.
      District Court for the State of Delaware. The Grantee hereby consents to
      the jurisdiction over the Grantee of any such courts and waives all
      objections based on venue or inconvenient
  forum.</FONT></FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>- 6 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>c.</FONT></TD>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Modification or Amendment</FONT></U><FONT face="Times New Roman" size=2>. This Agreement may be modified or amended
      by the Board or the Committee at any time; provided, however, no
      modification or amendment to this Agreement shall be made which would
      materially and adversely affect the rights of the Grantee, without such
      Grantee&#146;s written consent.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>d.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Severability</FONT></U><FONT face="Times New Roman" size=2>. In the event any provision of this
      Agreement shall be held illegal or invalid for any reason, the illegality
      or invalidity shall not affect the remaining provisions of this Agreement,
      and this Agreement shall be construed and enforced to reflect the intent
      of the parties to the fullest extent not prohibited by law, and in the
      event that such provision is not able to be so construed and enforced,
      then this Agreement shall be construed and enforced as if such illegal or
      invalid provision had not been included. In amplification of the preceding
      sentence, in the event that the time period or scope of any provision is
      declared by a court or arbitrator of competent jurisdiction to exceed the
      maximum time period or scope that such court or arbitrator deems
      enforceable, then such court or arbitrator shall have the power to reduce
      the time period or scope to the maximum time period or scope permitted by
      law.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>e.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>References to Plan</FONT></U><FONT face="Times New Roman" size=2>. All references to the Plan shall be deemed
      references to the Plan as may be amended.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>f.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Headings</FONT></U><FONT face="Times New Roman" size=2>. The captions used in this Agreement are
      inserted for convenience and shall not be deemed a part of this Agreement
      for construction or interpretation.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>g.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Interpretation</FONT></U><FONT face="Times New Roman" size=2>. Any dispute regarding the interpretation
      of this Agreement shall be submitted by the Grantee or by the Company
      forthwith to the Board or the Committee, which shall review such dispute
      at its next regular meeting. The resolution of such dispute by the Board
      or the Committee shall be final and binding on all persons. It is the
      intention of the Company and the Grantee to make the promises contained in
      this Agreement reasonable and binding only to the extent that it may be
      lawfully done under existing applicable laws. This Agreement and the Plan
      constitute the entire and exclusive agreement between the Grantee and the
      Company, and it supersedes all prior agreements or understandings, whether
      written or oral, with respect to the grant of Performance Shares set forth
      in this Agreement.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>h.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Section 409A Compliance</FONT></U><FONT face="Times New Roman" size=2>. To the extent applicable, it is intended
      that the Plan and this Agreement comply with the requirements of Section
      409A of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;) and any
      related regulations or other guidance promulgated with respect to such
      Section by the U.S. Department of the Treasury or the Internal Revenue
      Service (&#147;Section 409A&#148;). Any provision of the Plan or this Agreement that
      would cause this Award to fail to satisfy Section 409A shall have no force
      or effect until amended to comply with Section 409A, which amendment may
      be retroactive to the extent permitted by Section 409A.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD width="100%"><FONT face="Times New Roman" size=2>Notwithstanding any provision of the Plan to
      the contrary, if the Grantee is a &#147;specified employee&#148; (as defined in
      Section 1.409A-1(i) of the Treasury Department Regulations) at the time of
      the Grantee&#146;s &#147;separation from service&#148; (as defined in Section 1.409A-1(h)
      of the Treasury Department Regulations), and a payment to the Grantee
      under this Agreement is subject to Section 409A and is being made to the
      Grantee on account of the Grantee&#146;s separation from service, then to the
      extent not paid on or before March 15 of the calendar year following the
      calendar year in which the separation from service occurred, such payment
      shall be delayed until the earlier of the date which is six (6) months
      after the date of the Grantee&#146;s separation from service or the date of
      death of the Grantee. Any payments that were scheduled to be paid during
      the six (6) month period following the Grantee&#146;s separation from service,
      but which were delayed pursuant to this Section 12(h), shall be paid
      without interest on, or as soon as administratively practicable after, the
      first day following the six (6) month anniversary of the Grantee&#146;s
      separation from service (or, if earlier, the date of the Grantee&#146;s death).
      Any payments that were originally scheduled to be paid following the six
      (6) months after the Grantee&#146;s separation from service shall continue to
      be paid in accordance with their predetermined schedule.</FONT></TD></TR>
  <TR>
    <TD width="100%" colSpan=5>&nbsp;</TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">i.</FONT></TD>
    <TD noWrap></TD>
    <TD width="100%"><FONT size=2 face="Times New Roman"><U>Agreement with Terms</U><FONT face="Times New Roman">. Receipt of any benefits under this Agreement by
      the Grantee shall constitute the Grantee&#146;s acceptance of and agreement
      with all of the provisions of this Agreement and of the Plan that are
      applicable to this Agreement, and the Company shall administer this
      Agreement accordingly.</FONT></FONT></TD></TR></TABLE><BR>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"></TD>
    <TD noWrap style="text-align: center" width="20%"><B><FONT face="Times New Roman" size=2>THE CLOROX COMPANY</FONT></B></TD></TR>
  <TR>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%">&nbsp;</TD>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>By:&nbsp;&nbsp;&nbsp;/s/ Benno Dorer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="80%"></TD>
    <TD noWrap align=left width="20%"><FONT face="Times New Roman" size=2>Its:&nbsp;&nbsp;&nbsp;Chairman and Chief Executive
  Officer</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>- 7 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>

<P align=left><FONT face="Times New Roman" size=2>THE GRANTEE ACKNOWLEDGES AND
AGREES THAT THIS AGREEMENT IS A UNILATERAL CONTRACT AND THAT THE GRANTEE&#146;S RIGHT
TO THE SHARES PURSUANT TO THIS AGREEMENT IS ACCEPTED AND EARNED ONLY BY
CONTINUING EMPLOYMENT AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING
HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER) AND BY
ACHIEVEMENT OF THE PERFORMANCE CRITERIA AND BY COMPLIANCE WITH THE GRANTEE&#146;S
VARIOUS OBLIGATIONS UNDER THIS AGREEMENT. THE GRANTEE FURTHER ACKNOWLEDGES AND
AGREES THAT NOTHING IN THIS AGREEMENT, NOR IN THE PLAN, SHALL CONFER UPON THE
GRANTEE ANY RIGHT WITH RESPECT TO CONTINUATION OF EMPLOYMENT BY THE COMPANY, NOR
SHALL IT INTERFERE IN ANY WAY WITH THE GRANTEE&#146;S RIGHT OR THE COMPANY&#146;S RIGHT TO
TERMINATE THE GRANTEE&#146;S EMPLOYMENT AT ANY TIME, FOR ANY REASON OR NO REASON,
WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT ADVANCE NOTICE EXCEPT AS MAY BE
REQUIRED BY APPLICABLE LAW. </FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Grantee acknowledges that
a copy of the Plan and Plan Information are available for viewing on the
Company&#146;s internal HR website at
https://clxweb.clorox.com/hr/Pages/HRatClorox/HRContentPages/StockIncentiveProgram.aspx,
and the Company&#146;s Annual Report and Proxy Statement (the &#147;Prospectus
Information&#148;) are available for viewing on the Company&#146;s Clorox website at
http://investors.thecloroxcompany.com/sec.cfm. The Grantee hereby consents to
receive the Prospectus Information electronically or, in the alternative, to
contact the HR Service Center at 1-800-709-7095 to request a paper copy of the
Prospectus Information. The Grantee represents that s/he is familiar with the
terms and provisions thereof, and hereby accepts this Agreement subject to all
of the terms and provisions thereof. The Grantee has reviewed the Plan and this
Agreement in their entirety, has had an opportunity to obtain the advice of
counsel prior to executing this Agreement and fully understands all provisions
of the Agreement. The Grantee acknowledges and hereby agrees to accept as
binding, conclusive and final all decisions or interpretations of the Committee
upon any questions arising under the Plan or this Agreement. The Grantee further
agrees to notify the Company upon any change in the residence address indicated
below. </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Dated:&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="47%">&nbsp;</TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Signed:&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="50%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="47%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap style="text-align: center" width="50%"><FONT face="Times New Roman" size=2>Grantee</FONT></TD></TR></TABLE><BR>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="50%">&nbsp;</TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Residence
      Address:</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="50%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="50%">&nbsp;</TD></TR>
  <TR>
    <TD noWrap align=left width="50%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="50%">&nbsp;</TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>- 8 - </FONT></P>
<HR align=center width="100%" noShade size="2">

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>clorox3118958-ex102.htm
<DESCRIPTION>2016 US SO AGREEMENT CEC GL32
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT STYLE="BACKGROUND-COLOR: TRANSPARENT"><FONT face="Times New Roman" size=2>Exhibit
10.2</font></FONT></B></P>
<P align=center><FONT face="Times New Roman" size=4>THE CLOROX COMPANY<BR>2005
STOCK INCENTIVE PLAN <BR></FONT><FONT face="Times New Roman" size=4>NONQUALIFIED
STOCK OPTION AWARD AGREEMENT </FONT></P>
<P align=left><B><FONT face="Times New Roman" size=2>NOTICE OF STOCK OPTION
GRANT </FONT></B><BR>
<FONT face="Times New Roman" size=2>The Clorox Company, a Delaware
company (the &#147;Company&#148;), grants to the Optionee named below an option (the
&#147;Option&#148;) to purchase, in accordance with the terms of The Clorox Company 2005
Stock Incentive Plan (the &#147;Plan&#148;) and this nonqualified stock option agreement
(the &#147;Agreement&#148;), the number of shares of Common Stock of the Company (the
&#147;Shares&#148;) at the exercise price per share (the &#147;Exercise Price&#148;) set forth as
follows: </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="49%"><B><FONT face="Times New Roman" size=2>OPTIONEE:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD vAlign=top noWrap align=left width="49%"><FONT face="Times New Roman" size=2>(refer to UBS Financial Services Inc. (&#147;UBS&#148;)<BR>account for
      details)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="49%"><B><FONT face="Times New Roman" size=2>OPTIONS GRANTED:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="49%"><FONT face="Times New Roman" size=2>(refer to UBS account for details)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="49%"><B><FONT face="Times New Roman" size=2>GRANT ID:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="49%"><FONT face="Times New Roman" size=2>(refer to UBS account for details)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="49%"><B><FONT face="Times New Roman" size=2>EXERCISE PER SHARE:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="49%"><FONT face="Times New Roman" size=2>(refer to UBS account for details)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="49%"><B><FONT face="Times New Roman" size=2>DATE OF GRANT:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="49%"><FONT face="Times New Roman" size=2>(refer to UBS account for details)</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="49%"><B><FONT face="Times New Roman" size=2>EXPIRATION DATE:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="49%"><FONT face="Times New Roman" size=2>Ten years from Date of Grant</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=right width="49%"><B><FONT face="Times New Roman" size=2>VESTING SCHEDULE:</FONT></B></TD>
    <TD vAlign=top noWrap align=left width="1%"></TD>
    <TD vAlign=top noWrap align=left width="49%"><FONT face="Times New Roman" size=2>25% on each of the first four anniversaries of the<BR>Date of
      Grant</FONT></TD></TR></TABLE><BR>
<P align=left><U><FONT face="Times New Roman" size=2>AGREEMENT</FONT></U><FONT face="Times New Roman" size=2> </FONT></P>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>1.</FONT></TD>
    <TD width="101%" colSpan=2><U><FONT face="Times New Roman" size=2>Grant of
      Option</FONT></U><FONT face="Times New Roman" size=2>. The Company hereby
      grants to the Optionee the Option to purchase the Shares at the Exercise
      Price, subject to the terms, definitions and provisions of the Plan and
      this Agreement. All terms, provisions, and conditions applicable to the
      Option set forth in the Plan and not set forth herein are incorporated by
      reference. To the extent any provision hereof is inconsistent with a
      provision of the Plan, the provisions of the Plan will govern. All
      capitalized terms that are used in this Agreement and not otherwise
      defined herein shall have the meanings ascribed to them in the
    Plan.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="101%" colSpan=2></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>2.</FONT></TD>
    <TD width="101%" colSpan=2><U><FONT face="Times New Roman" size=2>Exercise
      of Option</FONT></U><FONT face="Times New Roman" size=2>.</FONT></TD></TR>
  <TR>
    <TD colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>a.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Right to
      Exercise</FONT></U><FONT face="Times New Roman" size=2>. This Option shall
      be exercisable prior to the expiration date set forth above (the
      &#147;Expiration Date&#148;), in accordance with the vesting schedule set forth
      above (the &#147;Vesting Schedule&#148;) and with the applicable provisions of the
      Plan and this Agreement. Except as otherwise specifically provided in this
      Agreement, in no event may this Option be exercised after the Expiration
      Date. Although vested within the meaning of Section 83 of the Internal
      Revenue Code since no substantial risk of forfeiture exists once the
      options become exercisable according to the Vesting Schedule above, the
      Options will not be earned until the Optionee has fulfilled all of the
      conditions precedent set forth in this Agreement, including, but not
      limited to, the obligations set forth in Sections 7(b), 7(c), 7(d), 7(e)
      and Section 8, and the Optionee shall have no right to retain the Shares
      or the value thereof upon vesting or exercise of the Options until all
      conditions precedent have been satisfied.</FONT></TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"></TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>b.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Method of
      Exercise</FONT></U><FONT face="Times New Roman" size=2>. This Option shall
      be exercisable only by delivery of an exercise notice (the &#147;Exercise
      Notice&#148;), available on the UBS website, the Company&#146;s designee, which
      shall state the election to exercise the Option, the whole number of
      vested Shares in respect of which the Option is being exercised and such
      other provisions as may be required by the Committee. Such Exercise Notice
      shall be signed by the Optionee and shall be delivered by mail or fax, to
      the Company&#146;s designee accompanied by payment of the Exercise Price. The
      Company may require the Optionee to furnish or execute such other
      documents as the Company shall reasonably deem necessary (1) to evidence
      such exercise and (2) to comply with or satisfy the requirements of the
      Securities Act of 1933, as amended, the Exchange Act, or any Applicable
      Laws. The Option shall be
      deemed to be exercised upon receipt by the Company&#146;s designee of such
      written notice accompanied by the Exercise
Price.</FONT></TD></TR>
  </TABLE>
<P align=center><FONT face="Times New Roman" size=2>- 1 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0>

  <TR>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top noWrap width="1%"></TD>
    <TD align=left width="97%" colSpan=2>
      <P align=left><FONT face="Times New Roman" size=2>No Shares will be issued
      pursuant to the exercise of the Option unless such issuance and such
      exercise shall comply with all Applicable Laws. Assuming such compliance,
      for income tax purposes, the Shares shall be considered transferred to the
      Optionee on the date on which the Option is exercised with respect to such
      Shares. </FONT></P></TD></TR>
  <TR>
    <TD noWrap width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top noWrap width="1%"></TD>
    <TD align=left width="97%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>c.</FONT></TD>
    <TD align=left width="97%" colSpan=2><U><FONT face="Times New Roman" size=2>Taxes</FONT></U><FONT face="Times New Roman" size=2>. Pursuant to
      Section 16 of the Plan, the Committee shall have the power and the right
      to deduct or withhold, or require the Optionee to remit to the Company, an
      amount sufficient to satisfy any applicable tax withholding requirements
      applicable to this Option. The Committee may condition the issuance of
      Shares upon the Optionee&#146;s satisfaction of such withholding obligations.
      The Optionee may elect to satisfy all or part of such withholding
      requirement by tendering previously-owned Shares or by having the Company
      withhold Shares having a Fair Market Value equal to the minimum statutory
      tax withholding rate that could be imposed on the transaction (or such
      other rate that will not result in a negative accounting impact) or in
      such other manner as is acceptable to the Company. Such election shall be
      irrevocable, made in writing, signed by the Optionee, and shall be subject
      to any restrictions or limitations that the Committee, in its sole
      discretion, deems appropriate.</FONT></TD></TR>
  <TR>
    <TD width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>3.</FONT></TD>
    <TD width="98%" colSpan=3><U><FONT face="Times New Roman" size=2>Method of
      Payment</FONT></U><FONT face="Times New Roman" size=2>. Pursuant to
      Section 6(f) of the Plan and subject to such limitations as the Committee
      may impose (including prohibition of one or more of the following payment
      methods), payment of the Exercise Price may be made in cash or by check,
      Shares or a combination thereof.</FONT></TD></TR>
  <TR>
    <TD width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>4.</FONT></TD>
    <TD width="98%" colSpan=3><U><FONT face="Times New Roman" size=2>Termination of Employment or Service and Expiration of Exercise
      Period</FONT></U><FONT face="Times New Roman" size=2>.</FONT></TD></TR>
  <TR>
    <TD width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>a.</FONT></TD>
    <TD align=left width="97%" colSpan=2><U><FONT face="Times New Roman" size=2>Termination of Employment or Service</FONT></U><FONT face="Times New Roman" size=2>. If the Optionee&#146;s employment or service
      with the Company and its Subsidiaries is terminated, the Optionee may
      exercise all or part of this Option prior to the expiration dates set
      forth in paragraph (b) herein, but only to the extent that the Option had
      become vested before the Optionee&#146;s employment or service terminated.
      Notwithstanding the above, if the Optionee&#146;s termination of employment or
      service (1) is due to Retirement and is more than 12 months from the Date
      of Grant set forth in this Agreement, or (2) is due to death or
      Disability, the Option shall become 100% vested and shall remain
      exercisable until the expiration dates determined pursuant to paragraph
      (b) of this Section.</FONT></TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top noWrap width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD align=left width="97%" colSpan=2></TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD noWrap width="1%"></TD>
    <TD align=left width="97%" colSpan=2><FONT face="Times New Roman" size=2>When the Optionee&#146;s employment or service with the Company and its
      Subsidiaries terminates (except when due to Retirement, death or
      Disability), this Option shall expire immediately with respect to the
      number of Shares for which the Option is not yet vested. If the Optionee
      dies after termination of employment or service, but before the expiration
      of the Option, all or part of this Option may be exercised (prior to
      expiration) by the personal representative of the Optionee or by any
      person who has acquired this Option directly from the Optionee by will,
      bequest or inheritance, but only to the extent that the Option was vested
      and exercisable upon termination of the Optionee&#146;s employment or
      service.</FONT></TD></TR>
  <TR>
    <TD width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>b.</FONT></TD>
    <TD align=left width="97%" colSpan=2><U><FONT face="Times New Roman" size=2>Expiration of Exercise Period</FONT></U><FONT face="Times New Roman" size=2>. Upon termination of the Optionee&#146;s
      employment or service with the Company and its Subsidiaries, the Option
      shall expire on the earliest of the following occasions:</FONT></TD></TR>
  <TR>
    <TD width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top noWrap align=left width="1%"><FONT face="Times New Roman" size=2>i.</FONT></TD>
    <TD width="96%"><FONT face="Times New Roman" size=2>The Expiration
      Date;</FONT></TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top noWrap align=left width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="96%"></TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top noWrap align=left width="1%"><FONT face="Times New Roman" size=2>ii.</FONT></TD>
    <TD width="96%"><FONT face="Times New Roman" size=2>The date ninety (90)
      days following the termination of the Optionee&#146;s employment or service for
      any reason other than Cause, death, Disability, or
Retirement;</FONT></TD></TR>
  <TR>
    <TD width="99%" colSpan=4>&nbsp; </TD></TR>
  <TR>
    <TD noWrap width="1%">&nbsp;</TD>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top noWrap align=left width="1%"><FONT face="Times New Roman" size=2>iii.</FONT></TD>
    <TD width="96%"><FONT face="Times New Roman" size=2>The date one year
      following the termination of the Optionee&#146;s employment or service due to
      death or Disability;</FONT></TD></TR>
  <TR>
    <TD width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top noWrap align=left width="1%"><FONT face="Times New Roman" size=2>iv.</FONT></TD>
    <TD width="96%"><FONT face="Times New Roman" size=2>The date five (5)
      years following the termination of the Optionee&#146;s employment or service
      due to Retirement, provided the Optionee&#146;s Retirement is more than 12
      months from the Date of Grant set forth in this Agreement; or</FONT></TD></TR>
  <TR>
    <TD width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top noWrap align=left width="1%"><FONT face="Times New Roman" size=2>v.</FONT></TD>
    <TD width="96%"><FONT face="Times New Roman" size=2>The date of
      termination of the Optionee&#146;s employment or service for
  Cause.</FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>- 2 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD noWrap width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">c.</FONT></TD>
    <TD width="97%" colSpan=2>
      <P align=left><FONT face="Times New Roman" size=2><U>Definition of
      &#147;Retirement.</U><FONT face="Times New Roman">&#148; For purposes of this
      Agreement, the Optionee&#146;s employment or service shall be deemed to have
      terminated due to &#147;Retirement&#148; if the Optionee terminates employment or
      service as an Employee for any reason, including Disability (but other
      than for Cause) after (1) twenty (20) or more years of &#147;vesting service,&#148;
      which solely for purposes of this Agreement, shall be calculated under
      Article </FONT>III of The Clorox Company 401(k) Plan (the &#147;401(k) Plan&#148;)
      entitled &#147;Service&#148; along with any other relevant provisions of the 401(k)
      Plan necessary or desirable to give full effect thereto, or any successor
      provisions, regardless of the status of the Optionee with respect to the
      401(k) Plan (&#147;Vesting Service&#148;), or (2) attaining age fifty-five (55) with
      ten (10) or more years of Vesting Service. </FONT></P></TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top width="1%"></TD>
    <TD width="97%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top width="1%"><FONT face="Times New Roman" size=2>d.</FONT></TD>
    <TD width="97%" colSpan=2><U><FONT face="Times New Roman" size=2>Definition of &#147;Disability.</FONT></U><FONT face="Times New Roman" size=2>&#148; For purposes of this Agreement, the Optionee&#146;s employment shall
      be deemed to have terminated due to the Optionee&#146;s Disability if the
      Optionee is entitled to long-term disability benefits under the Company&#146;s
      long-term disability plan or policy, as in effect on the date of
      termination of the Optionee&#146;s employment.</FONT></TD></TR>
  <TR>
    <TD noWrap width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>5.</FONT></TD>
    <TD width="98%" colSpan=3><U><FONT face="Times New Roman" size=2>Change in
      Control</FONT></U><FONT face="Times New Roman" size=2>. Upon the
      occurrence of a Change in Control, unless otherwise specifically
      prohibited under Applicable Laws or by the rules and regulations of any
      governing governmental agencies or national securities exchanges, the
      Option shall become 100% vested and immediately exercisable, unless such
      Option is assumed, converted or replaced by the continuing entity;
      provided, however, that in the event the Participant&#146;s employment is
      terminated without Cause or by the Participant for Good Reason upon or
      within twenty-four (24) months following consummation of a Change in
      Control, any replacement awards will become immediately exercisable. For
      purposes of this Agreement, the term &#147;Good Reason&#148; shall have the meaning
      set forth in any employment agreement or severance agreement or policy
      applicable to the Optionee. If the Optionee is not a party to any
      agreement or covered by a policy in which a definition of &#147;Good Reason&#148; is
      provided, then the following definition shall apply:</FONT></TD></TR>
  <TR>
    <TD noWrap width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD width="98%" colSpan=3><FONT face="Times New Roman" size=2>&#147;Good
      Reason&#148; means resignation of the Optionee in connection with the
      occurrence of any of the following events without the Optionee&#146;s written
      consent (provided that notice of such event is provided within 90 days
      following the first occurrence thereof):</FONT></TD></TR>
  <TR>
    <TD noWrap width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top width="1%"><FONT face="Times New Roman" size=2>a.</FONT></TD>
    <TD width="97%" colSpan=2><FONT face="Times New Roman" size=2>The
      assignment to the Optionee of any duties inconsistent in any material
      respect with the Optionee&#146;s position (including offices, titles and
      reporting requirements), authority, duties or responsibilities as they
      existed at any time during the 120-day period immediately preceding the
      Change in Control, or any other action by the Company which results in a
      material diminution in such position, authority, duties or
      responsibilities, excluding for this purpose an isolated, insubstantial
      and inadvertent action not taken in bad faith and which is remedied by the
      Company promptly after receipt of notice thereof given by the Optionee;
      or</FONT></TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="97%" colSpan=2></TD></TR>
  <TR>
    <TD noWrap width="1%">&nbsp;</TD>
    <TD vAlign=top width="1%"><FONT face="Times New Roman" size=2>b.</FONT></TD>
    <TD width="97%" colSpan=2><FONT face="Times New Roman" size=2>Any material
      reduction by the Company of the Optionee&#146;s Base Salary or bonus target,
      other than an isolated, insubstantial and inadvertent failure not
      occurring in bad faith and which is remedied by the Company promptly after
      receipt of notice thereof given by the Optionee; or</FONT></TD></TR>
  <TR>
    <TD noWrap width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top width="1%"><FONT face="Times New Roman" size=2>c.</FONT></TD>
    <TD width="97%" colSpan=2><FONT face="Times New Roman" size=2>The Company
      requires the Optionee to be based at any office or location which
      increases his commute by more than 50 miles from his commute immediately
      prior to the Change in Control.</FONT></TD></TR>
  <TR>
    <TD noWrap width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD width="98%" colSpan=3><FONT face="Times New Roman" size=2>Any notice
      provided by the Optionee under this &#147;Good Reason&#148; provision shall mean a
      written notice which (1) indicates the specific termination provision in
      the Good Reason definition relied upon, (2) to the extent applicable, sets
      forth in reasonable detail the facts and circumstances claimed to provide
      a basis for termination of the Optionee&#146;s employment under the provision
      so indicated and (3) the Optionee&#146;s intended separation date if the
      Company does not cure the issue (which date shall be not less than thirty
      (30) days after the giving of such notice).</FONT></TD></TR>
  <TR>
    <TD noWrap width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>6.</FONT></TD>
    <TD width="98%" colSpan=3><U><FONT face="Times New Roman" size=2>Transferability of Option</FONT></U><FONT face="Times New Roman" size=2>. This Option shall not be transferable by the Optionee other than
      by will or the laws of descent and distribution, and the Option shall be
      exercisable during the Optionee&#146;s lifetime only by the Optionee or on his
      or her behalf by the Optionee&#146;s guardian or legal
  representative.</FONT></TD></TR>
  <TR>
    <TD noWrap width="99%" colSpan=4>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap width="1%"><FONT face="Times New Roman" size=2>7.</FONT></TD>
    <TD width="98%" colSpan=3><U><FONT face="Times New Roman" size=2>Protection of Trade Secrets and Limitations on
      Exercise</FONT></U><FONT face="Times New Roman" size=2>.</FONT></TD></TR>
  <TR>
    <TD noWrap width="99%" colSpan=4>&nbsp; </TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD vAlign=top width="1%"><FONT face="Times New Roman" size=2>a.</FONT></TD>
    <TD width="97%" colSpan=2><U><FONT face="Times New Roman" size=2>Definitions</FONT></U><FONT face="Times New Roman" size=2>.</FONT></TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD width="1%"></TD>
    <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top width="96%"></TD></TR>
  <TR>
    <TD noWrap width="1%"></TD>
    <TD width="1%"></TD>
    <TD vAlign=top width="1%"><FONT face="Times New Roman" size=2>i.</FONT></TD>
    <TD vAlign=top width="96%"><U><FONT face="Times New Roman" size=2>&#147;Affiliated Company&#148;</FONT></U><FONT face="Times New Roman" size=2> means any organization controlling, controlled by or under common
      control with the Company.</FONT></TD></TR></TABLE>
<P align=center style = "margin-bottom: 8pt; margin-top: 8pt"><FONT face="Times New Roman" size=2>- 3 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0 width="100%">

  <TR>
    <TD noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>ii.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>&#147;Confidential Information&#148;</FONT></U><FONT face="Times New Roman" size=2> means the Company&#146;s technical or business or
      personnel information not readily available to the public or generally
      known in the trade, including inventions, developments, trade secrets and
      other confidential information, knowledge, data and know-how of the
      company or any Affiliated Company, whether or not they originated with the
      Optionee, or information which the Company or any Affiliated Company
      received from third parties under an obligation of
      confidentiality.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>iii.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>&#147;Conflicting Product&#148;</FONT></U><FONT face="Times New Roman" size=2> means any product, process, machine, or
      service of any person or organization, other than the Company or any
      Affiliated Company, in existence or under development that (1) resembles
      or competes with a product, process, machine, or service upon or with
      which the Optionee shall have worked during the two years prior to the
      Optionee&#146;s termination of employment with the Company or any Affiliated
      Company or (2) with respect to which during that period of time the
      Optionee, as a result of his/her job performance and duties, shall have
      acquired knowledge of Confidential Information, and whose use or
      marketability could be enhanced by application to it of Confidential
      Information. For purposes of this section, it shall be conclusively
      presumed that the Optionee has knowledge of information to which s/he has
      been directly exposed through actual receipt or review of memorandum or
      documents containing such information or through actual attendance at
      meetings at which such information was discussed or
      disclosed.<BR>&nbsp;</FONT></TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>iv.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>&#147;Conflicting Organization&#148;</FONT></U><FONT face="Times New Roman" size=2> means any person or organization that is
      engaged in or about to become engaged in research on or development,
      production, marketing or selling of a Conflicting Product.</FONT></TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD noWrap></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%">&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>b.</FONT></TD>
    <TD width="100%" colSpan=2><U><FONT face="Times New Roman" size=2>Right to Retain
      Shares Contingent on Protection of Confidential
      Information</FONT></U><FONT face="Times New Roman" size=2>. In partial
      consideration for the award of this Option, the Optionee agrees that at
      all times, both during and after the term of the Optionee&#146;s employment
      with the Company or any Affiliated Company, to hold in the strictest
      confidence, and not to use (except for the benefit of the Company at the
      Company&#146;s direction) or disclose (except for the benefit of the Company at
      the Company&#146;s direction), regardless of when disclosed to the Optionee,
      any and all Confidential Information of the Company or any Affiliated
      Company. The Optionee understands that for purposes of this Section 7(b),
      Confidential Information further includes, but is not limited to,
      information pertaining to any aspect of the business of the Company or any
      Affiliated Company which is either information not known (or known as a
      result of a wrongful act of the Optionee or of others who were under
      confidentiality obligations as to the item or items involved) by actual or
      potential competitors of the Company or other third parties not under
      confidentiality obligations to the Company. If, prior to the expiration of
      the Option or at any time within one (1) year after the date of exercise
      of all or any portion of the Option, the Optionee discloses or uses, or
      threatens to disclose or use, any Confidential Information other than in
      the course of performing authorized services for the Company (or any
      Affiliated Company), the unexercised portion of the Option, whether vested
      or not, will be immediately forfeited and cancelled, and the Optionee
      shall immediately return to the Company the Shares or the pre-tax income
      derived from any disposition of the Shares.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>c.</FONT></TD>
    <TD width="100%" colSpan=2><U><FONT face="Times New Roman" size=2>No Interference
      with Customers or Suppliers</FONT></U><FONT face="Times New Roman" size=2>. In partial consideration for the award of this Option, in order
      to forestall the disclosure or use of Confidential Information as well as
      to avoid the Optionee&#146;s intentional interference with the contractual
      relations of the Company or any Affiliated Company, the Optionee&#146;s
      intentional interference with prospective economic advantage of the
      Company or any Affiliated Company and to promote fair competition, the
      Optionee agrees that the Optionee&#146;s right to exercise this Option is
      contingent upon the Optionee refraining, prior to the expiration of the
      Option and for a period of one (1) year after the date of exercise, for
      himself/herself or any third party, directly or indirectly, from using
      Confidential Information to (1) divert or attempt to divert from the
      Company (or any Affiliated Company) any business of any kind in which it
      is engaged, or (2) intentionally solicit its customers with which it has a
      contractual relationship as to Conflicting Products, or interfere with the
      contractual relationship with any of its suppliers or customers
      (collectively, &#147;Interfere&#148;). If, during the term of the Option or at any
      time within one (1) year after the date of exercise of all or any portion
      of the Option, the Optionee breaches his/her obligation not to Interfere,
      the Optionee&#146;s right to the Shares upon exercise of the Option shall not
      have been earned and the unexercised portion of the Option, whether vested
      or not, will be immediately cancelled, and the Optionee shall immediately
      return to the Company any Shares acquired upon exercise of the Option or
      the pre-tax income derived from any disposition of such Shares. For
      avoidance of doubt, the <FONT face="Times New Roman" size=2>term
      &#147;Interfere&#148; shall not include any advertisement of Conflicting Products
      through the use of media intended to reach a broad public audience (such
      as television, cable or radio broadcasts, or newspapers or magazines) or
      the broad distribution of coupons through the use of direct mail or
      through independent retail outlets. </FONT><U><FONT face="Times New Roman" size=2>THE OPTIONEE UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO
      AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT
      PROVIDES FOR THE CANCELLATION OF THE UNEXERCISED
      PORTION OF THE OPTION AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF SHARES ISSUED UPON AN
      EXERCISE OF THE OPTION IF THE OPTIONEE SHOULD CHOOSE
      TO VIOLATE THIS &#147;NO INTERFERENCE WITH CUSTOMERS OR
      SUPPLIERS&#148; PROVISION PRIOR TO THE EXPIRATION OF THE OPTION OR WITHIN ONE (1) YEAR AFTER EXERCISE.</FONT></U></FONT></TD></TR></TABLE>
<P style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt" align=center><FONT face="Times New Roman" size=2>- 4 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0 width="100%">

  <TR>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>d.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>No Solicitation of Employees</FONT></U><FONT face="Times New Roman" size=2>. In partial consideration for the award of
      this Option, in order to forestall the disclosure or use of Confidential
      Information, as well as to deter the Optionee&#146;s intentional interference
      with the contractual relations of the Company or any Affiliated Company,
      the Optionee&#146;s intentional interference with prospective economic
      advantage of the Company or any Affiliated Company, and to promote fair
      competition, the Optionee agrees that the Optionee&#146;s right to exercise
      this Option is contingent upon the Optionee refraining, prior to the
      expiration of the Option and for a period of one (1) year after the date
      of exercise, for himself/herself or any third party, directly or
      indirectly, from soliciting for employment any person employed by the
      Company, or by any Affiliated Company, during the period of the solicited
      person&#146;s employment and for a period of one (1) year after the termination
      of the solicited person&#146;s employment with the Company or any Affiliated
      Company (collectively &#147;Solicit&#148;). If, during the term of the Option or at
      any time within one (1) year after the date of exercise of all or any
      portion of the Option, the Optionee breaches his/her obligation not to
      Solicit, the Optionee&#146;s right to the Shares upon exercise of the Option
      shall not have been earned and the unexercised portion of the Option,
      whether vested or not, will be immediately cancelled, and the Optionee
      shall immediately return to the Company any Shares acquired upon exercise
      of the Option or the pre-tax income derived from any disposition of such
      Shares. </FONT><U><FONT face="Times New Roman" size=2>THE OPTIONEE
      UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES NOT PROHIBIT THE CONDUCT DESCRIBED, BUT
      PROVIDES FOR THE CANCELLATION OF THE UNEXERCISED PORTION OF THE OPTION AND
      A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS TAXABLE PROCEEDS OF
      SHARES ISSUED UPON AN EXERCISE OF THE OPTION IF THE OPTIONEE SHOULD CHOOSE
      TO VIOLATE THIS NON-SOLICITATION OF EMPLOYEES PROVISION PRIOR TO THE
      EXPIRATION OF THE OPTION OR WITHIN ONE (1) YEAR AFTER
    EXERCISE.</FONT></U></TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"></TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>e.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Injunctive and Other Available
      Relief</FONT></U><FONT face="Times New Roman" size=2>. By acceptance of
      this Option, the Optionee acknowledges that, if the Optionee were to
      breach or threaten to breach his/her obligation hereunder not to Interfere
      or Solicit or not to disclose or use any Confidential Information other
      than in the course of performing authorized services for the Company (or
      any Affiliated Company), the harm caused to the Company by such breach or
      threatened breach would be, by its nature, irreparable because, among
      other things, damages would be significant and the monetary harm that
      would ensue would not be able to be readily proven, and that the Company
      would be entitled to injunctive and other appropriate relief to prevent
      threatened or continued breach and to such other remedies as may be
      available at law or in equity. To the extent not prohibited by law, any
      cancellation of the Option pursuant to any of Sections 7(b) through 7(d)
      above shall not restrict, abridge or limit in any fashion the types and
      scope of injunctive and other available relief to the
Company. Notwithstanding any provision of this
      Agreement to the contrary, nothing under this Agreement shall limit,
      abridge, modify or otherwise restrict the Company (or any Affiliated
      Company) from pursuing any or all legal, equitable or other appropriate
      remedies to which the Company may be entitled under any other agreement
      with the Optionee, any other plan, program, policy or arrangement of the
      Company (or any Affiliated Company) under which the Optionee is covered or
      participates, or any applicable law, all to the fullest extent not
      prohibited under applicable law.</FONT></TD></TR>


  <TR>
    <TD noWrap></TD>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>f.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Permitted Reporting and
      Disclosure</FONT></U><FONT face="Times New Roman" size=2>. Notwithstanding
      any language in this Agreement to the contrary, nothing in this Agreement
      prohibits Optionee from reporting possible violations of federal law or
      regulation to any governmental agency or governmental entity, or making
      other disclosures that are protected under federal law or regulation;
      provided, that, in each case such communications and disclosures are
      consistent with applicable law. Notwithstanding the foregoing, under no
      circumstance is Optionee authorized to disclose any information covered by
      the Company&#146;s attorney-client privilege or attorney work <FONT face="Times New Roman" size=2>product or the Company&#146;s trade secrets
      without prior written consent of the Company&#146;s General Counsel. Any
      reporting or disclosure permitted under this Section 7(f) shall not result
      in the cancellation of Options. Optionee is entitled to certain immunities
      from liability under state and federal law for disclosing trade secrets if
      the disclosure was made to report or investigate an alleged violation of
      law, subject to certain conditions. Please see the Company&#146;s Confidential
      Information Policy for further details.</FONT></FONT></TD></TR></TABLE>
<P align=center><FONT face="Times New Roman" size=2>- 5 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0 width="100%">

  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>8.</FONT></TD>
    <TD width="100%" colSpan=2><U><FONT face="Times New Roman" size=2>Right to
      Retain Shares Contingent on Continuing Non-Conflicting
      Employment</FONT></U><FONT face="Times New Roman" size=2>. In partial
      consideration for the award of this Option in order to forestall the
      disclosure or use of Confidential Information, as well as to deter the
      Optionee&#146;s intentional interference with the contractual relations of the
      Company or any Affiliated Company, the Optionee&#146;s intentional interference
      with prospective economic advantage of the Company or any Affiliated
      Company, and to promote fair competition, the Optionee agrees that the
      Optionee&#146;s right to exercise this Option is contingent upon the Optionee
      refraining, prior to the expiration of the Option and for a period of one
      (1) year after the date of exercise, from rendering services, directly or
      indirectly, as director, officer, employee, agent, consultant or
      otherwise, to any Conflicting Organization except a Conflicting
      Organization whose business is diversified and that, as to that part of
      its business to which the Optionee renders services, is not a Conflicting
      Organization, provided that the Company shall receive separate written
      assurances satisfactory to the Company from the Optionee and the
      Conflicting Organization that the Optionee shall not render services
      during such period with respect to a Conflicting Product. If, prior to the
      expiration of the Option or at any time within one (1) year after the date
      of exercise of all or any portion of the Option, the Optionee shall render
      services to any Conflicting Organization other than as expressly permitted
      herein, the Optionee&#146;s right to the Shares upon exercise of the Option
      shall not have been earned and the unexercised portion of the Option,
      whether vested or not, will be immediately cancelled, and the Optionee
      shall immediately return to the Company any Shares acquired upon exercise
      of the Option or the pre-tax income derived from any disposition of such
      Shares. </FONT><U><FONT face="Times New Roman" size=2>THE OPTIONEE
      UNDERSTANDS THAT THIS PARAGRAPH IS NOT INTENDED TO AND DOES
      NOT PROHIBIT THE OPTIONEE FROM RENDERING SERVICES TO A CONFLICTING
      ORGANIZATION, BUT PROVIDES FOR THE CANCELLATION OF THE UNEXERCISED PORTION
      OF THE OPTION AND A RETURN TO THE COMPANY OF THE SHARES OR THE GROSS
      TAXABLE PROCEEDS OF SHARES ISSUED UPON AN EXERCISE OF THE OPTION IF THE
      OPTIONEE SHOULD CHOOSE TO RENDER SUCH SERVICES PRIOR TO THE EXPIRATION OF
      THE OPTION OR WITHIN ONE (1) YEAR AFTER EXERCISE.</FONT></U></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%" colSpan=2></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>9.</FONT></TD>
    <TD width="100%" colSpan=2><U><FONT face="Times New Roman" size=2>Repayment Obligation</FONT></U><FONT face="Times New Roman" size=2>. In the event that (1) the Company issues a significant
      restatement of financial results and (2) the Committee determines, in good
      faith, that the Optionee&#146;s fraud or misconduct was a significant
      contributing factor to such restatement and (3) some or all of the Option
      that was granted and/or vested prior to such restatement would not have
      been granted and/or vested, as applicable, based upon the restated
      financial results, the Optionee shall immediately return to the Company
      the unexercised portion of the Option and any Shares or the pre-tax income
      derived from any disposition of the Shares previously received in upon
      exercise of the Option that would not have been granted and/or vested
      based upon the restated financial results. Notwithstanding anything herein to the contrary, in no event shall
      the Repayment Obligation apply to any portion of the Option that vested
      more than four years prior to the date the applicable restatement is
      announced. The Company shall be able to enforce the Repayment Obligation
      by all legal means available, including, without limitation, by
      withholding such amount from other sums owed by the Company to the
      Optionee.</FONT></TD></TR>

  <TR>
    <TD colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>10.</FONT></TD>
    <TD width="100%" colSpan=2><U><FONT face="Times New Roman" size=2>Miscellaneous Provisions</FONT></U><FONT face="Times New Roman" size=2>.</FONT></TD></TR>
  <TR>
    <TD colSpan=3>&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>a.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Rights as a
      Stockholder</FONT></U><FONT face="Times New Roman" size=2>. Neither the
      Optionee nor the Optionee&#146;s transferee or representative shall have any
      rights as a stockholder with respect to any Shares subject to this Option
      until the Option has been exercised and Share certificates have been
      issued to the Optionee, transferee or representative, as the case may
      be.</FONT></TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%">&nbsp;</TD></TR>
  <TR>
    <TD></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>b.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Choice of Law,
      Exclusive Jurisdiction and Venue</FONT></U><FONT face="Times New Roman" size=2>. This Agreement shall be governed by, and construed in accordance
      with, the laws of the State of Delaware, excluding any conflicts or choice
      of law rule or principle that might otherwise refer construction or
      interpretation of this Agreement to the substantive law of another
      jurisdiction. </FONT><B><U><FONT face="Times New Roman" size=2>The courts
      of the State of Delaware shall have exclusive jurisdiction over any
      disputes or other proceedings relating to this Agreement, and venue shall
      reside with the courts in New Castle County, Delaware, including if
      jurisdiction shall so permit, the U.S. District Court for the District of
      Delaware.</FONT></U></B><FONT face="Times New Roman" size=2> Accordingly,
      the Optionee agrees that any claim of any type relating to this <FONT face="Times New Roman" size=2>Agreement must be brought and maintained in
      the appropriate court located in New Castle County, Delaware, including if
      jurisdiction will so permit, in the U.S. District Court for the State of
      Delaware. The Optionee hereby consents to the jurisdiction over the
      Optionee of any such courts and waives all objections based on venue or
      inconvenient forum. </FONT></FONT></TD></TR></TABLE>
      <P align=center><FONT face="Times New Roman" size=2>- 6 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 border=0 width="100%">

  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>c.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Modification or
      Amendment</FONT></U><FONT face="Times New Roman" size=2>. This Agreement
      may be modified or amended by the Board or the Committee at any time;
      provided, however, no modification or amendment to this Agreement shall be
      made which would materially and adversely affect the rights of the
      Optionee, without such Optionee&#146;s written consent.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD vAlign=top noWrap><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD width="100%"></TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>d.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Severability</FONT></U><FONT face="Times New Roman" size=2>. In the
      event any provision of this Agreement shall be held illegal or invalid for
      any reason, the illegality or invalidity shall not affect the remaining
      provisions of this Agreement, and this Agreement shall be construed and
      enforced to reflect the intent of the parties to the fullest extent not
      prohibited by law, and in the event that such provision is not able to be
      so construed and enforced, then this Agreement shall be construed and
      enforced as if such illegal or invalid provision had not been included. In
      amplification of the preceding sentence, in the event that the time period
      or scope of any provision is declared by a court or arbitrator of
      competent jurisdiction to exceed the maximum time period or scope that
      such court or arbitrator deems enforceable, then such court or arbitrator
      shall have the power to reduce the time period or scope to the maximum
      time period or scope permitted by law.</FONT></TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>e.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>References to
      Plan</FONT></U><FONT face="Times New Roman" size=2>. All references to the
      Plan shall be deemed references to the Plan as may be
amended.</FONT></TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>f.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Headings</FONT></U><FONT face="Times New Roman" size=2>. The
      captions used in this Agreement are inserted for convenience and shall not
      be deemed a part of this Option for construction or
    interpretation.</FONT></TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>g.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Interpretation</FONT></U><FONT face="Times New Roman" size=2>. Any
      dispute regarding the interpretation of this Agreement shall be submitted
      by the Optionee or by the Company forthwith to the Board or the Committee,
      which shall review such dispute at its next regular meeting. The
      resolution of such dispute by the Board or the Committee shall be final
      and binding on all persons. It is the intention of the Company and the
      Optionee to make the promises contained in this Agreement reasonable and
      binding only to the extent that it may be lawfully done under existing
      applicable laws. This Agreement and the Plan constitute the entire and
      exclusive agreement between the Optionee and the Company, and it
      supersedes all prior agreements or understandings, whether written or
      oral, with respect to the grant of Options set forth in this
      Agreement.</FONT></TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>h.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Section 409A
      Compliance</FONT></U><FONT face="Times New Roman" size=2>. To the extent
      applicable, it is intended that the Plan and this Agreement comply with
      the requirements of Section 409A of the Internal Revenue Code of 1986, as
      amended (the &#147;Code&#148;) and any related regulations or other guidance
      promulgated with respect to such Section by the U.S. Department of the
      Treasury or the Internal Revenue Service (&#147;Section 409A&#148;). Any provision
      of the Plan or this Agreement that would cause this Award to fail to
      satisfy Section 409A shall have no force or effect until amended to comply
      with Section 409A, which amendment may be retroactive to the extent
      permitted by Section 409A.</FONT></TD></TR>
  <TR>
    <TD noWrap></TD>
    <TD width="100%" colSpan=2>&nbsp;</TD></TR>
  <TR>
    <TD vAlign=top noWrap></TD>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>i.</FONT></TD>
    <TD width="100%"><U><FONT face="Times New Roman" size=2>Agreement with
      Terms</FONT></U><FONT face="Times New Roman" size=2>. Receipt of any
      benefits under this Agreement by the Optionee shall constitute the
      Optionee&#146;s acceptance of and agreement with all of the provisions of this
      Agreement and of the Plan that are applicable to this Agreement, and the
      Company shall administer this Agreement
accordingly.</FONT></TD></TR></TABLE><BR>
<DIV align=right>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="50%" border=0>

  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="100%" colSpan=2><B><FONT face="Times New Roman" size=2 >THE CLOROX
      COMPANY<BR>&nbsp;</FONT></B></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >By:&nbsp;</FONT></TD>
    <TD vAlign=top noWrap align=left width="99%"><FONT face="Times New Roman" size=2 >/s/ Benno
      Dorer<BR>&nbsp;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD vAlign=top noWrap align=left width="1%"><FONT face="Times New Roman" size=2 >Its:</FONT></TD>
    <TD vAlign=top noWrap align=left width="99%"><FONT face="Times New Roman" size=2 >Chairman and
      Chief Executive Officer</FONT></TD></TR></TABLE></DIV><BR>
<P align=center><FONT face="Times New Roman" size=2>- 7 - </FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV><BR>
<P align=left><FONT face="Times New Roman" size=2>THE OPTIONEE ACKNOWLEDGES AND
AGREES THAT THIS AGREEMENT IS A UNILATERAL CONTRACT AND THAT THE OPTIONEE&#146;S
RIGHT TO THE SHARES PURSUANT TO THE OPTION HEREOF IS ACCEPTED AND EARNED ONLY BY
CONTINUING EMPLOYMENT AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING
HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER)
AND BY COMPLIANCE WITH THE OPTIONEE&#146;S VARIOUS OBLIGATIONS UNDER THIS AGREEMENT.
THE OPTIONEE FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS AGREEMENT, NOR
IN THE PLAN, SHALL CONFER UPON THE OPTIONEE ANY RIGHT WITH RESPECT TO
CONTINUATION OF EMPLOYMENT BY THE COMPANY, NOR SHALL IT INTERFERE IN ANY WAY
WITH THE OPTIONEE&#146;S RIGHT OR THE COMPANY&#146;S RIGHT TO TERMINATE THE OPTIONEE&#146;S
EMPLOYMENT AT ANY TIME, FOR ANY REASON OR NO REASON, WITH OR WITHOUT CAUSE, AND
WITH OR WITHOUT ADVANCE NOTICE EXCEPT AS MAY BE REQUIRED BY APPLICABLE LAW.
</FONT></P>
<P align=left><FONT face="Times New Roman" size=2>The Optionee acknowledges that
a copy of the Plan and Plan Information are available for viewing on the
Company&#146;s internal HR website at </FONT><FONT face="Times New Roman" size=2>https://clxweb.clorox.com/hr/Pages/HRatClorox/HRContentPages/StockIncentiveProgram.aspx</FONT><FONT face="Times New Roman" size=2>, and the Company&#146;s Annual Report and Proxy
Statement (the &#147;Prospectus Information&#148;) are available for viewing on the
Company&#146;s Clorox website at </FONT><FONT face="Times New Roman" size=2>http://investors.thecloroxcompany.com/sec.cfm</FONT><FONT face="Times New Roman" size=2>. The Optionee hereby consents to receive the
Prospectus Information electronically or, in the alternative, to contact the HR
Service Center at 1-800-709-7095 to request a paper copy of the Prospectus
Information. The Optionee represents that s/he is familiar with the terms and
provisions thereof, and hereby accepts this Agreement subject to all of the
terms and provisions thereof. The Optionee has reviewed the Plan and this
Agreement in their entirety, has had an opportunity to obtain the advice of
counsel prior to executing this Agreement and fully understands all provisions
of this Agreement. The Optionee acknowledges and hereby agrees to accept as
binding, conclusive and final all decisions or interpretations of the Committee
upon any questions arising under the Plan or this Agreement. The Optionee
further agrees to notify the Company upon any change in the residence address
indicated below. </FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="80%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>Dated:&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="47%">&nbsp;</TD>
    <TD noWrap align=left width="1%"><FONT face="Times New Roman" size=2>&nbsp;&nbsp;&nbsp;Signed:&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="50%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="1%"></TD>
    <TD noWrap align=left width="47%"></TD>
    <TD noWrap align=left width="1%"></TD>
    <TD style="TEXT-ALIGN: center" noWrap width="50%"><FONT face="Times New Roman" size=2>Optionee</FONT></TD></TR></TABLE><BR>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="65%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="50%">&nbsp;</TD>
    <TD noWrap align=left width="50%"><FONT face="Times New Roman" size=2>Residence
      Address:</FONT></TD></TR>
  <TR>
    <TD noWrap align=left width="50%">&nbsp;</TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="50%">&nbsp;</TD></TR>
  <TR>
    <TD noWrap align=left width="50%"></TD>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="50%">&nbsp;</TD></TR></TABLE><BR>
<P align=center><FONT face="Times New Roman" size=2>- 8 - </FONT></P>
<HR align=center width="100%" noShade size="2">

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>clorox3118958-ex311.htm
<DESCRIPTION>CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>

<P align=right><B><FONT face="Times New Roman" size=2>Exhibit
31.1</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>CERTIFICATION
</FONT></B></P>
<TABLE style="FONT-SIZE: 10pt; PADDING-BOTTOM: 12pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top noWrap></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify">
      <P STYLE="text-align: justify"><FONT face="Times New Roman" size=2>I, Benno
      Dorer,</FONT><B><FONT face="Times New Roman" size=2> </FONT></B><FONT face="Times New Roman" size=2>certify that: </FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 12pt" vAlign=top noWrap><FONT face="Times New Roman" size=2>1.</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>I have reviewed this quarterly report on Form 10-Q of The Clorox
      Company;</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>2.</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>Based on my knowledge, this report does not contain any untrue
      statement of a material fact or omit to state a material fact necessary to
      make the statements made, in light of the circumstances under which such
      statements were made, not misleading with respect to the period covered by
      this report;</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>3.</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>Based on my knowledge, the financial statements, and other
      financial information included in this report, fairly present in all
      material respects the financial condition, results of operations and cash
      flows of the registrant as of, and for, the periods presented in this
      report;</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>4.</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>The registrant&#146;s other certifying officer and I are responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
      control over financial reporting (as defined in Exchange Act Rules
      13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  <TR>
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="padding-right: 12pt; text-align: justify"><FONT face="Times New Roman" size=2>a)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>designed
      such disclosure controls and procedures, or caused such disclosure
      controls and procedures to be designed under our supervision, to ensure
      that material information relating to the registrant, including its
      consolidated subsidiaries, is made known to us by others within those
      entities, particularly during the period in which this report is being
      prepared;</FONT></TD></TR>
  <TR>
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="text-align: justify"><FONT face="Times New Roman" size=2>b)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>designed
      such internal control over financial reporting, or caused such internal
      control over financial reporting to be designed under our supervision, to
      provide reasonable assurance regarding the reliability of financial
      reporting and the preparation of financial statements for external
      purposes in accordance with generally accepted accounting
      principles;</FONT></TD></TR>
  <TR>
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="text-align: justify"><FONT face="Times New Roman" size=2>c)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>evaluated
      the effectiveness of the registrant&#146;s disclosure controls and procedures
      and presented in this report our conclusions about the effectiveness of
      the disclosure controls and procedures, as of the end of the period
      covered by this report based on such evaluation; and</FONT></TD></TR>
  <TR>
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="text-align: justify"><FONT face="Times New Roman" size=2>d)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>disclosed
      in this report any change in the registrant&#146;s internal control over
      financial reporting that occurred during the registrant&#146;s most recent
      fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an
      annual report) that has materially affected, or is reasonably likely to
      materially affect, the registrant&#146;s internal control over financial
      reporting.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>5.</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>The registrant&#146;s other certifying officer and I have disclosed,
      based on our most recent evaluation of internal control over financial
      reporting, to the registrant&#146;s auditors and the audit committee of the
      registrant&#146;s board of directors (or persons performing the equivalent
      functions):</FONT></TD></TR>
  <TR>
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="padding-right: 12pt; text-align: justify"><FONT face="Times New Roman" size=2>a)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>all
      significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect the registrant&#146;s ability to record,
      process, summarize and report financial information; and</FONT></TD></TR>
  <TR style="PADDING-BOTTOM: 0pt">
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="text-align: justify"><FONT face="Times New Roman" size=2>b)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>any fraud,
      whether or not material, that involves management or other employees who
      have a significant role in the registrant&#146;s internal control over
      financial reporting.</FONT></TD></TR></TABLE><BR>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="30%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Date:
      November 2, 2016</FONT></TD></TR>
  <TR>
    <TD width="100%">&nbsp;</TD></TR>
  <TR>
    <TD width="100%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="100%"><FONT face="Times New Roman" size=2>/s/ Benno Dorer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Benno
      Dorer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Chairman and Chief Executive Officer</FONT></TD></TR></TABLE><BR>

<HR align=center width="100%" noShade size="2">


</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>clorox3118958-ex312.htm
<DESCRIPTION>CERTIFICATION BY THE CHIEF FINANCIAL OFFICER
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit
31.2</FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>CERTIFICATION
</FONT></B></P>
<TABLE style="FONT-SIZE: 10pt; PADDING-BOTTOM: 12pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD vAlign=top noWrap></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify">
      <P STYLE="text-align: justify"><FONT face="Times New Roman" size=2>I, Stephen M. Robb,
      certify that:</FONT></P></TD></TR>
  <TR>
    <TD style="PADDING-RIGHT: 12pt" vAlign=top noWrap><FONT face="Times New Roman" size=2>1.</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>I have reviewed this
      quarterly report on Form 10-Q of The Clorox Company;</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>2.</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>Based on my
      knowledge, this report does not contain any untrue statement of a material
      fact or omit to state a material fact necessary to make the statements
      made, in light of the circumstances under which such statements were made,
      not misleading with respect to the period covered by this
  report;</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>3.</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>Based on my
      knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the
      financial condition, results of operations and cash flows of the
      registrant as of, and for, the periods presented in this
  report;</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>4.</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>The registrant&#146;s
      other certifying officer and I are responsible for establishing and
      maintaining disclosure controls and procedures (as defined in Exchange Act
      Rules 13a-15(e) and 15d-15(e)) and internal control over financial
      reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
      the registrant and have:</FONT></TD></TR>
  <TR>
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="padding-right: 12pt; text-align: justify"><FONT face="Times New Roman" size=2>a)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>designed such
      disclosure controls and procedures, or caused such disclosure controls and
      procedures to be designed under our supervision, to ensure that material
      information relating to the registrant, including its consolidated
      subsidiaries, is made known to us by others within those entities,
      particularly during the period in which this report is being
      prepared;</FONT></TD></TR>
  <TR>
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="text-align: justify"><FONT face="Times New Roman" size=2>b)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>designed such
      internal control over financial reporting, or caused such internal control
      over financial reporting to be designed under our supervision, to provide
      reasonable assurance regarding the reliability of financial reporting and
      the preparation of financial statements for external purposes in
      accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR>
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="text-align: justify"><FONT face="Times New Roman" size=2>c)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>evaluated the
      effectiveness of the registrant&#146;s disclosure controls and procedures and
      presented in this report our conclusions about the effectiveness of the
      disclosure controls and procedures, as of the end of the period covered by
      this report based on such evaluation; and</FONT></TD></TR>
  <TR>
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="text-align: justify"><FONT face="Times New Roman" size=2>d)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>disclosed in this
      report any change in the registrant&#146;s internal control over financial
      reporting that occurred during the registrant&#146;s most recent fiscal quarter
      (the registrant&#146;s fourth fiscal quarter in the case of an annual report)
      that has materially affected, or is reasonably likely to materially
      affect, the registrant&#146;s internal control over financial
    reporting.</FONT></TD></TR>
  <TR>
    <TD vAlign=top noWrap><FONT face="Times New Roman" size=2>5.</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" COLSPAN="2" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>The registrant&#146;s
      other certifying officer and I have disclosed, based on our most recent
      evaluation of internal control over financial reporting, to the
      registrant&#146;s auditors and the audit committee of the registrant&#146;s board of
      directors (or persons performing the equivalent functions):</FONT></TD></TR>
  <TR>
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="padding-right: 12pt; text-align: justify"><FONT face="Times New Roman" size=2>a)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>all significant
      deficiencies and material weaknesses in the design or operation of
      internal control over financial reporting which are reasonably likely to
      adversely affect the registrant&#146;s ability to record, process, summarize
      and report financial information; and</FONT></TD></TR>
  <TR style="PADDING-BOTTOM: 0pt">
    <TD vAlign=top></TD>
    <TD VALIGN="TOP" NOWRAP STYLE="text-align: justify"><FONT face="Times New Roman" size=2>b)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>any fraud, whether or
      not material, that involves management or other employees who have a
      significant role in the registrant&#146;s internal control over financial
      reporting.</FONT></TD></TR></TABLE><BR>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="30%" border=0>

  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Date:
      November 2, 2016</FONT></TD></TR>
  <TR>
    <TD width="100%">&nbsp;</TD></TR>
  <TR>
    <TD width="100%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="100%"><FONT face="Times New Roman" size=2>/s/ Stephen M. Robb</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Stephen M.
      Robb</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Executive
      Vice President - Chief Financial Officer</FONT></TD></TR></TABLE><BR>

<HR align=center width="100%" noShade size="2">

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>6
<FILENAME>clorox3118958-ex32.htm
<DESCRIPTION>CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor=#ffffff>
<BR>
<P align=right><B><FONT face="Times New Roman" size=2>Exhibit 32 </FONT></B></P>
<P align=center><B><FONT face="Times New Roman" size=2>CERTIFICATION
</FONT></B></P>
<P STYLE="text-align: justify"><FONT face="Times New Roman" size=2>In connection with the
periodic report of The Clorox Company (the "Company") on Form 10-Q for the
period ended September 30, 2016, as filed with the Securities and Exchange
Commission (the "Report"), we, Benno Dorer, Chairman and Chief Executive Officer of the
Company, and Stephen M. Robb, Chief Financial Officer of the Company, hereby
certify as of the date hereof, solely for purposes of Title 18, Chapter 63,
Section 1350 of the United States Code, that to our knowledge: </FONT></P>
<TABLE style="FONT-SIZE: 10pt; PADDING-BOTTOM: 12pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>

  <TR>
    <TD style="PADDING-RIGHT: 12pt; PADDING-LEFT: 15pt" vAlign=top noWrap><FONT face="Times New Roman" size=2>(1)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>the Report
      fully complies with the requirements of Section 13(a) or 15(d), as
      applicable, of the Securities Exchange Act of 1934, and</FONT></TD></TR>
  <TR style="PADDING-BOTTOM: 0pt">
    <TD style="PADDING-RIGHT: 12pt; PADDING-LEFT: 15pt" vAlign=top noWrap><FONT face="Times New Roman" size=2>(2)</FONT></TD>
    <TD VALIGN="TOP" WIDTH="100%" STYLE="text-align: justify"><FONT face="Times New Roman" size=2>the
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the Company
      at the dates and for the periods indicated.</FONT></TD></TR></TABLE>
<P STYLE="text-align: justify"><FONT face="Times New Roman" size=2>This Certification has not
been, and shall not be deemed, &#147;filed&#148; with the Securities and Exchange
Commission. </FONT></P>
<P STYLE="text-align: justify"><FONT face="Times New Roman" size=2>Date: November 2, 2016
</FONT></P>
<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: collapse" cellSpacing=0 cellPadding=0 width="30%" border=0>

  <TR>
    <TD noWrap align=left width="100%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="100%"><FONT face="Times New Roman" size=2>/s/ Benno Dorer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Benno
      Dorer</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Chairman and Chief Executive Officer</FONT></TD></TR>
  <TR>
    <TD width="100%">&nbsp;</TD></TR>
  <TR>
    <TD width="100%">&nbsp;</TD></TR>
  <TR vAlign=bottom>
    <TD style="BORDER-BOTTOM: #000000 1pt solid" noWrap align=left width="100%"><FONT face="Times New Roman" size=2>/s/ Stephen M. Robb</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Stephen M.
      Robb</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD noWrap align=left width="100%"><FONT face="Times New Roman" size=2>Executive
      Vice President - Chief Financial Officer</FONT></TD></TR></TABLE><BR>

<HR align=center width="100%" noShade size="2">
</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>7
<FILENAME>clx-20160930.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CLX 0916 10Q.xfr; Date: 2016%2D11%2D01T21:25:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80200000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:clx="http://thecloroxcompany.com/20160930">
    <link:schemaRef xlink:href="clx-20160930.xsd" xlink:type="simple" />
    <xbrli:context id="From2016-07-01to2016-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-10-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-10-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_VenezuelanSubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:VenezuelanSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_custom_VenezuelanSubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:VenezuelanSubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_DiscontinuedOperationsOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:DiscontinuedOperationsOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_custom_DiscontinuedOperationsOtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">clx:DiscontinuedOperationsOtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_RenewLifeHoldingsCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:RenewLifeHoldingsCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:RenewLifeHoldingsCorporationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:RenewLifeHoldingsCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clx:RenewLifeHoldingsCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_OpenMarketProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:OpenMarketProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_custom_OpenMarketProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:OpenMarketProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_EvergreenProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_custom_EvergreenProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:EvergreenProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_custom_OpenMarketProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:OpenMarketProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_AccumulatedTranslationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_LongTermIntercompanyLoansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermIntercompanyLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_custom_LongTermIntercompanyLoansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IntercompanyForeignCurrencyBalanceByDescriptionAxis">clx:LongTermIntercompanyLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_RetirementIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_custom_RetirementIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_RetirementHealthCarePlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementHealthCarePlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_custom_RetirementHealthCarePlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:RetirementHealthCarePlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_DomesticQualifiedRetirementIncomePlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">clx:DomesticQualifiedRetirementIncomePlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_CleaningMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_HouseholdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_LifestyleMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_custom_InternationalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_us-gaap_CorporateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_custom_CleaningMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:CleaningMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_custom_HouseholdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:HouseholdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_custom_LifestyleMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:LifestyleMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_custom_InternationalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">clx:InternationalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_us-gaap_CorporateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_WalmartStoresIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_WalmartStoresIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">clx:WalmartStoresIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_BankTimeDepositsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_BankTimeDepositsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_BankTimeDepositsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_BankTimeDepositsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_custom_TrustAssetsForNonqualifiedDeferredCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="invest:InvestmentAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_custom_TrustAssetsForNonqualifiedDeferredCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="invest:InvestmentAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_custom_TrustAssetsForNonqualifiedDeferredCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="invest:InvestmentAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_custom_TrustAssetsForNonqualifiedDeferredCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="invest:InvestmentAxis">clx:TrustAssetsForNonqualifiedDeferredCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_custom_NotesAndLoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_custom_NotesAndLoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_custom_NotesAndLoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_custom_NotesAndLoansPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">clx:NotesAndLoansPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_LongTermDebtMember_custom_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_LongTermDebtMember_custom_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_LongTermDebtMember_custom_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_LongTermDebtMember_custom_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clx:CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CarryingReportedAmountFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_EstimateOfFairValueFairValueDisclosureMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_us-gaap_InterestRateContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2016-09-30_us-gaap_ForeignExchangeContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_us-gaap_InterestRateContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2015-09-30_us-gaap_ForeignExchangeContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2015-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_custom_JetFuelMember_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:DerivativeNatureAxis">clx:JetFuelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_custom_SoybeanOilMember_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:DerivativeNatureAxis">clx:SoybeanOilMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_JetFuelMember_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:DerivativeNatureAxis">clx:JetFuelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_SoybeanOilMember_us-gaap_CommodityContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="clx:DerivativeNatureAxis">clx:SoybeanOilMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CommodityContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_us-gaap_ForeignExchangeContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-09-30_custom_OpenMarketProgramMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000021076</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">clx:OpenMarketProgramMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2016-07-01to2016-09-30">CLOROX CO /DE/</dei:EntityRegistrantName>
    <dei:DocumentType contextRef="From2016-07-01to2016-09-30">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2016-07-01to2016-09-30">2016-09-30</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2016-07-01to2016-09-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2016-07-01to2016-09-30">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2016-07-01to2016-09-30">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2016-07-01to2016-09-30">2017</dei:DocumentFiscalYearFocus>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2016-10-19" unitRef="Shares" decimals="INF">128743698</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCentralIndexKey contextRef="From2016-07-01to2016-09-30">0000021076</dei:EntityCentralIndexKey>
    <dei:EntityFilerCategory contextRef="From2016-07-01to2016-09-30">Large Accelerated Filer</dei:EntityFilerCategory>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-0" decimals="-6">401000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">408000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-09-30" unitRef="USD" decimals="-6">383000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-06-30" unitRef="USD" decimals="-6">382000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-09-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember" unitRef="USD" id="Foot-01-0" decimals="-6">253000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember" unitRef="USD" id="Foot-01-1" decimals="-6">234000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-09-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_BankTimeDepositsMember" unitRef="USD" id="Foot-01-2" decimals="-6">76000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_us-gaap_BankTimeDepositsMember" unitRef="USD" id="Foot-01-3" decimals="-6">79000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-1" decimals="-6">569000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">494000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-2" decimals="-6">443000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">465000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-3" decimals="-6">72000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">49000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2016-09-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-4" decimals="-6">1485000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">1416000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-5" decimals="-6">906000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">917000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-6" decimals="-6">1197000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">1196000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">137000000</us-gaap:Goodwill>
    <clx:TrademarksNet contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-7" decimals="-6">657000000</clx:TrademarksNet>
    <clx:TrademarksNet contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">657000000</clx:TrademarksNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-8" decimals="-6">78000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">76000000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-9" decimals="-6">187000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">204000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-10" decimals="-6">4510000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">4466000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2016-09-30_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">394000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2016-06-30_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">368000000</us-gaap:Assets>
    <us-gaap:CommercialPaper contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-11" decimals="-6">523000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">618000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="AsOf2016-09-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_custom_NotesAndLoansPayableMember" unitRef="USD" id="Foot-02-0" decimals="-6">618000000</us-gaap:CommercialPaper>
    <us-gaap:CommercialPaper contextRef="AsOf2016-06-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_custom_NotesAndLoansPayableMember" unitRef="USD" id="Foot-02-1" decimals="-6">523000000</us-gaap:CommercialPaper>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-12" decimals="-6">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-13" decimals="-6">1035000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">874000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2016-09-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">2000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">4000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-14" decimals="-6">0</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">30000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-15" decimals="-6">1558000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">1522000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-16" decimals="-6">1789000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">1789000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-17" decimals="-6">784000000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">783000000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-18" decimals="-6">82000000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">83000000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-19" decimals="-6">4213000000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">4177000000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2016-09-30_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">2410000000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2016-06-30_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">2317000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-20" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2016-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-21" decimals="-6">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-22" decimals="-6">159000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">159000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-23" decimals="-6">868000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">881000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-24" decimals="-6">2163000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">2238000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-25" decimals="-6">2323000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">2422000000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-26" decimals="-6">-570000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">-567000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2015-09-30" unitRef="USD" decimals="-6">-541000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2015-06-30" unitRef="USD" decimals="-6">-502000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-09-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-354000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2015-09-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-343000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-353000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2015-06-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-300000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-41000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2015-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-50000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2015-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-53000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-06-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">-44000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-172000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2015-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-148000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2015-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-149000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2016-06-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">-173000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-27" decimals="-6">297000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">289000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-06-30" unitRef="USD" id="Foot-00-28" decimals="-6">4510000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">4466000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-06-30" unitRef="USDPShares" decimals="INF">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-09-30" unitRef="USDPShares" decimals="INF">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-06-30" unitRef="USDPShares" decimals="INF">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-09-30" unitRef="USDPShares" decimals="INF">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">158741461</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">158741461</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">129355263</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">128707796</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TreasuryStockShares contextRef="AsOf2016-06-30" unitRef="Shares" decimals="INF">29386198</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2016-09-30" unitRef="Shares" decimals="INF">30033665</us-gaap:TreasuryStockShares>
    <us-gaap:SalesRevenueNet contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">1443000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">1390000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-07-01to2016-09-30_custom_CleaningMember" unitRef="USD" decimals="-6">534000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-07-01to2016-09-30_custom_HouseholdMember" unitRef="USD" decimals="-6">422000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-07-01to2016-09-30_custom_LifestyleMember" unitRef="USD" decimals="-6">236000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-07-01to2016-09-30_custom_InternationalMember" unitRef="USD" decimals="-6">251000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-07-01to2016-09-30_us-gaap_CorporateMember" unitRef="USD" decimals="-6">0</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2015-09-30_custom_CleaningMember" unitRef="USD" decimals="-6">497000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2015-09-30_custom_HouseholdMember" unitRef="USD" decimals="-6">411000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2015-09-30_custom_LifestyleMember" unitRef="USD" decimals="-6">231000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2015-09-30_custom_InternationalMember" unitRef="USD" decimals="-6">251000000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2015-09-30_us-gaap_CorporateMember" unitRef="USD" decimals="-6">0</us-gaap:SalesRevenueNet>
    <us-gaap:CostOfGoodsSold contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">803000000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">765000000</us-gaap:CostOfGoodsSold>
    <us-gaap:GrossProfit contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">640000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">625000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">200000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">186000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AdvertisingExpense contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">128000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">123000000</us-gaap:AdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">31000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">30000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:InterestExpense contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">22000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">23000000</us-gaap:InterestExpense>
    <clx:OtherIncomeExpenseNet contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-5000000</clx:OtherIncomeExpenseNet>
    <clx:OtherIncomeExpenseNet contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-1000000</clx:OtherIncomeExpenseNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">264000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">264000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-07-01to2016-09-30_custom_CleaningMember" unitRef="USD" decimals="-6">164000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-07-01to2016-09-30_custom_HouseholdMember" unitRef="USD" decimals="-6">69000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-07-01to2016-09-30_custom_LifestyleMember" unitRef="USD" decimals="-6">62000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-07-01to2016-09-30_custom_InternationalMember" unitRef="USD" decimals="-6">27000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-07-01to2016-09-30_us-gaap_CorporateMember" unitRef="USD" decimals="-6">-58000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2015-09-30_custom_CleaningMember" unitRef="USD" decimals="-6">149000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2015-09-30_custom_HouseholdMember" unitRef="USD" decimals="-6">82000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2015-09-30_custom_LifestyleMember" unitRef="USD" decimals="-6">59000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2015-09-30_custom_InternationalMember" unitRef="USD" decimals="-6">32000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2015-09-30_us-gaap_CorporateMember" unitRef="USD" decimals="-6">-58000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">85000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">91000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">179000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">173000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2016-07-01to2016-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2015-07-01to2015-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2016-07-01to2016-09-30_custom_DiscontinuedOperationsOtherMember" unitRef="USD" decimals="-6">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="From2015-07-01to2015-09-30_custom_DiscontinuedOperationsOtherMember" unitRef="USD" decimals="-6">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">179000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">172000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="From2016-07-01to2016-09-30" unitRef="USDPShares" decimals="INF">1.39</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="From2015-07-01to2015-09-30" unitRef="USDPShares" decimals="INF">1.34</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="From2016-07-01to2016-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="From2015-07-01to2015-09-30" unitRef="USDPShares" decimals="INF">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-07-01to2016-09-30" unitRef="USDPShares" decimals="INF">1.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-07-01to2015-09-30" unitRef="USDPShares" decimals="INF">1.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2016-07-01to2016-09-30" unitRef="USDPShares" decimals="INF">1.36</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="From2015-07-01to2015-09-30" unitRef="USDPShares" decimals="INF">1.32</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="From2016-07-01to2016-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="From2015-07-01to2015-09-30" unitRef="USDPShares" decimals="INF">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-07-01to2016-09-30" unitRef="USDPShares" decimals="INF">1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-07-01to2015-09-30" unitRef="USDPShares" decimals="INF">1.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-07-01to2016-09-30" unitRef="Shares" decimals="-3">129449000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-07-01to2015-09-30" unitRef="Shares" decimals="-3">129155000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-07-01to2016-09-30" unitRef="Shares" decimals="-3">132193000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2015-07-01to2015-09-30" unitRef="Shares" decimals="-3">131220000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">1911000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">1944000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:DepreciationAndAmortization contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">41000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">41000000</us-gaap:DepreciationAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">12000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">9000000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-2000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-5000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherNoncashIncomeExpense contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">14000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">5000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-74000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-39000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">23000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">30000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">6000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">10000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-153000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-95000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">62000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">18000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">170000000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">135000000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">0</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">12000000</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">170000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">147000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">59000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">28000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-12000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-58000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-16000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">95000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">36000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">110000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">103000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">104000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">99000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-104000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-120000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-1000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-10000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">7000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">1000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="From2016-07-01to2016-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="From2015-07-01to2015-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="From2016-07-01to2016-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="From2015-07-01to2015-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense contextRef="From2016-07-01to2016-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense contextRef="From2015-07-01to2015-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherExpense>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="From2016-07-01to2016-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax contextRef="From2015-07-01to2015-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="From2016-07-01to2016-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation contextRef="From2015-07-01to2015-09-30_custom_VenezuelanSubsidiaryMember" unitRef="USD" decimals="-6">0</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1 contextRef="From2016-07-01to2016-09-30_custom_RenewLifeHoldingsCorporationMember">2016-05-02</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="Pure" decimals="INF">1.00</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="From2016-07-01to2016-09-30_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">290000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="From2016-07-01to2016-09-30_custom_RenewLifeHoldingsCorporationMember">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember_us-gaap_TrademarksMember" unitRef="USD" decimals="-6">134000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-6">36000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">3000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">41000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">61000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="AsOf2016-05-02_custom_RenewLifeHoldingsCorporationMember" unitRef="USD" decimals="-6">290000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">361000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">374000000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">111000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">114000000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">3000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">3000000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryLIFOReserve contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">32000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:InventoryLIFOReserve contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">26000000</us-gaap:InventoryLIFOReserve>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2016-07-01to2016-09-30" unitRef="Pure" decimals="3">.320</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2015-07-01to2015-09-30" unitRef="Pure" decimals="3">.345</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="From2016-07-01to2016-09-30" unitRef="Shares" decimals="-3">2744000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="From2015-07-01to2015-09-30" unitRef="Shares" decimals="-3">2065000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2016-07-01to2016-09-30" unitRef="Shares" decimals="-3">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2015-07-01to2015-09-30" unitRef="Shares" decimals="-3">1271000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="AsOf2016-09-30_custom_OpenMarketProgramMember" unitRef="USD" decimals="-6">750000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="AsOf2015-09-30_custom_OpenMarketProgramMember" unitRef="USD" decimals="-6">750000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="AsOf2016-09-30_custom_OpenMarketProgramMember" unitRef="USD" decimals="-6">750000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2016-07-01to2016-09-30" unitRef="Shares" decimals="-3">883000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2015-07-01to2015-09-30" unitRef="Shares" decimals="-3">1006000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2016-07-01to2016-09-30_custom_OpenMarketProgramMember" unitRef="Shares" decimals="-3">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2015-07-01to2015-09-30_custom_OpenMarketProgramMember" unitRef="Shares" decimals="-3">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2016-07-01to2016-09-30_custom_EvergreenProgramMember" unitRef="Shares" decimals="-3">883000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2015-07-01to2015-09-30_custom_EvergreenProgramMember" unitRef="Shares" decimals="-3">1006000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">113000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">112000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2016-07-01to2016-09-30_custom_OpenMarketProgramMember" unitRef="USD" decimals="-6">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2015-07-01to2015-09-30_custom_OpenMarketProgramMember" unitRef="USD" decimals="-6">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2016-07-01to2016-09-30_custom_EvergreenProgramMember" unitRef="USD" decimals="-6">113000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2015-07-01to2015-09-30_custom_EvergreenProgramMember" unitRef="USD" decimals="-6">112000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-43000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">3000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">3000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">182000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">133000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax contextRef="From2016-07-01to2016-09-30_custom_LongTermIntercompanyLoansMember" unitRef="USD" decimals="-6">0</us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax>
    <us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax contextRef="From2015-07-01to2015-09-30_custom_LongTermIntercompanyLoansMember" unitRef="USD" decimals="-6">-5000000</us-gaap:AdjustmentForLongTermIntercompanyTransactionsNetOfTax>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="From2016-07-01to2016-09-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost contextRef="From2015-07-01to2015-09-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="From2016-07-01to2016-09-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">5000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost contextRef="From2015-07-01to2015-09-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">7000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="From2016-07-01to2016-09-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">5000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets contextRef="From2015-07-01to2015-09-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">4000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="From2016-07-01to2016-09-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses contextRef="From2015-07-01to2015-09-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="From2016-07-01to2016-09-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">3000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="From2015-07-01to2015-09-30_custom_RetirementIncomeMember" unitRef="USD" decimals="-6">5000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="From2016-07-01to2016-09-30_custom_RetirementHealthCarePlansMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost contextRef="From2015-07-01to2015-09-30_custom_RetirementHealthCarePlansMember" unitRef="USD" decimals="-6">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer contextRef="From2016-07-01to2016-09-30_custom_DomesticQualifiedRetirementIncomePlansMember" unitRef="USD" decimals="-6">15000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2016-07-01to2016-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_WalmartStoresIncMember" unitRef="Pure" decimals="2">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-07-01to2015-09-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_WalmartStoresIncMember" unitRef="Pure" decimals="2">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccrualForEnvironmentalLossContingencies contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">13000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <us-gaap:AccrualForEnvironmentalLossContingencies contextRef="AsOf2015-09-30" unitRef="USD" decimals="-6">14000000</us-gaap:AccrualForEnvironmentalLossContingencies>
    <clx:SiteContingencyAgreedPercentageOfCostSharing contextRef="From2016-07-01to2016-09-30" unitRef="Pure" decimals="3">0.243</clx:SiteContingencyAgreedPercentageOfCostSharing>
    <clx:RemediationPeriod contextRef="From2016-07-01to2016-09-30">P30Y</clx:RemediationPeriod>
    <clx:LetterOfCreditBorrowingCapacity contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">10000000</clx:LetterOfCreditBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">0</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2016-09-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">2000000</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue contextRef="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_AccountsPayableAndAccruedLiabilitiesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">4000000</us-gaap:CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-1000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2016-07-01to2016-09-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2016-07-01to2016-09-30_us-gaap_InterestRateContractMember" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2016-07-01to2016-09-30_us-gaap_ForeignExchangeContractMember" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2015-07-01to2015-09-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">-7000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2015-07-01to2015-09-30_us-gaap_InterestRateContractMember" unitRef="USD" decimals="-6">0</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="From2015-07-01to2015-09-30_us-gaap_ForeignExchangeContractMember" unitRef="USD" decimals="-6">6000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-4000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">3000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2016-07-01to2016-09-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">-1000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2016-07-01to2016-09-30_us-gaap_InterestRateContractMember" unitRef="USD" decimals="-6">-2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2016-07-01to2016-09-30_us-gaap_ForeignExchangeContractMember" unitRef="USD" decimals="-6">-1000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2015-07-01to2015-09-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2015-07-01to2015-09-30_us-gaap_InterestRateContractMember" unitRef="USD" decimals="-6">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="From2015-07-01to2015-09-30_us-gaap_ForeignExchangeContractMember" unitRef="USD" decimals="-6">-1000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-09-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">24000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-09-30_custom_JetFuelMember_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">14000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-09-30_custom_SoybeanOilMember_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">10000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">30000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-06-30_custom_JetFuelMember_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">16000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-06-30_custom_SoybeanOilMember_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">14000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-09-30_us-gaap_ForeignExchangeContractMember" unitRef="USD" decimals="-6">57000000</invest:DerivativeNotionalAmount>
    <invest:DerivativeNotionalAmount contextRef="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember" unitRef="USD" decimals="-6">84000000</invest:DerivativeNotionalAmount>
    <clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">4000000</clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits>
    <clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">2000000</clx:DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits>
    <us-gaap:MarginDepositAssets contextRef="AsOf2016-09-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">1000000</us-gaap:MarginDepositAssets>
    <us-gaap:MarginDepositAssets contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember" unitRef="USD" decimals="-6">1000000</us-gaap:MarginDepositAssets>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">8000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <clx:DerivativeIntrumentsMaximumContractDuration contextRef="From2016-07-01to2016-09-30_us-gaap_CommodityContractMember">P2Y</clx:DerivativeIntrumentsMaximumContractDuration>
    <clx:DerivativeIntrumentsMaximumContractDuration contextRef="From2016-07-01to2016-09-30_us-gaap_ForeignExchangeContractMember">P2Y</clx:DerivativeIntrumentsMaximumContractDuration>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="From2016-07-01to2016-09-30" unitRef="USDPShares" decimals="INF">0.80</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared contextRef="From2015-07-01to2015-09-30" unitRef="USDPShares" decimals="2">0.77</us-gaap:CommonStockDividendsPerShareDeclared>
    <clx:ProceedsFromStockOptionsExercisedAndOtherFinancingActivities contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">15000000</clx:ProceedsFromStockOptionsExercisedAndOtherFinancingActivities>
    <clx:ProceedsFromStockOptionsExercisedAndOtherFinancingActivities contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">46000000</clx:ProceedsFromStockOptionsExercisedAndOtherFinancingActivities>
    <clx:ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609 contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">6000000</clx:ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609>
    <clx:ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503 contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">8000000</clx:ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2016-06-30" unitRef="USD" decimals="-6">5000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2016-09-30" unitRef="USD" decimals="-6">3000000</us-gaap:DerivativeLiabilities>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">-1000000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-41000000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-1000000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-41000000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">6000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">4000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">4000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">3000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">2000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">1000000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">2000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">2000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">2000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">1000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">1000000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2016-07-01to2016-09-30" unitRef="USD" decimals="-6">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2015-09-30" unitRef="USD" decimals="-6">-39000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="USD" decimals="-6">-43000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" unitRef="USD" decimals="-6">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2016-07-01to2016-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="From2015-07-01to2015-09-30_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" unitRef="USD" decimals="-6">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <clx:ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609 contextRef="From2016-07-01to2016-09-30" unitRef="Pure" decimals="2">.02</clx:ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_custom_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" unitRef="USD" decimals="-6">62000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="AsOf2016-06-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_custom_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" unitRef="USD" decimals="-6">52000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember" unitRef="USD" id="Foot-01-4" decimals="-6">253000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_MoneyMarketFundsMember" unitRef="USD" id="Foot-01-5" decimals="-6">234000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_BankTimeDepositsMember" unitRef="USD" id="Foot-01-6" decimals="-6">76000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2016-06-30_us-gaap_CashAndCashEquivalentsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_BankTimeDepositsMember" unitRef="USD" id="Foot-01-7" decimals="-6">79000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-09-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-06-30_us-gaap_ForeignExchangeContractMember_us-gaap_OtherCurrentAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-09-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="AsOf2016-06-30_us-gaap_CommodityContractMember_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">1000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="AsOf2016-09-30_us-gaap_LongTermDebtMember_custom_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" id="Foot-03-0" decimals="-6">1911000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="AsOf2016-06-30_us-gaap_LongTermDebtMember_custom_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" id="Foot-03-1" decimals="-6">1922000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">394000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2016-06-30_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">368000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="AsOf2016-09-30_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">2532000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="AsOf2016-06-30_us-gaap_EstimateOfFairValueFairValueDisclosureMember" unitRef="USD" decimals="-6">2450000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:DeferredCompensationPlanAssets contextRef="AsOf2016-09-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_custom_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" unitRef="USD" decimals="-6">62000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:DeferredCompensationPlanAssets contextRef="AsOf2016-06-30_us-gaap_OtherAssetsMember_us-gaap_FairValueInputsLevel1Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember_custom_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" unitRef="USD" decimals="-6">52000000</us-gaap:DeferredCompensationPlanAssets>
    <us-gaap:ShorttermDebtFairValue contextRef="AsOf2016-09-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_custom_NotesAndLoansPayableMember" unitRef="USD" id="Foot-02-2" decimals="-6">618000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:ShorttermDebtFairValue contextRef="AsOf2016-06-30_us-gaap_NotesPayableOtherPayablesMember_us-gaap_FairValueInputsLevel2Member_us-gaap_EstimateOfFairValueFairValueDisclosureMember_custom_NotesAndLoansPayableMember" unitRef="USD" id="Foot-02-3" decimals="-6">523000000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:LongTermDebt contextRef="AsOf2016-09-30_us-gaap_LongTermDebtMember_custom_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" id="Foot-03-2" decimals="-6">1789000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2016-06-30_us-gaap_LongTermDebtMember_custom_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_us-gaap_FairValueInputsLevel2Member_us-gaap_CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" id="Foot-03-3" decimals="-6">1789000000</us-gaap:LongTermDebt>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The unaudited interim condensed consolidated financial statements&#13;for the three months ended September 30, 2016 and 2015, in the opinion of management, reflect all adjustments (consisting of normal&#13;recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows&#13;of The Clorox Company and its subsidiaries (the Company) for the periods presented. However, the financial results for interim&#13;periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Effective September 22, 2014, the Company&amp;#146;s Venezuela&#13;affiliate, Corporaci&amp;#243;n Clorox de Venezuela S.A. (Clorox Venezuela), discontinued its operations. Consequently, the Company&#13;reclassified the financial results of Clorox Venezuela as a discontinued operation in the condensed consolidated financial statements&#13;for all periods presented herein.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Certain information and footnote disclosures normally included&#13;in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have&#13;been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information&#13;in this report should be read in conjunction with the Company&amp;#146;s Annual Report on Form 10-K filed with the SEC for the fiscal&#13;year ended June 30, 2016, which includes a complete set of footnote disclosures including the Company&amp;#146;s significant accounting&#13;policies.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Recently Issued Accounting Standards &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In March 2016, the Financial Accounting Standards Board (FASB)&#13;issued Accounting Standards Update (ASU) No. 2016-09, &amp;#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee&#13;Share-Based Payment Accounting,&amp;#148; which simplifies several aspects of the accounting for share-based payment transactions,&#13;including requiring excess tax benefits and tax deficiencies to be recognized as income tax expense or benefit in the consolidated&#13;statement of earnings. Additionally, the standard requires cash flows from excess tax benefits and deficiencies, previously classified&#13;as a financing activity, to be classified as an operating activity in the consolidated statement of cash flows. The Company adopted&#13;this guidance in the first quarter of fiscal year 2017. Excess tax benefits of $6 were recognized in the consolidated statement&#13;of earnings and classified as an operating activity in the consolidated statement of cash flows during the three months ended September&#13;30, 2016. The prior period consolidated statement of cash flows has not been adjusted as permitted. The adoption resulted in approximately&#13;a 2 percentage point benefit to the Company&amp;#146;s effective tax rate for the first quarter of fiscal year 2017. The guidance allows&#13;for a policy election to account for forfeitures as they occur rather than on an estimated basis. The Company did not make this&#13;election and will continue to account for forfeitures on an estimated basis.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In February 2016, the FASB issued ASU No. 2016-02, &amp;#147;Leases&#13;(Topic 842),&amp;#148; which requires lessees to recognize a right-of-use asset and a lease liability for all leases with terms of&#13;more than 12 months. Recognition, measurement and presentation will depend on the classification of the lease as either a finance&#13;or an operating lease. ASU 2016-02 also requires expanded disclosures about leasing arrangements. The new guidance is effective&#13;for the Company beginning in the first quarter of fiscal year 2020, with early adoption permitted. The Company is currently evaluating&#13;the impact that the adoption of this guidance will have on its consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In April 2015, the FASB issued ASU No. 2015-03, &amp;#147;Simplifying&#13;the Presentation of Debt Issuance Cost,&amp;#148; which requires that debt issuance costs related to a recognized debt liability be&#13;presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.&#13;The Company adopted this standard in the first quarter of fiscal year 2017 and retrospectively applied the standard to the June&#13;30, 2016 consolidated balance sheet, resulting in an $8 reduction in Other assets and Long-term debt. The adoption had no impact&#13;on the Company&amp;#146;s consolidated statement of earnings or consolidated statement of cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In February 2015, the FASB issued ASU No. 2015-02, &amp;#147;Amendments&#13;to the Consolidation Analysis,&amp;#148; which changes the guidance for evaluating whether to consolidate certain legal entities. The&#13;amendments modify the evaluation of whether limited partnerships and similar legal entities are variable interest entities or voting&#13;interest entities. The Company adopted this standard in the first quarter of fiscal year 2017. The adoption did not have an impact&#13;on the Company&amp;#146;s consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"&gt;In May 2014, the FASB issued ASU No. 2014-09,&#13;&amp;#147;Revenue from Contracts with Customers (Topic 606),&amp;#148; which replaces most existing U.S. GAAP revenue recognition guidance&#13;and is intended to improve and converge with international standards the financial reporting requirements for revenue from contracts&#13;with customers. The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services&#13;equal to the amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional&#13;disclosures about the nature, timing and uncertainty of revenue and cash flows arising from contracts with customers, including&#13;information about significant judgments and changes in judgments. The new guidance is effective for the Company beginning in the&#13;first quarter of fiscal year 2019, with the option to early adopt in the first quarter of fiscal year 2018. The Company is currently&#13;evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 2. DISCONTINUED OPERATIONS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"&gt;On September 22, 2014, Clorox Venezuela&#13;announced that it was discontinuing its operations, effective immediately, and seeking to sell its assets. Since fiscal year 2012,&#13;Clorox Venezuela was required to sell more than two thirds of its products at prices frozen by the Venezuelan government. During&#13;this same period, Clorox Venezuela experienced successive years of hyperinflation resulting in significant sustained increases&#13;in its input costs, including packaging, raw materials, transportation and wages. As a result, Clorox Venezuela had been selling&#13;its products at a loss, resulting in ongoing operating losses. Clorox Venezuela repeatedly met with government authorities in an&#13;effort to help them understand the rapidly declining state of the business, including the need for immediate, significant and ongoing&#13;price increases and other critical remedial actions to address these adverse impacts. Based on the Venezuelan government&amp;#146;s&#13;representations, Clorox Venezuela had expected significant price increases would be forthcoming much earlier; however, the price&#13;increases subsequently approved were insufficient and would have caused Clorox Venezuela to continue operating at a significant&#13;loss into the foreseeable future. As such, Clorox Venezuela was no longer financially viable and was forced to discontinue its&#13;operations.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"&gt;On September 26, 2014, the Company reported&#13;that Venezuelan Vice President Jorge Arreaza announced, with endorsement by President Nicol&amp;#225;s Maduro, that the Venezuelan&#13;government had occupied the Santa Luc&amp;#237;a and Guacara production facilities of Clorox Venezuela. On November 6, 2014, the Company&#13;reported that the Venezuelan government had published a resolution granting a government-sponsored Special Administrative Board&#13;full authority to restart and operate the business of Clorox Venezuela, thereby reaffirming the government's expropriation of Clorox&#13;Venezuela&amp;#146;s assets. Further, President Nicol&amp;#225;s Maduro announced the government's intention to facilitate the resumed&#13;production of bleach and other cleaning products at Clorox Venezuela plants. He also announced his approval of a financial credit&#13;to invest in raw materials and production at the plants. These actions by the Venezuelan government were taken without the consent&#13;or involvement of Clorox Venezuela, its parent Clorox Spain S.L. (Clorox Spain) or any of their affiliates. Clorox Venezuela, Clorox&#13;Spain and their affiliates reserved their rights under all applicable laws and treaties.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"&gt;With this exit, the financial results of&#13;Clorox Venezuela are reflected as discontinued operations in the Company&amp;#146;s condensed consolidated financial statements for&#13;all periods presented. The results of Clorox Venezuela had historically been part of the International reportable segment.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"&gt;Net sales for Clorox Venezuela were $0&#13;for each of the three months ended September 30, 2016 and 2015.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table provides a summary of earnings (losses)&#13;from discontinued operations for Clorox Venezuela and earnings (losses) from discontinued operations other than Clorox Venezuela&#13;for the periods indicated:&lt;b&gt; &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="6" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&amp;#160; &amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 93%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Operating losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exit costs and other related expenses for Clorox Venezuela&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income tax benefit attributable to Clorox Venezuela&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="8"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gains (losses) from discontinued operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;other than Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Losses from discontinued operations, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 3. BUSINESSES ACQUIRED &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;On May 2, 2016, the Company acquired 100 percent of ReNew&#13;Life Holdings Corporation (RenewLife), a leading brand in digestive health. The amount paid was $290 funded through commercial&#13;paper. The amount paid of $290 represents the aggregate purchase price less cash acquired. The purchase of the RenewLife business&#13;reflects the Company&amp;#146;s strategy to acquire leading brands with attractive margins in growth categories. Results for RenewLife&amp;#146;s&#13;U.S. business are reflected in the Household reportable segment and results for RenewLife&amp;#146;s international business are reflected&#13;in the International reportable segment.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The assets and liabilities of RenewLife were recorded at&#13;their respective estimated fair value as of the date of the acquisition using U.S. GAAP for business combinations. The excess of&#13;the purchase price over the fair value of the net identifiable assets acquired was allocated to goodwill. Goodwill recorded primarily&#13;reflects the value of expanding the Company&amp;#146;s portfolio further into the health and wellness arena.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table summarizes the estimated fair value of&#13;RenewLife&amp;#146;s assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date. Due to the&#13;timing of the acquisition, the fair value of the assets acquired and liabilities assumed are based on a preliminary valuation and&#13;the Company&amp;#146;s estimates and assumptions are subject to change within the measurement period. The primary areas of the purchase&#13;price that are not yet finalized are related to goodwill and income taxes. The weighted-average estimated useful life of intangible&#13;assets subject to amortization is 15 years.&lt;/p&gt;&#13;&#13;&lt;p&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;RenewLife&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 96%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trademarks&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;134&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Customer relationships&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;36&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Property, plant and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Working capital, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Purchase Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;290&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Pro forma results reflecting the acquisition were not presented&#13;because the acquisition did not meet the threshold requirements for additional disclosure.&lt;/p&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 6. INCOME TAXES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In determining its quarterly provision for income taxes,&#13;the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax&#13;planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items&#13;are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from&#13;quarter to quarter. The effective tax rate on earnings from continuing operations was 32.0% for the three months ended September&#13;30, 2016, and 34.5% for the three months ended September 30, 2015. This decrease was primarily due to the recognition of excess&#13;tax benefits from share-based compensation upon the adoption of ASU No. 2016-09 in the first quarter of fiscal year 2017. Refer&#13;to Note 1 for further details.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 7. NET EARNINGS PER SHARE (EPS)&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following is a reconciliation of the weighted average&#13;number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 94%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;129,449&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;129,155&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dilutive effect of stock options and other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,744&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,065&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;132,193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;131,220&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="5"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Antidilutive stock options and other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,271&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company has two share repurchase programs: an open-market&#13;purchase program with an authorized aggregate purchase amount of up to $750, all of which was available for share repurchases as&#13;of September 30, 2016, and a program to offset the anticipated impact of share dilution related to share-based awards (the Evergreen&#13;Program), which has no authorization limit as to amount or timing of repurchases.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Share repurchases under authorized programs were as follows&#13;during the three months ended September 30:&lt;/p&gt;&#13;&#13;&lt;p&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="9" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in 000's)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in 000's)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 86%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Open-market purchase programs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Evergreen Program&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;113&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,006&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;113&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,006&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 8. COMPREHENSIVE INCOME &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Comprehensive income was as follows for the periods indicated:&lt;/p&gt;&#13;&#13;&lt;p&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Earnings from continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;179&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;173&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Earnings (losses) from discontinued operations, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;179&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;172&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other comprehensive income (loss), net of tax:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Foreign currency translation adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(43&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Net unrealized gains (losses) on derivatives&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Pension and postretirement benefit adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total other comprehensive income (loss), net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Comprehensive income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;182&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Changes in Accumulated other comprehensive net (losses) income&#13;by component were as follows for the three months ended September 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Foreign&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;currency&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;translation&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;adjustments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Net unrealized&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;gains (losses) on&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;derivatives&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Pension and&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;postretirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;benefit&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;adjustments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;other&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;comprehensive&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(losses) income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 84%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of June 30, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(300&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(53&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(502&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other comprehensive (loss) income before&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;reclassifications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Amounts reclassified from accumulated other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;comprehensive net losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(43&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of September 30, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(343&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(148&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(541&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="17"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of June 30, 2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(353&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(173&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(570&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other comprehensive (loss) income before&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;reclassifications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Amounts reclassified from accumulated other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;comprehensive net losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of September 30, 2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(354&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(172&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(567&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Included in foreign currency translation adjustments are&#13;re-measurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future.&#13;For the three months ended September 30, 2016 and 2015, Other comprehensive income (loss) on these loans totaled $0 and $(5), respectively,&#13;and there were no amounts reclassified from Accumulated other comprehensive net (losses) income.&lt;/p&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 9. EMPLOYEE BENEFIT PLANS &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table summarizes the components of net periodic&#13;benefit cost for the Company&amp;#146;s retirement income plans:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Service cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected return on plan assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization of unrecognized items&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The net periodic benefit cost for the Company&amp;#146;s retirement&#13;health care plans was $0 for each of the three months ended September 30, 2016 and 2015.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;During the three months ended September 30, 2016, the Company&#13;made $15 in discretionary contributions to the domestic qualified retirement income plan.&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <clx:ContingenciesAndGuaranteesDisclosureTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 10. OTHER CONTINGENCIES AND GUARANTEES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Contingencies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company is involved in certain environmental matters,&#13;including response actions at various locations. The Company had a recorded liability of $13 and $14 as of September 30, 2016 and&#13;June 30, 2016, respectively, for its share of aggregate future remediation costs related to these matters. One matter in Dickinson&#13;County, Michigan, for which the Company is jointly and severally liable, accounted for a substantial majority of the recorded liability&#13;as of both September 30, 2016 and June 30, 2016. The Company has agreed to be liable for 24.3% of the aggregate remediation and&#13;associated costs for this matter pursuant to a cost-sharing arrangement with a third party. With the assistance of environmental&#13;consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital&#13;expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Currently, the Company&#13;cannot accurately predict the timing of future payments that may be made under this obligation. In addition, the Company&amp;#146;s&#13;estimated loss exposure is sensitive to a variety of uncertain factors, including the efficacy of remediation efforts, changes&#13;in remediation requirements and the future availability of alternative clean-up technologies. Although it is reasonably possible&#13;that the Company&amp;#146;s exposure may exceed the amount recorded, any amount of such additional exposures, or range of exposures,&#13;is not estimable at this time.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company is subject to various legal proceedings, claims&#13;and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements, product liability,&#13;patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to&#13;these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at&#13;this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse&#13;effect, either individually or in the aggregate, on the Company&amp;#146;s condensed consolidated financial statements taken as a whole.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Guarantees &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In conjunction with divestitures and other transactions,&#13;the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously&#13;existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the&#13;total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it&#13;is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible&#13;payments would not have a material adverse effect, either individually or in the aggregate, on the Company&amp;#146;s condensed consolidated&#13;financial statements taken as a whole.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company had not recorded any liabilities on the aforementioned&#13;guarantees as of September 30, 2016.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of September 30, 2016, the Company was a party to letters&#13;of credit of $10 primarily related to one of its insurance carriers, of which $0 had been drawn upon.&lt;/p&gt;</clx:ContingenciesAndGuaranteesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 11. SEGMENT RESULTS&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company operates through strategic business units that&#13;are aggregated into four reportable segments based on the economics and nature of the products sold: Cleaning, Household, Lifestyle&#13;and International. As a result of Clorox Venezuela being reported as discontinued operations, the results of Clorox Venezuela are&#13;no longer included in the International reportable segment.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Certain non-allocated administrative costs, interest income,&#13;interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash&#13;and cash equivalents, other current assets, property and equipment, other investments and deferred taxes.&lt;b&gt; &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The table below presents reportable segment information and&#13;a reconciliation of the segment information to the Company&amp;#146;s consolidated net sales and earnings from continuing operations&#13;before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Net sales&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Earnings (losses) from continuing&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;operations before income taxes&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 86%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cleaning&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;534&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;497&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;164&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Household&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;422&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;411&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;82&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Lifestyle&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;236&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;231&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;62&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;59&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;International&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;27&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Corporate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,443&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,390&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;264&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;264&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;All intersegment sales are eliminated and are not included&#13;in the Company&amp;#146;s reportable segments&amp;#146; net sales.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Net sales to the Company&amp;#146;s largest customer, Wal-Mart&#13;Stores, Inc. and its affiliates, as a percentage of consolidated net sales, were 26% and 27% for the three months ended September&#13;30, 2016 and 2015, respectively.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The unaudited interim condensed consolidated financial statements&#13;for the three months ended September 30, 2016 and 2015, in the opinion of management, reflect all adjustments (consisting of normal&#13;recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows&#13;of The Clorox Company and its subsidiaries (the Company) for the periods presented. However, the financial results for interim&#13;periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Effective September 22, 2014, the Company&amp;#146;s Venezuela&#13;affiliate, Corporaci&amp;#243;n Clorox de Venezuela S.A. (Clorox Venezuela), discontinued its operations. Consequently, the Company&#13;reclassified the financial results of Clorox Venezuela as a discontinued operation in the condensed consolidated financial statements&#13;for all periods presented herein.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Certain information and footnote disclosures normally included&#13;in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have&#13;been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information&#13;in this report should be read in conjunction with the Company&amp;#146;s Annual Report on Form 10-K filed with the SEC for the fiscal&#13;year ended June 30, 2016, which includes a complete set of footnote disclosures including the Company&amp;#146;s significant accounting&#13;policies.&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Recently Issued Accounting Standards &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In March 2016, the Financial Accounting Standards Board (FASB)&#13;issued Accounting Standards Update (ASU) No. 2016-09, &amp;#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee&#13;Share-Based Payment Accounting,&amp;#148; which simplifies several aspects of the accounting for share-based payment transactions,&#13;including requiring excess tax benefits and tax deficiencies to be recognized as income tax expense or benefit in the consolidated&#13;statement of earnings. Additionally, the standard requires cash flows from excess tax benefits and deficiencies, previously classified&#13;as a financing activity, to be classified as an operating activity in the consolidated statement of cash flows. The Company adopted&#13;this guidance in the first quarter of fiscal year 2017. Excess tax benefits of $6 were recognized in the consolidated statement&#13;of earnings and classified as an operating activity in the consolidated statement of cash flows during the three months ended September&#13;30, 2016. The prior period consolidated statement of cash flows has not been adjusted as permitted. The adoption resulted in approximately&#13;a 2 percentage point benefit to the Company&amp;#146;s effective tax rate for the first quarter of fiscal year 2017. The guidance allows&#13;for a policy election to account for forfeitures as they occur rather than on an estimated basis. The Company did not make this&#13;election and will continue to account for forfeitures on an estimated basis.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In February 2016, the FASB issued ASU No. 2016-02, &amp;#147;Leases&#13;(Topic 842),&amp;#148; which requires lessees to recognize a right-of-use asset and a lease liability for all leases with terms of&#13;more than 12 months. Recognition, measurement and presentation will depend on the classification of the lease as either a finance&#13;or an operating lease. ASU 2016-02 also requires expanded disclosures about leasing arrangements. The new guidance is effective&#13;for the Company beginning in the first quarter of fiscal year 2020, with early adoption permitted. The Company is currently evaluating&#13;the impact that the adoption of this guidance will have on its consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In April 2015, the FASB issued ASU No. 2015-03, &amp;#147;Simplifying&#13;the Presentation of Debt Issuance Cost,&amp;#148; which requires that debt issuance costs related to a recognized debt liability be&#13;presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.&#13;The Company adopted this standard in the first quarter of fiscal year 2017 and retrospectively applied the standard to the June&#13;30, 2016 consolidated balance sheet, resulting in an $8 reduction in Other assets and Long-term debt. The adoption had no impact&#13;on the Company&amp;#146;s consolidated statement of earnings or consolidated statement of cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;In February 2015, the FASB issued ASU No. 2015-02, &amp;#147;Amendments&#13;to the Consolidation Analysis,&amp;#148; which changes the guidance for evaluating whether to consolidate certain legal entities. The&#13;amendments modify the evaluation of whether limited partnerships and similar legal entities are variable interest entities or voting&#13;interest entities. The Company adopted this standard in the first quarter of fiscal year 2017. The adoption did not have an impact&#13;on the Company&amp;#146;s consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"&gt;In May 2014, the FASB issued ASU No. 2014-09,&#13;&amp;#147;Revenue from Contracts with Customers (Topic 606),&amp;#148; which replaces most existing U.S. GAAP revenue recognition guidance&#13;and is intended to improve and converge with international standards the financial reporting requirements for revenue from contracts&#13;with customers. The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services&#13;equal to the amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional&#13;disclosures about the nature, timing and uncertainty of revenue and cash flows arising from contracts with customers, including&#13;information about significant judgments and changes in judgments. The new guidance is effective for the Company beginning in the&#13;first quarter of fiscal year 2019, with the option to early adopt in the first quarter of fiscal year 2018. The Company is currently&#13;evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <clx:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table provides a summary of earnings (losses)&#13;from discontinued operations for Clorox Venezuela and earnings (losses) from discontinued operations other than Clorox Venezuela&#13;for the periods indicated:&lt;b&gt; &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="6" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&amp;#160; &amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 93%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Operating losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exit costs and other related expenses for Clorox Venezuela&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela before income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income tax benefit attributable to Clorox Venezuela&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total losses from Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="8"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Gains (losses) from discontinued operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;other than Clorox Venezuela, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Losses from discontinued operations, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;) &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</clx:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gains (losses) recognized in&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other comprehensive income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest rate derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="9"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following is a reconciliation of the weighted average&#13;number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 94%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;129,449&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;129,155&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dilutive effect of stock options and other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,744&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,065&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Diluted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;132,193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;131,220&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: #c0c0c0"&gt;&#13;    &lt;td colspan="5"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Antidilutive stock options and other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,271 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Share repurchases under authorized programs were as follows&#13;during the three months ended September 30:&lt;/p&gt;&#13;&#13;&lt;p&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="9" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in 000's)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(in 000's)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 86%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Open-market purchase programs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Evergreen Program&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;113&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,006&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;113&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,006 &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <clx:FinancialInstrumentsAndFairValueMeasurementsTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 5. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&#13;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Financial assets and liabilities measured at fair value on&#13;a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following&#13;three categories of the fair value hierarchy:&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Level 1: Quoted market prices in active markets for identical&#13;assets or liabilities.&lt;br /&gt;&#13;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;br /&gt;&#13;Level 3: Unobservable inputs reflecting the reporting entity&amp;#146;s own assumptions.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of September 30, 2016 and June 30, 2016, the Company&amp;#146;s&#13;financial assets and liabilities that were measured at fair value on a recurring basis during the applicable periods included derivative&#13;financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund certain of the Company&amp;#146;s&#13;nonqualified deferred compensation plans, which were classified as Level 1.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Financial Risk Management and Derivative Instruments&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company is exposed to certain commodity, interest rate,&#13;foreign currency and counterparty risks related to its ongoing business operations and uses derivative instruments to mitigate&#13;its exposure to these risks.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Commodity Price Risk Management &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company may use commodity exchange traded futures and&#13;over-the-counter swap contracts to fix the price of a portion of its forecasted raw material requirements. Contract maturities,&#13;which are generally no longer than 2 years, are matched to the length of the raw material purchase contracts. Commodity purchase&#13;contracts are measured at fair value using market quotations obtained from commodity futures exchanges or commodity derivative&#13;dealers.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of September 30, 2016, the notional amount of commodity&#13;derivatives was $24, of which $14 related to jet fuel swaps and $10 related to soybean oil futures. As of June 30, 2016, the notional&#13;amount of commodity derivatives was $30, of which $16 related to jet fuel swaps and $14 related to soybean oil futures.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Foreign Currency Risk Management &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company may also enter into certain over-the-counter&#13;derivative contracts to manage a portion of the Company&amp;#146;s forecasted foreign currency exposure associated with the purchase&#13;of inventory. These foreign currency contracts generally have durations of no longer than 2 years. The foreign exchange contracts&#13;are measured at fair value using information quoted by foreign exchange dealers.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The notional amounts of outstanding foreign currency forward&#13;contracts used by the Company&amp;#146;s subsidiaries to hedge forecasted purchases of inventory were $57 as of September 30, 2016,&#13;and $84 as of June 30, 2016.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Interest Rate Risk Management &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company may also enter into over-the-counter interest&#13;rate derivative instruments to fix a portion of the benchmark interest rate prior to an anticipated issuance of fixed rate debt&#13;or to manage the Company&amp;#146;s level of fixed and floating rate debt. The interest rate derivative instruments are measured at&#13;fair value using information quoted by U.S. government bond dealers.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;As of both September 30, 2016 and June 30, 2016, the Company&#13;had no interest rate derivative instruments.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Counterparty Risk Management and Derivative Contract&#13;Requirements &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company utilizes a variety of financial institutions&#13;as counterparties for &lt;font&gt;over-the-counter&lt;/font&gt; derivative instruments. The Company&#13;enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter&#13;derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty&#13;to post collateral when the fair value of the derivative instrument exceeds contractually defined counterparty liability position&#13;limits. Of the derivative instruments of $3 and $5 reflected in Accounts payable and accrued liabilities as of September 30, 2016&#13;and June 30, 2016, respectively, $2 and $4, respectively, contained such terms. As of both September 30, 2016 and June 30, 2016,&#13;neither the Company nor any counterparty was required to post any collateral as no counterparty liability position limits were&#13;exceeded.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Certain terms of the agreements governing the Company&amp;#146;s&#13;over-the-counter derivative instruments require the credit ratings, as assigned by Standard &amp;#38; Poor&amp;#146;s and Moody&amp;#146;s&#13;to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating.&#13;If the Company&amp;#146;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could&#13;request full collateralization on derivative instruments in net liability positions. As of both September 30, 2016 and June 30,&#13;2016, the Company and each of its counterparties had been assigned investment grade credit ratings by both Standard &amp;#38; Poor&amp;#146;s&#13;and Moody&amp;#146;s.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Certain of the Company&amp;#146;s exchange-traded futures contracts&#13;used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account&#13;held by the Company&amp;#146;s broker for trades conducted on that exchange. As of September 30, 2016 and June 30, 2016, the Company&#13;maintained cash margin balances related to exchange-traded futures contracts of $1, which are classified as &lt;font&gt;Other&lt;/font&gt;&#13;current assets on the condensed consolidated balance sheets.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Trust Assets &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company has held interests in mutual funds and cash equivalents&#13;as part of trust assets related to certain of its nonqualified deferred compensation plans. The participants in the deferred compensation&#13;plans, who are the Company&amp;#146;s current and former employees, may select among certain mutual funds in which their compensation&#13;deferrals are invested in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable&#13;securities. These trusts represent variable interest entities for which the Company is considered the primary beneficiary, and&#13;therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests&#13;in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable&lt;b&gt; &lt;/b&gt;securities&#13;as trading investments.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair Value of Financial Instruments &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table summarizes the fair value of the Company&amp;#146;s&#13;assets and liabilities for which disclosure of fair value is required:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;6/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance sheet&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;classification&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;hierarchy&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;level&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 82%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Investments including money market&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash and cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;equivalents &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;253&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;253&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;234&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;234&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Time deposits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash and cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;equivalents &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trust assets for nonqualified deferred&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;compensation plans&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;62&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;62&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;394&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;394&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;368&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="17"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable &lt;sup&gt;(b)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;618&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;618&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;523&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;523&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable and&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;accrued liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable and&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;accrued liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current maturities of long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current maturities of long-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;and Long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;term debt and Long-term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;debt &lt;sup&gt;(c)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,789&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,911&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,789&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,922&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,410&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,532&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,317&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,450&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p&gt;____________________&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: normal; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(a)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 100%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(b)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(c)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, is determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Derivatives&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The Company designates its commodity forward and future contracts&#13;for forecasted purchases of raw materials, interest rate forward contracts for forecasted interest payments, and foreign currency&#13;forward contracts for forecasted purchases of inventory as cash flow hedges.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The effects of derivative instruments designated as hedging&#13;instruments on Comprehensive income and Net earnings were as follows:&lt;/p&gt;&#13;&#13;&lt;p&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gains (losses) recognized in&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Other comprehensive income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest rate derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="9"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gains (losses) reclassified from&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated other comprehensive loss and&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;recognized in Net earnings&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest rate derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The gains (losses) reclassified from Accumulated other comprehensive&#13;losses and recognized in Net earnings during the three months ended September 30, 2016 and 2015, for commodity purchase and foreign&#13;exchange contracts were included in Cost of products sold, and for interest rate contracts were included in Interest expense.&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The estimated amount of the existing net gain (loss) in Accumulated&#13;other comprehensive losses as of September 30, 2016, that is expected to be reclassified into Net earnings within the next twelve&#13;months is $8. Gains and losses on derivative instruments representing either hedge ineffectiveness or hedge components excluded&#13;from the assessment of effectiveness are recognized in Net earnings. During the three months ended September 30, 2016 and 2015,&#13;hedge ineffectiveness was not significant.&lt;b&gt; &lt;/b&gt;&lt;/p&gt;</clx:FinancialInstrumentsAndFairValueMeasurementsTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Changes in Accumulated other comprehensive net (losses) income&#13;by component were as follows for the three months ended September 30:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Foreign&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;currency&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;translation&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;adjustments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Net unrealized&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;gains (losses) on&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;derivatives&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Pension and&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;postretirement&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;benefit&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;adjustments&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;other&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;comprehensive&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(losses) income&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 84%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of June 30, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(300&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(53&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(502&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other comprehensive (loss) income before&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;reclassifications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Amounts reclassified from accumulated other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;comprehensive net losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(43&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of September 30, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(343&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(148&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(541&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="17"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of June 30, 2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(353&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(173&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(570&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Other comprehensive (loss) income before&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;reclassifications&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Amounts reclassified from accumulated other&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;comprehensive net losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Income tax benefit (expense)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net current period other comprehensive income (loss)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of September 30, 2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(354&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(172&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(567&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The table below presents reportable segment information and&#13;a reconciliation of the segment information to the Company&amp;#146;s consolidated net sales and earnings from continuing operations&#13;before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Net sales&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Earnings (losses) from continuing&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;operations before income taxes&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 86%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cleaning&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;534&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;497&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;164&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;149&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Household&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;422&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;411&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;82&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Lifestyle&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;236&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;231&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;62&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;59&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;International&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;27&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Corporate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(58&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,443&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,390&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;264&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;264&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;/p&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table summarizes the components of net periodic&#13;benefit cost for the Company&amp;#146;s retirement income plans:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Service cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected return on plan assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amortization of unrecognized items&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;/p&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Comprehensive income was as follows for the periods indicated:&lt;/p&gt;&#13;&#13;&lt;p&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Earnings from continuing operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;179&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;173&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Earnings (losses) from discontinued operations, net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net earnings&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;179&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;172&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other comprehensive income (loss), net of tax:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Foreign currency translation adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(43&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Net unrealized gains (losses) on derivatives&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Pension and postretirement benefit adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total other comprehensive income (loss), net of tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(39&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Comprehensive income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;182&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;/p&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Three Months Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="line-height: normal; vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Gains (losses) reclassified from&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated other comprehensive loss and&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;recognized in Net earnings&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 92%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Interest rate derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;/p&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Inventories, net, consisted of the following as of:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;6/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 91%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Finished goods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;374&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;361&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Raw materials and packaging&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;114&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;111&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Work in process&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;LIFO allowances&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;465&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;443&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;/p&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table summarizes the estimated fair value of&#13;RenewLife&amp;#146;s assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date. Due to the&#13;timing of the acquisition, the fair value of the assets acquired and liabilities assumed are based on a preliminary valuation and&#13;the Company&amp;#146;s estimates and assumptions are subject to change within the measurement period. The primary areas of the purchase&#13;price that are not yet finalized are related to goodwill and income taxes. The weighted-average estimated useful life of intangible&#13;assets subject to amortization is 15 years.&lt;/p&gt;&#13;&#13;&lt;p&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;RenewLife&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 96%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;137&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trademarks&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;134&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Customer relationships&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;36&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Property, plant and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Working capital, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Deferred income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(61&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Purchase Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;290&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;/p&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE 4. INVENTORIES, NET&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;Inventories, net, consisted of the following as of:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;6/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 91%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Finished goods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 2%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;374&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;361&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Raw materials and packaging&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;114&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;111&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Work in process&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;LIFO allowances&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #c0c0c0"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;465&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;443&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="text-align: center; font: 10pt Times New Roman, Times, Serif"&gt;&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="From2016-07-01to2016-09-30">&lt;p style="text-align: left; font: 10pt Times New Roman, Times, Serif"&gt;The following table summarizes the fair value of the Company&amp;#146;s&#13;assets and liabilities for which disclosure of fair value is required:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;9/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;6/30/2016&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; line-height: normal"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance sheet&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;classification&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair value&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;hierarchy&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;level&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Carrying&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Estimated&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 82%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 3%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left; width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Investments including money market&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash and cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;funds&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;equivalents &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;253&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;253&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;234&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;234&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Time deposits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash and cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;equivalents &lt;sup&gt;(a)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;76&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;79&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other current assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trust assets for nonqualified deferred&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;compensation plans&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;62&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;62&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;52&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;394&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;394&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;368&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td colspan="17"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable &lt;sup&gt;(b)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;618&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;618&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;523&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;523&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Commodity purchase derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable and&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;accrued liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign exchange derivative contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts payable and&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;accrued liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current maturities of long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current maturities of long-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;and Long-term debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;term debt and Long-term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: Silver"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;debt &lt;sup&gt;(c)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,789&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,911&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,789&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,922&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,410&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,532&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,317&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,450&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p&gt;____________________&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" border="0" style="line-height: normal; border-collapse: collapse"&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(a)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 100%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(b)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Notes and loans payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(c)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td nowrap="nowrap" style="vertical-align: top"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, is determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-2" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-3" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-4" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-5" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-6" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-7" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-8" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-9" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-10" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-11" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-12" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-13" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-14" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-15" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-16" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-17" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-18" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-19" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-20" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-21" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-22" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-23" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-24" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-25" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-26" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-27" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-28" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-04" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-0" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-1" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-2" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-3" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-4" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-5" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-6" xlink:label="Foot-01_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-7" xlink:label="Foot-01_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-01_loc" xlink:to="Footnote-01" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-0" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-1" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-2" xlink:label="Foot-02_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-3" xlink:label="Foot-02_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-02_loc" xlink:to="Footnote-02" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-0" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-1" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-2" xlink:label="Foot-03_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-03-3" xlink:label="Foot-03_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-03_loc" xlink:to="Footnote-03" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">Notes and loan payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-03" xml:lang="en-US">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of long-term debt, including current maturities, is determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-04" xml:lang="en-US">Condensed from audited financial statements.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>clx-20160930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CLX 0916 10Q.xfr; Date: 2016%2D11%2D01T21:25:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80200000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +a45o7xRiXhun8uHZnVMWaKFKbPtx5R6aekxs2R7HYm6Tywk1njwECVPI3LWgVgA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:clx="http://thecloroxcompany.com/20160930" elementFormDefault="qualified" targetNamespace="http://thecloroxcompany.com/20160930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://thecloroxcompany.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/StatementsOfEarningsAndComprehensiveIncome" id="StatementsOfEarningsAndComprehensiveIncome">
	  <link:definition>00000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/Statement-CondensedConsolidatedBalanceSheetsParenthetical" id="Statement-CondensedConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000004 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-do" id="clx-do">
	  <link:definition>00000007 - Disclosure - DISCONTINUED OPERATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/BusinessesAcquired" id="BusinessesAcquired">
	  <link:definition>00000008 - Disclosure - BUSINESSES ACQUIRED</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/InventoriesNet" id="InventoriesNet">
	  <link:definition>00000009 - Disclosure - INVENTORIES, NET</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/clx-fiafvm1" id="clx-fiafvm1">
	  <link:definition>00000010 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000011 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEps" id="NetEarningsPerShareEps">
	  <link:definition>00000012 - Disclosure - NET EARNINGS PER SHARE (EPS)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/ComprehensiveIncome" id="ComprehensiveIncome">
	  <link:definition>00000013 - Disclosure - COMPREHENSIVE INCOME</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlans" id="EmployeeBenefitPlans">
	  <link:definition>00000014 - Disclosure - EMPLOYEE BENEFIT PLANS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/OtherContingenciesAndGuarantees" id="OtherContingenciesAndGuarantees">
	  <link:definition>00000015 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/SegmentResults" id="SegmentResults">
	  <link:definition>00000016 - Disclosure - SEGMENT RESULTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/DiscontinuedOperationsTables" id="DiscontinuedOperationsTables">
	  <link:definition>00000018 - Disclosure - DISCONTINUED OPERATIONS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredTables" id="BusinessesAcquiredTables">
	  <link:definition>00000019 - Disclosure - BUSINESSES ACQUIRED (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/InventoriesNetTables" id="InventoriesNetTables">
	  <link:definition>00000020 - Disclosure - INVENTORIES, NET (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsTables" id="FinancialInstrumentsAndFairValueMeasurementsTables">
	  <link:definition>00000021 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsTables" id="NetEarningsPerShareEpsTables">
	  <link:definition>00000022 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeTables" id="ComprehensiveIncomeTables">
	  <link:definition>00000023 - Disclosure - COMPREHENSIVE INCOME  (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansTables" id="EmployeeBenefitPlansTables">
	  <link:definition>00000024 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/SegmentResultsTables" id="SegmentResultsTables">
	  <link:definition>00000025 - Disclosure - SEGMENT RESULTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesDetails" id="SummaryOfSignificantAccountingPoliciesDetails">
	  <link:definition>00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails" id="DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails">
	  <link:definition>00000027 - Disclosure - DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" id="BusinessesAcquiredDetails">
	  <link:definition>00000028 - Disclosure - BUSINESSES ACQUIRED (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/InventoriesNetDetails" id="InventoriesNetDetails">
	  <link:definition>00000029 - Disclosure - INVENTORIES, NET (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails" id="FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails">
	  <link:definition>00000030 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" id="FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails">
	  <link:definition>00000031 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails" id="FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails">
	  <link:definition>00000032 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
	  <link:definition>00000033 - Disclosure - INCOME TAXES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails" id="NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails">
	  <link:definition>00000034 - Disclosure - NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsShareRepurchaseProgramsDetails" id="NetEarningsPerShareEpsShareRepurchaseProgramsDetails">
	  <link:definition>00000035 - Disclosure - NET EARNINGS PER SHARE (EPS) (Share Repurchase Programs) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeNarrativeDetails" id="ComprehensiveIncomeNarrativeDetails">
	  <link:definition>00000036 - Disclosure - COMPREHENSIVE INCOME (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails" id="ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails">
	  <link:definition>00000037 - Disclosure - COMPREHENSIVE INCOME (Schedule of Comprehensive Income) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" id="ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails">
	  <link:definition>00000038 - Disclosure - COMPREHENSIVE INCOME (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansDetails" id="EmployeeBenefitPlansDetails">
	  <link:definition>00000039 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/OtherContingenciesAndGuaranteesDetails" id="OtherContingenciesAndGuaranteesDetails">
	  <link:definition>00000040 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/SegmentResultsNarrativeDetails" id="SegmentResultsNarrativeDetails">
	  <link:definition>00000041 - Disclosure - SEGMENT RESULTS (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://thecloroxcompany.com/role/SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails" id="SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails">
	  <link:definition>00000042 - Disclosure - SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="clx-20160930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="clx-20160930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="clx-20160930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="clx-20160930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
    <element id="clx_TrademarksNet" name="TrademarksNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherIncomeExpenseNet" name="OtherIncomeExpenseNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SiteContingencyAgreedPercentageOfCostSharing" name="SiteContingencyAgreedPercentageOfCostSharing" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RemediationPeriod" name="RemediationPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_LetterOfCreditBorrowingCapacity" name="LetterOfCreditBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" name="DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DerivativeIntrumentsMaximumContractDuration" name="DerivativeIntrumentsMaximumContractDuration" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities" name="ProceedsFromStockOptionsExercisedAndOtherFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609" name="ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503" name="ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609" name="ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ContingenciesAndGuaranteesDisclosureTextBlock" name="ContingenciesAndGuaranteesDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" name="ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" name="FinancialInstrumentsAndFairValueMeasurementsTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="clx_VenezuelanSubsidiaryMember" name="VenezuelanSubsidiaryMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DiscontinuedOperationsOtherMember" name="DiscontinuedOperationsOtherMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RenewLifeHoldingsCorporationMember" name="RenewLifeHoldingsCorporationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OpenMarketProgramMember" name="OpenMarketProgramMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_EvergreenProgramMember" name="EvergreenProgramMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_LongTermIntercompanyLoansMember" name="LongTermIntercompanyLoansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RetirementIncomeMember" name="RetirementIncomeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_RetirementHealthCarePlansMember" name="RetirementHealthCarePlansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DomesticQualifiedRetirementIncomePlansMember" name="DomesticQualifiedRetirementIncomePlansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_CleaningMember" name="CleaningMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_HouseholdMember" name="HouseholdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_LifestyleMember" name="LifestyleMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_InternationalMember" name="InternationalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_WalmartStoresIncMember" name="WalmartStoresIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" name="TrustAssetsForNonqualifiedDeferredCompensationPlansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_NotesAndLoansPayableMember" name="NotesAndLoansPayableMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" name="CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_JetFuelMember" name="JetFuelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SoybeanOilMember" name="SoybeanOilMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" name="FinancialInstrumentsAndFairValueMeasurementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_OtherContingenciesAndGuaranteesAbstract" name="OtherContingenciesAndGuaranteesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DerivativeNatureAxis" name="DerivativeNatureAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="clx_DerivativeNatureDomain" name="DerivativeNatureDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="clx_InterestRateForwardContractsSettlement" name="InterestRateForwardContractsSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_SettlementOfInterestRateForwardContract" name="SettlementOfInterestRateForwardContract" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" name="DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="clx_ShareRepurchaseProgramsTable" name="ShareRepurchaseProgramsTable" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" />
    <element id="clx_ShareRepurchaseProgramsLineItems" name="ShareRepurchaseProgramsLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>clx-20160930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CLX 0916 10Q.xfr; Date: 2016%2D11%2D01T21:25:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80200000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://thecloroxcompany.com/role/DocumentAndEntityInformation" xlink:href="clx-20160930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StatementsOfEarningsAndComprehensiveIncome" xlink:href="clx-20160930.xsd#StatementsOfEarningsAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BalanceSheets" xlink:href="clx-20160930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/Statement-CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="clx-20160930.xsd#Statement-CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StatementsOfCashFlows" xlink:href="clx-20160930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="clx-20160930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-do" xlink:href="clx-20160930.xsd#clx-do" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:href="clx-20160930.xsd#BusinessesAcquired" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/InventoriesNet" xlink:href="clx-20160930.xsd#InventoriesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:href="clx-20160930.xsd#clx-fiafvm1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/IncomeTaxes" xlink:href="clx-20160930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEps" xlink:href="clx-20160930.xsd#NetEarningsPerShareEps" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncome" xlink:href="clx-20160930.xsd#ComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlans" xlink:href="clx-20160930.xsd#EmployeeBenefitPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/OtherContingenciesAndGuarantees" xlink:href="clx-20160930.xsd#OtherContingenciesAndGuarantees" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResults" xlink:href="clx-20160930.xsd#SegmentResults" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="clx-20160930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/DiscontinuedOperationsTables" xlink:href="clx-20160930.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:href="clx-20160930.xsd#BusinessesAcquiredTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/InventoriesNetTables" xlink:href="clx-20160930.xsd#InventoriesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsTables" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsTables" xlink:href="clx-20160930.xsd#NetEarningsPerShareEpsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeTables" xlink:href="clx-20160930.xsd#ComprehensiveIncomeTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansTables" xlink:href="clx-20160930.xsd#EmployeeBenefitPlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResultsTables" xlink:href="clx-20160930.xsd#SegmentResultsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="clx-20160930.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails" xlink:href="clx-20160930.xsd#DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:href="clx-20160930.xsd#BusinessesAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/InventoriesNetDetails" xlink:href="clx-20160930.xsd#InventoriesNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/IncomeTaxesDetails" xlink:href="clx-20160930.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails" xlink:href="clx-20160930.xsd#NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsShareRepurchaseProgramsDetails" xlink:href="clx-20160930.xsd#NetEarningsPerShareEpsShareRepurchaseProgramsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeNarrativeDetails" xlink:href="clx-20160930.xsd#ComprehensiveIncomeNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails" xlink:href="clx-20160930.xsd#ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:href="clx-20160930.xsd#ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansDetails" xlink:href="clx-20160930.xsd#EmployeeBenefitPlansDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/OtherContingenciesAndGuaranteesDetails" xlink:href="clx-20160930.xsd#OtherContingenciesAndGuaranteesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResultsNarrativeDetails" xlink:href="clx-20160930.xsd#SegmentResultsNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:href="clx-20160930.xsd#SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DocumentAndEntityInformationAbstract" xlink:label="loc_clxDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StatementsOfEarningsAndComprehensiveIncome" xlink:title="00000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_OtherIncomeExpenseNet" xlink:label="loc_clxOtherIncomeExpenseNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_clxOtherIncomeExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareDilutedAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaapCommonStockDividendsPerShareDeclared" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCommonStockDividendsPerShareDeclared" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BalanceSheets" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaapReceivablesNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_TrademarksNet" xlink:label="loc_clxTrademarksNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_clxTrademarksNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaper" xlink:label="loc_us-gaapCommercialPaper" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapCommercialPaper" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredTaxLiabilitiesNoncurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/Statement-CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000004 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapTreasuryStockShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaapOtherNoncashIncomeExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherNoncashIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfShortTermDebt" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaapPaymentsOfDividendsCommonStock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities" xlink:label="loc_clxProceedsFromStockOptionsExercisedAndOtherFinancingActivities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_clxProceedsFromStockOptionsExercisedAndOtherFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-do" xlink:title="00000007 - Disclosure - DISCONTINUED OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:title="00000008 - Disclosure - BUSINESSES ACQUIRED">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/InventoriesNet" xlink:title="00000009 - Disclosure - INVENTORIES, NET">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:title="00000010 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS">
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_clxFinancialInstrumentsAndFairValueMeasurementsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/IncomeTaxes" xlink:title="00000011 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEps" xlink:title="00000012 - Disclosure - NET EARNINGS PER SHARE (EPS)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncome" xlink:title="00000013 - Disclosure - COMPREHENSIVE INCOME">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaapComprehensiveIncomeNoteTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNoteTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlans" xlink:title="00000014 - Disclosure - EMPLOYEE BENEFIT PLANS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaapPensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapPensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherContingenciesAndGuarantees" xlink:title="00000015 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES">
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_OtherContingenciesAndGuaranteesAbstract" xlink:label="loc_clxOtherContingenciesAndGuaranteesAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ContingenciesAndGuaranteesDisclosureTextBlock" xlink:label="loc_clxContingenciesAndGuaranteesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_clxContingenciesAndGuaranteesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResults" xlink:title="00000016 - Disclosure - SEGMENT RESULTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/DiscontinuedOperationsTables" xlink:title="00000018 - Disclosure - DISCONTINUED OPERATIONS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" xlink:label="loc_clxScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_clxScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:title="00000019 - Disclosure - BUSINESSES ACQUIRED (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/InventoriesNetTables" xlink:title="00000020 - Disclosure - INVENTORIES, NET (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsTables" xlink:title="00000021 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="loc_us-gaapFairValueByBalanceSheetGroupingTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_us-gaapFairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_us-gaapScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_us-gaapScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEpsTables" xlink:title="00000022 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaapScheduleOfWeightedAverageNumberOfSharesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:label="loc_us-gaapScheduleOfTreasuryStockByClassTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeTables" xlink:title="00000023 - Disclosure - COMPREHENSIVE INCOME  (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaapScheduleOfComprehensiveIncomeLossTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlansTables" xlink:title="00000024 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:label="loc_us-gaapScheduleOfNetBenefitCostsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResultsTables" xlink:title="00000025 - Disclosure - SEGMENT RESULTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609" xlink:label="loc_clxExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_clxExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609" xlink:label="loc_clxImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_clxImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503" xlink:label="loc_clxReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_clxReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails" xlink:title="00000027 - Disclosure - DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_VenezuelanSubsidiaryMember" xlink:label="loc_clxVenezuelanSubsidiaryMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxVenezuelanSubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DiscontinuedOperationsOtherMember" xlink:label="loc_clxDiscontinuedOperationsOtherMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxDiscontinuedOperationsOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:title="00000028 - Disclosure - BUSINESSES ACQUIRED (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_RenewLifeHoldingsCorporationMember" xlink:label="loc_clxRenewLifeHoldingsCorporationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_clxRenewLifeHoldingsCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="loc_us-gaapBusinessAcquisitionEffectiveDateOfAcquisition1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEffectiveDateOfAcquisition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/InventoriesNetDetails" xlink:title="00000029 - Disclosure - INVENTORIES, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryLIFOReserve" xlink:label="loc_us-gaapInventoryLIFOReserve" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryLIFOReserve" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails" xlink:title="00000030 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaapDerivativeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_us-gaapDerivativeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaapDerivativeLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapDerivativeLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeNatureAxis" xlink:label="loc_clxDerivativeNatureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_clxDerivativeNatureAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeNatureDomain" xlink:label="loc_clxDerivativeNatureDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDerivativeNatureAxis" xlink:to="loc_clxDerivativeNatureDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_JetFuelMember" xlink:label="loc_clxJetFuelMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDerivativeNatureDomain" xlink:to="loc_clxJetFuelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_SoybeanOilMember" xlink:label="loc_clxSoybeanOilMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxDerivativeNatureDomain" xlink:to="loc_clxSoybeanOilMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeIntrumentsMaximumContractDuration" xlink:label="loc_clxDerivativeIntrumentsMaximumContractDuration" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDerivativeIntrumentsMaximumContractDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_investDerivativeNotionalAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_investDerivativeNotionalAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_InterestRateForwardContractsSettlement" xlink:label="loc_clxInterestRateForwardContractsSettlement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxInterestRateForwardContractsSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_SettlementOfInterestRateForwardContract" xlink:label="loc_clxSettlementOfInterestRateForwardContract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxSettlementOfInterestRateForwardContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:label="loc_clxDeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers" xlink:label="loc_us-gaapGoodFaithAndMarginDepositsWithBrokerDealers" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapGoodFaithAndMarginDepositsWithBrokerDealers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:label="loc_clxDerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MarginDepositAssets" xlink:label="loc_us-gaapMarginDepositAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapMarginDepositAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="loc_us-gaapCashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapCashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:title="00000031 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="loc_us-gaapCashAndCashEquivalentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapCashAndCashEquivalentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="loc_us-gaapOtherCurrentAssetsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherCurrentAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaapOtherAssetsMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaapNotesPayableOtherPayablesMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapNotesPayableOtherPayablesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:label="loc_clxCurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_clxCurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaapFairValueByMeasurementBasisAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementBasisAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaapFairValueDisclosureItemAmountsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementBasisAxis" xlink:to="loc_us-gaapFairValueDisclosureItemAmountsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosureItemAmountsDomain" xlink:to="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosureItemAmountsDomain" xlink:to="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaapCashAndCashEquivalentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapCashAndCashEquivalentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaapMoneyMarketFundsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapMoneyMarketFundsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BankTimeDepositsMember" xlink:label="loc_us-gaapBankTimeDepositsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapBankTimeDepositsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentAxis" xlink:label="loc_investInvestmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_investInvestmentAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentDomain" xlink:label="loc_investInvestmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_investInvestmentAxis" xlink:to="loc_investInvestmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:label="loc_clxTrustAssetsForNonqualifiedDeferredCompensationPlansMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_investInvestmentDomain" xlink:to="loc_clxTrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_NotesAndLoansPayableMember" xlink:label="loc_clxNotesAndLoansPayableMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_clxNotesAndLoansPayableMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMember" xlink:label="loc_us-gaapLongTermDebtMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapLongTermDebtMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="loc_us-gaapDeferredCompensationPlanAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapDeferredCompensationPlanAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaper" xlink:label="loc_us-gaapCommercialPaper" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCommercialPaper" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:label="loc_us-gaapCashFlowHedgeDerivativeInstrumentAssetsAtFairValue" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShorttermDebtFairValue" xlink:label="loc_us-gaapShorttermDebtFairValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapShorttermDebtFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaapDebtInstrumentFairValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapDebtInstrumentFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:label="loc_us-gaapCashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails" xlink:title="00000032 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxFinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateContractMember" xlink:label="loc_us-gaapInterestRateContractMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapInterestRateContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/IncomeTaxesDetails" xlink:title="00000033 - Disclosure - INCOME TAXES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails" xlink:title="00000034 - Disclosure - NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEpsShareRepurchaseProgramsDetails" xlink:title="00000035 - Disclosure - NET EARNINGS PER SHARE (EPS) (Share Repurchase Programs) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ShareRepurchaseProgramsTable" xlink:label="loc_clxShareRepurchaseProgramsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_clxShareRepurchaseProgramsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ShareRepurchaseProgramsLineItems" xlink:label="loc_clxShareRepurchaseProgramsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsTable" xlink:to="loc_clxShareRepurchaseProgramsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaapShareRepurchaseProgramAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsTable" xlink:to="loc_us-gaapShareRepurchaseProgramAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_OpenMarketProgramMember" xlink:label="loc_clxOpenMarketProgramMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_clxOpenMarketProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_EvergreenProgramMember" xlink:label="loc_clxEvergreenProgramMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_clxEvergreenProgramMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeNarrativeDetails" xlink:title="00000036 - Disclosure - COMPREHENSIVE INCOME (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:label="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceLineItems" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_LongTermIntercompanyLoansMember" xlink:label="loc_clxLongTermIntercompanyLoansMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" xlink:to="loc_clxLongTermIntercompanyLoansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:label="loc_us-gaapAdjustmentForLongTermIntercompanyTransactionsNetOfTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" xlink:to="loc_us-gaapAdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails" xlink:title="00000037 - Disclosure - COMPREHENSIVE INCOME (Schedule of Comprehensive Income) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:title="00000038 - Disclosure - COMPREHENSIVE INCOME (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaapStockholdersEquityNoteAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNoteAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaapAccumulatedTranslationAdjustmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedTranslationAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaapAccumulatedDefinedBenefitPlansAdjustmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:label="loc_us-gaapOciBeforeReclassificationsBeforeTaxAttributableToParent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:label="loc_us-gaapReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossTaxPortionAttributableToParent1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlansDetails" xlink:title="00000039 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_RetirementHealthCarePlansMember" xlink:label="loc_clxRetirementHealthCarePlansMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCarePlansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DomesticQualifiedRetirementIncomePlansMember" xlink:label="loc_clxDomesticQualifiedRetirementIncomePlansMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxDomesticQualifiedRetirementIncomePlansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaapDefinedBenefitPlanServiceCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanServiceCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaapDefinedBenefitPlanInterestCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanInterestCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="loc_us-gaapDefinedBenefitPlanContributionsByEmployer" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanContributionsByEmployer" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherContingenciesAndGuaranteesDetails" xlink:title="00000040 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_OtherContingenciesAndGuaranteesAbstract" xlink:label="loc_clxOtherContingenciesAndGuaranteesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies" xlink:label="loc_us-gaapAccrualForEnvironmentalLossContingencies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_us-gaapAccrualForEnvironmentalLossContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:label="loc_clxSiteContingencyAgreedPercentageOfCostSharing" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_clxSiteContingencyAgreedPercentageOfCostSharing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_RemediationPeriod" xlink:label="loc_clxRemediationPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_clxRemediationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_LetterOfCreditBorrowingCapacity" xlink:label="loc_clxLetterOfCreditBorrowingCapacity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_clxLetterOfCreditBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="loc_us-gaapLettersOfCreditOutstandingAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_clxOtherContingenciesAndGuaranteesAbstract" xlink:to="loc_us-gaapLettersOfCreditOutstandingAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResultsNarrativeDetails" xlink:title="00000041 - Disclosure - SEGMENT RESULTS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaapMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_WalmartStoresIncMember" xlink:label="loc_clxWalmartStoresIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_clxWalmartStoresIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaapProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapProductOrServiceAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaapProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductOrServiceAxis" xlink:to="loc_us-gaapProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:title="00000042 - Disclosure - SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapSegmentReportingInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_CleaningMember" xlink:label="loc_clxCleaningMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxCleaningMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_HouseholdMember" xlink:label="loc_clxHouseholdMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxHouseholdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_LifestyleMember" xlink:label="loc_clxLifestyleMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxLifestyleMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_InternationalMember" xlink:label="loc_clxInternationalMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxInternationalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateMember" xlink:label="loc_us-gaapCorporateMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_us-gaapCorporateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>clx-20160930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CLX 0916 10Q.xfr; Date: 2016%2D11%2D01T21:25:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80200000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_VenezuelanSubsidiaryMember" xlink:label="clx_VenezuelanSubsidiaryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VenezuelanSubsidiaryMember" xlink:to="clx_VenezuelanSubsidiaryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_VenezuelanSubsidiaryMember_lbl" xml:lang="en-US">Clorox Venezuela [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DiscontinuedOperationsOtherMember" xlink:label="clx_DiscontinuedOperationsOtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationsOtherMember" xlink:to="clx_DiscontinuedOperationsOtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DiscontinuedOperationsOtherMember_lbl" xml:lang="en-US">Other Discontinued Operations [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_RenewLifeHoldingsCorporationMember" xlink:label="clx_RenewLifeHoldingsCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RenewLifeHoldingsCorporationMember" xlink:to="clx_RenewLifeHoldingsCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RenewLifeHoldingsCorporationMember_lbl" xml:lang="en-US">RenewLife [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US">Trademarks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_OpenMarketProgramMember" xlink:label="clx_OpenMarketProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OpenMarketProgramMember" xlink:to="clx_OpenMarketProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OpenMarketProgramMember_lbl" xml:lang="en-US">Open-market purchase programs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="us-gaap_ShareRepurchaseProgramAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareRepurchaseProgramAxis" xlink:to="us-gaap_ShareRepurchaseProgramAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareRepurchaseProgramAxis_lbl" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_EvergreenProgramMember" xlink:label="clx_EvergreenProgramMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_EvergreenProgramMember" xlink:to="clx_EvergreenProgramMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_EvergreenProgramMember_lbl" xml:lang="en-US">Evergreen Program [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xml:lang="en-US">Foreign currency translation adjustments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_lbl" xml:lang="en-US">Net unrealized gain (losses) on derivatives [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_lbl" xml:lang="en-US">Pension and postretirement benefit adjustments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_LongTermIntercompanyLoansMember" xlink:label="clx_LongTermIntercompanyLoansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LongTermIntercompanyLoansMember" xlink:to="clx_LongTermIntercompanyLoansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_LongTermIntercompanyLoansMember_lbl" xml:lang="en-US">Long term intercompany loans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:label="us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:to="us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis_lbl" xml:lang="en-US">Intercompany Foreign Currency Balance by Description [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_RetirementIncomeMember" xlink:label="clx_RetirementIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementIncomeMember" xlink:to="clx_RetirementIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RetirementIncomeMember_lbl" xml:lang="en-US">Retirement Income Plans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_lbl" xml:lang="en-US">Defined Benefit Plans Disclosures, Defined Benefit Plans [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_RetirementHealthCarePlansMember" xlink:label="clx_RetirementHealthCarePlansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementHealthCarePlansMember" xlink:to="clx_RetirementHealthCarePlansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RetirementHealthCarePlansMember_lbl" xml:lang="en-US">Retirement Health Care Plans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DomesticQualifiedRetirementIncomePlansMember" xlink:label="clx_DomesticQualifiedRetirementIncomePlansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DomesticQualifiedRetirementIncomePlansMember" xlink:to="clx_DomesticQualifiedRetirementIncomePlansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DomesticQualifiedRetirementIncomePlansMember_lbl" xml:lang="en-US">Domestic Qualified Retirement Income Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_CleaningMember" xlink:label="clx_CleaningMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CleaningMember" xlink:to="clx_CleaningMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_CleaningMember_lbl" xml:lang="en-US">Cleaning [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segment Reporting Information, by Segment [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_HouseholdMember" xlink:label="clx_HouseholdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_HouseholdMember" xlink:to="clx_HouseholdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_HouseholdMember_lbl" xml:lang="en-US">Household [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_LifestyleMember" xlink:label="clx_LifestyleMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LifestyleMember" xlink:to="clx_LifestyleMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_LifestyleMember_lbl" xml:lang="en-US">Lifestyle [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_InternationalMember" xlink:label="clx_InternationalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_InternationalMember" xlink:to="clx_InternationalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_InternationalMember_lbl" xml:lang="en-US">International [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateMember" xlink:label="us-gaap_CorporateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateMember" xlink:to="us-gaap_CorporateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CorporateMember_lbl" xml:lang="en-US">Corporate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Net sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_WalmartStoresIncMember" xlink:label="clx_WalmartStoresIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_WalmartStoresIncMember" xlink:to="clx_WalmartStoresIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_WalmartStoresIncMember_lbl" xml:lang="en-US">Walmart Stores, Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="us-gaap_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorCustomersAxis" xlink:to="us-gaap_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsMember" xlink:to="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xml:lang="en-US">Estimated Fair Value [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueByMeasurementBasisAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_lbl" xml:lang="en-US">Measurement Basis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US">Investments including money market funds [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CarryingReportedAmountFairValueDisclosureMember_lbl" xml:lang="en-US">Carrying Amount [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BankTimeDepositsMember" xlink:label="us-gaap_BankTimeDepositsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BankTimeDepositsMember" xlink:to="us-gaap_BankTimeDepositsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BankTimeDepositsMember_lbl" xml:lang="en-US">Time deposits [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="us-gaap_CommodityContractMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommodityContractMember" xlink:to="us-gaap_CommodityContractMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommodityContractMember_lbl" xml:lang="en-US">Commodity purchase derivative contracts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Derivative Instrument Risk [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="us-gaap_OtherCurrentAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCurrentAssetsMember" xlink:to="us-gaap_OtherCurrentAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCurrentAssetsMember_lbl" xml:lang="en-US">Other current assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="us-gaap_ForeignExchangeContractMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignExchangeContractMember" xlink:to="us-gaap_ForeignExchangeContractMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignExchangeContractMember_lbl" xml:lang="en-US">Foreign exchange derivative contracts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsMember_lbl" xml:lang="en-US">Other assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:label="clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:to="clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_lbl" xml:lang="en-US">Trust Assets for nonqualified deferred compensation plans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentAxis" xlink:label="invest_InvestmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_InvestmentAxis" xlink:to="invest_InvestmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="invest_InvestmentAxis_lbl" xml:lang="en-US">Investment [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="us-gaap_NotesPayableOtherPayablesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableOtherPayablesMember" xlink:to="us-gaap_NotesPayableOtherPayablesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableOtherPayablesMember_lbl" xml:lang="en-US">Notes and loans payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_NotesAndLoansPayableMember" xlink:label="clx_NotesAndLoansPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NotesAndLoansPayableMember" xlink:to="clx_NotesAndLoansPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="clx_NotesAndLoansPayableMember_lbl" xml:lang="en-US">Notes and loans payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl" xml:lang="en-US">Accounts payable and accrued liabilities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMember" xlink:label="us-gaap_LongTermDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMember" xlink:to="us-gaap_LongTermDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMember_lbl" xml:lang="en-US">Current maturities of long-term debt and Long-term debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:label="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:to="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_lbl" xml:lang="en-US">Current maturities of long-term debt and Long-term debt [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateContractMember" xlink:label="us-gaap_InterestRateContractMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestRateContractMember" xlink:to="us-gaap_InterestRateContractMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestRateContractMember_lbl" xml:lang="en-US">Interest rate derivative contracts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_JetFuelMember" xlink:label="clx_JetFuelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_JetFuelMember" xlink:to="clx_JetFuelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_JetFuelMember_lbl" xml:lang="en-US">Jet Fuel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeNatureAxis" xlink:label="clx_DerivativeNatureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeNatureAxis" xlink:to="clx_DerivativeNatureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DerivativeNatureAxis_lbl" xml:lang="en-US">Derivative Nature [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_SoybeanOilMember" xlink:label="clx_SoybeanOilMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SoybeanOilMember" xlink:to="clx_SoybeanOilMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SoybeanOilMember_lbl" xml:lang="en-US">Soybean Oil [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DocumentAndEntityInformationAbstract" xlink:label="clx_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DocumentAndEntityInformationAbstract" xlink:to="clx_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US">Net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="us-gaap_CostOfGoodsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsSold" xlink:to="us-gaap_CostOfGoodsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsSold_lbl" xml:lang="en-US">Cost of products sold</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_OtherIncomeExpenseNet" xlink:label="clx_OtherIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIncomeExpenseNet" xlink:to="clx_OtherIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherIncomeExpenseNet_lbl" xml:lang="en-US">Other (income) expense, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Earnings from continuing operations before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income taxes on continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Earnings from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xml:lang="en-US">Earnings (losses) from discontinued operations, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="us-gaap_EarningsPerShareBasicAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasicAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAbstract_lbl" xml:lang="en-US">Net earnings (losses) per share, Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xml:lang="en-US">Discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract" xlink:label="us-gaap_EarningsPerShareDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDilutedAbstract" xlink:to="us-gaap_EarningsPerShareDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDilutedAbstract_lbl" xml:lang="en-US">Net earnings (losses) per share, Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xml:lang="en-US">Continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xml:lang="en-US">Discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average shares outstanding (in thousands)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US">Dividend declared per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="us-gaap_ReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesNetCurrent" xlink:to="us-gaap_ReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesNetCurrent_lbl" xml:lang="en-US">Receivables, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventories, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property, plant and equipment, net of accumulated depreciation and amortization of $1,944 and $1,911 respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_TrademarksNet" xlink:label="clx_TrademarksNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TrademarksNet" xlink:to="clx_TrademarksNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_TrademarksNet_lbl" xml:lang="en-US">Trademarks, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="us-gaap_OtherIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsNet" xlink:to="us-gaap_OtherIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsNet_lbl" xml:lang="en-US">Other intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaper" xlink:label="us-gaap_CommercialPaper" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaper" xlink:to="us-gaap_CommercialPaper_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommercialPaper_lbl" xml:lang="en-US">Notes and loans payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current maturities of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">Long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock: $1.00 par value; 750,000,000 shares authorized; 158,741,461 shares issued as of both September 30, 2016 and June 30, 2016; and 128,707,796 and 129,355,263 shares outstanding as of September 30, 2016 and June 30, 2016, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury shares, at cost: 30,033,665 and 29,386,198 shares as of September 30, 2016 and June 30, 2016, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive net (losses) income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property, plant and equipment, accumulated depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xml:lang="en-US">Deduct: Losses from discontinued operations, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile earnings from continuing operations to net cash provided by continuing operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="us-gaap_IncreaseDecreaseInReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Receivables, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash provided by continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Net cash provided by discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used for investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfShortTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfShortTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfShortTermDebt_lbl" xml:lang="en-US">Notes and loans payable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US">Treasury stock purchased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="us-gaap_PaymentsOfDividendsCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xml:lang="en-US">Cash dividends paid</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities" xlink:label="clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities" xlink:to="clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities_lbl" xml:lang="en-US">Issuance of common stock for employee stock plans and other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used for financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Cash and cash equivalents:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">End of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xml:lang="en-US">DISCONTINUED OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US">Business Combinations [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">BUSINESSES ACQUIRED</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES, NET</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_lbl" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" xlink:to="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock_lbl" xml:lang="en-US">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">NET EARNINGS PER SHARE (EPS)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xml:lang="en-US">COMPREHENSIVE INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:label="us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_lbl" xml:lang="en-US">Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xml:lang="en-US">EMPLOYEE BENEFIT PLANS</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_OtherContingenciesAndGuaranteesAbstract" xlink:label="clx_OtherContingenciesAndGuaranteesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherContingenciesAndGuaranteesAbstract" xlink:to="clx_OtherContingenciesAndGuaranteesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_OtherContingenciesAndGuaranteesAbstract_lbl" xml:lang="en-US">OTHER CONTINGENCIES AND GUARANTEES [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ContingenciesAndGuaranteesDisclosureTextBlock" xlink:label="clx_ContingenciesAndGuaranteesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ContingenciesAndGuaranteesDisclosureTextBlock" xlink:to="clx_ContingenciesAndGuaranteesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ContingenciesAndGuaranteesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER CONTINGENCIES AND GUARANTEES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT RESULTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" xlink:label="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" xlink:to="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock_lbl" xml:lang="en-US">Summary of (losses) gains from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed as of Acquisition Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventories, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xml:lang="en-US">Schedule of Assets and Liabilities for Fair Value Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US">Effects of Derivative Instruments Designated as Hedging Instruments on OCI</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_lbl" xml:lang="en-US">Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="us-gaap_ScheduleOfTreasuryStockByClassTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfTreasuryStockByClassTextBlock_lbl" xml:lang="en-US">Schedule of Share Repurchases Under Authorized Programs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US">Schedule of Comprehensive Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US">Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:label="us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Net Periodic Benefit Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Selected Financial Information Relating to the Company's Segments</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609" xlink:label="clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609" xlink:to="clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609_lbl" xml:lang="en-US">Excess tax benefits impact from adoption of ASU No. 2016-09</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609" xlink:label="clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609" xlink:to="clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609_lbl" xml:lang="en-US">Reduction in effective tax rate from adoption of ASU No. 2016-09</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503" xlink:label="clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503" xlink:to="clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503_lbl" xml:lang="en-US">Reclassification of debt issuance costs from adoption of ASU No. 2015-03</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xml:lang="en-US">Net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_lbl" xml:lang="en-US">Operating losses from discontinued operations before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_lbl" xml:lang="en-US">Exit costs and other related expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_lbl" xml:lang="en-US">Total losses from discontinued operations before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_lbl" xml:lang="en-US">Income tax benefit attributable to discontinued operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3_lbl" xml:lang="en-US">Total gain (losses) from discontinued operations, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xml:lang="en-US">Business acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Percentage of business acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xml:lang="en-US">Amount paid for acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_lbl" xml:lang="en-US">The weighted-average estimated useful life of intangible assets subject to amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_lbl" xml:lang="en-US">Estimated fair values of assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property, plant and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xml:lang="en-US">Working capital, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials and packaging</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work in process</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryLIFOReserve" xlink:label="us-gaap_InventoryLIFOReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLIFOReserve" xlink:to="us-gaap_InventoryLIFOReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryLIFOReserve_lbl" xml:lang="en-US">LIFO allowances</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeTable" xlink:label="us-gaap_DerivativeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeTable" xlink:to="us-gaap_DerivativeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeTable_lbl" xml:lang="en-US">Derivative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="us-gaap_DerivativeLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLineItems" xlink:to="us-gaap_DerivativeLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLineItems_lbl" xml:lang="en-US">Derivative [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_2_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeNatureAxis" xlink:to="clx_DerivativeNatureAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="clx_DerivativeNatureAxis_2_lbl" xml:lang="en-US">DerivativeNatureAxis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:to="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss_lbl" xml:lang="en-US">Non-qualified deferred compensation plan assets, changes in fair value of trust assets</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeIntrumentsMaximumContractDuration" xlink:label="clx_DerivativeIntrumentsMaximumContractDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeIntrumentsMaximumContractDuration" xlink:to="clx_DerivativeIntrumentsMaximumContractDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DerivativeIntrumentsMaximumContractDuration_lbl" xml:lang="en-US">Maximum contract duration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="invest_DerivativeNotionalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_DerivativeNotionalAmount" xlink:to="invest_DerivativeNotionalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="invest_DerivativeNotionalAmount_lbl" xml:lang="en-US">Notional amounts</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_InterestRateForwardContractsSettlement" xlink:label="clx_InterestRateForwardContractsSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_InterestRateForwardContractsSettlement" xlink:to="clx_InterestRateForwardContractsSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_InterestRateForwardContractsSettlement_lbl" xml:lang="en-US">Settlement of interest rate forward contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_SettlementOfInterestRateForwardContract" xlink:label="clx_SettlementOfInterestRateForwardContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SettlementOfInterestRateForwardContract" xlink:to="clx_SettlementOfInterestRateForwardContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SettlementOfInterestRateForwardContract_lbl" xml:lang="en-US">Payment to settle interest rate forward contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt issued</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:label="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:to="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_lbl" xml:lang="en-US">Amortization period of settlement payment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Term of notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers" xlink:label="us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers" xlink:to="us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers_lbl" xml:lang="en-US">Cash margin balances related to exchange-traded futures contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilities_lbl" xml:lang="en-US">Derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:label="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:to="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_lbl" xml:lang="en-US">Derivative instruments subject to contractually defined counterparty liability position limits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MarginDepositAssets" xlink:label="us-gaap_MarginDepositAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarginDepositAssets" xlink:to="us-gaap_MarginDepositAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarginDepositAssets_lbl" xml:lang="en-US">Cash margin balances amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_lbl" xml:lang="en-US">Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="us-gaap_DeferredCompensationPlanAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationPlanAssets" xlink:to="us-gaap_DeferredCompensationPlanAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationPlanAssets_lbl" xml:lang="en-US">Trust assets for nonqualified deferred compensation plans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Current maturities of long-term debt and Long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:label="us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:to="us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_lbl" xml:lang="en-US">Derivative assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Trust assets for nonqualified deferred compensation plans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShorttermDebtFairValue" xlink:label="us-gaap_ShorttermDebtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShorttermDebtFairValue" xlink:to="us-gaap_ShorttermDebtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShorttermDebtFairValue_lbl" xml:lang="en-US">Notes and loans payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="us-gaap_DebtInstrumentFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="us-gaap_DebtInstrumentFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xml:lang="en-US">Current maturities of long-term debt and Long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:label="us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:to="us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_lbl" xml:lang="en-US">Derivative liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossLineItems_lbl" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:to="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_lbl" xml:lang="en-US">Gains (losses) recognized in Other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_lbl" xml:lang="en-US">Gains (losses) reclassified from Accumulated other comprehensive loss and recognized in Net earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective tax rate on earnings from continuing operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted Average Shares Outstanding - Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xml:lang="en-US">Dilutive effect of stock options and other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted Average Shares Outstanding - Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive stock options and other</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ShareRepurchaseProgramsTable" xlink:label="clx_ShareRepurchaseProgramsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareRepurchaseProgramsTable" xlink:to="clx_ShareRepurchaseProgramsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareRepurchaseProgramsTable_lbl" xml:lang="en-US">Share Repurchase Programs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ShareRepurchaseProgramsLineItems" xlink:label="clx_ShareRepurchaseProgramsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareRepurchaseProgramsLineItems" xlink:to="clx_ShareRepurchaseProgramsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_ShareRepurchaseProgramsLineItems_lbl" xml:lang="en-US">Share Repurchase Programs [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US">Authorized repurchase amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xml:lang="en-US">Remaining authorized repurchase amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Value of shares repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Shares repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:label="us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:to="us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable_lbl" xml:lang="en-US">Schedule of Intercompany Foreign Currency Balance [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceLineItems" xlink:label="us-gaap_IntercompanyForeignCurrencyBalanceLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntercompanyForeignCurrencyBalanceLineItems" xlink:to="us-gaap_IntercompanyForeignCurrencyBalanceLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntercompanyForeignCurrencyBalanceLineItems_lbl" xml:lang="en-US">Intercompany Foreign Currency Balance [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:label="us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:to="us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax_lbl" xml:lang="en-US">Other comprehensive net income (loss) before reclassifications</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xml:lang="en-US">Earnings from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xml:lang="en-US">Foreign currency translation adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Net unrealized gains (losses) on derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_lbl" xml:lang="en-US">Pension and postretirement benefit adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Total other comprehensive income (loss), net of tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_2_lbl" xml:lang="en-US">Comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2_lbl" xml:lang="en-US">Balance, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:label="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_lbl" xml:lang="en-US">Other comprehensive (loss) income before reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_lbl" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive net losses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_lbl" xml:lang="en-US">Income tax benefit (expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3_lbl" xml:lang="en-US">Balance, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis_2_lbl" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="us-gaap_DefinedBenefitPlanServiceCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanServiceCost" xlink:to="us-gaap_DefinedBenefitPlanServiceCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanServiceCost_lbl" xml:lang="en-US">Service cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="us-gaap_DefinedBenefitPlanInterestCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanInterestCost" xlink:to="us-gaap_DefinedBenefitPlanInterestCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanInterestCost_lbl" xml:lang="en-US">Interest cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_lbl" xml:lang="en-US">Expected return on plan assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_lbl" xml:lang="en-US">Amortization of unrecognized items</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl" xml:lang="en-US">Discretionary contributions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccrualForEnvironmentalLossContingencies" xlink:label="us-gaap_AccrualForEnvironmentalLossContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccrualForEnvironmentalLossContingencies" xlink:to="us-gaap_AccrualForEnvironmentalLossContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccrualForEnvironmentalLossContingencies_lbl" xml:lang="en-US">Liability for aggregate future remediation costs</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:label="clx_SiteContingencyAgreedPercentageOfCostSharing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:to="clx_SiteContingencyAgreedPercentageOfCostSharing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_SiteContingencyAgreedPercentageOfCostSharing_lbl" xml:lang="en-US">Percentage of liability for aggregate remediation and associated costs, other than legal fees</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_RemediationPeriod" xlink:label="clx_RemediationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RemediationPeriod" xlink:to="clx_RemediationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_RemediationPeriod_lbl" xml:lang="en-US">Remediation period</link:label>
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_LetterOfCreditBorrowingCapacity" xlink:label="clx_LetterOfCreditBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LetterOfCreditBorrowingCapacity" xlink:to="clx_LetterOfCreditBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_LetterOfCreditBorrowingCapacity_lbl" xml:lang="en-US">Letter of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount" xlink:label="us-gaap_LettersOfCreditOutstandingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LettersOfCreditOutstandingAmount" xlink:to="us-gaap_LettersOfCreditOutstandingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LettersOfCreditOutstandingAmount_lbl" xml:lang="en-US">Letter of credit, amount outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductOrServiceAxis_lbl" xml:lang="en-US">Products and Services [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StatementBusinessSegmentsAxis_2_lbl" xml:lang="en-US">Segments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Earnings (losses) from continuing operations before income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OtherIncomeExpenseNet" xlink:to="clx_OtherIncomeExpenseNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OtherIncomeExpenseNet_doc" xml:lang="en-US">The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TrademarksNet" xlink:to="clx_TrademarksNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_TrademarksNet_doc" xml:lang="en-US">Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract" xlink:to="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsAbstract_doc" xml:lang="en-US">Financial Instruments and Fair Value Measurements [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock" xlink:to="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock_doc" xml:lang="en-US">The entire disclosure for financial instruments and fair value measurements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ContingenciesAndGuaranteesDisclosureTextBlock" xlink:to="clx_ContingenciesAndGuaranteesDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ContingenciesAndGuaranteesDisclosureTextBlock_doc" xml:lang="en-US">This item represents the complete disclosure regarding the entity's exposure to loss pertaining to environmental matters, litigation and potential losses not disclosed in other notes and guarantees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock" xlink:to="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock_doc" xml:lang="en-US">Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and profit or loss reported in discontinued operations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_VenezuelanSubsidiaryMember" xlink:to="clx_VenezuelanSubsidiaryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_VenezuelanSubsidiaryMember_doc" xml:lang="en-US">Subsidiary in Venezuela [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DiscontinuedOperationsOtherMember" xlink:to="clx_DiscontinuedOperationsOtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DiscontinuedOperationsOtherMember_doc" xml:lang="en-US">Discontinued operations not otherwise disclosed.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RenewLifeHoldingsCorporationMember" xlink:to="clx_RenewLifeHoldingsCorporationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RenewLifeHoldingsCorporationMember_doc" xml:lang="en-US">Renew Life Holdings Corporation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareRepurchaseProgramsTable" xlink:to="clx_ShareRepurchaseProgramsTable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareRepurchaseProgramsTable_doc" xml:lang="en-US">Disclosure of information about share repurchase programs and shares repurchased.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ShareRepurchaseProgramsLineItems" xlink:to="clx_ShareRepurchaseProgramsLineItems_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ShareRepurchaseProgramsLineItems_doc" xml:lang="en-US">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_OpenMarketProgramMember" xlink:to="clx_OpenMarketProgramMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_OpenMarketProgramMember_doc" xml:lang="en-US">A program to repurchase issued and outstanding common shares of the entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_EvergreenProgramMember" xlink:to="clx_EvergreenProgramMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_EvergreenProgramMember_doc" xml:lang="en-US">Evergreen Program [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LongTermIntercompanyLoansMember" xlink:to="clx_LongTermIntercompanyLoansMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_LongTermIntercompanyLoansMember_doc" xml:lang="en-US">Long term intercompany loans included in foreign currency adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementIncomeMember" xlink:to="clx_RetirementIncomeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RetirementIncomeMember_doc" xml:lang="en-US">Retirement Income [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RetirementHealthCarePlansMember" xlink:to="clx_RetirementHealthCarePlansMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RetirementHealthCarePlansMember_doc" xml:lang="en-US">Retirement Health Care Plans [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DomesticQualifiedRetirementIncomePlansMember" xlink:to="clx_DomesticQualifiedRetirementIncomePlansMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DomesticQualifiedRetirementIncomePlansMember_doc" xml:lang="en-US">Domestic Qualified Retirement Income Plans [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CleaningMember" xlink:to="clx_CleaningMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_CleaningMember_doc" xml:lang="en-US">Cleaning [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_HouseholdMember" xlink:to="clx_HouseholdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_HouseholdMember_doc" xml:lang="en-US">Household [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LifestyleMember" xlink:to="clx_LifestyleMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_LifestyleMember_doc" xml:lang="en-US">Lifestyle [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_InternationalMember" xlink:to="clx_InternationalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_InternationalMember_doc" xml:lang="en-US">International [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_WalmartStoresIncMember" xlink:to="clx_WalmartStoresIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_WalmartStoresIncMember_doc" xml:lang="en-US">Walmart Stores, Inc. and its affiliates [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SiteContingencyAgreedPercentageOfCostSharing" xlink:to="clx_SiteContingencyAgreedPercentageOfCostSharing_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SiteContingencyAgreedPercentageOfCostSharing_doc" xml:lang="en-US">The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_RemediationPeriod" xlink:to="clx_RemediationPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_RemediationPeriod_doc" xml:lang="en-US">Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_LetterOfCreditBorrowingCapacity" xlink:to="clx_LetterOfCreditBorrowingCapacity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_LetterOfCreditBorrowingCapacity_doc" xml:lang="en-US">Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeNatureAxis" xlink:to="clx_DerivativeNatureAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DerivativeNatureAxis_doc" xml:lang="en-US">Derivative Nature [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_JetFuelMember" xlink:to="clx_JetFuelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_JetFuelMember_doc" xml:lang="en-US">Jet Fuel [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SoybeanOilMember" xlink:to="clx_SoybeanOilMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SoybeanOilMember_doc" xml:lang="en-US">Soybean Oil [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeIntrumentsMaximumContractDuration" xlink:to="clx_DerivativeIntrumentsMaximumContractDuration_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DerivativeIntrumentsMaximumContractDuration_doc" xml:lang="en-US">Maximum contract duration for a derivative instrument.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_InterestRateForwardContractsSettlement" xlink:to="clx_InterestRateForwardContractsSettlement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_InterestRateForwardContractsSettlement_doc" xml:lang="en-US">Cash payment to counterparties to settle an interest rate cash flow hedge in connection with the issuance of long-term debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_SettlementOfInterestRateForwardContract" xlink:to="clx_SettlementOfInterestRateForwardContract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_SettlementOfInterestRateForwardContract_doc" xml:lang="en-US">Payment for the settlement of interest rate forward contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:to="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_doc" xml:lang="en-US">Amortization period of settlement payment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:to="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_doc" xml:lang="en-US">Derivative instruments subject to contractually defined counterparty liability position limits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities" xlink:to="clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities_doc" xml:lang="en-US">The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609" xlink:to="clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609_doc" xml:lang="en-US">Amount of excess tax benefits (deficiencies) recognized as a component of the provision for income taxes on the statement of earnings as a result of adopting the Accounting Standards Update (ASU) No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting."</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609" xlink:to="clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609_doc" xml:lang="en-US">The decrease (increase) in the company's effective tax rate (as a percentage) as a result of adopting the Accounting Standards Update (ASU) No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting."</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503" xlink:to="clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503_doc" xml:lang="en-US">Amount of debt issuance costs reclassified from other assets to long-term debt on the statement of financial position as a result of adopting the Accounting Standards Update (ASU) No. 2015-03: "Simplifying the Presentation of Debt Issuance Cost."</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:to="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_doc" xml:lang="en-US">Current Maturities of Long-term Debt and Long-term Debt [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:to="clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember_doc" xml:lang="en-US">Trust Assets For Nonqualified Deferred Compensation Plans [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NotesAndLoansPayableMember" xlink:to="clx_NotesAndLoansPayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="clx_NotesAndLoansPayableMember_doc" xml:lang="en-US">Notes and Loans Payable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_NotesAndLoansPayableMember" xlink:to="clx_NotesAndLoansPayableMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_NotesAndLoansPayableMember_3_lbl" xml:lang="en-US">NotesAndLoansPayableMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:to="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_3_lbl" xml:lang="en-US">CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Earnings Per Share, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_2_lbl" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_2_lbl" xml:lang="en-US">Assets [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashIncomeExpense_2_lbl" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_2_lbl" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_2_lbl" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="us-gaap_ComprehensiveIncomeNoteTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock_2_lbl" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_2_lbl" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_2_lbl" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryLIFOReserve" xlink:to="us-gaap_InventoryLIFOReserve_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryLIFOReserve_2_lbl" xml:lang="en-US">Inventory, LIFO Reserve</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsFairValueDisclosure_2_lbl" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_2_lbl" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShorttermDebtFairValue" xlink:to="us-gaap_ShorttermDebtFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShorttermDebtFairValue_2_lbl" xml:lang="en-US">Short-term Debt, Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="us-gaap_DebtInstrumentFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFairValue_2_lbl" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_2_lbl" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2_lbl" xml:lang="en-US">Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_2_lbl" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_2_lbl" xml:lang="en-US">Defined Benefit Plan, Expected Return on Plan Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_2_lbl" xml:lang="en-US">Defined Benefit Plan, Amortization of Gains (Losses)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2_lbl" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>clx-20160930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CLX 0916 10Q.xfr; Date: 2016%2D11%2D01T21:25:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80200000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://thecloroxcompany.com/role/DocumentAndEntityInformation" xlink:href="clx-20160930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StatementsOfEarningsAndComprehensiveIncome" xlink:href="clx-20160930.xsd#StatementsOfEarningsAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BalanceSheets" xlink:href="clx-20160930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/Statement-CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="clx-20160930.xsd#Statement-CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StatementsOfCashFlows" xlink:href="clx-20160930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="clx-20160930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-do" xlink:href="clx-20160930.xsd#clx-do" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:href="clx-20160930.xsd#BusinessesAcquired" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/InventoriesNet" xlink:href="clx-20160930.xsd#InventoriesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:href="clx-20160930.xsd#clx-fiafvm1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/IncomeTaxes" xlink:href="clx-20160930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEps" xlink:href="clx-20160930.xsd#NetEarningsPerShareEps" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncome" xlink:href="clx-20160930.xsd#ComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlans" xlink:href="clx-20160930.xsd#EmployeeBenefitPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/OtherContingenciesAndGuarantees" xlink:href="clx-20160930.xsd#OtherContingenciesAndGuarantees" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResults" xlink:href="clx-20160930.xsd#SegmentResults" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="clx-20160930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/DiscontinuedOperationsTables" xlink:href="clx-20160930.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:href="clx-20160930.xsd#BusinessesAcquiredTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/InventoriesNetTables" xlink:href="clx-20160930.xsd#InventoriesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsTables" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsTables" xlink:href="clx-20160930.xsd#NetEarningsPerShareEpsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeTables" xlink:href="clx-20160930.xsd#ComprehensiveIncomeTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansTables" xlink:href="clx-20160930.xsd#EmployeeBenefitPlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResultsTables" xlink:href="clx-20160930.xsd#SegmentResultsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="clx-20160930.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails" xlink:href="clx-20160930.xsd#DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:href="clx-20160930.xsd#BusinessesAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/InventoriesNetDetails" xlink:href="clx-20160930.xsd#InventoriesNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/IncomeTaxesDetails" xlink:href="clx-20160930.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails" xlink:href="clx-20160930.xsd#NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsShareRepurchaseProgramsDetails" xlink:href="clx-20160930.xsd#NetEarningsPerShareEpsShareRepurchaseProgramsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeNarrativeDetails" xlink:href="clx-20160930.xsd#ComprehensiveIncomeNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails" xlink:href="clx-20160930.xsd#ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:href="clx-20160930.xsd#ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansDetails" xlink:href="clx-20160930.xsd#EmployeeBenefitPlansDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/OtherContingenciesAndGuaranteesDetails" xlink:href="clx-20160930.xsd#OtherContingenciesAndGuaranteesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResultsNarrativeDetails" xlink:href="clx-20160930.xsd#SegmentResultsNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:href="clx-20160930.xsd#SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StatementsOfEarningsAndComprehensiveIncome" xlink:title="00000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_OtherIncomeExpenseNet" xlink:label="loc_clxOtherIncomeExpenseNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_clxOtherIncomeExpenseNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEarningsPerShareBasic" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEarningsPerShareBasic" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEarningsPerShareDiluted" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEarningsPerShareDiluted" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BalanceSheets" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaapReceivablesNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapReceivablesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_TrademarksNet" xlink:label="loc_clxTrademarksNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_clxTrademarksNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIntangibleAssetsNet" xlink:label="loc_us-gaapOtherIntangibleAssetsNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaper" xlink:label="loc_us-gaapCommercialPaper" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapCommercialPaper" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredTaxLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:label="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/Statement-CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000004 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaapOtherNoncashIncomeExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapOtherNoncashIncomeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfShortTermDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_us-gaapPaymentsOfDividendsCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsCommonStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities" xlink:label="loc_clxProceedsFromStockOptionsExercisedAndOtherFinancingActivities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_clxProceedsFromStockOptionsExercisedAndOtherFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapEffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-do" xlink:title="00000007 - Disclosure - DISCONTINUED OPERATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:title="00000008 - Disclosure - BUSINESSES ACQUIRED" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/InventoriesNet" xlink:title="00000009 - Disclosure - INVENTORIES, NET" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:title="00000010 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/IncomeTaxes" xlink:title="00000011 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEps" xlink:title="00000012 - Disclosure - NET EARNINGS PER SHARE (EPS)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncome" xlink:title="00000013 - Disclosure - COMPREHENSIVE INCOME" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlans" xlink:title="00000014 - Disclosure - EMPLOYEE BENEFIT PLANS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherContingenciesAndGuarantees" xlink:title="00000015 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResults" xlink:title="00000016 - Disclosure - SEGMENT RESULTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/DiscontinuedOperationsTables" xlink:title="00000018 - Disclosure - DISCONTINUED OPERATIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:title="00000019 - Disclosure - BUSINESSES ACQUIRED (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/InventoriesNetTables" xlink:title="00000020 - Disclosure - INVENTORIES, NET (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsTables" xlink:title="00000021 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEpsTables" xlink:title="00000022 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeTables" xlink:title="00000023 - Disclosure - COMPREHENSIVE INCOME  (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlansTables" xlink:title="00000024 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResultsTables" xlink:title="00000025 - Disclosure - SEGMENT RESULTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails" xlink:title="00000027 - Disclosure - DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" weight="-1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:title="00000028 - Disclosure - BUSINESSES ACQUIRED (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/InventoriesNetDetails" xlink:title="00000029 - Disclosure - INVENTORIES, NET (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryLIFOReserve" xlink:label="loc_us-gaapInventoryLIFOReserve" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryLIFOReserve" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails" xlink:title="00000030 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:title="00000031 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails" xlink:title="00000032 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/IncomeTaxesDetails" xlink:title="00000033 - Disclosure - INCOME TAXES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails" xlink:title="00000034 - Disclosure - NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEpsShareRepurchaseProgramsDetails" xlink:title="00000035 - Disclosure - NET EARNINGS PER SHARE (EPS) (Share Repurchase Programs) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeNarrativeDetails" xlink:title="00000036 - Disclosure - COMPREHENSIVE INCOME (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails" xlink:title="00000037 - Disclosure - COMPREHENSIVE INCOME (Schedule of Comprehensive Income) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:title="00000038 - Disclosure - COMPREHENSIVE INCOME (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlansDetails" xlink:title="00000039 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaapDefinedBenefitPlanServiceCost" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_us-gaapDefinedBenefitPlanServiceCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaapDefinedBenefitPlanInterestCost" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_us-gaapDefinedBenefitPlanInterestCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherContingenciesAndGuaranteesDetails" xlink:title="00000040 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResultsNarrativeDetails" xlink:title="00000041 - Disclosure - SEGMENT RESULTS (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:title="00000042 - Disclosure - SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>clx-20160930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.14b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CLX 0916 10Q.xfr; Date: 2016%2D11%2D01T21:25:10Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80200000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://thecloroxcompany.com/role/DocumentAndEntityInformation" xlink:href="clx-20160930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StatementsOfEarningsAndComprehensiveIncome" xlink:href="clx-20160930.xsd#StatementsOfEarningsAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BalanceSheets" xlink:href="clx-20160930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/Statement-CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="clx-20160930.xsd#Statement-CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/StatementsOfCashFlows" xlink:href="clx-20160930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="clx-20160930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-do" xlink:href="clx-20160930.xsd#clx-do" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:href="clx-20160930.xsd#BusinessesAcquired" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/InventoriesNet" xlink:href="clx-20160930.xsd#InventoriesNet" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:href="clx-20160930.xsd#clx-fiafvm1" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/IncomeTaxes" xlink:href="clx-20160930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEps" xlink:href="clx-20160930.xsd#NetEarningsPerShareEps" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncome" xlink:href="clx-20160930.xsd#ComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlans" xlink:href="clx-20160930.xsd#EmployeeBenefitPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/OtherContingenciesAndGuarantees" xlink:href="clx-20160930.xsd#OtherContingenciesAndGuarantees" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResults" xlink:href="clx-20160930.xsd#SegmentResults" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="clx-20160930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/DiscontinuedOperationsTables" xlink:href="clx-20160930.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:href="clx-20160930.xsd#BusinessesAcquiredTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/InventoriesNetTables" xlink:href="clx-20160930.xsd#InventoriesNetTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsTables" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsTables" xlink:href="clx-20160930.xsd#NetEarningsPerShareEpsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeTables" xlink:href="clx-20160930.xsd#ComprehensiveIncomeTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansTables" xlink:href="clx-20160930.xsd#EmployeeBenefitPlansTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResultsTables" xlink:href="clx-20160930.xsd#SegmentResultsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="clx-20160930.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails" xlink:href="clx-20160930.xsd#DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:href="clx-20160930.xsd#BusinessesAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/InventoriesNetDetails" xlink:href="clx-20160930.xsd#InventoriesNetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails" xlink:href="clx-20160930.xsd#FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/IncomeTaxesDetails" xlink:href="clx-20160930.xsd#IncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails" xlink:href="clx-20160930.xsd#NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/NetEarningsPerShareEpsShareRepurchaseProgramsDetails" xlink:href="clx-20160930.xsd#NetEarningsPerShareEpsShareRepurchaseProgramsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeNarrativeDetails" xlink:href="clx-20160930.xsd#ComprehensiveIncomeNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails" xlink:href="clx-20160930.xsd#ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:href="clx-20160930.xsd#ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/EmployeeBenefitPlansDetails" xlink:href="clx-20160930.xsd#EmployeeBenefitPlansDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/OtherContingenciesAndGuaranteesDetails" xlink:href="clx-20160930.xsd#OtherContingenciesAndGuaranteesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResultsNarrativeDetails" xlink:href="clx-20160930.xsd#SegmentResultsNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://thecloroxcompany.com/role/SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:href="clx-20160930.xsd#SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StatementsOfEarningsAndComprehensiveIncome" xlink:title="00000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BalanceSheets" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/Statement-CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000004 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-do" xlink:title="00000007 - Disclosure - DISCONTINUED OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquired" xlink:title="00000008 - Disclosure - BUSINESSES ACQUIRED" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/InventoriesNet" xlink:title="00000009 - Disclosure - INVENTORIES, NET" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/clx-fiafvm1" xlink:title="00000010 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/IncomeTaxes" xlink:title="00000011 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEps" xlink:title="00000012 - Disclosure - NET EARNINGS PER SHARE (EPS)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncome" xlink:title="00000013 - Disclosure - COMPREHENSIVE INCOME" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlans" xlink:title="00000014 - Disclosure - EMPLOYEE BENEFIT PLANS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherContingenciesAndGuarantees" xlink:title="00000015 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResults" xlink:title="00000016 - Disclosure - SEGMENT RESULTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/DiscontinuedOperationsTables" xlink:title="00000018 - Disclosure - DISCONTINUED OPERATIONS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredTables" xlink:title="00000019 - Disclosure - BUSINESSES ACQUIRED (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/InventoriesNetTables" xlink:title="00000020 - Disclosure - INVENTORIES, NET (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsTables" xlink:title="00000021 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEpsTables" xlink:title="00000022 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeTables" xlink:title="00000023 - Disclosure - COMPREHENSIVE INCOME  (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlansTables" xlink:title="00000024 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResultsTables" xlink:title="00000025 - Disclosure - SEGMENT RESULTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails" xlink:title="00000027 - Disclosure - DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_VenezuelanSubsidiaryMember" xlink:label="loc_clxVenezuelanSubsidiaryMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxVenezuelanSubsidiaryMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DiscontinuedOperationsOtherMember" xlink:label="loc_clxDiscontinuedOperationsOtherMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="loc_clxDiscontinuedOperationsOtherMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOtherExpense_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapDiscontinuedOperationTaxEffectOfDiscontinuedOperation_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/BusinessesAcquiredDetails" xlink:title="00000028 - Disclosure - BUSINESSES ACQUIRED (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_RenewLifeHoldingsCorporationMember" xlink:label="loc_clxRenewLifeHoldingsCorporationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_clxRenewLifeHoldingsCorporationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:label="loc_us-gaapBusinessAcquisitionEffectiveDateOfAcquisition1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEffectiveDateOfAcquisition1_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesNetOfCashAcquired_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_50" xlink:to="loc_us-gaapGoodwill_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_50" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_50" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_50" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_50" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_50" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_50" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/InventoriesNetDetails" xlink:title="00000029 - Disclosure - INVENTORIES, NET (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails" xlink:title="00000030 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLineItems" xlink:label="loc_us-gaapDerivativeLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeTable" xlink:label="loc_us-gaapDerivativeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDerivativeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeNatureAxis" xlink:label="loc_clxDerivativeNatureAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeTable" xlink:to="loc_clxDerivativeNatureAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeNatureDomain" xlink:label="loc_clxDerivativeNatureDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_clxDerivativeNatureAxis" xlink:to="loc_clxDerivativeNatureDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeNatureDomain" xlink:label="loc_clxDerivativeNatureDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_clxDerivativeNatureAxis" xlink:to="loc_clxDerivativeNatureDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_JetFuelMember" xlink:label="loc_clxJetFuelMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxDerivativeNatureDomain" xlink:to="loc_clxJetFuelMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_SoybeanOilMember" xlink:label="loc_clxSoybeanOilMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxDerivativeNatureDomain" xlink:to="loc_clxSoybeanOilMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TradingSecuritiesUnrealizedHoldingGainLoss" xlink:label="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapTradingSecuritiesUnrealizedHoldingGainLoss_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeIntrumentsMaximumContractDuration" xlink:label="loc_clxDerivativeIntrumentsMaximumContractDuration_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDerivativeIntrumentsMaximumContractDuration_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:label="loc_investDerivativeNotionalAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_investDerivativeNotionalAmount_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_InterestRateForwardContractsSettlement" xlink:label="loc_clxInterestRateForwardContractsSettlement_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxInterestRateForwardContractsSettlement_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_SettlementOfInterestRateForwardContract" xlink:label="loc_clxSettlementOfInterestRateForwardContract_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxSettlementOfInterestRateForwardContract_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod" xlink:label="loc_clxDeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDeferredGainLossOnSettlementOfInterestRateCashFlowHedgeAmortizationPeriod_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodFaithAndMarginDepositsWithBrokerDealers" xlink:label="loc_us-gaapGoodFaithAndMarginDepositsWithBrokerDealers_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapGoodFaithAndMarginDepositsWithBrokerDealers_140" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapDerivativeLiabilities_140" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits" xlink:label="loc_clxDerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_clxDerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits_140" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MarginDepositAssets" xlink:label="loc_us-gaapMarginDepositAssets_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapMarginDepositAssets_140" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:label="loc_us-gaapCashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeLineItems" xlink:to="loc_us-gaapCashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_140" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:title="00000031 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="loc_us-gaapCashAndCashEquivalentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapCashAndCashEquivalentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:label="loc_us-gaapOtherCurrentAssetsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherCurrentAssetsMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaapOtherAssetsMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapOtherAssetsMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember" xlink:label="loc_us-gaapNotesPayableOtherPayablesMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapNotesPayableOtherPayablesMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember_280" xlink:type="arc" order="282" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember" xlink:label="loc_clxCurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_clxCurrentMaturitiesOfLongTermDebtAndLongTermDebtMember_360" xlink:type="arc" order="362" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="loc_us-gaapFairValueByMeasurementBasisAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementBasisAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaapFairValueDisclosureItemAmountsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementBasisAxis" xlink:to="loc_us-gaapFairValueDisclosureItemAmountsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="loc_us-gaapFairValueDisclosureItemAmountsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementBasisAxis" xlink:to="loc_us-gaapFairValueDisclosureItemAmountsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:label="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueDisclosureItemAmountsDomain" xlink:to="loc_us-gaapCarryingReportedAmountFairValueDisclosureMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueDisclosureItemAmountsDomain" xlink:to="loc_us-gaapEstimateOfFairValueFairValueDisclosureMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaapCashAndCashEquivalentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapCashAndCashEquivalentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCashAndCashEquivalentsAxis" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="loc_us-gaapMoneyMarketFundsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapMoneyMarketFundsMember_0" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BankTimeDepositsMember" xlink:label="loc_us-gaapBankTimeDepositsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="loc_us-gaapBankTimeDepositsMember_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentAxis" xlink:label="loc_investInvestmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_investInvestmentAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentDomain" xlink:label="loc_investInvestmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_investInvestmentAxis" xlink:to="loc_investInvestmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentDomain" xlink:label="loc_investInvestmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_investInvestmentAxis" xlink:to="loc_investInvestmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember" xlink:label="loc_clxTrustAssetsForNonqualifiedDeferredCompensationPlansMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_investInvestmentDomain" xlink:to="loc_clxTrustAssetsForNonqualifiedDeferredCompensationPlansMember_200" xlink:type="arc" order="204" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_NotesAndLoansPayableMember" xlink:label="loc_clxNotesAndLoansPayableMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_clxNotesAndLoansPayableMember_240" xlink:type="arc" order="244" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaapLongtermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapLongtermDebtTypeAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaapLongtermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLongtermDebtTypeAxis" xlink:to="loc_us-gaapLongtermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtMember" xlink:label="loc_us-gaapLongTermDebtMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLongtermDebtTypeDomain" xlink:to="loc_us-gaapLongTermDebtMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_450" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapOtherAssetsCurrent_450" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapOtherAssetsNoncurrent_450" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredCompensationPlanAssets" xlink:label="loc_us-gaapDeferredCompensationPlanAssets_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapDeferredCompensationPlanAssets_450" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssets_450" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommercialPaper" xlink:label="loc_us-gaapCommercialPaper_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCommercialPaper_450" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_450" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLongTermDebtCurrent_450" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLongTermDebt_450" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilities_450" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_450" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:label="loc_us-gaapCashFlowHedgeDerivativeInstrumentAssetsAtFairValue_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashFlowHedgeDerivativeInstrumentAssetsAtFairValue_450" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure_450" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_450" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShorttermDebtFairValue" xlink:label="loc_us-gaapShorttermDebtFairValue_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapShorttermDebtFairValue_450" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaapDebtInstrumentFairValue_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapDebtInstrumentFairValue_450" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue" xlink:label="loc_us-gaapCashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapCashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue_450" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFinancialLiabilitiesFairValueDisclosure_450" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails" xlink:title="00000032 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommodityContractMember" xlink:label="loc_us-gaapCommodityContractMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapCommodityContractMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestRateContractMember" xlink:label="loc_us-gaapInterestRateContractMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapInterestRateContractMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaapForeignExchangeContractMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapForeignExchangeContractMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:label="loc_us-gaapDerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeInstrumentsGainLossLineItems" xlink:to="loc_us-gaapDerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_90" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/IncomeTaxesDetails" xlink:title="00000033 - Disclosure - INCOME TAXES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails" xlink:title="00000034 - Disclosure - NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/NetEarningsPerShareEpsShareRepurchaseProgramsDetails" xlink:title="00000035 - Disclosure - NET EARNINGS PER SHARE (EPS) (Share Repurchase Programs) (Details)">
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ShareRepurchaseProgramsLineItems" xlink:label="loc_clxShareRepurchaseProgramsLineItems" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_ShareRepurchaseProgramsTable" xlink:label="loc_clxShareRepurchaseProgramsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_clxShareRepurchaseProgramsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis" xlink:label="loc_us-gaapShareRepurchaseProgramAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_clxShareRepurchaseProgramsTable" xlink:to="loc_us-gaapShareRepurchaseProgramAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain" xlink:label="loc_us-gaapShareRepurchaseProgramDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareRepurchaseProgramAxis" xlink:to="loc_us-gaapShareRepurchaseProgramDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_OpenMarketProgramMember" xlink:label="loc_clxOpenMarketProgramMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_clxOpenMarketProgramMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_EvergreenProgramMember" xlink:label="loc_clxEvergreenProgramMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareRepurchaseProgramDomain" xlink:to="loc_clxEvergreenProgramMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_clxShareRepurchaseProgramsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeNarrativeDetails" xlink:title="00000036 - Disclosure - COMPREHENSIVE INCOME (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceLineItems" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:label="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" xlink:to="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfIntercompanyForeignCurrencyBalanceTable" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntercompanyForeignCurrencyBalanceNameDomain" xlink:label="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceByDescriptionAxis" xlink:to="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_LongTermIntercompanyLoansMember" xlink:label="loc_clxLongTermIntercompanyLoansMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceNameDomain" xlink:to="loc_clxLongTermIntercompanyLoansMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax" xlink:label="loc_us-gaapAdjustmentForLongTermIntercompanyTransactionsNetOfTax_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIntercompanyForeignCurrencyBalanceLineItems" xlink:to="loc_us-gaapAdjustmentForLongTermIntercompanyTransactionsNetOfTax_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails" xlink:title="00000037 - Disclosure - COMPREHENSIVE INCOME (Schedule of Comprehensive Income) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails" xlink:title="00000038 - Disclosure - COMPREHENSIVE INCOME (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaapAccumulatedTranslationAdjustmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedTranslationAdjustmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaapAccumulatedDefinedBenefitPlansAdjustmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedDefinedBenefitPlansAdjustmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:label="loc_us-gaapOciBeforeReclassificationsBeforeTaxAttributableToParent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOciBeforeReclassificationsBeforeTaxAttributableToParent_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:label="loc_us-gaapReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossTaxPortionAttributableToParent1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossTaxPortionAttributableToParent1_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_90" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/EmployeeBenefitPlansDetails" xlink:title="00000039 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:label="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlansDomain" xlink:label="loc_us-gaapDefinedBenefitPlansDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis" xlink:to="loc_us-gaapDefinedBenefitPlansDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_RetirementIncomeMember" xlink:label="loc_clxRetirementIncomeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementIncomeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_RetirementHealthCarePlansMember" xlink:label="loc_clxRetirementHealthCarePlansMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxRetirementHealthCarePlansMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_DomesticQualifiedRetirementIncomePlansMember" xlink:label="loc_clxDomesticQualifiedRetirementIncomePlansMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlansDomain" xlink:to="loc_clxDomesticQualifiedRetirementIncomePlansMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost" xlink:label="loc_us-gaapDefinedBenefitPlanServiceCost_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanServiceCost_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost" xlink:label="loc_us-gaapDefinedBenefitPlanInterestCost_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanInterestCost_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:label="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanExpectedReturnOnPlanAssets_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:label="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanAmortizationOfGainsLosses_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:label="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanNetPeriodicBenefitCost_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="loc_us-gaapDefinedBenefitPlanContributionsByEmployer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapDefinedBenefitPlanContributionsByEmployer_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/OtherContingenciesAndGuaranteesDetails" xlink:title="00000040 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResultsNarrativeDetails" xlink:title="00000041 - Disclosure - SEGMENT RESULTS (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorCustomersAxis" xlink:label="loc_us-gaapMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NameOfMajorCustomerDomain" xlink:label="loc_us-gaapNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMajorCustomersAxis" xlink:to="loc_us-gaapNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_WalmartStoresIncMember" xlink:label="loc_clxWalmartStoresIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNameOfMajorCustomerDomain" xlink:to="loc_clxWalmartStoresIncMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="loc_us-gaapProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapProductOrServiceAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaapProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapProductOrServiceAxis" xlink:to="loc_us-gaapProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="loc_us-gaapProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductOrServiceAxis" xlink:to="loc_us-gaapProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://thecloroxcompany.com/role/SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails" xlink:title="00000042 - Disclosure - SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_CleaningMember" xlink:label="loc_clxCleaningMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxCleaningMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_HouseholdMember" xlink:label="loc_clxHouseholdMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxHouseholdMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_LifestyleMember" xlink:label="loc_clxLifestyleMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxLifestyleMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="clx-20160930.xsd#clx_InternationalMember" xlink:label="loc_clxInternationalMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_clxInternationalMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateMember" xlink:label="loc_us-gaapCorporateMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_us-gaapCorporateMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapSalesRevenueNet_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_130" xlink:type="arc" order="1" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6819838416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Oct. 19, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CLOROX CO /DE/<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000021076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,743,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6820278832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">$ 1,443<span></span>
</td>
<td class="nump">$ 1,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of products sold</a></td>
<td class="nump">803<span></span>
</td>
<td class="nump">765<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">640<span></span>
</td>
<td class="nump">625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling and administrative expenses</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherIncomeExpenseNet', window );">Other (income) expense, net</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings from continuing operations before income taxes</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes on continuing operations</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Earnings from continuing operations</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Earnings (losses) from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 179<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Net earnings (losses) per share, Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations</a></td>
<td class="nump">$ 1.39<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share</a></td>
<td class="nump">1.39<span></span>
</td>
<td class="nump">1.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Net earnings (losses) per share, Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations</a></td>
<td class="nump">1.36<span></span>
</td>
<td class="nump">1.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share</a></td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="nump">$ 1.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding (in thousands)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">129,449<span></span>
</td>
<td class="nump">129,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">132,193<span></span>
</td>
<td class="nump">131,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend declared per share</a></td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 0.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831223<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4613673-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20187-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20187-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355146-122828<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6819931008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 408<span></span>
</td>
<td colspan="2" class="nump">$ 401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">494<span></span>
</td>
<td colspan="2" class="nump">569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">465<span></span>
</td>
<td colspan="2" class="nump">443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">49<span></span>
</td>
<td colspan="2" class="nump">72<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,416<span></span>
</td>
<td colspan="2" class="nump">1,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net of accumulated depreciation and amortization of $1,944 and $1,911 respectively</a></td>
<td class="nump">917<span></span>
</td>
<td colspan="2" class="nump">906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,196<span></span>
</td>
<td colspan="2" class="nump">1,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_TrademarksNet', window );">Trademarks, net</a></td>
<td class="nump">657<span></span>
</td>
<td colspan="2" class="nump">657<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangible assets, net</a></td>
<td class="nump">76<span></span>
</td>
<td colspan="2" class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">204<span></span>
</td>
<td colspan="2" class="nump">187<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">4,466<span></span>
</td>
<td colspan="2" class="nump">4,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="nump">618<span></span>
</td>
<td colspan="2" class="nump">523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">874<span></span>
</td>
<td colspan="2" class="nump">1,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">30<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,522<span></span>
</td>
<td colspan="2" class="nump">1,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">1,789<span></span>
</td>
<td colspan="2" class="nump">1,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">Other liabilities</a></td>
<td class="nump">783<span></span>
</td>
<td colspan="2" class="nump">784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Deferred income taxes</a></td>
<td class="nump">83<span></span>
</td>
<td colspan="2" class="nump">82<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,177<span></span>
</td>
<td colspan="2" class="nump">4,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td colspan="2" class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $1.00 par value; 750,000,000 shares authorized; 158,741,461 shares issued as of both September 30, 2016 and June 30, 2016; and 128,707,796 and 129,355,263 shares outstanding as of September 30, 2016 and June 30, 2016, respectively</a></td>
<td class="nump">159<span></span>
</td>
<td colspan="2" class="nump">159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">881<span></span>
</td>
<td colspan="2" class="nump">868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">2,238<span></span>
</td>
<td colspan="2" class="nump">2,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares, at cost: 30,033,665 and 29,386,198 shares as of September 30, 2016 and June 30, 2016, respectively</a></td>
<td class="num">(2,422)<span></span>
</td>
<td colspan="2" class="num">(2,323)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive net (losses) income</a></td>
<td class="num">(567)<span></span>
</td>
<td colspan="2" class="num">(570)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="nump">289<span></span>
</td>
<td colspan="2" class="nump">297<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 4,466<span></span>
</td>
<td colspan="2" class="nump">$ 4,510<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Condensed from audited financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_TrademarksNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite or finite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_TrademarksNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31958-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6748505856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property, plant and equipment, accumulated depreciation and amortization</a></td>
<td class="nump">$ 1,944<span></span>
</td>
<td class="nump">$ 1,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">158,741,461<span></span>
</td>
<td class="nump">158,741,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">128,707,796<span></span>
</td>
<td class="nump">129,355,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="nump">30,033,665<span></span>
</td>
<td class="nump">29,386,198<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6820417824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 179<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Deduct: Losses from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Earnings from continuing operations</a></td>
<td class="nump">179<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile earnings from continuing operations to net cash provided by continuing operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">41<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables, net</a></td>
<td class="nump">74<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="num">(23)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other current assets</a></td>
<td class="num">(6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(153)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">62<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash provided by continuing operations</a></td>
<td class="nump">170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Net cash provided by discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operations</a></td>
<td class="nump">170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(59)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used for investing activities</a></td>
<td class="num">(58)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Notes and loans payable, net</a></td>
<td class="nump">95<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Treasury stock purchased</a></td>
<td class="num">(110)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Cash dividends paid</a></td>
<td class="num">(104)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(99)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities', window );">Issuance of common stock for employee stock plans and other</a></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used for financing activities</a></td>
<td class="num">(104)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(120)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Beginning of period</a></td>
<td class="nump">401<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">End of period</a></td>
<td class="nump">$ 408<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 383<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Condensed from audited financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options. Also includes the net cash inflow (outflow) from other financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4613673-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3095-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3098-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6812840112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Basis of Presentation</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The unaudited interim condensed consolidated financial statements
for the three months ended September 30, 2016 and 2015, in the opinion of management, reflect all adjustments (consisting of normal
recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows
of The Clorox Company and its subsidiaries (the Company) for the periods presented. However, the financial results for interim
periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Effective September 22, 2014, the Company&#146;s Venezuela
affiliate, Corporaci&#243;n Clorox de Venezuela S.A. (Clorox Venezuela), discontinued its operations. Consequently, the Company
reclassified the financial results of Clorox Venezuela as a discontinued operation in the condensed consolidated financial statements
for all periods presented herein.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Certain information and footnote disclosures normally included
in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have
been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information
in this report should be read in conjunction with the Company&#146;s Annual Report on Form 10-K filed with the SEC for the fiscal
year ended June 30, 2016, which includes a complete set of footnote disclosures including the Company&#146;s significant accounting
policies.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Recently Issued Accounting Standards </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In March 2016, the Financial Accounting Standards Board (FASB)
issued Accounting Standards Update (ASU) No. 2016-09, &#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee
Share-Based Payment Accounting,&#148; which simplifies several aspects of the accounting for share-based payment transactions,
including requiring excess tax benefits and tax deficiencies to be recognized as income tax expense or benefit in the consolidated
statement of earnings. Additionally, the standard requires cash flows from excess tax benefits and deficiencies, previously classified
as a financing activity, to be classified as an operating activity in the consolidated statement of cash flows. The Company adopted
this guidance in the first quarter of fiscal year 2017. Excess tax benefits of $6 were recognized in the consolidated statement
of earnings and classified as an operating activity in the consolidated statement of cash flows during the three months ended September
30, 2016. The prior period consolidated statement of cash flows has not been adjusted as permitted. The adoption resulted in approximately
a 2 percentage point benefit to the Company&#146;s effective tax rate for the first quarter of fiscal year 2017. The guidance allows
for a policy election to account for forfeitures as they occur rather than on an estimated basis. The Company did not make this
election and will continue to account for forfeitures on an estimated basis.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In February 2016, the FASB issued ASU No. 2016-02, &#147;Leases
(Topic 842),&#148; which requires lessees to recognize a right-of-use asset and a lease liability for all leases with terms of
more than 12 months. Recognition, measurement and presentation will depend on the classification of the lease as either a finance
or an operating lease. ASU 2016-02 also requires expanded disclosures about leasing arrangements. The new guidance is effective
for the Company beginning in the first quarter of fiscal year 2020, with early adoption permitted. The Company is currently evaluating
the impact that the adoption of this guidance will have on its consolidated financial statements.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In April 2015, the FASB issued ASU No. 2015-03, &#147;Simplifying
the Presentation of Debt Issuance Cost,&#148; which requires that debt issuance costs related to a recognized debt liability be
presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.
The Company adopted this standard in the first quarter of fiscal year 2017 and retrospectively applied the standard to the June
30, 2016 consolidated balance sheet, resulting in an $8 reduction in Other assets and Long-term debt. The adoption had no impact
on the Company&#146;s consolidated statement of earnings or consolidated statement of cash flows.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In February 2015, the FASB issued ASU No. 2015-02, &#147;Amendments
to the Consolidation Analysis,&#148; which changes the guidance for evaluating whether to consolidate certain legal entities. The
amendments modify the evaluation of whether limited partnerships and similar legal entities are variable interest entities or voting
interest entities. The Company adopted this standard in the first quarter of fiscal year 2017. The adoption did not have an impact
on the Company&#146;s consolidated financial statements.</p>

<p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">In May 2014, the FASB issued ASU No. 2014-09,
&#147;Revenue from Contracts with Customers (Topic 606),&#148; which replaces most existing U.S. GAAP revenue recognition guidance
and is intended to improve and converge with international standards the financial reporting requirements for revenue from contracts
with customers. The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services
equal to the amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional
disclosures about the nature, timing and uncertainty of revenue and cash flows arising from contracts with customers, including
information about significant judgments and changes in judgments. The new guidance is effective for the Company beginning in the
first quarter of fiscal year 2019, with the option to early adopt in the first quarter of fiscal year 2018. The Company is currently
evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6725092096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">DISCONTINUED OPERATIONS</a></td>
<td class="text"><p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><b>NOTE 2. DISCONTINUED OPERATIONS</b></p>

<p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">On September 22, 2014, Clorox Venezuela
announced that it was discontinuing its operations, effective immediately, and seeking to sell its assets. Since fiscal year 2012,
Clorox Venezuela was required to sell more than two thirds of its products at prices frozen by the Venezuelan government. During
this same period, Clorox Venezuela experienced successive years of hyperinflation resulting in significant sustained increases
in its input costs, including packaging, raw materials, transportation and wages. As a result, Clorox Venezuela had been selling
its products at a loss, resulting in ongoing operating losses. Clorox Venezuela repeatedly met with government authorities in an
effort to help them understand the rapidly declining state of the business, including the need for immediate, significant and ongoing
price increases and other critical remedial actions to address these adverse impacts. Based on the Venezuelan government&#146;s
representations, Clorox Venezuela had expected significant price increases would be forthcoming much earlier; however, the price
increases subsequently approved were insufficient and would have caused Clorox Venezuela to continue operating at a significant
loss into the foreseeable future. As such, Clorox Venezuela was no longer financially viable and was forced to discontinue its
operations.</p>

<p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">On September 26, 2014, the Company reported
that Venezuelan Vice President Jorge Arreaza announced, with endorsement by President Nicol&#225;s Maduro, that the Venezuelan
government had occupied the Santa Luc&#237;a and Guacara production facilities of Clorox Venezuela. On November 6, 2014, the Company
reported that the Venezuelan government had published a resolution granting a government-sponsored Special Administrative Board
full authority to restart and operate the business of Clorox Venezuela, thereby reaffirming the government's expropriation of Clorox
Venezuela&#146;s assets. Further, President Nicol&#225;s Maduro announced the government's intention to facilitate the resumed
production of bleach and other cleaning products at Clorox Venezuela plants. He also announced his approval of a financial credit
to invest in raw materials and production at the plants. These actions by the Venezuelan government were taken without the consent
or involvement of Clorox Venezuela, its parent Clorox Spain S.L. (Clorox Spain) or any of their affiliates. Clorox Venezuela, Clorox
Spain and their affiliates reserved their rights under all applicable laws and treaties.</p>

<p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">With this exit, the financial results of
Clorox Venezuela are reflected as discontinued operations in the Company&#146;s condensed consolidated financial statements for
all periods presented. The results of Clorox Venezuela had historically been part of the International reportable segment.</p>

<p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">Net sales for Clorox Venezuela were $0
for each of the three months ended September 30, 2016 and 2015.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table provides a summary of earnings (losses)
from discontinued operations for Clorox Venezuela and earnings (losses) from discontinued operations other than Clorox Venezuela
for the periods indicated:<b> </b></p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="6" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font>&#160; &#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 93%"><font style="font: 10pt Times New Roman, Times, Serif">Operating losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exit costs and other related expenses for Clorox Venezuela</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Income tax benefit attributable to Clorox Venezuela</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="8">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gains (losses) from discontinued operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;other than Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Losses from discontinued operations, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721533-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721665-107760<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=SL51724579-110230<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721663-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64862545&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721659-107760<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721671-107760<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721677-107760<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1474-107760<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6812842544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESSES ACQUIRED<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESSES ACQUIRED</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 3. BUSINESSES ACQUIRED </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">On May 2, 2016, the Company acquired 100 percent of ReNew
Life Holdings Corporation (RenewLife), a leading brand in digestive health. The amount paid was $290 funded through commercial
paper. The amount paid of $290 represents the aggregate purchase price less cash acquired. The purchase of the RenewLife business
reflects the Company&#146;s strategy to acquire leading brands with attractive margins in growth categories. Results for RenewLife&#146;s
U.S. business are reflected in the Household reportable segment and results for RenewLife&#146;s international business are reflected
in the International reportable segment.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The assets and liabilities of RenewLife were recorded at
their respective estimated fair value as of the date of the acquisition using U.S. GAAP for business combinations. The excess of
the purchase price over the fair value of the net identifiable assets acquired was allocated to goodwill. Goodwill recorded primarily
reflects the value of expanding the Company&#146;s portfolio further into the health and wellness arena.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table summarizes the estimated fair value of
RenewLife&#146;s assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date. Due to the
timing of the acquisition, the fair value of the assets acquired and liabilities assumed are based on a preliminary valuation and
the Company&#146;s estimates and assumptions are subject to change within the measurement period. The primary areas of the purchase
price that are not yet finalized are related to goodwill and income taxes. The weighted-average estimated useful life of intangible
assets subject to amortization is 15 years.</p>

<p>&#160;</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>RenewLife</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 96%"><font style="font: 10pt Times New Roman, Times, Serif">Goodwill</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">137</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trademarks</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Customer relationships</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">36</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Property, plant and equipment</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Working capital, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Deferred income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(61</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Purchase Price</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">290</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Pro forma results reflecting the acquisition were not presented
because the acquisition did not meet the threshold requirements for additional disclosure.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1497-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1490-128463<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1486-128463<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1524-128463<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7000-128479<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4922-128472<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4934-128472<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4926-128472<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=SL65897772-128472<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1383-128463<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6996-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6744566320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES, NET<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES, NET</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 4. INVENTORIES, NET</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Inventories, net, consisted of the following as of:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>6/30/2016</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 91%"><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">374</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">361</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Raw materials and packaging</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">114</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">111</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Work in process</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">LIFO allowances</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(26</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(32</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">465</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">443</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: center; font: 10pt Times New Roman, Times, Serif"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6812842544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock', window );">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 5. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS
</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Financial assets and liabilities measured at fair value on
a recurring basis in the condensed consolidated balance sheets are required to be classified and disclosed in one of the following
three categories of the fair value hierarchy:</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Level 1: Quoted market prices in active markets for identical
assets or liabilities.<br />
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.<br />
Level 3: Unobservable inputs reflecting the reporting entity&#146;s own assumptions.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of September 30, 2016 and June 30, 2016, the Company&#146;s
financial assets and liabilities that were measured at fair value on a recurring basis during the applicable periods included derivative
financial instruments, which were classified as either Level 1 or Level 2, and trust assets to fund certain of the Company&#146;s
nonqualified deferred compensation plans, which were classified as Level 1.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Financial Risk Management and Derivative Instruments</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company is exposed to certain commodity, interest rate,
foreign currency and counterparty risks related to its ongoing business operations and uses derivative instruments to mitigate
its exposure to these risks.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Commodity Price Risk Management </i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company may use commodity exchange traded futures and
over-the-counter swap contracts to fix the price of a portion of its forecasted raw material requirements. Contract maturities,
which are generally no longer than 2 years, are matched to the length of the raw material purchase contracts. Commodity purchase
contracts are measured at fair value using market quotations obtained from commodity futures exchanges or commodity derivative
dealers.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of September 30, 2016, the notional amount of commodity
derivatives was $24, of which $14 related to jet fuel swaps and $10 related to soybean oil futures. As of June 30, 2016, the notional
amount of commodity derivatives was $30, of which $16 related to jet fuel swaps and $14 related to soybean oil futures.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Foreign Currency Risk Management </i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company may also enter into certain over-the-counter
derivative contracts to manage a portion of the Company&#146;s forecasted foreign currency exposure associated with the purchase
of inventory. These foreign currency contracts generally have durations of no longer than 2 years. The foreign exchange contracts
are measured at fair value using information quoted by foreign exchange dealers.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The notional amounts of outstanding foreign currency forward
contracts used by the Company&#146;s subsidiaries to hedge forecasted purchases of inventory were $57 as of September 30, 2016,
and $84 as of June 30, 2016.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Interest Rate Risk Management </i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company may also enter into over-the-counter interest
rate derivative instruments to fix a portion of the benchmark interest rate prior to an anticipated issuance of fixed rate debt
or to manage the Company&#146;s level of fixed and floating rate debt. The interest rate derivative instruments are measured at
fair value using information quoted by U.S. government bond dealers.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of both September 30, 2016 and June 30, 2016, the Company
had no interest rate derivative instruments.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Counterparty Risk Management and Derivative Contract
Requirements </i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company utilizes a variety of financial institutions
as counterparties for <font>over-the-counter</font> derivative instruments. The Company
enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter
derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty
to post collateral when the fair value of the derivative instrument exceeds contractually defined counterparty liability position
limits. Of the derivative instruments of $3 and $5 reflected in Accounts payable and accrued liabilities as of September 30, 2016
and June 30, 2016, respectively, $2 and $4, respectively, contained such terms. As of both September 30, 2016 and June 30, 2016,
neither the Company nor any counterparty was required to post any collateral as no counterparty liability position limits were
exceeded.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Certain terms of the agreements governing the Company&#146;s
over-the-counter derivative instruments require the credit ratings, as assigned by Standard &#38; Poor&#146;s and Moody&#146;s
to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating.
If the Company&#146;s credit ratings were to fall below investment grade, the counterparties to the derivative instruments could
request full collateralization on derivative instruments in net liability positions. As of both September 30, 2016 and June 30,
2016, the Company and each of its counterparties had been assigned investment grade credit ratings by both Standard &#38; Poor&#146;s
and Moody&#146;s.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Certain of the Company&#146;s exchange-traded futures contracts
used for commodity price risk management include requirements for the Company to post collateral in the form of a cash margin account
held by the Company&#146;s broker for trades conducted on that exchange. As of September 30, 2016 and June 30, 2016, the Company
maintained cash margin balances related to exchange-traded futures contracts of $1, which are classified as <font>Other</font>
current assets on the condensed consolidated balance sheets.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Trust Assets </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company has held interests in mutual funds and cash equivalents
as part of trust assets related to certain of its nonqualified deferred compensation plans. The participants in the deferred compensation
plans, who are the Company&#146;s current and former employees, may select among certain mutual funds in which their compensation
deferrals are invested in accordance with the terms of the plans and within the confines of the trusts, which hold the marketable
securities. These trusts represent variable interest entities for which the Company is considered the primary beneficiary, and
therefore, trust assets are consolidated and included in Other assets in the condensed consolidated balance sheets. The interests
in mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable<b> </b>securities
as trading investments.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Fair Value of Financial Instruments </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table summarizes the fair value of the Company&#146;s
assets and liabilities for which disclosure of fair value is required:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; line-height: normal">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>6/30/2016</b></font></td></tr>
<tr style="vertical-align: bottom; line-height: normal">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance sheet</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>classification</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fair value</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>hierarchy</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>level</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Carrying</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Estimated</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Fair</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Carrying</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Estimated</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Fair</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left; width: 82%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Assets</b></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 3%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Investments including money market</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">equivalents <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">253</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">253</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">234</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">234</font></td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Time deposits</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">equivalents <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">76</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">76</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other current assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other current assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trust assets for nonqualified deferred</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">compensation plans</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">62</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">62</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">394</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">394</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368</font></td></tr>
<tr>
    <td colspan="17">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Liabilities</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Notes and loans payable</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Notes and loans payable <sup>(b)</sup></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">618</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">618</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">523</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">523</font></td></tr>
<tr style="background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable and</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">accrued liabilities</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable and</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">accrued liabilities</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Current maturities of long-term debt</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Current maturities of long-</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">and Long-term debt</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">term debt and Long-term</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">debt <sup>(c)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,789</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,911</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,789</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,922</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,410</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,532</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,317</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,450</font></td></tr>
</table>
<p>____________________</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: normal; border-collapse: collapse">
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">(a)</font></td>
    <td nowrap="nowrap" style="vertical-align: top">&#160;</td>
    <td style="width: 100%"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</font></td></tr>
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">(b)</font></td>
    <td nowrap="nowrap" style="vertical-align: top">&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Notes and loans payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.</font></td></tr>
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">(c)</font></td>
    <td nowrap="nowrap" style="vertical-align: top">&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, is determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b><i>Derivatives</i></b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company designates its commodity forward and future contracts
for forecasted purchases of raw materials, interest rate forward contracts for forecasted interest payments, and foreign currency
forward contracts for forecasted purchases of inventory as cash flow hedges.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The effects of derivative instruments designated as hedging
instruments on Comprehensive income and Net earnings were as follows:</p>

<p>&#160;</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Gains (losses) recognized in</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>Other comprehensive income</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest rate derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr>
    <td colspan="9">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Gains (losses) reclassified from</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>Accumulated other comprehensive loss and</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>recognized in Net earnings</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest rate derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The gains (losses) reclassified from Accumulated other comprehensive
losses and recognized in Net earnings during the three months ended September 30, 2016 and 2015, for commodity purchase and foreign
exchange contracts were included in Cost of products sold, and for interest rate contracts were included in Interest expense.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The estimated amount of the existing net gain (loss) in Accumulated
other comprehensive losses as of September 30, 2016, that is expected to be reclassified into Net earnings within the next twelve
months is $8. Gains and losses on derivative instruments representing either hedge ineffectiveness or hedge components excluded
from the assessment of effectiveness are recognized in Net earnings. During the three months ended September 30, 2016 and 2015,
hedge ineffectiveness was not significant.<b> </b></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments and Fair Value Measurements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments and fair value measurements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6812830160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 6. INCOME TAXES</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In determining its quarterly provision for income taxes,
the Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax
planning opportunities available in the various jurisdictions in which the Company operates. Certain significant or unusual items
are separately recognized in the quarter in which they occur and can be a source of variability in the effective tax rates from
quarter to quarter. The effective tax rate on earnings from continuing operations was 32.0% for the three months ended September
30, 2016, and 34.5% for the three months ended September 30, 2015. This decrease was primarily due to the recognition of excess
tax benefits from share-based compensation upon the adoption of ASU No. 2016-09 in the first quarter of fiscal year 2017. Refer
to Note 1 for further details.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6812812352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS PER SHARE (EPS)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET EARNINGS PER SHARE (EPS)</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 7. NET EARNINGS PER SHARE (EPS)</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following is a reconciliation of the weighted average
number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; width: 94%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Basic</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">129,449</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">129,155</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dilutive effect of stock options and other</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,744</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,065</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Diluted</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">132,193</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">131,220</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="5">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Antidilutive stock options and other</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,271</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company has two share repurchase programs: an open-market
purchase program with an authorized aggregate purchase amount of up to $750, all of which was available for share repurchases as
of September 30, 2016, and a program to offset the anticipated impact of share dilution related to share-based awards (the Evergreen
Program), which has no authorization limit as to amount or timing of repurchases.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Share repurchases under authorized programs were as follows
during the three months ended September 30:</p>

<p>&#160;</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="9" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>(in 000's)</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>(in 000's)</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 86%"><font style="font: 10pt Times New Roman, Times, Serif">Open-market purchase programs</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Evergreen Program</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">113</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">883</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">112</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,006</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">113</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">883</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">112</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,006</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6812791184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">COMPREHENSIVE INCOME</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 8. COMPREHENSIVE INCOME </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Comprehensive income was as follows for the periods indicated:</p>

<p>&#160;</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Earnings from continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">179</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">173</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Earnings (losses) from discontinued operations, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net earnings</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">179</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">172</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other comprehensive income (loss), net of tax:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Foreign currency translation adjustments</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(43</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net unrealized gains (losses) on derivatives</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pension and postretirement benefit adjustments</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total other comprehensive income (loss), net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(39</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Comprehensive income</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">182</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">133</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Changes in Accumulated other comprehensive net (losses) income
by component were as follows for the three months ended September 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Foreign</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>currency</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>translation</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>adjustments</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Net unrealized</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>gains (losses) on</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>derivatives</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Pension and</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>postretirement</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>benefit</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>adjustments</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Accumulated</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>other</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>comprehensive</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>(losses) income</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 84%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance as of June 30, 2015</b></font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(300</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(53</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(149</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(502</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other comprehensive (loss) income before</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;reclassifications</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(41</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(41</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;comprehensive net losses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income tax benefit (expense)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net current period other comprehensive income (loss)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(43</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(39</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance as of September 30, 2015</b></font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(343</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(50</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(148</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(541</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr>
    <td colspan="17">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance as of June 30, 2016</b></font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(353</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(44</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(173</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(570</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other comprehensive (loss) income before</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;reclassifications</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;comprehensive net losses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income tax benefit (expense)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net current period other comprehensive income (loss)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance as of September 30, 2016</b></font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(354</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(41</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(172</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(567</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Included in foreign currency translation adjustments are
re-measurement losses on long-term intercompany loans where settlement is not planned or anticipated in the foreseeable future.
For the three months ended September 30, 2016 and 2015, Other comprehensive income (loss) on these loans totaled $0 and $(5), respectively,
and there were no amounts reclassified from Accumulated other comprehensive net (losses) income.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e640-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e716-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e709-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Reclassification Adjustments<br> -URI http://asc.fasb.org/extlink&amp;oid=6522872<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6744543360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract', window );"><strong>Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">EMPLOYEE BENEFIT PLANS</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 9. EMPLOYEE BENEFIT PLANS </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table summarizes the components of net periodic
benefit cost for the Company&#146;s retirement income plans:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Service cost</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest cost</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected return on plan assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Amortization of unrecognized items</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The net periodic benefit cost for the Company&#146;s retirement
health care plans was $0 for each of the three months ended September 30, 2016 and 2015.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">During the three months ended September 30, 2016, the Company
made $15 in discretionary contributions to the domestic qualified retirement income plan.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450702-114947<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e2410-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39675-114964<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6812839312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONTINGENCIES AND GUARANTEES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherContingenciesAndGuaranteesAbstract', window );"><strong>OTHER CONTINGENCIES AND GUARANTEES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ContingenciesAndGuaranteesDisclosureTextBlock', window );">OTHER CONTINGENCIES AND GUARANTEES</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 10. OTHER CONTINGENCIES AND GUARANTEES</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Contingencies</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company is involved in certain environmental matters,
including response actions at various locations. The Company had a recorded liability of $13 and $14 as of September 30, 2016 and
June 30, 2016, respectively, for its share of aggregate future remediation costs related to these matters. One matter in Dickinson
County, Michigan, for which the Company is jointly and severally liable, accounted for a substantial majority of the recorded liability
as of both September 30, 2016 and June 30, 2016. The Company has agreed to be liable for 24.3% of the aggregate remediation and
associated costs for this matter pursuant to a cost-sharing arrangement with a third party. With the assistance of environmental
consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital
expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Currently, the Company
cannot accurately predict the timing of future payments that may be made under this obligation. In addition, the Company&#146;s
estimated loss exposure is sensitive to a variety of uncertain factors, including the efficacy of remediation efforts, changes
in remediation requirements and the future availability of alternative clean-up technologies. Although it is reasonably possible
that the Company&#146;s exposure may exceed the amount recorded, any amount of such additional exposures, or range of exposures,
is not estimable at this time.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company is subject to various legal proceedings, claims
and other loss contingencies, including, without limitation, loss contingencies relating to contractual arrangements, product liability,
patents and trademarks, advertising, labor and employment, environmental, health and safety and other matters. With respect to
these proceedings, claims and other loss contingencies, while considerable uncertainty exists, in the opinion of management at
this time, the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse
effect, either individually or in the aggregate, on the Company&#146;s condensed consolidated financial statements taken as a whole.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Guarantees </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In conjunction with divestitures and other transactions,
the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously
existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the
total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it
is probable that it will make, any material payments relating to its indemnifications, and believes that any reasonably possible
payments would not have a material adverse effect, either individually or in the aggregate, on the Company&#146;s condensed consolidated
financial statements taken as a whole.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company had not recorded any liabilities on the aforementioned
guarantees as of September 30, 2016.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">As of September 30, 2016, the Company was a party to letters
of credit of $10 primarily related to one of its insurance carriers, of which $0 had been drawn upon.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ContingenciesAndGuaranteesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the complete disclosure regarding the entity's exposure to loss pertaining to environmental matters, litigation and potential losses not disclosed in other notes and guarantees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ContingenciesAndGuaranteesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherContingenciesAndGuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherContingenciesAndGuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6725236944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT RESULTS</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>NOTE 11. SEGMENT RESULTS</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The Company operates through strategic business units that
are aggregated into four reportable segments based on the economics and nature of the products sold: Cleaning, Household, Lifestyle
and International. As a result of Clorox Venezuela being reported as discontinued operations, the results of Clorox Venezuela are
no longer included in the International reportable segment.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Certain non-allocated administrative costs, interest income,
interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash
and cash equivalents, other current assets, property and equipment, other investments and deferred taxes.<b> </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The table below presents reportable segment information and
a reconciliation of the segment information to the Company&#146;s consolidated net sales and earnings from continuing operations
before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate.</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Net sales</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Earnings (losses) from continuing</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>operations before income taxes</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 86%"><font style="font: 10pt Times New Roman, Times, Serif">Cleaning</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">534</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">497</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">164</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">149</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Household</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">422</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">411</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">69</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">82</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Lifestyle</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">231</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">62</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">59</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">International</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">251</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">251</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">27</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">32</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Corporate</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(58</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(58</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,443</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,390</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">264</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">264</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">All intersegment sales are eliminated and are not included
in the Company&#146;s reportable segments&#146; net sales.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Net sales to the Company&#146;s largest customer, Wal-Mart
Stores, Inc. and its affiliates, as a percentage of consolidated net sales, were 26% and 27% for the three months ended September
30, 2016 and 2015, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8981-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9038-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 33<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8971-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8595-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8380-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 35<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8984-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9031-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8538-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8864-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6813554784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Basis of Presentation</b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The unaudited interim condensed consolidated financial statements
for the three months ended September 30, 2016 and 2015, in the opinion of management, reflect all adjustments (consisting of normal
recurring accruals) necessary for a fair presentation of the consolidated results of operations, financial position and cash flows
of The Clorox Company and its subsidiaries (the Company) for the periods presented. However, the financial results for interim
periods are not necessarily indicative of the results that may be expected for a full fiscal year or for any other future period.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Effective September 22, 2014, the Company&#146;s Venezuela
affiliate, Corporaci&#243;n Clorox de Venezuela S.A. (Clorox Venezuela), discontinued its operations. Consequently, the Company
reclassified the financial results of Clorox Venezuela as a discontinued operation in the condensed consolidated financial statements
for all periods presented herein.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Certain information and footnote disclosures normally included
in financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have
been omitted or condensed pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (SEC). The information
in this report should be read in conjunction with the Company&#146;s Annual Report on Form 10-K filed with the SEC for the fiscal
year ended June 30, 2016, which includes a complete set of footnote disclosures including the Company&#146;s significant accounting
policies.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif"><b>Recently Issued Accounting Standards </b></p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In March 2016, the Financial Accounting Standards Board (FASB)
issued Accounting Standards Update (ASU) No. 2016-09, &#147;Compensation-Stock Compensation (Topic 718): Improvements to Employee
Share-Based Payment Accounting,&#148; which simplifies several aspects of the accounting for share-based payment transactions,
including requiring excess tax benefits and tax deficiencies to be recognized as income tax expense or benefit in the consolidated
statement of earnings. Additionally, the standard requires cash flows from excess tax benefits and deficiencies, previously classified
as a financing activity, to be classified as an operating activity in the consolidated statement of cash flows. The Company adopted
this guidance in the first quarter of fiscal year 2017. Excess tax benefits of $6 were recognized in the consolidated statement
of earnings and classified as an operating activity in the consolidated statement of cash flows during the three months ended September
30, 2016. The prior period consolidated statement of cash flows has not been adjusted as permitted. The adoption resulted in approximately
a 2 percentage point benefit to the Company&#146;s effective tax rate for the first quarter of fiscal year 2017. The guidance allows
for a policy election to account for forfeitures as they occur rather than on an estimated basis. The Company did not make this
election and will continue to account for forfeitures on an estimated basis.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In February 2016, the FASB issued ASU No. 2016-02, &#147;Leases
(Topic 842),&#148; which requires lessees to recognize a right-of-use asset and a lease liability for all leases with terms of
more than 12 months. Recognition, measurement and presentation will depend on the classification of the lease as either a finance
or an operating lease. ASU 2016-02 also requires expanded disclosures about leasing arrangements. The new guidance is effective
for the Company beginning in the first quarter of fiscal year 2020, with early adoption permitted. The Company is currently evaluating
the impact that the adoption of this guidance will have on its consolidated financial statements.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In April 2015, the FASB issued ASU No. 2015-03, &#147;Simplifying
the Presentation of Debt Issuance Cost,&#148; which requires that debt issuance costs related to a recognized debt liability be
presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.
The Company adopted this standard in the first quarter of fiscal year 2017 and retrospectively applied the standard to the June
30, 2016 consolidated balance sheet, resulting in an $8 reduction in Other assets and Long-term debt. The adoption had no impact
on the Company&#146;s consolidated statement of earnings or consolidated statement of cash flows.</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">In February 2015, the FASB issued ASU No. 2015-02, &#147;Amendments
to the Consolidation Analysis,&#148; which changes the guidance for evaluating whether to consolidate certain legal entities. The
amendments modify the evaluation of whether limited partnerships and similar legal entities are variable interest entities or voting
interest entities. The Company adopted this standard in the first quarter of fiscal year 2017. The adoption did not have an impact
on the Company&#146;s consolidated financial statements.</p>

<p style="text-align: left; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">In May 2014, the FASB issued ASU No. 2014-09,
&#147;Revenue from Contracts with Customers (Topic 606),&#148; which replaces most existing U.S. GAAP revenue recognition guidance
and is intended to improve and converge with international standards the financial reporting requirements for revenue from contracts
with customers. The core principle of ASU 2014-09 is that an entity should recognize revenue for the transfer of goods or services
equal to the amount that it expects to be entitled to receive for those goods or services. ASU 2014-09 also requires additional
disclosures about the nature, timing and uncertainty of revenue and cash flows arising from contracts with customers, including
information about significant judgments and changes in judgments. The new guidance is effective for the Company beginning in the
first quarter of fiscal year 2019, with the option to early adopt in the first quarter of fiscal year 2018. The Company is currently
evaluating the impact that the adoption of this guidance will have on its consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6812768032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock', window );">Summary of (losses) gains from discontinued operations</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table provides a summary of earnings (losses)
from discontinued operations for Clorox Venezuela and earnings (losses) from discontinued operations other than Clorox Venezuela
for the periods indicated:<b> </b></p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="6" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font>&#160; &#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 93%"><font style="font: 10pt Times New Roman, Times, Serif">Operating losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exit costs and other related expenses for Clorox Venezuela</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela before income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Income tax benefit attributable to Clorox Venezuela</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total losses from Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="8">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Gains (losses) from discontinued operations</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;other than Clorox Venezuela, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Losses from discontinued operations, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">) </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and profit or loss reported in discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6744694416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESSES ACQUIRED (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Estimated Fair Values of Assets Acquired and Liabilities Assumed as of Acquisition Date</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table summarizes the estimated fair value of
RenewLife&#146;s assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date. Due to the
timing of the acquisition, the fair value of the assets acquired and liabilities assumed are based on a preliminary valuation and
the Company&#146;s estimates and assumptions are subject to change within the measurement period. The primary areas of the purchase
price that are not yet finalized are related to goodwill and income taxes. The weighted-average estimated useful life of intangible
assets subject to amortization is 15 years.</p>

<p>&#160;</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>RenewLife</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 96%"><font style="font: 10pt Times New Roman, Times, Serif">Goodwill</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">137</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trademarks</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">134</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Customer relationships</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">36</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Property, plant and equipment</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Working capital, net</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">41</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Deferred income taxes</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(61</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Purchase Price</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">290</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6812743536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories, Net</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Inventories, net, consisted of the following as of:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>6/30/2016</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 91%"><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">374</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">361</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Raw materials and packaging</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">114</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">111</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Work in process</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">LIFO allowances</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(26</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(32</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">465</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">443</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: center; font: 10pt Times New Roman, Times, Serif"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6820445440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract', window );"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Assets and Liabilities for Fair Value Disclosure</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table summarizes the fair value of the Company&#146;s
assets and liabilities for which disclosure of fair value is required:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; line-height: normal">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>6/30/2016</b></font></td></tr>
<tr style="vertical-align: bottom; line-height: normal">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance sheet</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>classification</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Fair value</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>hierarchy</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>level</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Carrying</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Estimated</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Fair</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Carrying</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Estimated</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Fair</b></font><br />
<font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left; width: 82%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Assets</b></font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 3%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Investments including money market</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">funds</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">equivalents <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">253</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">253</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">234</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">234</font></td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Time deposits</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">equivalents <sup>(a)</sup></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">76</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">76</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">79</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other current assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other current assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Trust assets for nonqualified deferred</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Other assets</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">compensation plans</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">62</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">62</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">52</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">394</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">394</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">368</font></td></tr>
<tr>
    <td colspan="17">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Liabilities</b></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Notes and loans payable</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Notes and loans payable <sup>(b)</sup></font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">618</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">618</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">523</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">523</font></td></tr>
<tr style="background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable and</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">accrued liabilities</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td></tr>
<tr>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Accounts payable and</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">accrued liabilities</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Current maturities of long-term debt</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Current maturities of long-</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">and Long-term debt</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">term debt and Long-term</font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: Silver">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">debt <sup>(c)</sup></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,789</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,911</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,789</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,922</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,410</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,532</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,317</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,450</font></td></tr>
</table>
<p>____________________</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: normal; border-collapse: collapse">
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">(a)</font></td>
    <td nowrap="nowrap" style="vertical-align: top">&#160;</td>
    <td style="width: 100%"><font style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</font></td></tr>
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">(b)</font></td>
    <td nowrap="nowrap" style="vertical-align: top">&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Notes and loans payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.</font></td></tr>
<tr>
    <td nowrap="nowrap" style="vertical-align: top"><font style="font: 10pt Times New Roman, Times, Serif">(c)</font></td>
    <td nowrap="nowrap" style="vertical-align: top">&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of Long-term debt, including current maturities, is determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock', window );">Effects of Derivative Instruments Designated as Hedging Instruments on OCI</a></td>
<td class="text"><p>&#160;</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Gains (losses) recognized in</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>Other comprehensive income</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(7</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest rate derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr>
    <td colspan="9">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Effects of Derivative Instruments Designated as Hedging Instruments on Net Earnings</a></td>
<td class="text"><p>&#160;</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Gains (losses) reclassified from</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>Accumulated other comprehensive loss and</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>recognized in Net earnings</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Commodity purchase derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest rate derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Foreign exchange derivative contracts</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_FinancialInstrumentsAndFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments and Fair Value Measurements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_FinancialInstrumentsAndFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13476-108611<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13467-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6447952&amp;loc=d3e13220-108610<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6819984768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS PER SHARE (EPS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares Outstanding and Antidilutive Shares</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following is a reconciliation of the weighted average
number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left; width: 94%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Basic</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">129,449</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">129,155</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dilutive effect of stock options and other</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,744</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,065</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Diluted</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">132,193</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">131,220</font></td></tr>
<tr style="background-color: #c0c0c0">
    <td colspan="5">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Antidilutive stock options and other</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,271 </font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of Share Repurchases Under Authorized Programs</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Share repurchases under authorized programs were as follows
during the three months ended September 30:</p>

<p>&#160;</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="9" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="4" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>(in 000's)</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Amount</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Shares</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>(in 000's)</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 86%"><font style="font: 10pt Times New Roman, Times, Serif">Open-market purchase programs</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: right; width: 2%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Evergreen Program</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">113</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">883</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">112</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,006</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">113</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">883</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">112</font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,006 </font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6745623584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME  (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Comprehensive income was as follows for the periods indicated:</p>

<p>&#160;</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 80%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Earnings from continuing operations</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">179</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">173</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Earnings (losses) from discontinued operations, net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net earnings</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">179</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">172</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Other comprehensive income (loss), net of tax:</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Foreign currency translation adjustments</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(43</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net unrealized gains (losses) on derivatives</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pension and postretirement benefit adjustments</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total other comprehensive income (loss), net of tax</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(39</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Comprehensive income</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">182</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">133</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: center; font: 10pt Times New Roman, Times, Serif"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Changes in Accumulated Other Comprehensive Net (Losses) Income</a></td>
<td class="text"><p style="text-align: left">&#160;</p>

<p style="text-align: left; font: 10pt Times New Roman, Times, Serif">Changes in Accumulated other comprehensive net (losses) income
by component were as follows for the three months ended September 30:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Foreign</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>currency</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>translation</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>adjustments</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Net unrealized</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>gains (losses) on</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>derivatives</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Pension and</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>postretirement</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>benefit</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>adjustments</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Accumulated</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>other</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>comprehensive</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>(losses) income</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 84%"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance as of June 30, 2015</b></font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(300</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(53</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(149</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">(502</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other comprehensive (loss) income before</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;reclassifications</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(41</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(41</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;comprehensive net losses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income tax benefit (expense)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net current period other comprehensive income (loss)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(43</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(39</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance as of September 30, 2015</b></font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(343</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(50</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(148</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(541</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr>
    <td colspan="17">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance as of June 30, 2016</b></font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(353</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(44</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(173</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(570</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other comprehensive (loss) income before</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;reclassifications</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amounts reclassified from accumulated other</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;comprehensive net losses</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income tax benefit (expense)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Net current period other comprehensive income (loss)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif"><b>Balance as of September 30, 2016</b></font></td>
    <td nowrap="nowrap" style="text-align: right">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(354</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(41</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(172</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(567</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6812748144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract', window );"><strong>Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Components of Net Periodic Benefit Cost</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The following table summarizes the components of net periodic
benefit cost for the Company&#146;s retirement income plans:</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 92%"><font style="font: 10pt Times New Roman, Times, Serif">Service cost</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Interest cost</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected return on plan assets</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4</font></td>
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Amortization of unrecognized items</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 2pt double; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6608294640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2016</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Selected Financial Information Relating to the Company's Segments</a></td>
<td class="text"><p style="text-align: left; font: 10pt Times New Roman, Times, Serif">The table below presents reportable segment information and
a reconciliation of the segment information to the Company&#146;s consolidated net sales and earnings from continuing operations
before income taxes, with amounts that are not allocated to the reportable segments reflected in Corporate.</p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 13pt; border-collapse: collapse; width: 100%">
<tr style="line-height: normal; vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Net sales</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Earnings (losses) from continuing</b></font><br /><font style="font: 10pt Times New Roman, Times, Serif"><b>operations before income taxes</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="5" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="7" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Three Months Ended</b></font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="2" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2016</b></font></td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" colspan="3" style="border-bottom: #000000 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>9/30/2015</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left; width: 86%"><font style="font: 10pt Times New Roman, Times, Serif">Cleaning</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">534</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">497</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">164</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: center; width: 1%">&#160;</td>
    <td nowrap="nowrap" style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td>
    <td nowrap="nowrap" style="text-align: right; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">149</font></td>
    <td nowrap="nowrap" style="text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Household</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">422</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">411</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">69</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">82</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Lifestyle</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">236</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">231</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">62</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">59</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">International</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">251</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">251</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">27</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">32</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #c0c0c0">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Corporate</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(58</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(58</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom">
    <td nowrap="nowrap" style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,443</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,390</font></td>
    <td nowrap="nowrap" style="text-align: left">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">264</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td>
    <td nowrap="nowrap" style="text-align: center">&#160;</td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">264</font></td>
    <td nowrap="nowrap" style="border-bottom: #000000 1pt solid; text-align: left">&#160;</td></tr>
</table>
<p style="text-align: left; font: 10pt Times New Roman, Times, Serif"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8813-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6748895472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609', window );">Excess tax benefits impact from adoption of ASU No. 2016-09</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609', window );">Reduction in effective tax rate from adoption of ASU No. 2016-09</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503', window );">Reclassification of debt issuance costs from adoption of ASU No. 2015-03</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess tax benefits (deficiencies) recognized as a component of the provision for income taxes on the statement of earnings as a result of adopting the Accounting Standards Update (ASU) No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting."</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ExcessTaxBenefitsRecognizedInStatementOfEarningsFromAdoptionOfASUNo201609</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the company's effective tax rate (as a percentage) as a result of adopting the Accounting Standards Update (ASU) No. 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting."</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ImpactOnEffectiveTaxRateFromAdoptionOfASUNo201609</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt issuance costs reclassified from other assets to long-term debt on the statement of financial position as a result of adopting the Accounting Standards Update (ASU) No. 2015-03: "Simplifying the Presentation of Debt Issuance Cost."</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ReclassificationOfDebtIssuanceCostsFromAdoptionOfASUNo201503</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6748717744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Total gain (losses) from discontinued operations, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember', window );">Clorox Venezuela [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Operating losses from discontinued operations before income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense', window );">Exit costs and other related expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Total losses from discontinued operations before income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax benefit attributable to discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Total gain (losses) from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember', window );">Other Discontinued Operations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Total gain (losses) from discontinued operations, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65896914&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_VenezuelanSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=clx_DiscontinuedOperationsOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6822968512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESSES ACQUIRED (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th"><div>May 02, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Estimated fair values of assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 1,196<span></span>
</td>
<td colspan="2" class="nump">$ 1,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=clx_RenewLifeHoldingsCorporationMember', window );">RenewLife [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1', window );">Business acquisition date</a></td>
<td class="text">May  02,  2016<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of business acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Amount paid for acquisition</a></td>
<td class="nump">$ 290<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">The weighted-average estimated useful life of intangible assets subject to amortization</a></td>
<td class="text">15 years<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Estimated fair values of assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Working capital, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=clx_RenewLifeHoldingsCorporationMember', window );">RenewLife [Member] | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Estimated fair values of assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=clx_RenewLifeHoldingsCorporationMember', window );">RenewLife [Member] | Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract', window );"><strong>Estimated fair values of assets acquired and liabilities assumed and related deferred income taxes as of the acquisition date:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Condensed from audited financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=73531572&amp;loc=d3e845-128460<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Acquisition Date<br> -URI http://asc.fasb.org/extlink&amp;oid=6919109<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=73531572&amp;loc=d3e848-128460<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=clx_RenewLifeHoldingsCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=clx_RenewLifeHoldingsCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811474912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES, NET (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 374<span></span>
</td>
<td class="nump">$ 361<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials and packaging</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReserve', window );">LIFO allowances</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 465<span></span>
</td>
<td class="nump">$ 443<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Condensed from audited financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6820311408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivatives</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits', window );">Derivative instruments subject to contractually defined counterparty liability position limits</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Estimated amount of the existing net gain (loss) to be reclassified into earnings in the next 12 months</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DerivativeIntrumentsMaximumContractDuration', window );">Maximum contract duration</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amounts</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarginDepositAssets', window );">Cash margin balances amount</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts [Member] | Jet Fuel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amounts</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts [Member] | Soybean Oil [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amounts</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange derivative contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_DerivativeIntrumentsMaximumContractDuration', window );">Maximum contract duration</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amounts</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative instruments subject to contractually defined counterparty liability position limits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeInstrumentsSubjectToContractuallyDefinedCounterpartyLiabilityPositionLimits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeIntrumentsMaximumContractDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum contract duration for a derivative instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeIntrumentsMaximumContractDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Article 12<br> -Section 13<br> -Sentence Column B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>invest_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=35736893&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=51825145&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13495-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarginDepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash or securities placed with a broker or counterparty as security for a trading or derivatives securities position which was partially obtained with funds provided by the broker dealer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarginDepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeNatureAxis=clx_JetFuelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeNatureAxis=clx_JetFuelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_DerivativeNatureAxis=clx_SoybeanOilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_DerivativeNatureAxis=clx_SoybeanOilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6824646464">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 408<span></span>
</td>
<td class="nump">$ 401<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 383<span></span>
</td>
<td class="nump">$ 382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">204<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,466<span></span>
</td>
<td class="nump">4,510<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">618<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">874<span></span>
</td>
<td class="nump">1,035<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,177<span></span>
</td>
<td class="nump">4,213<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">394<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,410<span></span>
</td>
<td class="nump">2,317<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">394<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,532<span></span>
</td>
<td class="nump">2,450<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents [Member] | Level 1 [Member] | Carrying Amount [Member] | Investments including money market funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">253<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents [Member] | Level 1 [Member] | Estimated Fair Value [Member] | Investments including money market funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">253<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents [Member] | Level 2 [Member] | Carrying Amount [Member] | Time deposits [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">76<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Time deposits [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">76<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other current assets [Member] | Level 1 [Member] | Carrying Amount [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other current assets [Member] | Level 1 [Member] | Estimated Fair Value [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Derivative assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other current assets [Member] | Level 2 [Member] | Carrying Amount [Member] | Foreign exchange derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other current assets [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Foreign exchange derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Derivative assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets [Member] | Level 1 [Member] | Carrying Amount [Member] | Trust Assets for nonqualified deferred compensation plans [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationPlanAssets', window );">Trust assets for nonqualified deferred compensation plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets [Member] | Level 1 [Member] | Estimated Fair Value [Member] | Trust Assets for nonqualified deferred compensation plans [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Trust assets for nonqualified deferred compensation plans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets [Member] | Level 2 [Member] | Carrying Amount [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Derivative assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Notes and loans payable [Member] | Level 2 [Member] | Carrying Amount [Member] | Notes and loans payable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Notes and loans payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">618<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Notes and loans payable [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Notes and loans payable [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Notes and loans payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">618<span></span>
</td>
<td class="nump">523<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts payable and accrued liabilities [Member] | Level 2 [Member] | Carrying Amount [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts payable and accrued liabilities [Member] | Level 2 [Member] | Carrying Amount [Member] | Foreign exchange derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts payable and accrued liabilities [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Commodity purchase derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue', window );">Derivative liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts payable and accrued liabilities [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Foreign exchange derivative contracts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue', window );">Derivative liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember', window );">Current maturities of long-term debt and Long-term debt [Member] | Level 2 [Member] | Carrying Amount [Member] | Current maturities of long-term debt and Long-term debt [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Current maturities of long-term debt and Long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">1,789<span></span>
</td>
<td class="nump">1,789<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember', window );">Current maturities of long-term debt and Long-term debt [Member] | Level 2 [Member] | Estimated Fair Value [Member] | Current maturities of long-term debt and Long-term debt [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Current maturities of long-term debt and Long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 1,911<span></span>
</td>
<td class="nump">$ 1,922<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Condensed from audited financial statements.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Cash and cash equivalents are composed of time deposits and other interest bearing investments including money market funds with original maturity dates of 90 days or less. Cash and cash equivalents are recorded at cost, which approximates fair value.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Notes and loan payable is composed of U.S. commercial paper and/or other similar short-term debts issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Current maturities of long-term debt and Long-term debt are recorded at cost. The fair value of long-term debt, including current maturities, is determined using secondary market prices quoted by corporate bond dealers, and is classified as Level 2.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all liability derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13476-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of assets held under deferred compensation agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Trading Securities<br> -URI http://asc.fasb.org/extlink&amp;oid=6526789<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27723805&amp;loc=d3e24584-111560<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884222&amp;loc=d3e22054-111558<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Available-for-Sale Securities<br> -URI http://asc.fasb.org/extlink&amp;oid=6505594<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentAxis=clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">invest_InvestmentAxis=clx_TrustAssetsForNonqualifiedDeferredCompensationPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=clx_NotesAndLoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=clx_NotesAndLoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=clx_CurrentMaturitiesOfLongTermDebtAndLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6748839456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gains (losses) recognized in Other comprehensive income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gains (losses) reclassified from Accumulated other comprehensive loss and recognized in Net earnings</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember', window );">Commodity purchase derivative contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gains (losses) recognized in Other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gains (losses) reclassified from Accumulated other comprehensive loss and recognized in Net earnings</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate derivative contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gains (losses) recognized in Other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gains (losses) reclassified from Accumulated other comprehensive loss and recognized in Net earnings</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign exchange derivative contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Gains (losses) recognized in Other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Gains (losses) reclassified from Accumulated other comprehensive loss and recognized in Net earnings</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624177-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64837297&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CommodityContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6608902416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate on earnings from continuing operations</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="nump">34.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6613393120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Shares Outstanding - Basic</a></td>
<td class="nump">129,449<span></span>
</td>
<td class="nump">129,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of stock options and other</a></td>
<td class="nump">2,744<span></span>
</td>
<td class="nump">2,065<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Shares Outstanding - Diluted</a></td>
<td class="nump">132,193<span></span>
</td>
<td class="nump">131,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive stock options and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1500-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6824659776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET EARNINGS PER SHARE (EPS) (Share Repurchase Programs) (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareRepurchaseProgramsLineItems', window );"><strong>Share Repurchase Programs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Value of shares repurchased</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased</a></td>
<td class="nump">883<span></span>
</td>
<td class="nump">1,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=clx_OpenMarketProgramMember', window );">Open-market purchase programs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareRepurchaseProgramsLineItems', window );"><strong>Share Repurchase Programs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized repurchase amount</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount</a></td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Value of shares repurchased</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember', window );">Evergreen Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_ShareRepurchaseProgramsLineItems', window );"><strong>Share Repurchase Programs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Value of shares repurchased</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased</a></td>
<td class="nump">883<span></span>
</td>
<td class="nump">1,006<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_ShareRepurchaseProgramsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_ShareRepurchaseProgramsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=clx_OpenMarketProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=clx_OpenMarketProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=clx_EvergreenProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6724552432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermIntercompanyLoansMember', window );">Long term intercompany loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntercompanyForeignCurrencyBalanceLineItems', window );"><strong>Intercompany Foreign Currency Balance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax', window );">Other comprehensive net income (loss) before reclassifications</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current period adjustment resulting from gains and losses on intercompany foreign currency transactions that are of a long-term-investment nature because settlement is not planned or anticipated in the foreseeable future.  Resulting from the entities to the transaction being consolidated, combined, or accounted for by the equity method in the reporting entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6939497&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32157-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForLongTermIntercompanyTransactionsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntercompanyForeignCurrencyBalanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntercompanyForeignCurrencyBalanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermIntercompanyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntercompanyForeignCurrencyBalanceByDescriptionAxis=clx_LongTermIntercompanyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6811808736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (Schedule of Comprehensive Income) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Earnings from continuing operations</a></td>
<td class="nump">$ 179<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Earnings (losses) from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent', window );">Net unrealized gains (losses) on derivatives</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement benefit adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831223<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4613673-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721675-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e1012-107759<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721525-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=SL51721523-107759<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65878427&amp;loc=d3e957-107759<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss), attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569643-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of (increase) decrease in accumulated other comprehensive (income) loss related to pension and other postretirement defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6817024432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPREHENSIVE INCOME (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">$ (570)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (502)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive net losses</a></td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Income tax benefit (expense)</a></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">(567)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(541)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">(353)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive net losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Income tax benefit (expense)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">(354)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(343)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Net unrealized gain (losses) on derivatives [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">(44)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(53)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive net losses</a></td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Income tax benefit (expense)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">(41)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension and postretirement benefit adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, beginning</a></td>
<td class="num">(173)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive (loss) income before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive net losses</a></td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Income tax benefit (expense)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Balance, ending</a></td>
<td class="num">$ (172)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (148)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Condensed from audited financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6812071872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember', window );">Retirement Income Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of unrecognized items</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCarePlansMember', window );">Retirement Health Care Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_DomesticQualifiedRetirementIncomePlansMember', window );">Domestic Qualified Retirement Income Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Discretionary contributions</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of gains or losses recognized in net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions made by the employer to defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 35<br> -Paragraph 123<br> -Subparagraph B<br> -URI http://asc.fasb.org/extlink&amp;oid=64937487&amp;loc=d3e36068-114959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 35<br> -Paragraph 63<br> -Subparagraph B<br> -URI http://asc.fasb.org/extlink&amp;oid=64937038&amp;loc=d3e12551-114930<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An amount calculated as a basis for determining the extent of delayed recognition of the effects of changes in the fair value of assets. The expected return on plan assets is determined based on the expected long-term rate of return on plan assets and the market-related value of plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Expected Return on Plan Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6512171<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of net periodic benefit cost for defined benefit plans for the period. Periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period. The portion of the expected postretirement benefit obligation attributed to employee service during the period. The service cost component is a portion of the benefit obligation and is unaffected by the funded status of the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Service Cost (Component of Net Periodic Pension Cost)<br> -URI http://asc.fasb.org/extlink&amp;oid=6525008<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65897934&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCarePlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_RetirementHealthCarePlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_DomesticQualifiedRetirementIncomePlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=clx_DomesticQualifiedRetirementIncomePlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6815625680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CONTINGENCIES AND GUARANTEES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_OtherContingenciesAndGuaranteesAbstract', window );"><strong>OTHER CONTINGENCIES AND GUARANTEES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForEnvironmentalLossContingencies', window );">Liability for aggregate future remediation costs</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_SiteContingencyAgreedPercentageOfCostSharing', window );">Percentage of liability for aggregate remediation and associated costs, other than legal fees</a></td>
<td class="nump">24.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_RemediationPeriod', window );">Remediation period</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clx_LetterOfCreditBorrowingCapacity', window );">Letter of credit</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letter of credit, amount outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_LetterOfCreditBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Borrowing capacity under the letter of credit without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_LetterOfCreditBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_OtherContingenciesAndGuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_OtherContingenciesAndGuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_RemediationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated time frame of disbursements over which remediation efforts are estimated to occur for an individual site.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_RemediationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clx_SiteContingencyAgreedPercentageOfCostSharing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of costs that the entity has agreed to under cost-sharing arrangements with other potentially responsible parties for an individual site.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clx_SiteContingencyAgreedPercentageOfCostSharing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForEnvironmentalLossContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs accrued as of the balance sheet date for environmental loss contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13207-110859<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6395460&amp;loc=d3e13647-108346<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForEnvironmentalLossContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6615327728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net sales [Member] | Customer Concentration [Member] | Walmart Stores, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6351-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=64851502&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersAxis=clx_WalmartStoresIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersAxis=clx_WalmartStoresIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.5.0.2</span><table class="report" border="0" cellspacing="2" id="idp6746288480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">$ 1,443<span></span>
</td>
<td class="nump">$ 1,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember', window );">Cleaning [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">534<span></span>
</td>
<td class="nump">497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember', window );">Household [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">422<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember', window );">Lifestyle [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember', window );">International [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations before income taxes</a></td>
<td class="num">$ (58)<span></span>
</td>
<td class="num">$ (58)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_CleaningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_HouseholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_LifestyleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=clx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>55
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M.MO*W'7;]NI>>J+,Y$('DQ%7YC^U8E73IA'-=2?*0C<A$)<IPM+ <D1$EJE
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M\],6,<&PV>*:^Y4Y#TV<YM!BSB<'*:?F65PN*W8L[5ORZ;3S\7]02P,$%
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MI^J-]]_(F$-J'%:<2OL-JKM4G#TI8<#PQS VK1W[82<!(\U/@",!3@28_)>
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M?H/M2WGE7!$=3/RBDZUU;YP6E%R5F>9Z+H9N,2P4[Y[-;^K Y5]02P,$%
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M"<A!(Z0^!*9&2!<&?_$YC6,^A -?@CHA_!(DRZ<(.V$T#LH)%G/W J@3B9T
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MI#:#\4?:I@]_&_<4*X;,R9#9#*'!D%E5)M-#-_?C,\H5DVJHKAX$;*K(;$+
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M?Q9#0>/C\5,XVVFD)L-C?_T@RR\M?P-02P,$%     @ #()B28!?\(:@ 0
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M+NC#RZ;^-X@>@I3L[D!)%_[/8BAH?#Q^"F<[C=1D>.QO'V3YI>4?4$L#!!0
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M.-MII";#8W_[(,LO+7\#4$L#!!0    (  R"8DDG<5@5K@$  !8$   9
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M "[/%_;'6*U7?^(6'E#^$Y5KO=@T(174O)?N!8??,)6P"X0E2AM74O;6H;I
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M<W,]WMMQ8;&[OL+YKZ#X!%!+ P04    "  ,@F))&-@Q':T!   6!   &0
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M<[T6S6AN-HI7EYM&=]U)_P-02P,$%     @ #()B24]*+Q20 P  B@\  !D
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M6\Q!RE:H%>T\J2_(25V,IY="'-KN,53/]7!5'%Y:>;[=?*?K]^8_4$L#!!0
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MZ C/+?\@PR\T+B&6"2O2,O7K5&?&";Y:7 ?#+_UL.O4<])LX&&UV0S@:PLD
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MJ79T)(0C0>Z_B"-8B_MJFK3HR.4P%6.J6[B><-)?+Z3I5BS^ U!+ P04
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M0@?"J"YF"88BD"?>C8DI9PBC\90MG++E<7@RY3/$7T]G3&;,(8'LD2482.%
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M\M3.9=IH-LJ\4RL3RGI./.S&SED'ZC7;3H-'&C0H'!5]2(&A%%L\<\>W"5)
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M"*O!H;5^^]7M]3PCLV'5<)WX];=3_0=02P,$%     @ #()B25(SK4SP @
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MI;Z-U7W3;MSM@^2GZP=$_Q63_P=02P,$%     @ #()B23B2[M3I,@  .?T
M !0   !X;"]S:&%R9613=')I;F=S+GAM;.U]Z7+;V+G@[^ I3G4Y$ZD*HKEH
ML9RDJ]0RY5:N+2FBW)U4:FH*!"$);1!@ Z!D==VGN'=>8!Y@?LT;)"\VWW(V
MX  D*+ESZU:8M&69!,[RG6_?SA^*HA1?YDE:_/&;^[)<O'W]N@COHWE0]+)%
ME,(WMUD^#TKX9W[WNECD43 K[J.HG">OA_W^X>MY$*??B&4:_[R,3K-E6O[Q
MF]'!\)MO_U#$W_ZA_/9=%B[G45J*()V)<5K&Y9,X3WG,.$O%GBCN@SPJ_O"Z
M_/8/K_$=?F\D/F9I>5_ .[-H5O]V$BUZ8M3WQ; _.*Q_>1F6/3$X;OY2K^>D
M<3WUQ^43U]%=7)1Y .]=!/.H_M3IA\OKR[^(TTOQ^MWX=<L8IS!K'B0PVRSZ
M(OXM>FI=VLW3PIEBT-_[<^L+5U$>9[B=F7@7E,Z["EK>;W[3!)(3&&-&XYPE
MP5W]V]L@*=P-+_.<7HB+$+;TURC(6V??V^L?[HWZ+5 YBY,H%Z?PWEV6.R#Y
M$.1WD3@)PPB>@F=F_'P;A+/Y'%!J4F;A9U],"*_$Y;(L2D"^.'6VIN$GMR'!
M> 8?._CXY\&ZMPD(C>^>9G#D:0&KA]^*+(EGM)5)"7_A"(7(;L4XR%-88T&$
M CL!2KN'E^*'"# FS.:1V/F4!LM9#*_N ME\FKP3.Z]V)?F(.!4W]]FR@+<+
M7[S"?W^,DP10VEF.33P']2_E7'IMXF\G4\3\L/R?]4<OHE(40>+2[FD&/ 6V
MM,BSV3*$[<&>'1)^GV=%@8_<QJ6[0EAY>D>@"&;S."7B*Q$6T9<%@M*9\V3V
M$.5E7.!K(<SO/' =%7! X3T-.HL>HB1;T 8;GSY/RPC 6JKY'!Y3W@/:[L0$
MK5WUE"_2R-F,/MC;/)O#;("KZ1*7"?PU)Z93B&D$'"@2/)PH@R_N!L^M[P1@
M>>- SYB[]96=! XH*G;YW1D@.;\.F&O>IAWC6<.ZFO CDJ.M^L[,!,,R/OOB
MNZ"(PP9"6K^!=\TKK3]&$]#J]3KT]!NO]EV<+$M73,F/.\[R8Q3?W>/C :!R
M 'Q/DG9F.!ABG"@5G>\V[JEE$>['#S%P):2%,(%Y9NT+JW(C1M*./.Z[( G2
M$/@)J@Q%"PM;R:W^M$S;1?W?!@Y74J(I@$-RZ?HT*)@#A/A+]/,R?@ .EC:Q
MBS""[Z; WAJI^CQ]@->R/&[YGAE$N'(Q-UD)<F/U,U<YHG#YY(M%$D@U"I=-
MO$M37Q""+%HF!/)9!(<5QJQ>$0>=9\ 9?^$/X.%7 _]X?Y^^PE\' P%8MHA"
MY*^)(X+?9]GL$<[&67P>S$!-S#^OVG^< N+>Q0!%N;T5SZZ"4<MA2L@E<3"-
MD[B,7:YYD941B]0D"X#1+H(G/-.VD4 )7.8T$ (JR=*[/9 #P/VBJ;-JT$I0
MW=5C,JS#,$>^LV))%4;>LIXJ9JP8[,/*)3)@5[S^+KJ-<J3]59*'%[-B%-2[
MXI(U&:(M8K]W41JZ#Z.M\;98!&'TQV\ 3XLH?XB^^58X&@#J</>@-D1Y\3M"
M^-+!S*M<K;[ I]\"-O?Z?0!I+H"HE]'OQ8'?[_?QCV*EP1*89Q[_$LU^+](L
M!696%"0F<IO+-NT/2*=MEJ.#_JIY!@=O_*/]@;]_.-#*&L\:$)9-L_)>@$X&
M^M843DNQ.H(D,+](?_)[^F@PA.'Z1_[1\:'\][$_.CCPAX>C)H'!<W09WE_)
M!DYFP+:!@0 F+()XM@<<.PP6,6"&RSE+, EA>VVR_P9LR&*9/\GE^B)@)>PM
M+J4_&OF'AP>T/-S9FT-_</Q&P_5K[<;BEQESZHJ,0[:JY7RSP'.H@M90=,!;
M(RI)LY("4=S&*8C*& 8MM&'0>[F8W;D*D(G<1V4,5DIGL6L,  #XF5[:5580
M&JPP"]9(K,ZB:@VY^X8$US[I4&77-YA0NS[=D86L6'GUL;7+;GR\><V-CZY8
ML"%2^XUG6;:D<YTEV>.S]+]+UN"1E2$Q$ZF]=>48&IIOQ0<BV6=;+">SGY:%
M%&1E!AP$!@AC$.U1!QL.7L"12;$$LQ:UZYF8/C4_W;"##4B!7!M[TP !CXP+
MCJ#Q.9+_SIG=@TI&'@-G$1>=U]_IS983Z/1N^^.H>1?K$.*491,;YH!PRP;D
MU?,NB1=GJ*ZZ0]??DKQP]?0M:F>C]ENE-+%8YN$]GFRCZ3*35EM!4M@!#9 ^
MR0% [] B>-I<-%\DV5,4J7D27!@N,6O"$A<XMPT;=YP'M[<@<G'ZZ$M(>";0
M;2="B7/HM^AJ@>$*0/0B=-#H[/YBJXWG'--WT5V<IH39MVC^QID#4O1JMGXY
M^?3QX\GU7\7EF9B<O[\X/SL_/;FX$2>GIY>?+F[.+]Z+J\L/YZ?GXTF+\8!3
M7P';1$5YE:?M\F8L!CW1?3[RGQ#WO4(E&\PP8BPW]Y%8*A:,UAELB_B9Y.*A
MS<6;%!(/,0'P!?[D@$IS]M%'Z*-O4\O0R^@+\EL 8B[B5)JA\R -[B)6"D"@
M)H@X00*VGL6$=W!!,9,DO)*BFS[Q@%&"9<28".96D("2EH*]7A0!D!&N,!"W
M09R+A;UW9/FP@LH6X?MEPE+*EA!FYPNE[VA\ND5!YL$+",O3),NS+^2N#=(G
M>BA&?^=R6L2S.$#O@-C!6>43NT+!CQ&J4$N,9CWQ??88/42Y3]^;):@U,H.B
M$_/4VR & "BEWGV</,$S,]#TR%DJMZQ&*.\#-'&?Q)3]J&$I21O M03(W[(C
M^PD=V4CP^ WLBA7DVR4R4;GNGF!*QTG,L0^'=.S[O .YY;__1R%^B-+HEV64
M!%YP>POJ,L#>A^_S10;H'O_C_Z4*D+/(/"LFO9.>V)'?Z(]W_:I<07B;L^N1
M(@(T#S!-GBH+0;1)@J*(;V-XK1G&J*W4YD.;(V@190JK-R4@1',' 01 .8I3
MV %HSV!!P> F3(:8=9ME)1QV1(L!XP1EFB0).O8P60(9>O!FT\0XT2)@6Q_I
M)LMG)"H>8S _P5:'+>$P\ V>)WDR%(=: *V%\2+A, -N^%,::ST/M;K>I"?>
MGYQ<[8K[X"'RIE$$]#:/RY)M:P,?D&XHHDK4E@@UEXD4E'ETAU8!J5(2;VG8
M"1*[,;#&2JZ0TP%.$X"S,QF?[O:(("V8>;168(*P;U"E0(/-ELD,<1]CF"11
MLO2G91H2@ D,-;0]25-@+N*:WX>'SF!L,>CO_1M .('=Z)=@ 9JRF8H\HB)F
MC#7#]/$^#N_5>2%RH0J71'"P!6NFC0?-S^-QU%99Q'<IX'1(MI8^-&\AQ4I/
MH"L3J4&<L]O!DCT3U/Z#'-#P'#1P"H_P&G$.8_4UOO%=!G^)G;.3R7>[7KQB
MZ$\+) >Q<S+YM"LNLAY-L=<_]L7?__/4TE[WR.DC[(_$S@U(C% <#=[LOA7G
M<]00(ZV?CZ5&X[$^_!WIPU?!$\=W]5+\O_]O"?,BAC>0_@%JR&K)LXA\4*.<
MA?5XGH6E:"_DP!@&+H*0185GCB5'38.D$N@^P(W1P !L2Z/;6/K%\(,9_!..
MA5QCN ="QS"#(_R%/4+&$Z>B2DA!<AR+X6@VXQ6VJ:XLE9XP'AO%" MY)'*I
ML  CT=BR:5NYO6H?.<E#G"T+0"G#43WBDXZ2B%/3+BW>BT^FBHM:CS;M3E1V
M9];+Y*X%[RQ#IN41O=\M8V9M<KC;."]*\?,RR$%X$GU9<@YP\:B'7,79-WK*
M#\4C,&7[A%8NT;,.@#6&K[MI,5OFB@.L4L \Q6P82L"_ 858X'2;!PP0TBN(
MD;-"QEN 09BM\\@$=Z13%J!2N"R 3+_$P(6CY,D+Q!#?0A:$,:U%!CJ,1F<I
M!2QN%FF] @^#C ?#6->>(ZY)'S\@/JIJK. 0.WP2$:J9N&"86=(Z&S=9?ANQ
MF8C;A.E [PE!\N 24/T!W2D5)(@%FHAS M\4E>PJ)L[B&4%N'GR.2/QX>DI$
M"(RD*(LZ6K6(EJF 39]%4]!Y0=&U.#7P8.54!BYK,=DA,MD/:$(5GN2E;_:'
MNX8E:E8 <KB((NWW('0'N.48D]S+;O? #N0P#'LGX'FTRY3_4ZK=L#GZO)"B
M$; %"<F;8W2;0#@82IPEN833(&Q\,2<C.-*I0A75G: VB]"41\ 0N4C*"BO*
M/2\*#A# 2#$ER9 BCW19B_SHR1Y!2T(*5E]D!A[ ? .B*EL(!]-L6=*[1,)Y
MCJH(>VH)"]+HT6(_%C9KNTGAR52;GMVXU! HFF *_TR>#.'5"%(-#W/+Z!$\
M'*&OD;;MX4P@!('YL#50VD1,0+09*,$=-3J$.O+$M>HM8>@),)Q$VGTKT/-@
MKS]"])RP5'Y2Z[NJ66WOHFDIM&L#DTL:T)=V@S$PFHB>I,0.>()]S4AK-B.G
M9PWZ3B//:.+R2*;2JT[Y;LH.R-%.G9&_$=='8I,0$K#AB;!B3@1-P%1KTO/X
M0EJTB.=TGO0]F1<83.QY#6*-3T5+[ZYB3:K599Z90 @RYT39/WI$R8913]6B
MHWK6%5#XDMU+[ 6Z>O4&/E(@@8_LB"XMHQJGK F/^P!YIL1+3Q*X)1/:1986
MMFQD=- ::@QT+882 ]49<H6G)9::##=P DK6$YRJP4OE\"IM@41>.$V+\&3$
MHB6SURY":?XET1TZ,#&UC=1X )D7Z(4 %YT!S= $:DPF%S5L$L_)2 .CKP3K
MKKB/%S)&!5\D@"/5"<B7\!#D,<6R8YW_I+Z&M3]DQ$.<[QIUL6<B;0TUE#@E
M)@2(U@U'6CG3Q^#)\E"TG/H^VB;>W__S&DP$E-)$XIAZA+XY*=E.02,"-3TO
ME(5RV#^L2-5%$H!*":=$.632A:7M9'B Q\Z-#-1XXI$;J: S( E4$FV@Z:/"
MZV"[W$G3G4XC#61LMM!65]W!@3:L,5.D$848F=O;#-4V/1H\5-OD8PE1C&MO
M !Z?E)\(,EPR<3S46S@A4YK<1I_0<RDO(MI2MXP)=QFZ0]#HBO*'&(#GP4IA
MZ9+B)%NE&>)2^J^4"47S)0RJG#)WU!P9Z /.R+W*NJMR/]!FD^=*?EQ(BCDB
M$6 0D)',45RFDFAAS[ 3M<NJSQ (C-,3JX 654#[QM#W*@X@FM^V]7]:SNZL
MG L=U3%?K-%)Q#J=Q%M'K<>^<8%(@H4#L#24KF3_IEU[\2R.^:MK+TY4[GQR
M>HF>]4_C=^+R:GQ]<G-^>>%X\RLIAY<F)(@' ]\ML@*F>9]GR\5:+_^P)UHF
M%9=IHZ^U[K $]I%FB)$S32R/H+L8#R8=<,5KZEM($<_GT2PFV\UG<1%%GPGX
M&?P*$"6? $GVGIC$)->JASGT/<>)BBN0)#;3(QFKH'Q$(H^1;\$QQN2ME+G#
ML /@."%'=7\!<W3*0D^/#8P3.&.>X@D"\,A"9D=  >)2FKTNF(B#Y.C30'5A
M&:(# />/NZ!5W#_A]^DM.R6K*H]-AP60+B>\J&A5@:Y'W$2<+I8RP=BB:Y#(
MX>?@#CU38%T^8M(93 1<R&=^B)S:>'T?P6I&AE60^HIK:-@+:E!DJQ><.>W5
M00CV6E84-<4-=++,"NNB543Q\YX[ <B/",D&"'L>2<W5@%VE*)"B0!JA!PB%
M3E,XZOLH6>")S8%-8EI,2:XP]/T&BQ@'Q 34F-@.4:*RY:9+X)9148$<\=](
M16L5IOI5'R@9B;0SCS#'G(L)=XH05QN29*11$B%=>F0HS&8Y^8/N(S0G,;6\
M4)P'H,..1JF#-.(A:"1>'MDV;-%R:CH.8V^AONQ'Y;E&F-Z'&0F>^3)D:S".
M\M^+>SMX1.][YGV,1ZF8"+MG'M!['5'*>;&\9><>@X[G(K89!A3\==;-"BN[
M,"R'%F*9M0L/D0G5$Y;?F. .K(2T2XXE$5(#Y=TW@.:1'%"4@1GEAE?#\A]B
MG6R)#\&P(;,4*T2#Q.?90:$JZSQL"%-)#8E\B+ 3ZU1_P+- FQ0#[Z7X4T8E
M*2"=@E\"H7FMLL[360:X0D0!C,J\=A&'6?*/_U. "CI;YIEO!)B9RK,H"G$#
M'5 +9:Q- *2!^+ ,__%_ ]K]^V4 -F>@R)R,T2!4R6@-D2P"PP4ZT!$*34#P
M%!":5B=JJULLITD,]N",&5.6+%F+Q2HIP@?KA3U@:B![D?E/%A''%*IU'11-
M\"@,J9C)$VMSP!1R2=5THE&%.S1ME/:41U,\5 PXYG/%.\R*?D<>GCP#4M&6
M$X_CZ7'0KE"2[FR9XZ!^^Y$*6^[6IB)57NE'\I343I E PORK'/$K- D"F2Q
MBF18\$'*T3C#UAVZH90[6.[W$:NU9DTH$)GT ?B8,FYI0, G0.E%VY8S8)"'
M5R23=,GI!4KD4+/=,)^4#'25@&:F4P:?(PZY*:4:53-RH%,23I8\:./=/5R2
M;934J+Z<+-!@GO0^F'@Q?;0K5 B;1$H,_U#QYP8AI]B0Q\-),55Y2<B,9?4-
M>4<+%FR<O(#NE9 X5!(\RK /8"&;R3^RLHQ*^)>X; OT9[>N_A10%(*2)-@1
MWY);I13NJF7<-3B-W-1K#$ZS?KXJ3(XL 7:&)1$A,6K21]#YH 3Z><52959#
MD"JB.U;>=$49R7=7*"#NO.J3+Y6H0PZ\62X*;^4VP^@ \05:@\P]0RT+R'&.
M[B';OZ22@;U5J87-JZ;\UXV*JB3%DV;L:/?U!!*9[A'-WGHW! >[;M8[?CWJ
MOZ;MJ]\.O,N:NB<='/5U-]2DB5=B#_]X8T!?Z5\U'$IY6E6)7C,X]N!UF3N]
MZ>SXJJF>T$&DH"SS>+KD<P0>]LPI[<10>N4]<(&.)^:M.+':N#L#L>MMF*<J
MX8ZO.BELGR;G%^/)9#P1)Z=__G1^/7[G/*)$)3"%:9Q*'%MCAXY S76'1@V"
M?&B^%7W2CK]0VG<#K(_@D!]NX#JZB!Z]#_%M)+[/DAG1@4S^X1C_-8#J$;_?
M]3FP1+K^-"<_&/H [S .!DK"?10DY;UT$;(_"-,@21%\-3SN@V+)#K-[L+7O
M[BD'$M8!3,Y;!+ B]TT,\N*+6EEGQUEP=Y='=RBA53JFU,DQ2B8S$>5N98A5
M/299DMZ25E0\R;X+)W\#5:#H[HFC@31H%0;2181H'K"-#NSI+F9F?Y=GC^@_
MX@)JF>]A$L;T.M B(?>C5IRJ(D7*C>\S4/FQ?J&!/\MX0O/@-3]D\RR>G&6]
M)*!S,N$#N\R",$I!5X?G<SSWH/2D7-:U'U8(E5("*>U>UI'@4F:6Q4G0E_E^
MRZ+JL,7]ZDV%%B'Q6F7B!(CN\MY!&M1^6-:;%<@ID<9)FP2C*3!E<H:6$+4Q
MD!VJ(-:=K,>#=<G?S/YANCDE 5:13<_(,<V&'"(\ )"(,2BGK.<:NXUICNVM
M*$G4H:9!LQQEX1G_(F,?C= '*%50I[[G^HG#]Z@A2_Q3I2,-E6O6N=IGB6>,
MGJ%(^I(]Z;IU'_5;CJGS"G.,&DKO )IF$49A4M0F3(P&7O;J60\23(SM--I"
MNA!SA.GT)XPZHMW-R6_($"0MV8%SE9PIDSY(BPG0!Z#VH1!3.D;872]S2)\
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M7Y(0H_!C54+XJE7I,YO"<;<^NO[@\3Y+ (O?+P/L\HC7A9PW7*,UB^D:35T
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M_3*V<D\L-."4A$%%VK0L!K[JD"3'B3)M:_K;\*LM<R4LOL9:-UC8L"/\JCF
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MB==%47[[_P%02P$"% ,4    "  ,@F))F9/Y]\P!  #3&@  $P
M    @ $     6T-O;G1E;G1?5'EP97-=+GAM;%!+ 0(4 Q0    (  R"8DE(
M=07NQ0   "L"   +              "  ?T!  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    (  R"8DEYY7JTL0$  !L:   :              "  >L"  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  R"8DDN'I6L! ,
M &@+   0              "  =0$  !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ #()B28D=6PD] 0  :0,  !$              ( !!@@  &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ #()B29E<G",0!@  G"<  !,
M         ( !<@D  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  ,
M@F))*QSBQ#D"  """0  #0              @ &S#P  >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    (  R"8DD7$\?]" 0  #8.   /              "  1<2
M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  ,@F))S:9'0D "  "-!P
M&               @ %,%@  >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ #()B2>:)"7^= P  !1$  !@              ( !PA@  'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (  R"8DEF>75GQ@0
M !\8   8              "  94<  !X;"]W;W)K<VAE971S+W-H965T,RYX
M;6Q02P$"% ,4    "  ,@F))\EL1JF$"  "I"   &               @ &1
M(0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ #()B26.'
M3GTE!   YA0  !@              ( !*"0  'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+ 0(4 Q0    (  R"8DEN&A8+GP$  +$#   8
M  "  8,H  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  ,
M@F))A'C<,)\!  "Q P  &               @ %8*@  >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&UL4$L! A0#%     @ #()B2?B!B$^@ 0  L0,  !@
M         ( !+2P  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0
M   (  R"8DFS20YNG@$  +$#   8              "  0,N  !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6Q02P$"% ,4    "  ,@F))R9T9RJ !  "Q P
M&0              @ '7+P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+
M 0(4 Q0    (  R"8DFUDEM$H $  +$#   9              "  :XQ  !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ #()B2?U0EP>>
M 0  L0,  !D              ( !A3,  'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6Q02P$"% ,4    "  ,@F))@%_PAJ !  "Q P  &0
M@ %:-0  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    (  R"
M8DEH$I07G@$  +$#   9              "  3$W  !X;"]W;W)K<VAE971S
M+W-H965T,30N>&UL4$L! A0#%     @ #()B2<)F%=B@ 0  L0,  !D
M         ( !!CD  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
M    "  ,@F))OH ?<Z !  "Q P  &0              @ '=.@  >&PO=V]R
M:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (  R"8DDG<5@5K@$  !8$
M   9              "  ;0\  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
M4$L! A0#%     @ #()B2?#FC^6@ 0  L0,  !D              ( !F3X
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    "  ,@F))BY2I
ME: !  "Q P  &0              @ %P0   >&PO=V]R:W-H965T<R]S:&5E
M=#$Y+GAM;%!+ 0(4 Q0    (  R"8DFG:-7EH@$  +$#   9
M  "  4="  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @
M#()B25A*"TBZ 0  >P0  !D              ( !($0  'AL+W=O<FMS:&5E
M=',O<VAE970R,2YX;6Q02P$"% ,4    "  ,@F))LF?WP:T!   6!   &0
M            @ $11@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4
M Q0    (  R"8DD8V#$=K0$  !8$   9              "  ?5'  !X;"]W
M;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ #()B20&@Q'.@ 0
ML0,  !D              ( !V4D  'AL+W=O<FMS:&5E=',O<VAE970R-"YX
M;6Q02P$"% ,4    "  ,@F)) B1[>:,!  "Q P  &0              @ &P
M2P  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    (  R"8DEI
M^7G)T0$  ,L$   9              "  8I-  !X;"]W;W)K<VAE971S+W-H
M965T,C8N>&UL4$L! A0#%     @ #()B22-4H7U? @  ^@@  !D
M     ( !DD\  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  R"8DFTRX_><@(  (8)   9              "
M 9=A  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ #()B
M2;@@VH*_ 0  000  !D              ( !0&0  'AL+W=O<FMS:&5E=',O
M<VAE970S,RYX;6Q02P$"% ,4    "  ,@F))XY3&60\"  #I!0  &0
M        @ $V9@  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0
M   (  R"8DE%B*/J80(  .\(   9              "  7QH  !X;"]W;W)K
M<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ #()B20%VOAG, 0  ?P0
M !D              ( !%&L  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q0
M2P$"% ,4    "  ,@F))\-8L.%T"   \"   &0              @ $7;0
M>&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    (  R"8DDX!]E4
MSP,  '\3   9              "  :MO  !X;"]W;W)K<VAE971S+W-H965T
M,S@N>&UL4$L! A0#%     @ #()B2<(V&RAA @  D0@  !D
M ( !L7,  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    "  ,
M@F))=4MYB?$!  "X!0  &0              @ %)=@  >&PO=V]R:W-H965T
M<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (  R"8DE;K6A7QP$  (($   9
M          "  7%X  !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#
M%     @ #()B25(SK4SP @  T0P  !D              ( !;WH  'AL+W=O
M<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    "  ,@F)).)+NU.DR   Y
M_0  %               @ &6?0  >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P4&
2     #, ,P#7#0  L;

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.5.0.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>116</ContextCount>
  <ElementCount>185</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>42</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/StatementsOfEarningsAndComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/Statement-CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - DISCONTINUED OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-do</Role>
      <ShortName>DISCONTINUED OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - BUSINESSES ACQUIRED</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/BusinessesAcquired</Role>
      <ShortName>BUSINESSES ACQUIRED</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - INVENTORIES, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/InventoriesNet</Role>
      <ShortName>INVENTORIES, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/clx-fiafvm1</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - NET EARNINGS PER SHARE (EPS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/NetEarningsPerShareEps</Role>
      <ShortName>NET EARNINGS PER SHARE (EPS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/ComprehensiveIncome</Role>
      <ShortName>COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - EMPLOYEE BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/EmployeeBenefitPlans</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/OtherContingenciesAndGuarantees</Role>
      <ShortName>OTHER CONTINGENCIES AND GUARANTEES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - SEGMENT RESULTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/SegmentResults</Role>
      <ShortName>SEGMENT RESULTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - DISCONTINUED OPERATIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/DiscontinuedOperationsTables</Role>
      <ShortName>DISCONTINUED OPERATIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-do</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - BUSINESSES ACQUIRED (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/BusinessesAcquiredTables</Role>
      <ShortName>BUSINESSES ACQUIRED (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/BusinessesAcquired</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - INVENTORIES, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/InventoriesNetTables</Role>
      <ShortName>INVENTORIES, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/InventoriesNet</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/clx-fiafvm1</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - NET EARNINGS PER SHARE (EPS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/NetEarningsPerShareEpsTables</Role>
      <ShortName>NET EARNINGS PER SHARE (EPS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/NetEarningsPerShareEps</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - COMPREHENSIVE INCOME  (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/ComprehensiveIncomeTables</Role>
      <ShortName>COMPREHENSIVE INCOME  (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/ComprehensiveIncome</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/EmployeeBenefitPlansTables</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/EmployeeBenefitPlans</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - SEGMENT RESULTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/SegmentResultsTables</Role>
      <ShortName>SEGMENT RESULTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/SegmentResults</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/DiscontinuedOperationsSummaryOfLossesGainsFromDiscontinuedOperationsDetails</Role>
      <ShortName>DISCONTINUED OPERATIONS (Summary of (Losses) Gains from Discontinued Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/DiscontinuedOperationsTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - BUSINESSES ACQUIRED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/BusinessesAcquiredDetails</Role>
      <ShortName>BUSINESSES ACQUIRED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/BusinessesAcquiredTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - INVENTORIES, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/InventoriesNetDetails</Role>
      <ShortName>INVENTORIES, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/InventoriesNetTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfFinancialInstrumentsMeasuredAtFairValueDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Assets and Liabilities for Fair Value Disclosure) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsScheduleOfEffectsOfDerivativeInstrumentsDesignatedAsHedgingInstrumentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/FinancialInstrumentsAndFairValueMeasurementsTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/IncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/IncomeTaxes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/NetEarningsPerShareEpsScheduleOfWeightedAverageNumberOfSharesDetails</Role>
      <ShortName>NET EARNINGS PER SHARE (EPS) (Schedule of Weighted Average Number of Shares) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/NetEarningsPerShareEpsTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - NET EARNINGS PER SHARE (EPS) (Share Repurchase Programs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/NetEarningsPerShareEpsShareRepurchaseProgramsDetails</Role>
      <ShortName>NET EARNINGS PER SHARE (EPS) (Share Repurchase Programs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/NetEarningsPerShareEpsTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - COMPREHENSIVE INCOME (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/ComprehensiveIncomeNarrativeDetails</Role>
      <ShortName>COMPREHENSIVE INCOME (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/ComprehensiveIncomeTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - COMPREHENSIVE INCOME (Schedule of Comprehensive Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfComprehensiveIncomeDetails</Role>
      <ShortName>COMPREHENSIVE INCOME (Schedule of Comprehensive Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/ComprehensiveIncomeTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - COMPREHENSIVE INCOME (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/ComprehensiveIncomeScheduleOfChangesInAccumulatedOtherComprehensiveNetLossesDetails</Role>
      <ShortName>COMPREHENSIVE INCOME (Schedule of Changes in Accumulated Other Comprehensive Net (Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/ComprehensiveIncomeTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - EMPLOYEE BENEFIT PLANS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/EmployeeBenefitPlansDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - OTHER CONTINGENCIES AND GUARANTEES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/OtherContingenciesAndGuaranteesDetails</Role>
      <ShortName>OTHER CONTINGENCIES AND GUARANTEES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/OtherContingenciesAndGuarantees</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - SEGMENT RESULTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/SegmentResultsNarrativeDetails</Role>
      <ShortName>SEGMENT RESULTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/SegmentResultsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="clx-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecloroxcompany.com/role/SegmentResultsSelectedFinancialInformationRelatingToCompanysSegmentsDetails</Role>
      <ShortName>SEGMENT RESULTS (Selected Financial Information Relating To Company's Segments ) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecloroxcompany.com/role/SegmentResultsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>clx-20160930.xml</File>
    <File>clx-20160930.xsd</File>
    <File>clx-20160930_cal.xml</File>
    <File>clx-20160930_def.xml</File>
    <File>clx-20160930_lab.xml</File>
    <File>clx-20160930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>61
<FILENAME>0001206774-16-007477-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001206774-16-007477-xbrl.zip
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M8NSP/PJO__,DF,7[3'SW-9_,Q2>+F6:+=VS7#O@7^X5;-RY0OFL_._S<]WD
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MH<W6*I&QX[G]OF=13T8\_F..G^>Z"WI<R*YHP;GO\U7LY31=B5P"@5Y =;P
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MYEG&)$@J6,A2]#AHR4-&I2UDI!A_(& V4D;PV>'4<L?%!J4BL/^B[R=>E+A
M%?A82'.6/5E=%E K7NP<\=O9U+8CI2XV/=C8&*5$P]FN0E-F+ C<PH%R(> B
MQY9;V#J"NWYY2&ME2VIR)UL>I,63]<M!%+6QKG)S8W=B7^\Y]Q.6 '+QE'%F
M!V9!("D_ACM)S.^-'$TLJ0QO'+R)\Q4";&&\9= V-USP(Y8T\DLN_[UQ'[C)
M[1>Z'ZP<QLM>JS1UTL(0+LYU!WE;6$4@O'%?P(IX8KPK]]*G5//VK2;/61C
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M6<?S@:?G,GJ9?-MRR*H6Y\<:YRO'^0B?JVVSJ&E14S&?VXFV=I@_WD#,9]R
MDC"?]Z:/P3WZ$ZFB)G?2_DU\A%YMYXT79970S[D*&->%AQ)VTC8)'=,"MPEV
M:BO99AJ>HLQW5+JB434155.-P59B:UKJ8"D!W,W9J]D.=&DYG!M5!>0P4QM9
M!YPYS/<I>8IK3]V)>'=Q USA5>LI[>;LN54#[CK14ORPVB9BI73_:7%W<]/0
MMJP:S]M#W2[,%=#JV\%VI3M;6\%R5?A<6X^X1LFJ39>:I*:Y]? )YLS<$RDH
M7K%G-0."$@!5.ZU_Y\%UR)WQ;=IEH&^M'OI';_C,F7MGE[. _94L8)[-D;E<
MS94 6@&?'*\<^I+Y9(6,7H+^/#I9/5L7 /=T4>SBKG>N17@,G_\ %?_D1=.'
MS'&&ZI#0!0[!Q8")8!AM70SO/=D-]XO=MR>V&IS=TRE>066@K6OM<S236MG:
M(V_@*Q-=V[WD WQJ:I/(XA8ZXXKD3+X\?,4MPS+PC>SL15[4D_>)ISVI?]I!
MSW:?7KGSPK\"0+UR[@O*7)&W)#"3Y"'BN:_LA]T/^Q$J+\/%^L3/HLFO]^U_
M9SE^QN0K@GFZ*BX$>7+8+K[[*[X/+&J*=(ETF[\#^"B[W&=;4U [\_V]T]&2
MLYG3EP7RS+1@#LAT./'D9#F D33I2P'IK;L!'6B]^L&%:?O4*)6RS55=J98<
MM2T*3I7+6CAE>WA<Q;) TCCH+/9#G4,>V11X#" 01=E*VH=1D&IY UGH</[X
M[9;HLG]6"NE&EE@::*,')R/-;*IB#;RC\L;W0\ 2U:=-&.=H_V!I%^LTO:PB
M$$Q.F,QNFCP;S)PCZCG#%X&AT,;$%!CN3%O>S#*.7%]^#4Q463>$G&KNY:"I
M<%%+-+YHP*JF.1*I1%INXXWE<GGUP\&T-&8I.-@@1KCE0>2DTP5/W =7DU*M
M(FG$,>+3+UJ_5#_4S,D?VXB:.;DF6Z?E+R9"M4;"G/Q10R2,OTU.DV?:ZLH*
M6=)2O?G/'+DI#M=J5KIX -+4E5;M)S00)56[#0U$R7J=B,8*UWH=C$RXV!2T
MK<KYR)SE: J"5N689,*;\A$TK;O;]%9_\];S+\@#!0"J>&T+.R4-6ML*W9#Z
M(J%JQV/S^*$BR[E0#\I&\,P*<ABU1=&JW(G-XYI2,QNK04;M^CS/"=0*UKCX
M1L?!6?-6N8:-C]KCI/J-D :*PWI=C 8BK&;9C/HCK):.1SU0L[8,1DFHP<,J
M-_T!,X,[-ZX_4;> EG@,**<[WMY^6YZ567CZ[.6<>"J;C@?F]):9Y^0M(5.>
M19VCQTVK0(^;Z/S_DX!_Y8S7GKCUW#^C[I/1;>)(6R"L;-TV;P?*X]R[>R<C
MIQ14'F\D*H\*HA(MP[EKX3]7?X;V"W,*,&C^8%4C.'KIJ^?RH;S1ZCITK0GH
MLRU0!IX7@!;8/<RD;(ZR]S+,BZ"R,7O<9,P>93![D-L9:RV8+8=GB_00BU_Z
MQ-SO3S9>Q$.%!G-@]CC3<S^S[=]PEET38D\RB,V$XX40.[4)G#0,)3?EE,Z7
MW"M:B:TKNQUD!BN5X76AQIL:K\OQZWPM'I?";IV:F*Z):S5VUZYK-4)+5K*;
MB5 JLHD?7X@-HYO$<(C1^%+)]%<6A((*4^XZZ8?!;<EY=U4H3?RL@]W]#(;/
M6CF=2G)15 R3QQN&R586D^V<ACES85)E)I:+H<J3MH.S[#T*DR KNH3CBI9P
MG"G.GGL)JD*2.:D"L[73I'UTD.&J.0$M=WT5$:Q]J*H-BZ]O4BIO_NX*Q1*3
M%TP(W.]Y@*A7!-R2#3_JD^:=CI]2L%EBFK=>V,QF>A?#YF,/%A$HJ[60TW'K
M!3SJN"\O_I6?*T_F*(32_&1V 55J[EG6L;W;SK!C*Z.8\W%2"'/'S<?<09;U
M,FGQ^3"7=I1J[MXN*.S3_+(,Y[5.3C.YQ#2X2Z"M+KYLB6C+L-VB:/O$?!L6
M>"^X#VN6!VM<Z]'NNG2"'B(S>7L(@'OO.39>OO4$F/WD>.;WN2^M^D\G^#@P
M_&#H\%_>X!N[H-R[[@?#X9W@H]&!83X8K?U!8&#ZV3=N^:OQX/69NR._V#$>
M(6;LO/G/;O 1QWK&#[=W3U=&:\]X_/;UZ_G#OXV[:^/QYO/MS?7-Q?GMDW%^
M<7'W[?;IYO:S<7_WY>;BYNH17WW_' WR?D"?_J-UH/ZG"B )O8;7,=((7AT<
M3ST.S,-"RP8V,VSL=F7WD6P6V#[9=,8'JEIXD,'H1/X;3*ZZ<_@$4<<3!BAB
M^*_@W.C+CDP<QK!@JD% 3&H<[.\82'.#N19^.-J!^>@U;V"[V$L(L !0LBZ-
MO&,(WG&X&1C,<0P6GYCPC;<(E.TCQ^$KKB> NPD.P4T03?R>R7OB_'>&R['+
M"!-# Z%D1@>DR!BDD(UC(!0C2X7?0R<@PG@#+AL- >(2# Q4%S!:C<G\GM%Q
MO%>)#G@)\7KA>,+[85S(J\GI0>QEYH?/OFW93& ;C;<XLWKBG1'A<4 U*'X$
M)K?VC-^\5] 48H=^3\"(X,0W%?4(A&@$!GZ_ZP4Q%FQG",]95/KRPJ.E1Z,$
M/18 "8;&,S>XNJ@X0EL(5.B XH%)AYP) [ZE7V!E'AIA>"+ *$/.O%<UX\8G
M1E(<UFX3AQU*)"FL_B?K#S[^1^OP^*-O_,Y=_E?('4;@L$X'@A @]PX\*T#3
M,M.63[</#SZZ$?TLGKQG/.Z=[QEOU2_QU^]V# M0XZ$6#+DD<\(V>S \"-.?
M(9#2&8X"I[@V;B8V@;Q I_$Y#0;4'9TVGC(2K&7D&*4MPW\&$)C;;N54O> B
M8#;"WT&IC@6L ]8,V)C3>J7I\Y7@$T.;3@C*AL"!M_/6AVL94!\M> "T@R<L
M;,=CO-I!S^@"4@4-!;\@.UGTB+1J\"9,8 _ P8SP^LTE=4D]BD"&O^T][AF?
MS\_OWQD]]L()C&?.0;/T[0 ?]$2*%(-08"N@P @\*7PACHRK%+P;RJ.K?B29
M-/0CJC79=@<?BS8CD(GZ-C .(.GMX]7%NSU2.RG<10@)>F!C!#D3AM_S0L="
M"1><$38 M#]"UR1D$SHF2,^YZX)*-:138L##$(CU@;*[_PT8=V!E\<L 3*S+
MI,X@2$AO2+/P]]#EL478,5Y[MMF+Z(A\;<+T#@>"0]"%N,AE /D\DF@"Q'[B
MI:0(*A6D\E4J9^G8TC]PDQ2 @:V@  6)WX2,Y%I,@,2MSO+?N,97)@#KD@*(
MP3@_DP_;)P_^,=Y>GS]^>B<Y:\I"O@U0UQAOSQ^_O3-NO3U#N7L[1D2@DX_I
M$'N7FIP9Z:^,MT_@&9C&2>OTW0?CIC\0WHL29A ==7NRE#9J5K<+OA2  Q$9
M/I0":R>:\O2CXC3?AK=1X0*/H%F%)3,?[5TL>"GY1T[V:8)GFF"@)@CPJ#DS
MI6N@1"UB2 'JWB9/A%.7,R-@/T#F9)\SDF+\PH(_@0GE);FP)A+*J <:*GB;
MSG72LVB/07^@+E'CI+1\K-L)C%CKX6*XZIZV9YQ;EBU;UD96R%?D4N!B6Z_8
MDS$ZX*]/A#X-^0[JUA?;"WU@[L2421N+PMR)6M093/:HP^EIM2G#AT^ZD0E+
M/9JW2F-DA0G,4@'&#A<>(%5PD ;LAK94^FK(CBW\P/@S9!!C"=(R*?\&^/5D
MS[C*63\\^-.Q\0H6,4VMJ6!&;F%$#.DUEKMXPPI%I NG.>($2Z1Z)<; P@%;
M#>*+AF?/U6,^^95DYJ1S+I<!@TBC)T=FZA"O\F24^1V */^@O(LC72!FM/%-
M=2LR.-?@R\9LKNQDCG[GL1.(!!*H<!*S,Y.V"%_,$B 4D?LN'5XR$$.#8PB"
M"P HE$Z@.>"_'6X'9(<8>LX<_& 3[#2"@>XP^-*N0>Z+P562":PN1GNC7&K9
M%F&RS[YS,M0$0SPM,LJK#3Y9Y.9- R1_NA58DFO^#.$6Q%@I8P)FPH@LQ..W
ME UHIVW %PXZ5:Y9J?O3P_:[K,:.-10X2SZ7ZC*6/B"7L+N]8-?K[(:@(QGF
M:@EU#)Z'"0PGZMYL1#XN?>\KGP68%N6:P.A[@DOJM=I*A/8,U9H22;)C].%5
MP#>)!4XR$DT2L2P.RMI">I#TCO0;B"R,! QX!ZB'#!/I26G1*+1*:01Z>H\P
MJ; (J_"]!"]@'Q@)>MI#8L]>&-"[I%6$0+^13*AD0A?(FFC%E$"-A/41JS[S
MKNVB_II3@;9!R1!^X4]GF.B",1T1#0_SFS*S!@_S%^:$+';7<#:;B@5DD!JD
M=0LA-*W?B0;HBB,%5/_PZ>'/*H3D'-2LHS(?4R3D:'?_("TAC])7&:91<3^6
MOZ"<9M1BU, >HU,DB!!HX1MV](:)74GA"2I8(0V3-FWT;")!SY([DN!0<<,S
M<V@PO\=1^F1X*C"# VP92G5&3@7)A$IQ&DRV\2<:1G#%<^T8*M>#HD:L1+]3
MU!L2V1"2'*,O&2+V;^8U^"H,"X1'WB ( O+M /"O0O-X1&64,(X9,:BCK#:"
MDAUE!)4 @7C_= I?1:B!K^ZD(I [<0@*)F9W43O1NL=,:H^AY5!B(96&.\E2
M3C;JL4LB@]39/M:*S<E,81DQ)^< L)4D-&+7(5H7XNT</. A,%561&1<3=8\
M42:H!1-M!$]R:=^]-+H,4V4N'-X%A@( *%XGBDD/)P;,P!-:G2%-$HTKI3@:
MVL&;!2C0$('+A=^S!Y(=(&RQ'6#5T4DHR??"A(T;43(+""Y \C/ _^+%FC3S
M>Z[3O*3\C'%HY-N0*@9^7YQ5R]+5?;IY8/?9"P*O_\'87R98'J:2BQ/8\1 C
M7 E/S)(/$&"BWT:J+SJ7IQR/"]I0 A)'L>[Q_G&N\S-P& 0BP#I(N!\J^1WG
MG> !.8=(W)28@27[8?+9)^8@)R$@O8$!M0Q%/!>BX*Y*AQ&+N$S&BC$3^)G<
M).:!DF!7A>8H+B*]9#-:,@%"$YC1LB6_F.AQQ5DVY"OEYB Z$6RR#.C9(LL.
MHQ16XO[%\T7[$!B9=R2+=CW,9&((S\6+;2I?D^/Q@4B)*Q-$L]B!RGQ' 3G-
MZ4B4P8P<HPTYCP?N6V;TO1'81UTT%@?@!$/644-@7-Q5Y,!E(.MH'H$ZH:NT
M"ZP=5A2M=G3G ;2 35[>*-*-483O)$DSI0U2B5:"(9TS^R.TNI*J-)?2CJ ,
MXA]FN)'&+!=2^IDSU,K93I):5)H%B)%R*N?53Z>3'4[)%8F:7Z'#F>S#%MEK
MS9SSL?V!YS/GL_#"@7\34?TRM6%P%V]1)#O*I>_=%M2\H[NY[3WC\N;QX@ZW
M;;]=71IW]U</YT\W=[?%MFX+PGCGYFY"C>_8*$7L>BC/5JQN7L%33K9Q2#1&
MMH]V4N)D]_O<LBEOLB,] LZ_$[MZ\!%XD/)SY#_N&8\VN2^C(M"6YBFSFX10
M*$5EQ:,EH7#PBJK21BL S&_3?HJ'GBM,%Z#N1NL$FN<O[AK/TK>)QP93!'9&
MN,CW0#_*4B5).1\\(Y5ZRJ*,=+' /",ZI*&)R3C$ ZZ&(.D-\7>W([=-1AWL
MM";S00$R+,-'_2>2G(,MQ=7&LQ@R"DII2'# S.^LBQED0[!7 Y,JX&4Y\ Q9
M&+1_R1[5*^N2^O<I>$(X<M:#/COES!"_L1(>0R<S0!;]L7 !(@&/=KR3E  \
MA#-F)@'+S%'Q@'KL<Q4W)20P6 BV2^TG41PB=5^G@]LZ0/H>=P9(P3X8'@ML
M1D#I:MRI8@,;![6X"; C"*3/HH3&<PCVA_LC&"2+QM4N<LR].Z,[,Y0IH=6I
MP-*F'*VBD_R='&,3H3;)]Z"1'$.EWREDM2Q!N=H>Q[R*!>OU(QT.6)*; \KM
MS.7-E!.J]F73B1U_ C7C??+TDL:7\!KMN2&.>Z9'IKT?FC(U8G/QT>BE-_CI
M_6A+08V!YP:B36290GW!/3=,0]NN'W9D0EZB4\Y'!LED(2X\ [N,7V1*,95X
M1NY+K81@0$9#IU!Z2]@8$]0.!1MRSY^8'J2SEX.B5TH4 Z^"ZR 22PA+>)'Q
MBA0=\AM-J7I2>]HHG#)<2';3UZW?CW,.&2AG.-YL #2F6.QW9 8TZGBY4F#\
MW4-/^QP<#_87,V*#$.7*7,L#QB5)!4V:O'9KFYZCSB>TCR!0^LJL4'@[B7^2
M3$E@I$0>&16STX,HC_$(M&7&E]!4 QZ<?&1$BL\A,YE@D3ZBG TSHUM?<LXA
M[!F GEO<F4/LY"$G$B9"4!ZTQABD@_#9L?T>;BB@#O2<4 8TH',EDZ9>V 4M
M#*X66JU'$$3:O+1 O"!$$O*,"VU;2C\3S[!$VF\H'7K08$*I(&(Q/J+*\A9,
M:Q/\&8F.1TA$/U)T"53_1?E8X8$<Q]&]'(< 25R"5-P;F>WK4. $.[-);Z2=
MB;'I*=*+7&5%P6AU:%?ZBE=3= 8802 9**64QH4O7'D((K%/&2&'Z)1B@=^X
MC'@2N-#"2UT%A($)6,H9!L4&\5"4IY'W:Z)!&C&U*L$> ZF8)YKQ22I[906F
M>1Y24P;L.Y>G'*)X"SWU>(<.#U&]>,Y+G/?*$I^,M>P)I'Y\'&#BYW'O2W(R
MB+YZ9T3GH\@^VO!'=.(HQVKOI!E$#JGL[LB+2#P(-7GT"^U[^-)2RY-RF*TT
M2;4Z[%7M-0.G!DL>=BBH._\I S<,"G_8P:3C:VKK)7O&B?98Z1B@W%[,/^\4
M'\S)3R?->P8*;9!TTO/.0,G8<=J)+-1=L-( U(M))HX\/<SB12[2S4AF1>I$
M(I7/*9Y> X'P^G0($[G,W&3M-TK-3_OQ?A#I![6:Q8Y[5IXX?B+G!/=Q22$3
M7E'SV/)($>B\/N:4TSGOM]*'EL=9*'$RB<%RD8-+RXQE3!W'2S:'<^/#\2.@
MZK FMS[$D? <AX3DXDV(,7QP?P&\7][LOZ&_!YB$4G\_>P*T!GU4% "WGN^"
M7@&= F@_&,!D\J%=,$ .&_C\@Q%]^@AJU IZ2)[]G]\D,.#T(AH0M"]Y[!%9
M)9<F3V/*@M[ 1/$K!!B_O)'_OIG$%/)=*>#'^Q(#@;7D@'C@@(OEAP1< (+=
M7]X<Q\,K?$7B^!_RK+W1 A8F[?/1F 0 3('\'@VT7)KDB61278I[A3(YQBTX
M;/R'6B5]%%M.PG9=2'CV_F#_/:K..2BW1GP=U U?1Y/P%2_3R%_Q$NP/>I&9
MW[L"W%P+=:,G8-WF/OY?$<F(=>K9P<_%,70WEBI26U#C5NR9[KI(G37D?HG\
M-K*LUL^ERG[NV$4P]E,*LNH^E8=<\OY+Q<"N)GV5I->L5#4KK<67*8*F*XB+
MU0&L).\2'<52I[[SXX^2\5M8/A?S ]8P)?%X_1A;(WY%B"\53_7Q&HLC]LD+
MF+-N+[%T_Z#4 6O"PAIIU:ZQ<>[#35(B%A7,L%33?]S^T7[#9I@OC7CM-S3-
M;]@Q7%G!#0I*LW\SV5\C?N/USF+Z)=X#.-TD3PIO_)IS&[=N K4J)[ZN(#9_
MS8V3EG(2V%..0VC/H?D&3"-^2<2_;:W)=2@"]+N),&]2S/,E%>U,< \:J+K:
ML';+"Y\=7@5G_%0--T\">LNTGZ;=ZA1HM;A>2(.^IP0O?I7J7EZPZC/3_5<5
M0EQX_6=;'ERNL%:T0&7HP9[QZ=OCS>W5X^/5HW%^\8]O-P]7EROLIW>G6@3L
MI'H@Q4T53%58V0(.4GVNT#P\<!B1(/EB=[CQF^=8=)18M2.53? >P"%^Q=_?
M[<AV1E18]RRHI!][+'2QX=,+-WJ<.4%/M6"0)>T#9LOJJI_:9_M&)Y2U_SU@
MCFX/>RSV 19;E:,/&$"6?1N[G>'+<36<[ / NEW!NUA1,@B%V<-61K+H#?LS
MR;+T:-6JQUCTF#H\'B\K+K91=4)TVM^?V-(1RWIX=RC;8-$$HSA1%>^X!\)D
MT:P\($\U N!.O&(Y/ [A"6I^\9#JH!O#-%X*2)T6XJ*@T:H$57KPFQ?ZO.=1
M7X+Q8_VJK<STB<;:+N3/%A6M5E5,L/"!>Y8TJW&26STD<T<$CEOE"60_IDI^
M9/D*CQKMI-J648OF%[H.@,4-&:U4I2D17O5?#OW15AB(WAAW9J*V5*L"U=!0
M%9P$O0S_8L&0K%))H%#3HE-'!5EV1]4NJL5'XHV2AHWDS*B-$K:'P-X  )OZ
ME. !INM30^8LW\>SRJ9>4SJ<(LT[X,][(-Q4-I;4:4IU(.LKN>-$O.2RM11B
MR.H+^R_572>7V(HHN<(QCNIQAH/?L:9-29H\/&6IJSQ&#BVD6"K-1LA>6)S.
M55,0R1ZR!T?V\9T)'#(WE +;9:F"9"RVY-CSQ\7RE*0C$+P<,VE>\T.%0BE\
M-/) UIC@Z'[X_ >VWL(R7]DM&-6BTASI!G:J7W?4!Y)*9!B6'$=KBN1#E0NB
MC,A^+*JU^!"D JNI'-FTE$3=&1< V?T\108YX2N5FG!KEV$3UFZ:+T";=D('
ML-<A[ );PRIL='BH0DLB.K5*L%D01OXE46?[1NM(=@F8S.TYWGAEI32'\Y72
MG#:VDJ;8@/4K*DB4T*@'6>_L1E(_<%S" =[(9I4<!NLCX0T\S-TZ.%D+&S1N
M7^1),(N#%?V^M9N$Q=CL<'5HJX_>+HZXJ).@=+[0#<2ND9H%%\?DP7&M.7"]
M;'8O<)<#&_-2!PY9 0_!SH :*&EN6YS;:LULM55W__0$];TSV< .F$,;;IK]
M%L?C8=%MDDU6=I=Y^:.Z<=G6G(@XUD<BZJJ-[Z,4^CWU+6R&A.A=\RS4[;/]
MU<*]N,E(=KU+W[< Y]:@=MCQ7IW:E8DV8-(;!K2IA?GON$$8P?/,J>%F=G\A
MNN8'[\:(FF?Y:K]PK'UZTB<\=9E+?L/HN;;GQS?U9<G8$_M1SZW\XSWCYO;B
M[NN5\73^KU5>RGL#9.)XVX9L;HN=_E0O<6<H.XG178ORKM7$(]@9WZ7!O0M_
M]"8F)N].S%Y8%=]]Z"<;0G%+6?66G&S'P$YU8>")8?QV?)6<W)R!D,R5/8)Q
M7Q OA:9-IQ=F.^IN"+6]*/"V-N./4-B^99MQ"ST)2GHEJBDF]BM4%URDV]P"
M(D(W] G&@/?E7CGM/N%=F]2F.N>*M*@_>WK"Z/(LV=/>Q5:Y#*PRV!7:_9&W
M6\CK9]0H653*,WD$0S1%X$6SJ=W?[(5AB.^HA5O<.E\UXD[U;<.MW8/VWO[/
MR24#\]ZQ)CMU'QSN'<WW<M0Z[PAA!KZPN&P!3##$N\:&%>]5CES[0+O&9G2<
M8N3B.EI>^B9#,WW;8CA0S9'3;>Y';^XZ6^ BD =TGB4,'@P!F&[)^\K4/C5(
M&K!E?A_\:0IJ7)E=*>+=<T&W0-9)DP$:;J^>C*OSA]N;V\^/QOW5@_'XV_G#
ME?'VZO[QW>HTV^B.O.VK^YU<D[J*IBXEBS9D#;4A2Y"X(;$E/$+,XQM>&%!7
M<!SL+;$$J!,\>_/.H&;3N.G,'!,OLZ5];MNDLQ.P9LFQ>'-&]D'+=D*<6CWZ
M81)25KHCV^#FA@5K6.JW)]N$WH;)#NQAN;N;^5MZ*XOB)3'C^=LE;"G&=%U%
MP\/-QMS$UH<;FG# BW+,$GFD_'*_LO9#VV<[AX=GV[+4UM%1711Y">EC]&?H
M9"M%'>0_T27G7G1.+VKW5CORKB7#V]XY.2QS][_1J-@_+E42:JO)+Z73WQ2R
M5YQ_;1VT=UIG9>X)-QL;K9UV>W)&>JH<+-G1XFB3-C#/W<"V(BO4%-M3\T+.
MVBX29.5D\A;I:G=2TK=L]IA/UP=2[@C+E))Z&Z\K6-__H&ZZ=W?QV"27Y4'C
M3ZFJ+C>ZOXEJ#;(U:,EMXN$ LTL_G1SM[]"].'2_,F:;J4@G3HEC2G(<,JS3
M("#@G>R%)C*=RV+ 8!:OT_'5M@Y>467: TKZJ_M#H[R93'#):PKC HET.I:]
MTC6[;W&<*[R/5W NK_*ZEW.]BW8+>O)6M0@7,H5'UT9C>8NLA@AE@CZI84DM
ML/(2H,<,2M4-10GU(O++G32Z 0X3E!+S%MT2.4^J?&*:4-=WE*FD2JKO.-.Y
MQ&83\+ N!&S(+2FUPU?A5.&(XG/QN(3ST=@.YJ_-%4'G9-YKR?GU0!#Y'_X4
M!#T+XWUYT^$F*"SOO_SQ/=UZT$0SL&;@$AFX/OG'Q+$NH][U+HE!C4R46B*'
M;GP1;,G9EE+W3DO/!55%R7HO7?/PAA!R8WAX+<%YD:7$*3Y#I?=*%L\5NT#-
M+2UJM1JSXU8M(DY/5UB.JGEPE ?;F@<)$3O[^Y,K\.L3>A1?*5V>TA2BZVJY
M1MN-BC%1KN'0C+QR1FZ,\:D:$XM:G[PFS!-+DL9KE_"(A. ][OKV"Y=%3U@I
M5:<2IM,]X^+NZ_W#U6]7MX\WOU]%I9EC:<(*CQ*,("DJO*1#'/&1@;BL3C:S
MQ%I&RZ8FK/IT0)/VUT[JDGW7IP,:7BK6D-,!M<-7LPJ)DF*[,E*+5[/+P$O.
MCFQT KT^*?=2^I^>E%F$M7+B:\:J+V.5G7/=T,:ZL7J>ZX;.!E[!M7$Y[5I=
M?ZMI76U[/MV=KZ[[#+>@"*,61UH5KFE7J[#[J)5ADZA=-)^^NIO?Z^CJW5&'
M,#,O\4O.W[NT=_>A;CI-#Z@'W%AGHIR(_-H3'( RS% ([II#(Q#,]>7%%0:S
M_@C]@-JA;I5HU\437Z6?70.TUY:.A]4<QJM-P+0)B@QCJ] 5G,G;#[L,+YJ-
M$U38]QDF?&'8@$,KLR6H5+OSJ,T:L'E4T+[2^*=[#(#D=;#&P/,#P0/5+3[J
M[%QGCVEK0OXZ!?R:UMM#Z\8Y7G3L7?8>FS?%HY7:>AB]J-W72JTYM'Y[L*X=
MBMH$I+5U)/..0#=$)^IRBQS_X;2B[:$E;]G2'%-[CCFHR!0WXEZVBQYSNYQN
MJ#HWS; ?RNZ9>2XD^HQQ^DTI2@3G>4@/>BZ&S6,-)^>]E*G^%](TL37;YIVE
M5YM;M(;G6%S2HEMN[Z9H$VUE$Z8VZU8VYWB**W_."3RS%6PWNA6Q,L)DMCQ6
M-O/XULJJ6:)^+)!*%:^,"J,IZ95-JU+?S= _6VD&4Z[:RJB4W&BP$L.;=CU7
M-NNX>SN;&^N3"DE*G0_+O ;M$W.8:Y)/[W6,OX<NC^]0K418*^V9UM :J^96
M8+T]V"]ZZWFE]"O[])1F7"T(^8)P5'DIHI:#K9&#6G-ZJ]0[-36K;S>K-X3I
MC_;+;/.U0J9?(H!9[X9M.=R45P8E#\=$1V6>><<3M=L*7M61UKJ"6/\!-1(U
M$NLQX,J1N*6V1'#38;YO=[ O8@6MK!K#984\J$-=6[<1A"S[)I1Z(TU382,'
MW$JEMH3YKNVQWG(LN[Q*SS<2"\\MV1J-C1^6VRIYT^ZY1F(]!M1(;"(2M:49
M_Y0]:BV/HFRK6=&^;].IH-M+U($*U<0?=45:7:EPN#HJ+&%:-\%^RAM^L* ]
M[MSQEO\8@#WEM<OB;4W9\[HZ=5:3'M'<HCN::UIK6FM:;[,5V*34!98UR@K7
M0%WO-[MWD#:/:Q*CPBU+ZR5'FEUT>RE-ZUKD>#2MFT-KW4ILW>DJ)[<P-MW,
MINKJV*HX5W>'RI.WJORN:K'=%,=+\UQN,9%F.<UR*V6YUN&IYCG-<ZM5<X5/
MQ]:,YW*=V;SEQ!V%6B?;<DHJWVU.]Y,YKK''7#^9K<37+;U)Q09J^.U@A<-J
MCJQH3F@<)[1.M%+0K" =MI.RFWGIU*+N;+'B<YQU!;'^ VHD:B368\ F%"QM
M@BW1G2U*\: ;Y#35 .UUI:,N*]-4:/R VZC3EC#>]<VCZ[X6F^17;N* &HD:
MB?48L EAXH9;&MW70KN^-1FP>;7\FSA@250HN]MZO9%65RH<KXX*2YC63;"?
MNJ]%B5/6Q [K>JOFT+IPHJM>Y5::6S2W:&ZI"[?HSAAU37[HSA@-$B.M=#6W
MZ,88]5Z#;HRA:;T]<MV\9)4S7U>+.M?HZ=+;12K]BFYCU*STME[:5?-<7DGA
MAE5[:Y:K/<NU3BI*L6B>TSPWJ4CR^&2S>"['F7T?, !CY*O!).;[:"P$QXUK
M.J'%+<-V#2Q3A'%4)LX<&H%@KN]0*8K!K#]"/^AS/,?*!"= !-_M<^:'@N/W
MZJB1 0\[GMO=#;CHP[#P#V;QF#N$KV$\X[7'!3=\'@2.?,_V@32!,0!7V,5S
ML,)@+KCL]H".Q0)@08\3<#[GB BC$P8PYQ[!< V/X^]!3W!N]&'M/=_@+BXI
MZT[#P!9UB]LQ\NHV1_*+N YXQN<*[, +F .C_K1/H_ST]NC=C@$P#;@9P,O.
M<(?@P=\"6N$K_H_K&6SBZ=_S\=._1O;\UEN)U:B:=(_X88"D^]O[T-_M,C;X
M<)%^2VYAWWH!?P+6^.1XYO=?__?_0C'X6_3\/3[IN>>N15BX]_Q \,"69/PD
M][W]2]LW86Y =#P.@.<BOSWPSB]OKF$%B-/=_9/=_5;@R<]GNP?[;WXMDT/C
M6.GV[NG*.-LSKK[>?[G[]]65\>GJ]NKZYLFX_W)^^VB,A4J#1%S*EIDG8D?'
M\5YMMVN0;!I^V.\S8?\%KR(W(AT]EX0%XCJDHTQKVR9!$YTM, 'SR-GTSH64
M$F4X#H\_(LM$5(EX$X7$_S!IA1(6DSO8[\8$Z'YYL_^&_AXPRXK^E@J//BJ$
M.+;+=WL<53)@X6  &%%:T81ULH'//QC1IX_&JVT%/<36_L]O1I12]4%W+5(]
M<3NADR73&29'K5AB&N&)E-]7J?RN4/G-D3A82]:D7@0\J L!S]X?[+^O+.&3
M!G>S\#5/V]<E^+RBC=)8=9ZU?RZ.#/CT8IN<C$C)$4RBXW\N76PS8Q<+6DHY
M]E?2IY)3M*5BJNS3["ME$<U^FOV689&UN#A%T'2#=I+[015*O48.6'5'Y(^V
M"FEUI4+1E-R6U@!>_<!D$K<P[@^%BQDHC/<-YOL\T#5\2Z6'*\%:-9G?&J"]
MMG1L4G_4QGD=YWT/@/I+)OJ]CA&Z@IM>U[7_POQ[P/NUTSWZF%5M\:1IO:8:
MVW4?J:NM6_6$.W<-T6!ZCW]E2G VJAN@!36_E)\#*)=?<C1IA><Y<&\ZO=UL
M++[53##U.'."GF$RH?:<C5?FX]D''((SLX=^XN+G+E+'%ZK9F[\,!6W*SPO9
MS@@^$)H^L[CQ4^L(#YY8MF\B8CR7B2&=?A#V<TBM68W HU<M#R  :VC\&0+4
M=+8C?]<^]^3&LB<QHA,=IO/CPP6 !6OFKFES'T;Z'#+!W(#SFA[A:.WO&7=/
MOUT]&!=WMT\WMY^O;B]NKAZ-\]M+X_.W\X?SVZ>KJT?"UDJ.<\30C2!R=?,_
M)0R(1Z%L]\5S7N3!)Q,<+0;_<O?%%IZ+3,$<H\^"@ M?GC>RZ0 7\CR>10+&
MY 8S)8>RP'AAH 9"WP#24W3G[QGIZ7K,,A@>3$*-9QF.S9YMQPZ&*-P_M0[D
M0:?6X<3R!'R H!BY6&CL6!2I#&!CP^^A-H&!6+<K>)<%T4DN _G=LF7\B8H*
MU9$\%B6E#!:E%@VLXT9_((8N;?.[[?J>2V!<X$DKF/&K;?;L+F(;YW[MP9]I
M.4<T_^'9;N ,:8D^!X^6.? 78L#A.]B7$8?"@UIX',WPPV<_P%-IA/X_/*&0
MA(-FT2</@A'.P(CT)BG$$:2-$P;(!TB2&'CF"C""IGVX=_!S-'F"RC0.([(P
MW_=,FQ IT2H- "Q?87 0"C^$=>$LC)[912HA.S$!6J0KU=BK#:M@^*:PC $3
MP7#/^"=^1R#XOHW(,8FV(ZQ*0(#&\4,'L>>/:%N  4@ _X6EN@8$#:"M%-(3
M1A1\@.?^2#")B:(RX6?<)4'-V\?%P\0C'$9GL-C CF"@'BZ6C<P&0-#$W)65
M-VYR]@XQ%/1 ;/ILB$@'V<+9X '@#P0RFL\"LNT..1,C6)<V=\^XD" BZX\;
M%Y.Y>-01VWX*& <X#I8'9CJ0%LONXS(!?B47 S:4)R[34)&! G1Q14KO&50/
M0;!GW.!!35@G_+$SP=)+?,0+P>.%!J"'S 0*AH\F"457\@1J$"Z9/70C?=0!
M%>.!!C(2[8.3\0YV+C?IX31BX'M/(/7-'K*4KQ37R#."_QDJN^<;ZA!EA ;V
MPFPGI9K ->'"902DZ7#F[H8#<,G,G@M19Q>4]YYQ#MZ+%W9[P!:X*,$9Z @0
M(4 X+-A&]PN!(+Q.\(ABI"#>^0^3A!'YG<YSQF(/R@)X67T)P/DA*)N("* N
MHF%@^2!\)%,D)_'7$AOR#*RD"THZP07?PM^\<J]IS 2!MON#FZ048@,"2L8!
M9O40#4!O)*;#[+X?'WJ50D3L9*8-:8I)=DB1>&$  MX'V91LFGU%:G_B*D]Z
M7<!OX%ZE=1*,"]!8H1DDVD*B$H\-QTPD0%CZ3'R'QYE%>0N?  %VHG/&EL'[
M \<C,=L955X[AG*"R42P#DI!LM#8'I$>5 8/X%5LA28K!UO&=$R!I<+SFZ P
M;1!OXH-8Z )D0E"TA%!B1&]@NRIC"V1E2E>S0(&@F$?J 5# 4E."E@7&LZ-4
M[XAQW8F<6N F'(I.90O^@AQ JLI[L2UI$Y&4CD-/]!B((<,Q@)^02(AG7\H7
M2#Z@!1!KTYIMT,$P1$BVUA/10F(CMJ,.7>>)(V#%PCY<%N$'$UJDOSHVZG&<
M%VQ0H/1'P+YSW#8#L%Y[GE.] ,4^9.)\K_! \@UZ3>X?P"I$5K+6@&A4)F3Q
M4EQ'1_J5@[@3\6K*(L=4-H+A '-\2#/>=Y,[*8RW?*^[MY/]'GV+V%RK[W#B
M5Y+:P%9P0'R#YERR7\)=RDP#@Z/<CPDB]F-+9)7S6.1M/!E/2IRX$$L.E+%\
MP8@-0S@TM,HGBOAMX!$(R*NQVH;O)3HP69BRJ?@>25P?$63:P@S[TMM!E4(G
M_ -4YHYMVNA/6A"RN=S*NG/X')KN'?@D(&P$=-CHQC@V1\@19CN(; $0X9G$
M7WTOI:T/;"W-32QLL8>05IGH"HV39X<0H*93.,*1)EG&>.!7+W2L:8)N5"[D
M!% ]!'T\>D*\Q $ U;@DG!FMDV'M2E\RO5I,-U$3DV*KRI=R/F'B42?]E9!+
M/C^REL/)4A P\+:)WFL@P\5]X%H;BR"<83I\@S5'[CFX^B"-Z'6;H!-LLCCP
MDXS/?MHGA#YS(*@EV"N$!!#.CF1-%LYVC!>^//(NTN&!#W##T^W6-$'2VC,>
MKSY_O;I],AZN'K]]>5IA-B3-X!Y$-$!&U!:"G&D_P+^[F%8,P8_BX,&$KJWB
M$^D)BI2DH\(%#NAX(5D&P+FLE9%4\(UGAI*NI 2$R/7ZMBFM!'CW81+**4_/
MQXTLZX-Q@3X_N7&_@>W@(/B@HK_8'4XHB#U2.DSG,NF'0TC@4ZX#8U$<]\+Q
MA/?#^)V[_*\0V!4X3V91$$X49I_2?\1N(8))R)"J5(;].)*?.U14(.=Z5 I'
M2C&IL\.W1V#+04[ETG^A0CG7<V$4R@_AHBV(0&TB,P57GO(WU:E$F<Z,$D_J
M2]4?E<@6A0O2V<"Q%=HP>I>Y4++C\A6J)(3%=QQY[ G N? $H )@V4L^JO-/
M$0Y!>?B]F,CXAX&QXPMS9%B@HGF5)Y#O4K  D"@7'I\?2)??4S8+O:4D^ 0K
MSBGR!\\#PLE8/E=<9299 HRV]VHHQ\K/818 'TQ,?RSW0W8)U*1CLY2WG_N.
M<OOS#7+B:^/&@@]HECCB3* 0^K*640D*Y2]B25'%;FC_(O(30G=41DE51DIG
M1/E2"3,JJ/(TQP2>F423VM3%C0SH(OZ=C\9VU%H=U:5VZ#;BXC%9KEFM56V*
M"Z\B.8]+D<<$?@H>GX7QOCQ($L5BY"B5.<BYEI-Y6@S+JUG5\JB+?9<E8+LN
M!&Q(L6_M\#5/L>\:\56[XNB:\U?M\-708O+3XQ+J,Z.42HF,HBMY&U"7>W10
M=F6-)GG-27YX5G9YIB:YKO#_V#INBB:1#H1F6LVT'UN'9VMAVK6$XT40%6^T
ME8RN&B4*JJM>/FQOU_V99:&M5;2%]5:B[;ALE59OK-65#*<KE/GZ9"6*XRTY
MQ[%-7%Q6#?G!"N\(KL& I:%-6YIE+,UVN35U)</1"@U^XP*7D8-V6\6N9>G&
M(ZT;-=I6AK85M@[<Q '+:KFB@Y?EME&CHZAUX^)M::)5=I]AC7B-^'HC_NW1
M:4'4ZPNY-;LTEET:%Y VJ1MAI32MJ+E<Q7><[QP>%NU'J*FW/NH=G.UKZC64
M>NW")XS6W ZYZ-%IS3"-9I@<5Z7"3J#GCB,+MZ."7U6Y*[C!L?V2*PN^72NN
MO(UJU%5Y]^1.H9EZW.3GI$:X\@KVN(YS2OFRPT27KM,)?2 @%SO&/\$;_,J$
M[%;P&'C4F.O&-?=D@QBL_^YTJ&::&KQ0\PLN4'*9;-R57Q&](Z][;1__+'N=
MGOP<-UN=UH>4H,BYG3;=0#&W<>@<G2S&FU]\4BT;+KEO"GL0R+ZCGYAO^W>=
M^U3;GIKTPB#($.-IV @7S[$X55Q_'[HLM&S5R )^Z2_2A8H@FH<)\JXGGM;B
M:R<J?\=:^9&+F=]2ZS#90@GOG:4"<X)#<&R(0'T=35.$S/'? ?.:P [8)TDV
MN>PP6QCI_DUQ)\7T4E-]+](M,1(,Q.W%XO8,'<=[C5O&4(,1V3 CZC,221YV
MV;0M&SL.PEI2(OTN%B;98]&/P,1&2[]YK]B_4W;E2,"(X*3NHY)Z!$(T0J3U
M(BQ@VQIL763*UA=Q<T\Y2KH!(X^NZ5%H"X$*'9 _F)1Z0L*W] MV4*'N$E$W
M1]D?LFK&O:)V3+B&A,/:;>*PPTE-(9/>)01.K )WHN8*IBV?;A\>?'0C^ED\
MU?/D<>]\SW@[W@KEW<YH%Q4D<\(VV.0#A.G/<$*[S)$KL_/)F]M^!;5V?O.6
M2+"6D6.4M@S_&7C7M^VNK%_+6*L/&,0+@(VIL9^R +X2?&+H49.>VT0+UC)@
M0O;2P,:WPJ(>3=2BHPM(E:UQX1=D)ROJC8NZ9  :Q;0':(,57K^YI"X? ^H;
M]/;;WN.>\?G\_/X==0\C,*C#D]>W@T!>]IZ0(MV-EH0OC'J-"-X-'57ZKR23
MAGY$M6;'O>6N?L@.H\A$?=O'UMK&V\>KBW>R'5L*=XF/8T<>C>'WJ-79,TH]
MD_V7Q[OJ39"><]?%]I32&F-#HVN8!RB[^]^ <;PT/GX9@(EUF=09! GI#6D6
MQEHIR^98BHX^->GM \(#=+ZHCU$N XSV9<V!V <^I.9P;I BJ%20'O:R&W'@
M$K]C<2=BW T!)C^/)[P7GNMABTOBQ'N<>2C_MR9.R ,W23<9-[Z/BB0!'7G<
MM9BP5MSI$9Q78(BD4=MU+-*YL'WRX!_C[?7YXZ=WDNFG+.3; -6@\?;\\=L[
MX];;,Q1^=XR(=TX^(C.!N!*1=\&!!@JEOS+>/H'38AHGK=-W'XR;/K:3C)KU
M><:5:N HO6_LUKS[B9J W<MV@RFP=J(I3S\J(?!M>!MM@1]U[ 9-CZ8XU@DI
MU81"1NV@=V67,=7/,*<!9KJ#.O8@IOZ3/] IH+Z3Z@(%U4^6_: .CR ?LE.M
M[,Z=NBZ+^:FF)'%O+  FNH@A,4"C_0UCA4S=@57/E3WC/.XD'!E(7Y$K:IGL
MIYPLV9IE$O1IR'?2G5T3*RO-/^H992K(8P1O MOKJM6F;#*CWMU)CZ_HT;Q5
M&B,K3& >;97)+&\0H824<S>TI3U20W9L 0'=GR'$<.#8H ),N5[ KR=[: 8R
MZ\<6A<<R2$M?;C8-S,ACC1M=D4-;[N*Q/^D\%U:,!(H28V!\@:VD0S+?7%$;
M4K+ ,FZ0RX!!I#V6(Q,-9%-N=+*49S  4?Y!3815MU9FM-.Q\0 [ZL=L/CDF
MY[%_B@2B!F^)19Q)6X0O9@GL%?::<M ,LEU#@V-TI!J;*9U <\!_.SSJB8M.
M/0<7'7NQ(QC4'K?'Z-K-D5[OSVC=1KG4LBW5T/4[)Q^"8(BGI;:WV+$U\D"G
M 9(_W0HLR35_AD@0PK^4,0$S8406XO%;R@:TTS;@"P>=*M>LU/WI8?M=5F/'
M&@K\.)]+=1E+'W9CQ#S?KM?9#7W5Y4\FI.!YF"!U#4#D?M/WOG*GJ-FOUR$P
M^M@-BJC7:BL1V@-_C*:2;<;[\&JHKF7!248"72*6Q?&2@*@?923HYD@H+ $#
MWE'-;B,]*2T:17TIC4!/[Q$F%19A%;Z7X 7L R-!3SMO[)E:I,.[8_<P*"9T
M@:R)5DP)U$C&(6+59]ZU75<V8)Q'R-K[JCL?_.D,$UTPIB-2[>+-Z+X#@[\P
M)V2Q)XFS@<UF=+V!:K0?CT<(3>MWH@'U&,8P+?!G1V:K$))S4+..2LI,D9"C
MW?V#M(0\2E]EF$;%_5AJY9(_!^17TO(O/#^8(D&$0 O?L*,W,C>EL+1IHV<3
M"7I6;9WCN%5QPS-S:#"_QU'Z9.0L,+D$;!E*=49.A;Q20X@A,66J;W8$5]*&
MWU!IJ/CJ$/H]NM\#R(:0Y!A]R1"Q?S.OP8_:B@LO29JBN7*BK$$\HC)*&&*-
M9EY'6&T$)3O*""H! O'^Z12^BE #7]U)12![E"(H7SRWNXO:B=8]9E)ETV@E
M%E)I3.N&/<&HQRZ)C)]G^U@K-B<SA67$G)P#P%:2:XE=AVA=B+=S\("'P%19
M$5&7BM [L3*A:\IB;01/<FG?O32ZXON5Y.T6V*$[H-M#GE0S>!8#!C;% G&6
MG8K5N%**HZ'I2@LNK\=QN?![]D"R X0MM@.L.CH)Y1^Q72YMI"3-=*.? ?X7
M+]:DF=]SG>8EY6>,0R/?1K9[=Y=@U;)T=9\)L%WQ[MO^,L'R,)7WG,".AQCA
M2GABEGR  !/]-E)]V',<KR!1CL>%VDSRHUCW>/\XU_D9. P"$6 =ZI*L\O)Q
M2@P>D'.(Q$V)&5BR'^;%?6(.<A("TAL84,M0Q',A"NZJ3)T]TE':CV/Z\;2I
MVC :O7!'WMV06G)TZXJ42)H@VD-3O&>BQQ4G )&OE)N#Z$2PU14#DF6'478M
M<?_B^:(M$HS,.Y)%NQXF63&$Y^+%-I6OR?&.O4B)*Q,479 @D_)10$YS.A)E
M,"/':$/.XX'[EAE];P3V41<MN<J'8,@Z:@B,;%>^$]W@A-1)7]Q"]R')U8YN
MBH 6H MIQI!NC"(\=86.T@:I'##!D$[G_1%:W:23=:0=01G$/\QP(\>OB<RX
MD-+/G*%6SG:2K*?2+$",E%,YKWXZG>QP2JY(U/P*'<XD);IH0C-]=^.CV0-7
MPN%WG4NZEX<YGX47#OR;B-Z7J5V,NWC?Y(8R3(\17,GFK_^$YF2]N5,D5L?#
MR)Q(0O9-72KCTU5Z_3YZ"6DO)NHL+!D+16%"ZWUBS>Q^3[H;^6B7XDGC>$FX
M/S[<2!05[?>HG4%N?8A3PW.D?6O3=[SF'5Y+ZREY7)>>DEO7I'=SV\[J-JHE
MM5&-EVG,?3YNW;U5SPY*:#)VE^0#R32IH")[_TQ^2_OZ-]1K:,N[\I!;?F.Z
MLLOI-.DU*^D.AU./S?VP Y523Z[+C)+K\855>?''IA24-*V449<<-Q3Q55=5
M-+9]!-6&KMM+W(H&)[73'1IIS78?;I)#?]$1*!8$PGX.91(P\+3?L"'F2R->
M^PU-\QMVJ%01M\#8#\W^S61_C?B-USN+Z9=X#^!TDSRIS\QVY]S&K9M K<J)
MKRN(S5]SXZ2EG 3VE.,0VG-HO@'3B%^V6U[1)LZ-;Y97VYCG2RK:F> >-%!U
MM6'MEA<^.[Q!79PF ;UEVD_3;G4*M%I<OS,64:%)$Z^_O5_!H=[QA@JIZ6 !
M+]2^YL;U Q'2&639#N;.I3(E/$0M>(^[/CV$$Z(>+7)J.$>8*CL)>SC?2=C3
MQAZ$+39@G \XJ<N9P/*/P8XPA.QS\]&H.55+.^M9&[J.Y6A&.BI,H?"S,-Z7
M!X0LO#33*DWMBQ=ELIKS4TE:HG8GA_5)ZY).6M<RY$L.5;=+.-6(';X\"PL+
M!Z$P>]B5P8K=GU3Y8KFA@SY&NT&?RF.-33FT6];*M50T]U.=I>)MV;?#E0K=
M!EU2<A/UFZ#V7"LPK#7RCS?B_&0#MEJW@0SU\;Z+H^W:$QR&P^Z2LLEN$]3"
MMFQ4UNJ(T[J4S[80^[A.Q&Z<;].D"]CTEN+*5-UL5#=!UVF&V9@]Z,6BR;SE
MQ)GKL\7T=WI#N[)=YLG;V/^DW3UNG6./]RZ_#;$!]EV'VL77K\&5[:N^JZY)
M=Z:DF@6_JH483*Z$$.S2<O 1:D_O&UX84+<^'.PM]43S0A_^]M\9H2];V($%
M-?'^"T[-H4TZUG1U_RA;X6%'N^R#ENV$T0U5\"BUK5K[QGR#6U05U-KUVT1J
M0H>J9,OHL.9IZV6(&<]?QGY83-=5;*9N-N::M:U:' %X>X]9(H^4GTDLZ_K?
M]MG.X>'9MBRU=714%T5>?$&7Z,]@JE&VJ27_B2X?DMU=4TU[:D?>]=Q]NW-R
M6/3VVXU!Q?YQJ9)06TU^*9W^II"]XKB_==#>:9T=:&PH;+1VVNW]Y>1@R;KD
MHTW*&Y^[@6U%5J@IMJ>&^==&+!)DY:2U=!5(H9S6Y,38DZ [K(9TZ^*GX07>
M4+7>5!C!CY=*J#.8O@$J F_#"8.>)^A ^$!X7<'ZOKQ[C_DJ=29O=)CS]COC
M8']B DL7H)0I/B4=+3_36:YF$_"P+@1L2&U [?!5.(G5Q$*KDIB_-E<0G-,=
M1[7D_'H@2/I/4Q!4;L49;L_!\O[+?U=+FF@&U@Q<(@/7)S.6.-;'Y=S'X>[V
MF?C.@Z1X+ I32N30C2\8*SD/4.JN7NE9BM544-5MZ9J'-X20&\/#:PG.BRSE
M"B]I%9R[QKVT,26+YXI=H.8>FV^U&K,75"TB3D_+1(3FP85XL*UYD!"QL[\_
MN8ZE/J%'\96676^BZP=6O7/>'+M1,2;*-1R:D5?.R(TQ/E5C JU/B=O[4W?F
MTQ>^7T>WRJ=J9\Y=ZYK9XG?FA/PKC2-OCU_OUGZ<,[R]>[HRCO:,ZYO;\]N+
MF_,OQLWMX]/#MZ]7MT^/QOGMI7%]?O-@_'[^Y=N5\?7J_/';PQ7]EN NR3/F
M;>"7!'",6@.0S]4UCH[-GFW'#FQXN2]Q:QDL,#J <.,%,6YX+H%"13RAH/,(
M6&6#=[[3P01 OH67/^*Y)I<<(KH2\IDY,!TW_!ZGR>@<Q)^A+60ESC.\B%Q@
M=VR<$4"Q9$-/ZI$'D_*H2B@N)2(PY#$(O&J^ZPF$.GHJ ;AG<\&$V1M./A-1
M$DJ_\!?N&*T/QC]"#]<<)4V%;7+"#S/I-)3\7MZ.:0.RR#V36)6D@.]3E-@;
M26SC8W*B]@?C[MGGXH7.:LA!=X$6A+)!*,<)72]Y1GT=]("D2 '3$\(#E2(I
M-(P !HJQ29,>?#"^Y0PI>,?A9A"=3A%\X GZ"U<7#)7*.SS^"$"]NLAR85^>
M!MNKFBKGQ!3IPS$[!FH!XK*_A\!9T3<[!#N6XS$W#3*!U)DE+X15.K4S47*,
MK-2DCO2PP< !3D"L#@!ZST*>P1ZX,%+2/&(,&#M1C#O&:\\V>Q*&M#3Y!K>I
M^:-B4.0+Q4([M P8P0^B=8$T=B H,$R(&Y@=5^=-0(OKN7^&0!R:R>(=+@2)
M?A]O@)7E?0.0_&G *:@J9X1812>J[\'VOQM?F<NZ9$,(&4G!II&R.JM3S$\)
MLK%:DO\8>%&YHJ*(&37SVP'RISH/[4C>4(U'D,^X:PYI429N+'(Q8"(8@E?@
M?_?CRWIA8!MUA=OUB"U#WW:Y[Z<:P],((1Y72_4P23$>#M$'(>C"> 0"CD=P
M@Q3(JDON<SGMZJB,'VS\D/0^O$=-G"$Z063'I%TYD?MLB-A-R)KTC D$0^GO
MA $VMD8Z$"0>Q/2[@-1=15;#?V6#I*L,B;#]@\26C _*,#-()<MR6UM:'VXR
M'UE L%>  @9"F5!FF2B[!T#*0?%W4%6HZ22;27%&*]+E+G"*XPS!:34<X*/H
M;I2V,>1,P+KQ*7@?_3_%#H SMQOT(N4R D"\R1@O",$8[U])0"1+9I/U+C)T
M-[)M?X)I5ESM/:,T(7KQ4H0$^Q&V(RJ0'4U^'E/%%F<.%^LS8])HN1ZN"8T3
M'2' 1V.(%9@1U+[Q"DKWI_;A#CXER?A3ZS"M#_X 1'5"4,K(5U+\?VKMIY_P
MO>$S!Q)[MA/A:\^0(.:8U @ZZ>-D(30RT.'[*>B.9T)W. NZU>N=J /41:2(
MZZAXF.-[!AW30%N2V)AQ%3/&1*/*ID]K&E4Q^3Y#6NMD#%5L,L [\, ^XT.O
MX+E(19:6>U1A[@N [8GAGO%$YB4S7 )BHJ%Z#& 'GRM2 9T).HL&C8>,]7'2
MN(LX>9;.L=T.G@0DE/PI8P+PLC.CKDJ%/&45!:$@W5(A@T7XXI4):TS=4@<%
M6,L$*OOALV];-J.0#!@$%'^7IVF?G(!/DU)ZAS\=G:!;F*_M).)1Y$\/U5,C
M"F<-<AYW?WS 3A)-$/*,_Q"YD03)>!/+,4\//8N,I#\#K_30Q(YZI.A^@/&$
MMT"T& :Z]H#$VH8 D/(!\#X,2#X(S?HL89 O*;TR@<D<BAOB 9 I.H['*.R,
M1Y.";$]JT)E>VY@X2V=Z/I'^MO>X9W01K2X1_=G##,9*/8-G#Q3EXE$N M-C
MF&^<"TEK<=]3H<N,@"WR5@FLAY0CNW8Q# /;L?]"'Q[8"=0BK(4X-QW'VT$H
M[^F4J:!TT(9Z%--%41H7A\^8Z'1^=A+]C*<QXI-:\*5>8'CP0N)+,G.4FL#P
M! W%N-Z8)$E %<HE$$NAM7'LO@PR9::C"Q-AM#C3S4A&!8WCV])J][BC' /.
MP#U,Q[80*2@'!K[I1^E GZ>7I@*<M!B@AR^3E\E0,K_HX;R!K%D*T(D GY2[
MXSE&I07S 0<[S[GEQ\Y#2)Z(Q3L4?(Q$YE$^:1BOEJ"0V-LS[J9,0VO]Z4"Z
MPT=10DZF3\]-4QK[ 1M2?@D?8J8I\ *X= YKDMF-K>Z8)@%U,>"4U'2&.Q!3
MR-D/QW_ E<M0RP^!8$2:*%R87V_)?)-*9:6)YP+U\-\15&(8D<XP$QGE4S$I
MX1'0>S,H$/$N^B928HB>W*I<%^:Q\F09G9"@FU=FTU)A LYLL@,P.,;OR!D^
M+$-:NT=T%L$G-.1<!Z<?C7O/$VG;C-3[ZGE6!AP5_D>DP^<0N:.J;@<)!IH;
M%X^I:F7J.68:\2>@]S,/@LAGQP'[MFOWPSYE.ESR*/V I*^+*931%>T1)#<3
M8Y31Y4NG%!T?D%N8U_%>,^/OC&L/Y?=.D59XV)%>-6(>S6XGA/$3[K3_DEX&
M_/^$(0 [V*\LR[(+"1?!D'$,Z!%2KRI=-+8X]!F>\91>S!C3<>XCXTAP9G)/
MK&W&.6AE$C<Y?HV"MMVQU-QH9$CA46<D;203<9@#56XM84HE^$>2;O1BFA0Y
M1DAMMJ$O*I-[$%?U,,?5I6TF(I;T[=!63@[4GH7W'1B#9L0%T4*LD P'&6L6
MQ$N.F&HY)Q.%61F!-*QJ7W D'3T3QV3J6M&6 LOL**2]I+MLHP$*92F^C3<]
MO 4V+U?G S_1OLRY!'$]?BL$Z=+?BJ(#4CO]$+T8VB>2NIY(BCP,_A!MER@7
M%M4%25-ZARE%ZM0F$RJ9>7>3I!M+N@@C2J4,I;;->8F@B;>A/.*82;H_X@N7
M!+@/7,[[ \<;<L01!M,^1\<*\R=@>"/X1Q "?TO.A#ELD85$P@A!.0$B]:9T
MU%!RA46\%B>^1JP_+8* P]^3+7?T)>.'"-GQCEO/ ^J1B:0,.)W+0"A\W(F4
M&\PJ@R;?P\U;(#0B 2,5M<NK0D/:SHV"D7B1Z?TJ%!P;#!:WHOT'F'>("0)P
M>"'4$<.=>!\#19-C5FAGE$'DWG1* ,E-B/9"8=7R+COU]"('#T;3 9)-,_P\
M*ZWW9\[V_DA@15(#RA0$4#(ZH3>%_TC 4T*=D".2'=1^,N40&=85JAX\8F/\
M'@4WR8YI:DMTQ1HIZ2$KFU/X81\P2C%U?C0VP2&>L'V?,+057R5+(7HRKIU$
M%$UM$/O1R"E4WY""].JJ7K=OR%1/JIJ4_C:DLT5M\'6\ +YR#G!J1;)N GY*
M.RY3B#AR2*^<J:-HRI0^:QT%KAXTNHZ=@]42*#[3NMII*0U72W:H7R^/"R;$
M$(\IKY1"->X@4C\27?F!C:?.IC4YJX!&J#16.^/O,S249@HMMPTBD9;;,OSW
M;/WOH^V\1(1:SN=..@^5>M6$S(!7(ATK[]C2M+$/&@JW'EN/K<=NV-A+&++B
M.:<B)NHFV9M1&U14:^*Y/*JF+-E6598E+H*%"]S]C;:!:^2Z-B;5J ?4 ^H!
M2QZP<<:$CA]L@[U('12BV?V0=M+?,MEG5_U9;T-2%BZ*WK:\,GM99)%%&P!5
MT-.F?52_YDP:\1KQ%2+^H'XW'&X]XI=P4JI)W19?)GYA6)R*$+;"C=%AKQY0
M#Z@'K-> -;,H=<5B8V/9VF*BS&ZI33"!)7F')Y/[>M?+*]=HVP2TG6FTE8NV
M)>SM>N.T;"\](Z^QUS:8+%E'.%H+7&\KMG5IYWKI@3+1MCW:4V--8VW]6*M9
M8%QDD=?9%I+:@&^7 =?1ME:J&FL::UN$-1UI-]U0:P-=FV4V3_RUTM18TUBK
M,]8V*,)^2O>CP]Y@N:T)M>6NDTEKQI!5BG5M1]2+KB>(&[#H#3(ZV4:W=38P
M]1^PCINE:VA-MX8I2W(UCQMS _=L/&C<:]S/B_LCC?LZXGX)5Z.X0U%7XZH'
M+)6IV\"<EA<^.WR2\2["U$6KXA8$NB11/#BK7\6B)I\FWY:0[_A4DV\SR9?K
MR.2M*&[^V3K9CA0,OOR,'[XD=X/0^I[CE=8H#Z 'U /J ?6 M1MP+9%R$;U_
MZP5<70KEX15KZJ;<9BC\"A9.<$2US,^ZEKFN>\CK]&NK2#JWZA=S:,1KQ%>'
M^*.V;H=6.\1/=5_J&;CJL^8Q*L[E_=>)+X/WS=;:GC=C2'V>J9X@ZD4W<]%+
M!,FZ4]?R9H&9I@CYR*W/S;$*6Q',-J7.8=.UE<::QEJSL99K6M<:G^F6'3HZ
M:ZP9K>V(>M'U!'$#%KU$=*9C,!V#Z1BL3 ^O?G40&FN;BK7Z'59N-M:6,*!U
M/15ZH1H,]ED0"K):AM<Q',_M[H(F[D,L][P=%[U.QL.6V3<]H!Y0#UC' 3?(
M[."IS"];9V3BQ1HCZZ^W@6G&D#IS5$\0]:*;N>B:V9JZHK$LRT!& 4>("A/,
M+;PPO,SDCFY&M,AN\\[):?UNS]J:OBRMG;-6_8Y);!'Z-?>OE_O;NC&1'G#U
M=ESWULCQP78.6_M-48::@'D$/#JHWRZI)N "!#QHG6@"-IF AT>356B.0_,^
MH(8,Z:\HZO^?G/_0\X/DV=@IH@.G)G>PJY%IN]U?WNR_H;\'S+*BOR5"Z*-:
MF6.[?+?'<>4? (VBSYR/ZC',X3ALX/,/1O3IS0B0"YT['O?5 F]0'-717?3+
ML\A$L.:1%37&JVT%/81Y_^<2-J*9WZ/M 1,_\#]#^X4Y'$\5,X'GJ?L#S^<6
M;DX'\*IA<?C;#F2?"X\N-+ Q&\/]P'CF3 #EX8L7^+-/@]BNZ83(#T;?<_G0
MZ#/QG0=&)W0MWWBU@Y[A@1C8+G.BK?"A8;% ;H>?[</G(7P4(."^OV=,!U9P
M$QG),E@ @/O!CO':LTUX83 0W@^[3\-VF"T,>"OD>XL% 6OGO>=U\EYA\"=U
M1[']$2;[MO>XAU_TN3!M8(H!&^"=&:[U'IA \IMO]VV'P;\]3P3)AA[PFN_C
MB<CG(2# W:61_/#9MRT;^!*A88Z#<RBNV'R.,1O-,?,<%3*R&[NYA-TSGGH\
M14D<:?2UG92J,C,S[R"?6AR?!@-F&:&/S_DPBVLQ$:NU@;!- ///$)B=&!&@
M&'@"V ALG(NWW8"Z$LB)\ =ROL-\7UZ$PWSC"W_ACM%>B,OR;/FDN/:CL1#^
M<:SGZ(.-'R[C0AMYUMB.H8J?R_,5R@((27@!NH*Y8".X#\.0?*(U,N.>#1U/
MO#)A$88[(= O712$$.$51/!?#B8$B13U>"#F$NP5B0XS,@=I'EDVHF T<CR<
M,394_#CH-K)^DLX=5:\DN<H<1E!,'VP$+K2H;N !HP&;D.WK.-ZKT>-6E_M[
MJ\ [[W0X0@G I,JM;-</1"@M?4P1XF4$#42$8$D_Y;E$0L%[W/7E$$ [*ET"
M& (#7 @7W@/? %") W7 %?1>_0\3%YFCCZKR5UN'@V"*M_K14)[9:>28;5D*
M,>YQ>K)DBK>LG;U8=3WU!.?&5WBWYQM7KJ4N&DO4U<(YX-P IN94+;H'6S^Z
M?F:@5(RWCN>#AGQ'YK[KVG^1$IY"X6=AO"\/"'5E>HXZ*\ID->>GDK3$05VX
MZ>S]P?[[]G[K> ZZK5'Z:H>OHVKX/.]@SW^8^_A_140@-L]G[3+R)FOI$A:O
MH?5SZ1*=&;M8*C6!3'_*_U1RSKU4^I59A5(EX^:O7$M%<S_562K>EKE15CIW
M3<[VK<79++*4FY',2],:O-2UPK1LI;[%A]@;0H;Z>-_%T=;(OD_;<J2[*$^O
M 4_K/L_:7&(?___VKK6W<9M9?R_0_T#DG (MD(LON6RR%R";W?3L0=[=8C=O
MS\<7C$3'ZLJ2*DJY]->?(27?$CF;6*0\E*9 6]NQ1^3,<#B<F6>(2=C.^3:7
M<<9#1^P4U5LU9NI^S&H7;!TI3,6IL2[89B.\?N%ILFHZL\CU,3;[C>*$@2^M
M1NG2KJ1+YX5'HS2>/"%ELRG34\_+)WFHJT3BBO2I&N&LC6T3 UK*'"]5H-35
M?.1*3CE<RN&ZE\-U-6]K:>ENTI?&Z"@WZ07CBG"W3!,:;,WA7/R(<F-6;(\=
ME>N"[<$E2-RF ZU?1-DUQ D76Q'$'S*J7>:+U,5)=7'.0Z,,G^,)F[H7&"!+
MV""SMZ1RCT==]^IZLTGE"HMK$6BL\*77/\A0L!]D#O2@BE]K+.GJN#[S<]VE
M FC ORK?-2GR74+ENV!8228F5T!_V-MF*J"LZ:E(Z;;&Z'J/ X@+*%\]CID/
M/4?W:CAK@3 OAG06PPD^'K$DC?U<?0,V5G\&&'X /7Z"SBP:(.X28(5H!@TL
M,]T<P6=\HJX@U.U!U.=W ?P%F!L!PY5("XG^I@:Z($ ]IE7I'R5 C3-^+(EM
M> C/%'!>3=93S\]B=B66U058%S_ $@?9&$:@1AC!Y%EV*\)294K9 \G_?K7+
MBCQ9T:1"CR2.5L&=4P'CEO!235<$>C(:CPW?*L#2\(M(2-V]I/B#[G,1Z5^#
MAF@)%EAPI=]J<%P]4RKZ:O[+5*9=#:J5>I=]6%NK]1BJAWX+DHABL&B@+,!<
MCT>9UB^=+M 6Z2'R_\V>%]Z=G <1CU3_CD]SCIU&_CD/TC]5^X5_"2[S5.C/
M+T$B[\/8^_[NYY^4G7N3RYUKSI.3;QX,*@_%E]&"ZFC,Y1*"_)-&7%Z O"Z5
MA9J1TXL&WGP5H[=;Y\!B->N=WM%.KY_%Q>OCG6%OZ]V3BZ/*2%I<7&?:;L@'
MZZ4R5:J6V,Q>EK!3-1S==:)4M(<H>FU:GJ$B*]'VC<+HYPV.J*X 9Q*Q#!H]
M, 3VLO6S%AI-/1!VW4C"&@SBYB;)_;_RLGW6$\]\ND58N]5.[7QYE J@_\^3
M)4IF!?/ 1VU0)>8^R&94 I\*_*%V0?#.FJP52L!E3T46%(Y+8X^] E]L%#3W
MO%KVIY/;X.+1IBDI:9>PN8UWZ:S=U%,?NK<_UL:*P,6FNTV\VC< [9VQY#T/
MX60ERB/R_^:1F)[HGE/(1?CZCN/7ASV3S=8;1+#CZCK12L7MU$(XJ!MPIW5
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M]T[=TFE2&*<5IL)5F6.>9Q^9P@]K\AH+6P6G?A'^>36,^K/(WA<=I,]BF3U
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M1:Z:^?"+7?8!1I'%ZH]Z)#!&?>7/HZ]O%ZG?Q:$77WGN*%,!V[=46>2(<9;
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MBM';K?\ZAV'L]'H[O>GG(;\2X=NM\O/_P*^VV%XMTGU[I ?V2 _MD=ZW1_K
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MR,=\2'P9BF*,+5*2:A+7F%(&X0_#/&Z1;>.Q _$-#7_Y* /ADC.7]$ ))#_
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MZ1E$+(*3.$74!:?9=9;4HSR(HS3KY5DX0HD)4*ROVS*TCWXUR9KG!;K.BK"
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M<\Q<\"@^K:8[ZT1)=_GUCAIC&=:9MEAM)A(!J#\ >#(@J=WBDS-WO*6V@3,
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MNPLTIDT(4!&DF=>["TOQ,"*%CFR-NP]>E2R %3_Y][H ?ET _R@+8*H?N>-
M0)[LY/F/\V54/>5,567$(;+J*8<JOR\H].$<.1.> +<*U:"[E8B01B93B)5*
M\<Z>0C]8.=R;^EN%E#UU+9 BC4SFQ%NI%*.KE6YDLH'#DR2EH*I=J$B:+%*9
MLZ/J$#H/KY_P]"\, LD75'6[GBM^#JG,DQ[%Z[E\P"5G+9$O^-A2J_ZEMEHT
M%B1<, I@V:3M([E!XXM;(>:VCS<JV<2R<;DQ>(&^^1)X !-ON\!;16+H(9<L
MQ+!PG4A0\35R-L0U=GJ(ZE*[."266RSO7_(Y^>\)^!!_\O]02P,$%     @
M#()B21;;A8_=3@  00$$ !0   !C;'@M,C Q-C Y,S!?;&%B+GAM;.U]>W/<
M.)+G_Q=QWP'7NQ=C1TBV97?WC#VSNU%ZV=J551I)[IFYCHL.BD25V&:1U7S(
MJOGTAP3 -P""K"HRU7L7<3MN568R$_@AD0 2B;_\Q],J((\T3OPH_+?OCEZ]
M^8[0T(T\/US^VW=?;@]GMR<7%]^1)'5"SPFBD/[;=V'TW7_\^__\'X3]O[_\
MK\-#<N[3P/M 3B/W\")<1'\F5\Z*?B ?:4AC)XWB/Y.?G""#OT1_/[ZY9/\I
M/O>!?/_JZ/M[<GAH(>TG&GI1_.7FHI#VD*;K#Z]??_OV[548/3K?HOAK\LJ-
M[,3=1EGLTD+6R>7?R9OW1S^2HS=_??6T8"J?.BG[^]LW1S_^[[>G1T?L_[PY
MNGM[].'M#Q^.WOP?RX^D3IHEQ4?>//WIS=LW\/\$^U\"/_SZ ?[/O9-0PCHB
M3#X\)?Z_?5<Q[=N[5U&\?,WXCE[__?/EK?M 5\ZA'T*'N/2[G NDJ/B.WK]_
M_YK_FI.V*)_NXR#_QKO7N3J%9/:K;Z"O:)+X'Q*NWF7D.BG'4^=GB)8"_NLP
M)SN$/QT>O3U\=_3J*?&^RQN?MV <!?2&+@@W\T.Z63.,)OYJ'8!2_&\/,5VH
ME0GB^#7POP[IDO6X!Q]Z#Q\Z^A$^]"_RSY?./0V^(T#)(*BUZWU-EF1Z/;:R
MUS3V(^\L'*9UDWLB]=G8B=,M#*CRCV["790ZP2#EJYRCJWU%A[5XR3=^2[.I
MA YKZ0KG7M1.VRKW;EYUNP;PQTOVKYJ*]"EE<R3U<B5!A,$#\R_PB4'*+J1'
M;DUN -X\BNNVN\'3(4R.;]Z_>\.-8W_XA<W1])\9#9SP-KM/?,]WXLUGNKJG
M!3/7G',;B5\W50*V69SKY<1NAW&2XK4;L:EIG1X&HAD%^R*.5MTZR":(NBA_
M">X+R:+!V,<U)M3(8IKP(*17?U7ML&I,J=XJ8.00TM'P\,OM=_]^$D1Q]$0*
M/O*S(/^_?WE=RAX"#*D_UWWA)/?<@"PY7#K.^C4@YC4-TB3_"\?0X9LC.:__
MB_SS+Q<L!%U1B)_HBH;IL1- C''[0&DZ"[V9Y_D07SC!J9^X091DK"V/-^P_
MUE'B!!_C*%LG3$2001@+-%&8^F%&O?D:0E+&FLR>_*31D&-_? R43].@,&K&
M_?+DHW 2<YNC.I=#N""^"B$_ _W6PUKI[]7ZS=,'&FO=O@7/6-[?6OU\$NAD
MF!R%?;1L@H=3D"HW*=EW-C\H@73#IJ%OE_Z"?HH" 'YR$L7K2'Q:BR0;IK&@
M9&] CJ5N#A1@LE:SB::"$5ED<9PE?DB39.;^EOD)=\:&4$!+/>;<W:%R=;+5
MD$X.)3O]FAC*J4F%?$?SV6[ =!<['ETY\==$Z:7T9&/"1Z=D%3=-&C2 T2C6
M1$I)ALS=7+ 5^<(/_91>^H_4NPA3IK9_']!9DM"4A7Z?G5^C^"1P$O.*I*>4
M<9<6@TRLKQ%ZB4"#SF%Z-\%;2CD,0 PIY1 AB-QO"!=%N"Q4/O D2U*VXHEO
M:"!"Q0=_;7:'1HXQD6NA>A6E!G(TB.S6L;43)#E(C069&SW?VH7VDC F" >8
M5@5E#_910?I(X_NHV&#?MDN0>4[E(I8MEL//+ 2AZ74<+6-GI5VY:BG'6JYV
MJ)JO435DDSN[;MU:>QN,^G#%R<F:J?  1\]KP8C-U]T^.#&]H;F:TCR#:S,Q
MC.G)NA6O.BX]]>3XLE:Q"3/.0$H.(EGVZ7;.F*==QI2&75Y'1SB6TS$KFOL<
M-=7DD.A4K0F%@KC$ "HO,W/=;)4%_"0\=L)$Q'XS[U<6#L+!A3&"MV4>T_OT
M,ZCJB>PX)X?@('6;L#R/8NHO0^)F<4Q#=T/24@1Q"AGHYL3\/.WLM\Q/-R?1
M:AV%H*=I6C3SC#HSVJA?FQQ-#&B0:*-ERR]R4E+2HMK,J(RM*YI^=/SP,DJ2
M<]:9IS1AXP9^F,=_S9S 7VS\<'GB) _G0?3M$_66U+SKL1O1$WG4K1M#XV\'
MRT4S!G9H3'.H,'DD"V/*6/_)UK9+)IN\")ATFKPDS%U[-/8?F>=^I-C<=:51
M3F&!3KUC&K)_I-?,P*1_D&$E9**AT<- S2"PD( 1[O9J-X%]3<.$QQNA1]91
MDL8T]6,^D9![(6TOH8AR^709A<L[&J\NPI3&+IN5G'!S&3%;M.NH3HZQ%E26
MJN<KJP[RR2%FKV,33\!%&,.*^!4^$@ C,L]8-4S&XB<R%)>I8L<;-G&XL;_N
M2$T8)&G<<\'!IM;/!GN+F1S*V^O>WNFN #M?Q.6RB!0&F]T5<?O<=;HI7+9(
M>#1D::D)Q\O,,BE:9F.IJ";'4:=J[:RK8B85U(3/R\B<H")RJ*3#JN(*O1L<
M*&M,1[B5N557.$C0Y"#>A?:M1&=!322Y1'E%W %1DXSB$C^Q)5OZ<.+$E'_4
MPC=J.,9WDD;5V]Y223XYXNQU-/A/P4: ;\=.5)U+SYQUDOJNV"GPJ=?T^V8H
M]6,?+<-^@%%%LGT/7A2(&Z!PRZU)$:200=0S^GZQ>!)0)_3#I19M38*Q\*16
M+$=,_5<4F%"JU+Z+)XB016GE'2:9AGU+ERO;,Q<USR1G+B;UE6<N*H;)T=1'
MRU9:@B"!Q(0H3@%I4*4B7O%3OP-8->84>PR//D590A^BP--ZE1;%6&Y%HUKN
M5QH_3PX%O4[-CB^H]KR'ZB_8M+4)]+L +8K1]DC5JA5[HO6?472M6J?6GF=.
MM=^NY?M.H2/NK&J[5TDU5A<;5,R[64&"HJOU>BGW_W)*9(%"?B50/?RU5*-F
M^JM5K&7WUTDFQX=9KU8,F5,AP\:M$]#DAC[2,*-7U'S@JZ$=-6@TJ5L+%E6$
M:#!CTDZ599  /3+DG$!OA:FX:GSC)U^/-\<T=!\@B]NP NEF&]?OV!E1=T1F
M'C0HLU2T[:HJ; 3X2,&&*ADLOQG5LM/J=IN6:XH;;ATFJ&ZY:5CPH,]*3^UM
MMSH*T;N^._;-?EZOY)C8X355[_!U.3D>H'7J:.'A@&.?NRM_<P+F/]-;1DVA
M@)!VJ:8C'&NU9E8T7["IJ2:'1*=J321(8B*H#V +_Q4R9R,N6DJW:-K;51&.
MZ5KTBE8]2IMJ<M1TJJ:=I%!%0T[R, L]^!_(X7]D2X8P[;CH;V09=5JR4+XV
M+QGHT>#)0LD6LA@M3[OE_ZAP(7-*U;)Y>35I4YDF+?FH=9HZE*X5:M+0H@%7
MAX*M4DTR Y'3DYP!E0,[=_R85V*_"-=9FES21QH<&?V7D6/4&A'=JM=J0NC)
MT>"K6\?6B0>0D"-DGJJPXWA3_/.33V/6K \;KK*I*(DE\R18LS)("3LC)SX$
MVJC;ND?+.,2[#@>D8$+E[LZ2U%\Y*9TO"NN*?Y2)DD;_UT_$F" =8EP5JGWX
MT0!V@-*MV[=2A$=* .-UJ)^I Q:).LJ);RSOU,4UD0LUF:#QG2H6-!BTT[,)
MNPHIX;2H/.7G**0;44OH/ L]\YI61SSJ3HA1X=INB)(2#9J,ZK53(!YI?B74
MSTNDDQ6((+*TTP*$(/-GZE6Z:2_?P##]GHEV)U]+C09MG2KVV"U!Y+Y.G#B&
MR@(BNY-ZLU64A6G?6*^WE'&A.,C$.CY[B4 $VB%ZMY$LI!#!CLQ%JO8"WO;>
MF7F+96?F;;^=F;?($->MHWIGYBTR5!T[X=<[?T5/V<A)_(ZC"AWQN/O')H7K
MN\<J2C0(,JK7*MW."(DG*9%!Z"1:K2*/E[:"XWS7G+^HI1XW <.H<CWY0DF*
M!D9F_=I)%Y*Z+/!:%D@BKA2!#6&GA8H789+&&2QO(&'$>./=Q#+NQ?9NY>OW
MU_7T:%!GH63[-GJ!LY(G.2 ?><4NJ ?V4I3F4)")]"!,ZPG^#I0H+9**(MI&
MKZ<G'Q.*74I78:BC10/!#@75#W>)BIXI<43=<UQN3E:L.7MBCCE<4JOIM(-G
MU"C?1OU:G&]B0(,S&RUU!62I9'H.DRP?(+:N;&(?9N6\\'HM:W>U8S>E3(J]
MB[-$.E &VZLH_"TOJW!*%Y2Y2P_*T-(PX<DJY@(;6\@:*[5V:W/S[-O!@B;'
MXBZT;[\MQN3ESXDLHIB$%9',_0F9Q*T()>N]5=U*J/MJ&3V^]OEI"/C =_+?
M@/]W%>\G_OI+>6RB6%-H:,9 K%$]0**28'*$F;32GUBA"O"OHI0FU\[&N0\H
M=\;RW^;)L9-KS*G2TH3JQ-G!,CFP^NG9NL4)7/RL2E0]70NF_<ZO_*.ST.,5
M6J6:V@G41#S6#-FM<#X%ZBFQO*)EI>78,-G5"TA1G$(9X%-ZGW;<?-/0COON
MD4'=^I-'"D(TCL>D7?NA(T9[R$LN _7!+N^W[:P$/9QTYJ."#1+VESBCWJ7O
MW/N!G_K=[S58"QBY]'Q/PQIEYRVYT>"RM\I-L.8""F\'_L\1,DA0"D'F!?-:
MZ## C$A5$8Z)2+VB5>2UJ= @3*M:^V*>V&-=.6D6"\Q$"S:5ADOA"STF@*/K
MLOXG?,!*[697->G8X-(IVX17DPX5P#3*J=XRV-/$JJ[U*2#]N4#T?%$=#CRX
M[/!#P\6,5C=T"R.+ZJ(#9&!:*VRA_^_3#?*2:C1);YS4[D#*Q##ZPQI&Q5OO
M9RBIT;C'3A65U? 8 ^$5S_9Z J5TFO\)^>I47P^Q\?M8;DZI5NZ_:C].WO4Z
MC9H]S6@($.VY^'J!H"MP::J(2$\V6C%U@Y)%T70%#8J^-BAFR*81M/L,?VZC
MS3UUPKFO'\QMDK%Z7*=<WMO-WU'TM$:IU@Z2(".,;M\/*[@\T8H%.&=AZJ>;
M2NWKV7W"IPL58*W8QGM(P=Z(\@&%;AX4B.FA:/O!!,%*&"\1S-7:YOLX>/6H
M#S'F]_ /0-OWE="2_>D7H<4-7?J@>9A>.2O:,%I/-@:>NI0$_.AH)L=+AV*M
M^\X"$B4M >+I8''"R\(%%Z%'G_Z+;K3&M>C&!89&S3HR&D2(H*'63(,-24PX
M-6'D4Z C]V.PVZ,PJ_[S6%A0*95#H/H;BIY7**2=+(!FREZ^9A%NQ.8Z[Y0M
M7PVV-.C&[G>EFDT U(A0(4&EF182@IB%$!X!\BG0,6.*>*#,>> L%78U?A\+
M#4JU<A34?D31^RJ-6@>".0T!HBGZ6NZ@GON)ZP3_H$ZL=P9ZTK$0T*5L#@8=
M'0I<="BGV^(6] 08)G4.(E@Y]P,:GS 5EE&L#QX;5..&CDH5ZX%CC00%./1Z
M:8)&3DIRV@G7$W#I,;Q-(_?K[8/#FF2>I4GJA% :11\>&YE&7FE8&-!8=A@X
M$(')0DW=@H1S$LYZ0 0SJ7!/&;D*=RB"I7/VM^8N>0?MV!&L5MUF%-LB1(&D
M+NVTT:R<M610RUFF1PW,H7:8J5!.@YB6JFJ\%&0(T=+4K0LK/,+9.5*V.9V'
MQVZ+URXU._6=U..>RQM5KA_**TDGQY&=?NWC>/XP<4%.?LX9D*1Z--[#TAC=
MHIKPY3$5:!HD:,"BUDO[SA@.2)Q$23I??(PB+[F- D]C6HMJW%(N2A7K)5QJ
M)&@@H=:K7;(E22%S;!U'7@9).PFCQ0&/CW&4)-=QM/!UWJ)&,28L%*I5(5'Y
M>50XI%'J!)<&3+05:^*!4P :& D.&-S2@,E<?J0AC9T KAYX*S_D9XF0H'+V
M!%=^F[MV?9E'G69Z&52;?:PXT7B@7NJV'TSGS.*B2(V/4,&(9!:;>8\T3OV$
M*6O&HHIPU%M+6D5KMY-:5&CPI%6M=;A0$A*737!(D')#$[;"<Z$ [BF4:XS6
M$*F;0=/!,R9^K-2O0LG(@ 95-EHV 9;S<._DE5R8T)8G:)OQU:*:(HO>@*$&
M"1K4J/72)LG+*6LOV96\0H%8_TMMVNMK ]U8^9-&-?.$2271Y)W>I9FZO-(+
MGU._S#O_@(0424PM[("JB.>L?^"^AQ]F;+:<KZEX,34YIHLHIH+NSGFBR=D3
M"[^BV/-#)]Y<I'257+'^AKL>$0_4<J@;=[/V],7Q=QCWVG3M7<J]? [7TG3_
MAK;.^IPX9%0)@0[FUY;$%TE4?)+<\V\2,9))"E_%-()9,TAG=,P66?J-$BWU
M^"-'JW(;]2W2R2<"._TT>_,</20*U5##!"O3*!P\?+&YZ6'>]KDYS>&^#R,@
MX:D-H2OU2AM9(#9?L,%HU4A=(J8#J9UQ>KB:^9'YSEY*:]'[(F!B:/)2P-BK
MR*H F<?=<,;!'# .4#/SRE;0-%.#9M3*?BKU:G7\J@2X/*)*-=4Q*)40P@&(
M'-#7-.;)9O! G]N1;]'!,^I3H#;JU][^-#&@\50V6IJP5;HGYHM( B(.^-N+
M+@[4=4</S'*N+S=_< S2D((K#%2:V"\FK(E @]YA>K?S WX7H6%_(/>2AS5H
M[ GN'L*0PKR_!:VD3'40B0/RRAFIS^R%("ZPC@=P!98F%9L8XK_Q54<1"A01
M $X@G?I!!B];]@LY6UQ3@DMC@@EF#18T/LU.S]ZAIQ2# X%6X8G4>.OPLRX'
M70"J,K-W"%H5@J7HX;8&_'ZCT=[([BD1<43:#^V]Q.'&_1!3GG5X*NWI-\NA
MB")Z1 ^XP]2ZDFTT\5]1AZI_H_[R :(?-MZ<);W*H$[=?-&ZT=L1N_87,R8,
MAQI9Q6=?&6C"W8&*-\&<BR&.D"- G)"HE  Y621]B+*$_7?R\GD!W+38[RD#
M([2UFP.]!#P[4'?N(Z &:35B,12^&"P% 5"[3+2 JDX$=K!VZ*V))G  ME+\
MX]1_]#W*''X1%%$W8/^COW%JPSKN-51[8^IW4[OYT("PA[)MY EZXDDZ;$$L
M/'<:TP<:)OQ1>U@5=F0M&3E&QEZ7Z@W(Z<@Q(:U#Q_;&4X5#I@/C0%91\6&^
M./=#)W1])[B.$M]06[L?ZZA78WL84[L8:\&'!GT]E&U=BBW*>T0+4C"3G!M=
MT0_Q8G,'#)M$H]Z)52I8NP];HQAWLX?&YNU%I6ZMR["WMV=WMYCP( L[6L&B
M13L^.C3JMD'2($3C<$S:Z8IN.IP'!VI.G 1NY\+_G/V6^8].P#1,9NF)$\<;
MMASYR0DRW2&*)>^H 54?<VJAE0TC&M3UT;:%0L;$[U:[\ ]:LN, Y UU*=,(
M7@1G<:,<,IIFT-".>W'?H&[]PKZ"$ V@3-JU+^@7M*BNW3XRE:-XHR^ 5B<9
M]Q2WK5S]6+;\'0TF%$JU;]\)$A\5%/@5\=K$K+%013@F+/2*5L'1ID(#$:UJ
MZEO[+L( R 8G$T*D$QW3 :/SO-P&&'<@!"4PKF-( 4DWUTQ?_G87BY1X(1K]
M!&-F&1,V-LI7462B1^-M+)1LPBMG.2!K8.)Q+\W9BLN+CNMFJRQPX(#;H^N8
MNCY/_1$%TE91G/K_%']@Q/]Z=/#^^^_Y3_#/HR/"[%Q3%\JG!3NME;]%><<H
M\K[Y@:XARY]'+>S84*I6U5'^A@9K#85:I1SESWLI.G07.QY=.?'71%ULJ/'[
M6$6&E&KEQ85J/T[>BSJ-6K-/08,M?+T(4Z:HSQ998A;53SIZ\M%#68/2K8!6
M03LY;"P55 >W?D$OPQALD))FL+ZT7115:2=:%[75U2R-2D)<,-)HI\80IOA7
M*&X,[:=8"NG70!@7/\95#Z;>OO2=>S_P4Y\F+++FB2(/4>#1.($H.]UT'"C9
MLX^)F+Y&53%ERXO&V_14N G)RXO9\<7EQ=W%V2V979V2V[OYR7]]FE^>GMW<
M_H&<_?7+Q=T_T$'5[K33Q# 1'"W./?74&"'7[P0T*!EQ8 KRXVC,LT6<-8TU
M]K:HQLY35*C83$FLD*#!B5JOUAW;**4)WU<)(B=,R-K9P"$3#H!<1N'RCL:K
M4WK?<2BII!S5S>A5K?F7-AD:P.AUTWF4E9-F,7<HL$<7,/[#E D@'I.  T$S
MUXVR,$VN!:SAR0;7C3/JM;VH+J3L(V'4R+R_:;7PW9X=#4+[Z]S*'9,2<C\G
M-IN%$'P3I+2N4B&X$ZLZ^I&1:5:[@4,U,2;4&34T5L?%-9_:.KVI?9N="YO8
M4W7N1EA[I?IY+#HW5 T,.G<R=<13!6/FO4PU)1K78U2OM9F ,/ZJ# &^V7KW
MX(2@9VH-IQX")O)0EH9I/%<'-QXH]E59O=F.SKF=T@5E:GML8J^8V(G+;K8Q
MT6AK1!6#73QHD&>I:.L*I61#^-9%Q8SNT3:97^MP7&AC+6.0A<[_P#:=GZ[X
M58+0$_7 EC1T]=@P<HR].=JA>G.C5$..QM=TZZBX2)MSB L>51X<$.M]L(CE
M*+'?X>$S."[L?4!89?@#3Z),D60[7L=R?N4JFFZL*2G'S<O5JEI/QVV1H0&.
M7K=V\FT>]R1 ^H'\Z]&K-V_(VHG)([#]F?QP\.;-&_C_>3TI)TL?HMC_)_7^
M3,(HI,1/$EZ-+ZZ6FL(!NTI-#>,MR1;91-5-]'<?&S1HH*913#7O1:$69'_\
MX8T)9D<__.G@C]\?'7S_XU'^LP2=P\^2[J/T@=RR9J90N(>\>W-  !!\AOW/
MC$$T_\N?^9^.WC)Q;_YX\,?W/\K_?G_P[H<?#M[^^$Y5-$U\PT;\ <(\\YGG
M\>((<+#K>Q?AB;/V66A;Z3?=1K8%X[CO=]L:4G_/NXL+S5"R5K7]WG?.R,:4
M[QWZ(7$%+PX(WM#4\4/JY<4Y9^5=#K;L]EWMNXTVC./>)+8UI'ZMN(L+#02M
M56U?.!:,R!Z6NHNIDV3QIC,"4!&.B2R]HE4DM:G&0<Y[@9R0+@$)IHT5K8;M
M:QV"4$ZX!\01K\=_@,GTS;MW!S_^^ .?8&%N_M./!T?O_U1$!L][/BZ'%-_C
M5A3C@H+9'>71>DL9^41_B(F-<_X^(M XT&%Z*_).BLN.D;B672O !G<BBQ<N
M<%5C:^Y86&]M3+U79+='A&L;6ZO?\]D8ZDJ)[][ U[!ANL30<3:BY,&%-$MM
M.T]1^!R=H$5C+=XM+YFS?P>4UR<,O5GEKKGVMGOW[+"E^(FF\YTTBF:>WTHV
MQ@!@%P;U+)9@724!QW"K[U-?._$\YB4^/;YRR(L?6VURZYFG.SOH,DA_G*#C
M1 /S7NIV'#H<E#O!&&$IRK_/BNUHJQ9I,TT'0YT!>O@U.9#"3J-F)]Q:)PQX
M87?!CSEZM$;.,#7<ZHIW04U0HX99345;B(E3*KSPZGZRI)-K:J!U/$G2P8(:
M<MU/CNAPA_D@OF>89\4YT7%]GP#/@@T-&.UU-9WSHXOK*F99!G5&CHE 9Q/.
M&<@Q@LPRD*N#"VD4US++&,)IJ2<%ESYXTY#B!94Q;%,""E/,UC*G.V SLTP*
MJXY0S42/%V#=09H29>@BM-K)O3#-YHP_IYPL6:*NJC9;0I"A@9%>-WVB1!4_
M.#!3><H)GJPX#Z)O7:\=F5DF>FQ+J[SFD:T6/1I<62AI?%2+OSS"N= ]I@6/
M7C#MKN,('COTCC=?$BBS(%^2#Y<S2/,1)Y1F" X1-"8PAQM:A6M_*6A /%CU
MUB7BG(,X!<L'$YKWVZME_H^FPTJ"7]YBZ@V%7JW*8#2UROW<8PN76IZSOY_Z
MB;A<QX)YB8,H-.:<]>$?N7\>:7P?F1_#&Z1]^Q:TE[GI!W+)<\L(M"_Q*J)(
M5,@J*O.GSA.."6+F_9HEXF[E771# 3%^0&OPO8MV,X7LYU/CWJ;87V/5[U_L
M_CMH7.,>C6O?\2@^1=*(Q/G'"J<K!JL<J3#EE4,5&&"P\M?DUE(5<K]14QLG
MR#$K;93I*XVD&4UO&#G&K:_1J7J]M(:6' W2NW5L3R7HTX_XNOO882,2TK1I
MF)C0I2,>=<EJ5+BV6%52HH&34;W6 A6(#^^!FN?!Y^0X0)07CBD*_IT]@8;T
MF(9TH;W9ULDU13V@#A-4Y8 T+-B"8SMUGU%-('ZY!(H:L2E=&"4MTC2 @7[T
M5T-,:K=>#E$18[OTUJ6HLK89#APQ=6%_F9Y2\;^5T%1>/^Y8"?41,.YSKGT-
M:VP%6'*CF5)[J]PZIGI@_P7GGR&2%4#;HLJSQM:M4..9%H$*]<V@JS!@\WDV
MRCZ75ZF;EE2>3+:VOL8S+<P4ZIMA5F' #[.VLL_CQ6N%?X8PH-P),KWE9<L\
M\0QK,*AC=E5PXH>B0>OG\[AVVRR;=Q.LV\A.V+2X[6.P&<<VDK"MC;>RXGF_
MF*$TO?%Z@VR$/HVGDS YRLVF=4);S?XL\&Q4_?D\R6&?&7%2'.V4Q[];IUNH
MA>+,C3$UP+ \&95$7%4:=F*+*K/#[N00QQBQ; %UAH2F8;>4.6K6]2[,KZ5E
M;R,0S?;8+JRP&AF:=!D<8\/>06SM8;#."]O- <_5W_=!\#,!+6SS)+M(_#4*
M0@!B"T,MP&R0@L9)#U9=M068]$G\'?$:OK.1"6,S][?,CVG?(E)]!(QZ.;^W
M8;5[^M;<V/8%>VO>.G@3QW.$PJ&QYZ<9FOL]N6GG4<R,<BGU>'(QW\Q4#,J.
M!K*6,@5J>YJH@JZE"*SX[:<^XIP&^UEDZVD(:WRP75SP+()<>V@606X&&82+
M*":^(CQ C=US/W1"=P>QKE$0 BQ;&&J!:8,4[+%NM^I->!<<"&/=RGQR0]=R
MHIDO;A^B.,U?JM5-2W:\XY:?ZF%.O0B5!2,:9/;1MN5KHU06^0TB)RQ.3Q#E
M853"'68<:[<')Z'S1?=[.#:,$T6N'89H@E4-%^+XU*RQN7("R5F1E':Y+L;5
MJ0\S0.@E]AC4,4V!/[,!*NRI.;#BSJAM>RW/XDPOI^?/,6T+-S=XXAAZ\_[=
M&XX@]H>:C^;ZS-=\Q_;LB<:NST ^"\4#%(IXHF'O]N+&0-VNC 8\;BMK\IEZ
M1P:T=DV3)&.D%&YUNY6B17S-1%?K(-I0FGO3 *9WF.@C]"O_[C$P1 #.U=)V
MJZ1GL?*W!W1[Y;]0+)9P8/=LL:!N.E^</;G\(L8-FY_F(=@/3TNS_X%MY$<G
M@"E)TU[]1(R)WR'&51'<AW]R[[R%TDT "Q'@CZD40F(FA;CRKDX4"GSSI\3A
M'[04B0/6:G.O:>Q'7C-3SY"Z82]B[%R;OL8U4VML^7&YY@&:JYRS+TF)_[L"
M<L?>[#!16(%MVI\=(@>-_]Y">>6R4(7MJ:J1J6V;L7@KCC<L/-(_1&[#.')U
MK#7ODMO4B=/^/DNG>K,+C^G2#T.>\+H@XHN_S[Y[-T'?G87&K9A^BK>"*%BD
MVO39J._,P349IOIU%/BN1<$Q \/(;\%U*-YXW4U#C<;)=ZJHN>$$CB#G0%<J
M]=A)_&2^N&:-Q09*7K3IUE^&_L)W(2NI9?4=?4J/ _W.\W8BQX3H+HRO@G@;
M>6A@O@,C6F69OGS^/+OY!YF?D]N+CU<7YQ<GLZL[,CLYF7^YNKNX^DBNYY<7
M)Q=GMS@&A3JUG[4"^V$=)4[P,8ZR=9<C[BUEU$).PTRL%7;J)P(-P(?IW:KX
M5+V\48KAH7LNB A)Z)Q^W5"V0 DR>%U W3#PUR!*LIAV.?[MQ8X\ G;2"(TA
ML97,<7=N:-Q1"FTWUK1&SL7MR1S<_I>S4S*_/KN9W5W,KY"X_N,L\4.:P/GM
MO1]*UV#V\V:64>,9"^5K\8J!'HV[ME"RM0"7+*3*@\X+*PRS][6VS!/#S])O
MVG%BAJ2]^SO^<GMQ=79[>W;+ N"_?KFX.3O%@<>\&-*FM*6SHI^!8]P2%IVJ
MUTM6:,G18*Q;1UTQJPTI6= Y/8597:[.S#(QS(QNS42/*]2ST+0%MZN?SJ[N
MYC=LU7Y KL[N]I*\)A,XG. B9##.>)8=6ZF=.W[,=W(_\[Q-*OZN=E;#Q8R5
MK+:-D7F2VA 9D_NZ+15O76^XN)I=G5S,+LG%U>W=S9?/#)]LDKTZ)>>SBQOR
MT^SRRQGY?#:[_7)S)G[;G7?<&KTZ+[B%'(SX5?K+P4*>'8*[G&IO"&.9U66]
MK!ZAHX%CY.IG7:JW7WY2DD\.1GL=-67,& ONV+%E5W?L:&*9&&<=L:.>'C/2
MNL/&D_GG,W(W^SN6TYXS^2Q2_EY]A^?2DX^:)MNA="TE5D.+!D8="K:R-/)W
MK!@]X0SH7%73HBX_9:"?$E5&#Z4E1HNK+M_$5K'D;'9S=7'U\99<G]V0VT^S
MFS/RXNSZ]B4.7/'K.P]1X+$%/>0WI1NX1MOYD+*9:=RGE&T,J#^F;.) @S4K
M-=L/*I=,?R""C0 ?.H<&CV_%](&&B?](Q;0/>G;YM6ZV47.5+8VH94)V\.#:
MQ[/4MI5T//]\?7/VZ>SJ]N*G,R)"-!RX.Z4+/Z2>?'WK&@R+0BB7Q1,VZC]&
M;,30U!=+;4YCO1S=_6=&?I5M+XW4>,9MI]] X[CW9)CBA3B01*0H(C]$KHO;
ML2V*VM<D(>+EN;0HOTQ<5U\:U2.;:+BX44L;;&ETK>C!0%EHAM*6!K36>9^O
M+^?_.#LCQV=79^<7=^3Z<K9]GI!RIY[K*RJ=+VG(<[M#[V/FQ$Z84FW*?2_.
ML7;C>YJ2[[];LDV.M?ZZMNH/WGUB2SN1@O;Q[ K2COD.^\<OLYO9U=W9V=[/
MA?2J=[O' ?QC(6^063G^>C&C0.$0C?MC$<?<?DN7X,-OZ!I>Y@Z773L.6O)1
M]QHZE*[M,FAH)T>:I8*MG05!3@IZ=.%BTR#[R-"*<TJ@6<9[%FQHX6?OXF[/
M/L))-;DYN_URB>7 .L_@/*6)&_MK><E)<?7)-@^WCZ I<G+[&ZK*S[67@@:X
M@U5OY>T""]P.KC+A0/,5_5:YE!='(?NG*Q).^!6]C?B_75CN+V;<PE;#C*R7
MM^HG PV*!RJN>E8Y3(,-@?IMU".5&\JWJ1-Z3NQM74-%N>*Y=1^HEP44*B3V
MN%0D=K"9:BFWM9QTDCNH%6M:(^W]BV.MJD9JNGP=MN?/33ZBQK.Q%0AEJY43
M;V *><'X$IJ\)$O'#Q,"G8W[-;"RQ9@+B9:A_T_J77BL$?R%3SWQGK%\TP2J
M259>?V6_92OJ&<?KWKXRZB)@/TU46S#L]A.3C\7]VM4:?_(K, #/DM1?05E?
M FFZA.?I\N!.?(SD7^,',Y7O$?E!X@AJ($M\&*CDE(G#-EB+:QTGXCGQGJ.P
MBWV:X65GE'K<F'D1#@@KA4U(SP4P\!Z0*RRE]8OD^./-L1- )>';!TI3/@VS
M^;<+HO;L8T*TKU%5B-KRHH%H3X5-$)4^M^EJH0AOZ9TK)]\X(%P)(FGL/[)H
M#3)NBAL@LJ1K*,^J6FDYERP"[.F.=_:=:?SVCIM)[>!W]!$TPVQ?EJG+!_.@
MIOP0J7R)_3GQER&/F5CP\XEZ2]@VJ%*P(&A^<H%W="8598M57#)?%!>XKFG,
MG,X*G!E<X"K^'(D0[Q+4A9W"H<-V7PI,/9[WV[!= WT_7T?M ?9J\IY< Q1Q
MSA/RL?F(OU%_^<#4GSW2V%G2JVQU3V-XQLKIVFK<4M8T(W> N>I!V$,0PO'4
M7WM3%)M+(U(<$?+@)R&1S+,T@5UV_J8$"W9G8>I[?I#Q\21HL V,_&$L?E'A
M>',2.$EG_4]K[FG ;V62&NY&5H0 M]'7!&EQMZY\2BTA7T*/07J6I0]1#+MT
MY#J.EK&S0@?<W:RX4*^G=K!:>JYKH6U6.E6 U^00(0@;DF>NFZVR **K'>XE
M#)0Z#=*W:@(U\@>)1#@2MK'#.#+DLT%^2"J?(/P;C6$#@?V+2WF@B7,,,17E
M]8.3*$G[CI4.[FG&A)5):NP;61%BW$;?+B\?A6(=NN!P%2^S^&YQUPH$8P-M
M,^7R(N1+>EBW'V_DC_8@[BEM&E /,ED-\EZB$()^B/[M)/" NOR0.]\ (A4Q
M++!G3AT6HVE$F%_GX\0)-W](B)2_GURPLR>7PHSTE-\(JQSZA\5NUGR1;Q;!
MLZ4S+^*IFVS"N_UR%0F9BLR>'<H>*[]KY\V19W+M3/#DHV,?UK1V.;E\DCI/
MY%Y^@?AL/+BI2,]RI"Q^8'G[A5Q%KXAPX>_W,DHN^+?GH=A]97$6,QV>A>PS
M&@;(& OU@\W+T=U;  H4#]6ZG<CK92Z'(PO0:2Z,HY>_^CD)9-F(A!TF_DR,
M,.24WJ?Y4]$\=E/;^<.;=XJVVD[<6$#>A=$YIK>1A0+>.S! D;)>$PE@]IA0
MXN=/D+L@UHCX'P[?O,,1W3=2B*N9,[/0FWD>/YYS@DIN\?&F5Y(R7QUIHLO1
MOCY^8<71FK1=HW'OGYY\:$]CK^+%I>JK2@>DD$5TCS']S.4AN?"Z_]:[]$-Z
MP:3K7GT?58/?EP]H->VX?J#X_'\C7]"T65.TN%#A@$@E"-="'+$7>E3R1Q-R
MOVF^T6;E34 CPE5"XE)J[6ENSAOZ2,-,%QD,$3398VV]#-4^SV8E9=3A]DCC
M^ZC'DVQ]+&B5.F4#A,G!DG'2PR[Y#]@1S4^WMF\LI5"D #<TP$"P*R2BF6=V
M8D:K[$Y.2<1%3.,-3')/%U%,B2_FF]1Y>HZC!@YNSY[6-$QV, ?4I6$=)PJ3
MAPZ0BJAQ1L9[,3)"NH1S]QU-"0HSVMO@?BIW5"!^BOAY?TS%Z3\5K&C W[:P
M'/FPSZ0D.>:CN7BY0-^JNY$^^:/.PYND\['G_J+'K98<I4[0,71V:%1S*-W!
MYY_]!-.VGEDLKQTME+_W:>QN69./'UMS.T=+ER"$$\M@(S1K]<KI*G'2-/;O
MLQ1VZ" #84#]B[WO*!F]0,+64/.%QE_VX?]EW,.;3K<X2'>U]X/Z)F6U$Y,3
M/" A6Y)&"\ (#N=7YN+D-<0JY1Z2XTWEOTR'+OW%3)-[U<](==*5G0PT:\N!
MBIMR#7-!U=(@#-OWFUJM$%3G$@K;NPX2S"Q3U#<T*:^J9*BB1X-+"R6U3][7
M8&:Y8;W7>=2#9PW\E%[ZCY"JE3*M?09^4?3A>//9^36*^<VDV9.O.5WI)>*7
MM]@V;8<:T ZB<CF' 0@BI:2\AL;/(&"JOC[?KI][L(_<QZ:Q.D3KUJNOHE,O
M-9W*)@\NB'!)%GT\Z=Q1I+9!02RXH%+\<F3O[HQ")IY?+ SLF'$,$M#@>I#:
MVEG)J<Q*'II":0H;KVD,)5*=)3/PIT@<)J24-6Y9@<Z^P:R$38SF'@9WH-I"
M$F9TVZO?1'G)"2N ^QKF&1<.K%\[&_$">22MR9N BK7\B9,\=""\GXA17V$:
M8%SMY:4>_&@P/$#I)G)G*RC_3-:.[_%R:Q4WC0.UN?Z&**M1Q>-+0A=9<.DO
M=/LQVXD<$]6[,+Z*\FWDH4']#HQH;54^4/)-\APZLGH++2K$9IR?!$P ^'>_
MC,\=$9\GV?VO+#""36QG!;?U_HGH;8#<*9Q$JWL_E)E!S2*[3M%VQC*[S*UT
M//RSMZ]-$27MJ<E48=2./X5FM.[7OE;R0C%F%U W]+&HZBP':AZ1\=2&H%)J
MU,FK.K._Y\D.'EW0&(BKQ[*R[C/<EFTN:3[\_L9[T['R_)&[!R?\&$7>-S\8
MH]<M='BNOL&Z>??E,3H5^%WZ$5NK6TF#/!>J-?W__H;]=0S'LND&7AR&9'YX
MEWX-2XT1.L?P[><ZS#N;<U_#6_OAW^6P[K*VM6LCZ0_(&CCXW$]SGM_?H);O
M!PC*$;JC\;WG.GB5S;:O 5O[V.]RD*HL; [,OT7Q5TC-=YVUGSH!3PSZ_8W'
M4[F\N'.>*C^.T 6Z#S_7$6INR'T-5?57L:5PCF9QZZZV:O'\K =QOCC0;4WL
MM@>ZO_8,AJMMD^U@C'9]"E>"[7Z-; 6ZLGHS6<>^B^3DO7C6"K;QDP=AF[YL
M@9IXW H#)H7KZ6HJ2C31G%$]56(2T) E$"&#SHWS[3.; &/?"3J14Z>=!#@J
M=96XJ1+B@XU"NU;))N<;6>4T?%V]=MRO#CP*@@Q"L-2X"*_C"&K_=5G>()X$
M1$J%E2BJ4>*#D4H]U4(0ZMNM!14R[%Q>G,]O:$+C1WVY+17I)+A1**M$384.
MVUK&H&,3.$!!G""(OD$YF.FND$F%-:%N]?>1$YHMKH I=%->\<(Q*LN'J4Q7
ML5I4HUXN5:M8NS9:)T'CM=5ZM=?\Q>-@J.XWE7I==EQK4E).@Y&6JFJ<%&0(
ML=+4S827R\DO*JF>U[SQDZ^ZVRHF>GQ7D*RT-710R37-%2,H+ENJ<^6D64R;
M/:.CP=,;G1KJ>Z D1G7_YRYVH-K,+76SF.]&?0ECZ@2PC_4I"N"GCXX?&FIT
M]1$PIB?N;UC5.=ASH_';O55N592+PL/?,L:Q\*O9<VZT@J)!HG8SG+3+M)D#
MXI9/#)7I>CR[+LZ2=$?9-<I"Y55OF#]1^MEY\E?9ZB0*>8;A::8L9M*;>ZPR
MY -,:OO,3M;)T3I,WR94)35Q)3GQ)/TNG6I"W5?+Z/&USY9220HN]9W\-P#R
M7<69BK]69X9(U"P5US,:3=!)/0;D+%4&B'603@XI._W:WDZ6E74XU7[\5'X!
MC;\0$<7?G-C+$9[<TC0-J"(KKP_C:*]]]#*D>.+#BFMR /56M?U,4TX@[Y=P
M4?(A#R&L<%7[ 5JIP7QA,$5AN#7G6%#K:4J.-4LV%&#KIVOK.%A<&X3;2@D7
MM&_$[6H7YSXM5Z'GCDN5LV,W^;C[.6:EZQL*:MK)(6>I8'OM*A]IV?X&M":(
M%RN,?%DR#W7C B["G@?1MT_46X+.Q0T]\0RD,L3<F>SQ%@ [;HYR>; CP9,#
M>1_6*&Y4%X1DS2EA4D_**7XM_"]&KWI'XY75X!>$TWG2JJ)Z'PI4DX.N4[76
MJ1K["2 31BF6E$E($3IW_/1A%GJ?G7CIAZ=T'25^FOR-_?$XCK[2^)0Z 8UU
MVWR])(R)JP&F50'7@QT-$OOKW(0HN$:RXJSD7KRYDA3W9EE<29_$WMXA"R ]
MN(V;I?S9%70A97E4U96!KZ&=ZG#0F.>N)$0#/Y-V^O./_6\$YZXYN17E'.ZB
M?"&5.4&P.872>Y0MKC*($=9.G&YR_3?745ZD<>6W+E?M\3M3;"[OO)E4V] [
M^\CDJ-^W988S6[_\6+5$B5O]'O'$!]E?RR\6I1$V9"V_R?X$'\7AMVN3EO%"
MHY)R3)]M4+7JL15DDR.W6S>KL$#LC^, 3FU)EZ\ [Z)C6CXR2ST(@OSP[AL-
M'NEG-E8>=. :+&U, &YI<A6D T6A ?)V^NMKS0B$YV5AZ).?\)>EH)Q]6?[^
M);C>>\JBY/);L/'*@F7Y8#V<@X. D#ZEY.@M6?&OXQ@X;+D0_P3'\_)"4NT"
MTF?JP*N*WAPN,65QS(QA!%=1&.?_>>PDOO%AXAW*'W-P[;Q9:N60=R4<S0#<
MM46MVTJ01<(_0*0T'OP<D$(BOXQ2E8DK4W47#739D>.ZXV\\M^'6:IY=#[E+
M=!FY^[!*/_0.\JKE,-0J'\J'I$?8:L(P(/GG,#ZU*P\.3BKY;%!JQKC^Z&(:
M=_O(QH#Z/I*) PV^K=1L[;)7<@QYZ=LP"FVR%Y$$9)=1N(2# CA5T#1+G61,
MI*F4J^*J^CL:%"F4:JUO1?$:N-LJ<V0AZ \8XV$*AS8>G'ASMU?[$P[$\&K0
MH0?_ Y6Q'IT 8J-B;BA?1S>LGBSYQU[?]C*KN:*U8L9R@6"HXLJ=&D"J"_^@
MI0@\6"U6ZJK=4QG)I(7%-DM^2T&3[<[T,E2[,6,E!8W7':RZ8=\;4UG."YY<
MO.KG:KN8QKY!WFU \UJSG@.;)[72]G<6/(HQ98]' _VHSR%TJ5U[ZT!'C.N>
M?9>:ZE=5,7FXVX<H3E,9.'?-QSKB45\\-2I<>]=428G-@QFU5%Q;H6)K)HB8
M/X)D1-C_Q &E9H*Q&4M:ZBD3O UHTI!B@Y-9S=_=DM@8?%:K[&V_UM!)0[7@
M,)O<:]6A%O5\EAY&_0WKC\K#(CAP?NZ'3NCZ+!(I-;./_JRY1ST*ZF=2XYE9
M&U9<<6(_I=51(SI<*O/B\L2,XPT,3#]<WD!>,;RB_N"OCS<7O)[P;>JD_'#W
M$K1C/QYO=!5.[.I![5^!:3*%QVK8KLHX^_DZFKED=).M2O4D!^0C3T"ZY E(
MJ%(=C"UV:5VGR\R,9LRU#+(>+Y?HT@EZJ3L(IY?XSOX-)E<J=X?\B2@XAX[I
M PT3S@"CO'@Y^QIN!T:AOE[\?CZ%9B!LV5C6PV;@=Y['(-O.N.:0!*F)2%*E
M;/3%A7!(2!5OGKE5^?))A^<Q,HM<VW.&T9GK9JN,WU*;GUQ<A&FTZ]$Y_'.8
M1NBVC=9GE []UK,9J5L:V#U:RW1RZ&52^02)%*,7..4[I]6!SKY89*+C&-I%
MFX@FNG.>^*W\*$S],&-JSM=4%.W218E]!(PY_/H;5AU0]MQHADAOE5MW+7(!
M\(Z0J%(3A>7%"8Y[MQ!'HD+>1+5D&P^07V6K>QK/%[</#FO:>98F*1N ,K76
M575R+P%XZIMNIWZK_+^40J08(OA)10 YY/G"+@Z/Q> MKAPX 8O(5E$H%)ZE
M:>S?9RFLON\B_C>F-/5D(:99',-=>3YO:),4MA<\;M+(KAJBGEBRK50T'G%G
MIK36UWZ0<4=)N<ODI6?2R/W*?")WB'SFYV$!+M?(]:9>RT/T<(XZ$=B>5ABJ
M_C#W*,7B<) S-D5[$J%EH>&S)S?(/!$@PTJ6X1^P.E^<R0G^FL;<-F/!MQW)
M'C6A:9?-44M^VH5@-,YRE]:TRG559 _QE,,K;H)J-W0MW^:[CJ-E[*R4EV2[
MR4>KK6FA=%%0TT [.;0L%6P5:@464O*0G&E79RM]H*([)+%CF1@RR@,1&WK,
MT.DZ_## !]V1QRWXPI:)LRQ]B&+8,Q)>]4B7DVC+/6KB9S^3:IF@=JR3@W.8
MOJU)L: C<0E63(5<U/;=T)7CP]Q?&E#2# &LG<#I,=S'\&Y8VTA#CO0>)K0>
M+\U9B?/<AH%WFL$5>E&?UIB&W\TW(:CU9ABPVV;""E&MIDTD_I2_AY.(A7T)
M0B3+>9-A8C-B0(ODC%@ 6#?$%H&"ZUE L*:J,F3%"#WW@7I90&7);CCB=,+-
M>113?QF*2PGNYEC4H#-E@ Z0,RHPAYI9PVE?(7A@.U#S%HJE''"F54E$BB*Y
M+"*%X<J5[#9>MQ<P2,*X)T6]3:L?"5FSHP%U?YV;<+:$,+H]A9GW:R;N6C.E
M\WHK56/N8B=,')?OOU[1=+ZX<YYTF\+#9(VZO;^-N;7M_"&"T.!]&^V;R%>E
M(T*=39&2F%?:O*<+-B@JN5'NI-D@(NL%TL'$685=GD\WU\@'FQWGV;;*MG)[
MMLOB&<][Z3)MP>H<MB*BYJ?[+%8^I>)_9_>)ZOFT70H>TZ_MKB&J>-]>*IK1
ML#-3;-Q?S?4=<&\(E8B=IP_XATTC_*E,!+/0X_\E+DR54TA'5+"OCV$97MLW
MF.V0&_ZE9S$,MS:O50!5AN%N'H:GI1#B%%*0SV65]U;^RNL9;6 //>%7Y$O7
M)7+4Z\EJUT[<?HIV_Y_#,#!WU6@V0W/;;Z$?G#LRL%7WADV+6?&@/:_+7[E%
MP8:HM[N7AO8_;U[#'[BKXE37$8L::.J+E-)C&M*%GT(%W&0G$^=67\,P0'?4
M9+93YQ:?&F=XOA?#,Z1+N"5DRE7=KYFMEXF%1)YYMZZ)8TMZ+N_YS*2U6']G
M$Z:U5"S#;L?3GZ5(7 G?NS%&7=-%=<-/NR*<:/]+8;K)M1K(L:7RVZC:JIB&
M]BYU]7*J ;*FX]1^(D;=C!]@7&T/O@<_FB![@-*M7,#*=6*Q_50'\(5T-@A+
MS%A:?]EQ=MI?#$)<MXP<@.U+=$>I Q7?$N.7=N>JTW>Z\4RQGXB19]ZUR$Q*
MG3@US;]#C6@"0!Z9'[!EQM(/X3@*AP>;N_XQ/\N\:1YEBC\SF_HL*H9*&W4Q
ML9W)M47$,%%HO-MV^MN<'<GS<KE@&')L/MY8:#8"+Z<2N;ZL0"S.TX8,BUT(
M'G.$[*XAJH-E>ZEHQLW.3&G%"3SU/U$4W7$ZBN[ &EQL-N,83.;5@&DW0G>!
M9BN)6':K+$VWW:GJ$/><-GOM3&DG*O*)!8KVY!NX+^@3O(E"7_[W"9W?31 Z
MGX7&KAYJ@C9PIKS>! [G5F:-GS+(A=2K'D:4M;*-&UD]94QS)Z"'>>K[ !8"
MT,SJ0[0VW0.04H@40[@<4A&$:S.K;72I:M<.EB7OR(_1VIO3>).VFQ$-:/MH
MVRZ5W 9H!9\8]J',(U'QZ^S)M^Q5"T'XZMYM9X8- $19&K&6KY^X-\A^!M%H
M?=<MC1]]EYXP"ZR;LL8SK:]2J&]&<X4!L6]J:]F:0 4%6]TF2*[ MZW@5TMH
MDO8"5YUI6G2I####J\J!&%\*-957VQ@):H2=L26LFT))B32+PWGEL7GKIC")
MF!9]W<:9L:CGQ[;?,4#WUN4ER4!BSD'D.Z^H'NALFSE;P5;./V6]/%Y1_))O
M3EHWE$'"M.CM-,T,7BT[?NQVJ:[8S"[H83T,V=%E07A856"%[Q65>_B^*__:
M:ZK7L4\+7+-19M2J>7&ERO746IGMB!60<-^5[XGSL]G-V6H=1!L:6[>$EG]:
M2':89<:DAAEQ=&K6N%UH.W%A\1V%3KSAUY8+7APPG;ENG#G!>12?A8]^'(6B
MW#C,">)^]I*&KJ^=\^W91\YVZV54X]C&BA<-1'LJW$1H_E+HABRBF#C+9<S#
M"K+(THRG>:RHYXOI'Q9;6\-67;O6SQ_Z &4W,Z8$]9C;=\&4)9TOP.=#D:E*
MK7?9#/W91ZMI.\"HHKYM#][)D3A0X?:]GIR:/PZNP645D+#)R=90D>OSE J.
MSP.969$^L 56P'@"LJ#;)U0H87M3ZB)B%$7#*&C& J!6O1QE+0(44-)II2C!
M62!!'&?OI9,O:9K"RPLG,?M:>AS%<?2-@?C$63LN@Z?"@$Z.L0!@J7H.APYR
M%."PT[$UR7$N<"LNY\,1>PFMDMR8RHL<QB<LNMG&C+5LC:C&6%T\DR.MIZ)=
M<#N0Y8!)5 K  <$3Z&"V*.%>M.L==!WQF' S*UR_(*BB1 ,MHWKMVX 58@+4
MN-).6L9<=N2:F!@FA5-+<2.D"FJ\L&JJ: .M2VPE(:_CR,O<=![+D^5J@DBC
M =2D8V+*I&P532HZ-#@R*-=:MPE2D7,BR6TR2_:9_)BR!2$O,)$E#,M)<DN7
MO!J$KB^,#/@RB.S4;:=E"")463\MAU5N ^@N$9A9)IT^%,H;)Y */9JA;Z&D
M>1)9%_0X(%;F!,L1<$/7<*H9+B_"112ON-;'&_FC7;YW#TG39'WW-E6=^VTM
M!@U\A^MNR@.7Y*001BK2#LC]IJ! %9@;FJ K1+=C'17</8RIH=F"#P]\[975
MS.]JC&)(!.^N_RSN6Q8/P,/[G6Q6B6+/AP-4KOP5^PZ<HT9!P)M'9 *J^GV/
MGWM61;6WMU);C;NHC:@ORYU?&/>+6W[FTY@][87S9'C1!F?B;N$5K:%&2_2+
M%[FC]33[5L8/<*'M%/O?)@U;V3 /XDIQOOFXD$=CLB=@N2:O61Z0;P^^^T"\
MB*W<PB@EOXFBFOSL+:%K)X:C-Z^\5<+\"1.52TKRY0C)0H]]@'D<&OL./[U;
M9KY' UBDO)J@U^]BQZ,K)_Z:*'J[]B.J7E9IUHJYG3C>\ ?H1/>^B&)_R49T
M(,Y!90U$N'K.^G =TT<_RI)@0RKY>TXUN0_@X*_6CA^#9B^)D_!Z<*R7[^53
M(<D#96CR>'9 %/.?8GA<G'W+_2WS8R8Q?8BC;/G /K+TDWP]P,0X4.A8F$32
MB!=6)5RM*(7WYRF\TLROP&<)%?3W<F5+0F?%\)EL5O=1 #P"PQ[E-PP GNDF
M$ HY(.]7D6GK,R N_-!/.8W\ES@E!/GRGO$4D#QG?12Z;'1<A*R%,K%L#[US
MUO#\*;?/U($A)OZNJ(0_5 8J@&]A0*ND=BZ*5&1Q-(,T(I['J\HC/^<2QXZ#
M^EI^1Y_28[8Z^+I-_Q="GBT FA:HYCE&QQQ0=8I:B'$OL>$WL+$ ;#QR;*PJ
MGYK"(=2RM%@;?,S8=,LB,%JY%:A%0B]F5 @8HGF[Y_V$9Z'#TX-,2=Z],"]!
M796 UF,62"""F'?)*0 PZ>8/"81 XG<V+T$T"[-$*M]V97^BU:0ZB&S@0/B
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M&(F$9J_(+$BBZDT0<2&]^LD749;"/V0) ;'/NL@M($YAPB3)<4\NY:\:RP<
MDIOB=LQ%6-S5F2_R>@C\#7%/6#]?S&Z_7$6BGG 3E#L3C JAN[9*_;(ZS)64
M?ZGZ9'1"7H!?<WUQH;!VD0FV^_F5P"B401H@<1U'CPRZ<G56+4^1[_^5-YO@
MDWG-"RZ--5\6\+\[W !YJW#F<J<*_WD+6X L]$O(ES6_,_^"&?B27$6OB"C6
M\_Z ? <O*M,PX0UZR <UJ?Z)O+B+UKY+_GCTIY<?R,4*5)9[VLRKR[<G*.%)
MSH?'D$!.\N"TU.35=U.L,%=K-G3GX=EB :N>1R@\PB-LVQ'26P"JD3!4>Y6#
M]J@;4T@H?L$PRO_U,K^:)S,CX19K_B$^)OC2XP4':GD>]O+_(]?NY,P-V#SH
M,U_BB&XZ90OR"[E4AT-(C=_ZX<V[]B';<%FH\+P#0_3.'#8\RKT0<60;%Q_,
M0PX1&8@G\\1=[>J&B=)EEQ<VBIAV)T/@A\,W[SZ0[VY]!F-_L<GYK\4]D>)X
M"9J(Y&U$H)$F ?2).)CZ#&<C/)*:+_*T;-"018W5_]0D[ V0@0K 6QC0VA:4
M)X:E+.CLRP*.O-LAH:3QIPEW\^_B+$G%$Y7G47P5A;_EN:/Y7D?5=QL2;P<+
M0@6&;:UHS=(@CPB!A$DD59$DEUF?'R?/T+V"4A0<]TP1-O?"O3%UI^LI4?5J
MIYK-;KLJBG%P%B)YGGVGO)N\-J&E@LH.4;+\=YHV<73?5JIKILQ>PB:J4?HQ
MCI+DFA<BJ?:FXF=$-4!56C7[@-,00311V^;[/M<TY@L_MN[S754K*PD1M;=9
M/VVU5$8N5KP'A'.@+</+%#WU@RRE'E=7U46]A2#JON&ZMW/Y^:[ABTM>.XFO
M4TMQI)1WP/M>BA080-'YZKHR5S2=+^Z<I]XPZ"4.+2"&66$!C5HUGE(R#T'S
M8F%\XT!-=T"8#O [TP(/H)J^4.IDX]8E*2(@=&EHX]HEST3=(5:AJL*Q:@I$
MC:]1K+5Q*-;9DU5QK:LK0UM]0TL"=.W<U$O=S =$TDW:R/K61=>L'>TY43/F
M"25LZ64 ;)L*4?,:E-.]:>[3R?%;4:6CQ7$VM4T;3]2T=S$OW+SAAX^\:+2J
MA=M4B!K:H%Q[CUF0$DY[(.J:3_:\'E-!I@"=_98UKJ#IJ1"UO$&YUHV,"ND?
MB" FLS2-_?M,5'!+(W+MX' RL]"SZYTN'D1]9:VJP4?Q-98@GZB3\F.@XAT>
M^7Z+S)52]5$'"Z(NLM6TG;HJS\;D:IEQ$LE*7DCFEQ-U&,^EA(>1G.2A]N*.
MJJNTQ(@ZJ5O'9O=P#B)9\CYZ(;FFZI<+F05U*O.B+L(;GIL*KE@99!D9$/6/
MG9Z*?2:9'I;S\?2P"BN:?KH(']DD&<6:8-C(@+J?5'I:]E.%%4T_\6$O]QW#
MI7X);L>)NN>,"EMVH?"2A1 RZ4J_;:),:\L/U%D(Q?X29]3K6)L.DX2ZMWL9
M8-G[N<PB?00B32F63+]*5C8"Z%9Y#U)J;@T"-3OVGN_0VMI?YX$J+;I\HJZ]
MHBE<0+R&>PP>]8XW7Q*PL/1FQ=T9U1&GJK>WDX@( #LRI)6@1%/";X7G@N'A
MYQ=?Q!-/+ZM30"'_0'T@C!XRV\'C64)AE]T^4?_*.Q3)73033W(RC>$]LPVD
MFT*>%6R!K)O%'?IS(^K? 4IK+O3S:P52",FE'/!,W?2@V$#BHB;NWO,HKMX&
ME8\"/T(1LZXQW%,$PH[NJ[FVM^':WXM<%,_0>"EC^4+<]"-:X[XL>]N>&U%'
M#U"ZI\=&U+\55)?/U$"Q2W@EA.]U=XQB#1>B_NRAK'&LELR0!"78Q7'8Q'T'
M3ST"RD(OL>PW-0?"/NM05-M?K(/F\-@JO!%82#C T&D:[])12:(_-Z+.'*!T
M3X=:B)K>H8*6+.J#_X%P[=$) )"B($]S7T#5PWWX$?7Q(+65%<\@T.7_J,CA
MZ:90ITBQ*S+5>6J?UW4[7M+>E4Q$>-B9*8HG#T6B\D?YIG A6Y^W7'DF\6?X
M N&?F"IQ,S]RV5BBPD2/J,>MU&SO<DHF9'T$=V5C^D##A)?0@CU7N!UH[*<N
M'D1]9:UJRT-7&8L3>7'' "1@Z+N:ZS%[GAOQ_'>G+[:2@JA_MU#>[&^[W>T!
MD1+Q]S[?;#$DU0P4]3QQH+1@>S"(#2TI=SI(M.VUN'-U3.&!Q^+,3@.178C&
M!9F=6F1\$KX"%.O[:@?DGG^J<A2*"5>0?,B+8<'6A>)W:Q1U"<*.&6O];1'"
MDS.Y1/TEQ8F0<)PE?D@3V*.Z]T,YKQ:U!SUXM&?A\Y0/<<=,'/) Q<QJ<G&2
M9*NR!@PSMR-#9O]?182Q$8UM/?<B/TTJWX8PIRCP6/U\7H<G5T 4>*ED@DL=
M#LK"/ #LZ3-U!C;PQRCROOE!H&SH*ZH\Z-W3IYX_6JTMW"E$#TC^W0,]6MG7
MI]XON;PXG]_0A,:/FERQ-ATB2!C5T^Z+'! @)Y(>U9[VN>/'_!I8N75COZ&M
M8$;45_UU[K&5#6+$_;G*IM>$8TL^6&_9G68.1'UHJ:AJY$DV7%TE"P;:]9*6
M&%$'=>NHJPF J5MN'Z(8'OSCI<,*8U1]HJ9$U"$="K8NI@)Y66"TVBV3W7&\
M3\OW+HR=H2%%U!M=&K;O,D*YWX(!UR@YSTLA5V)+2U=FR8JHY_IJW.S)@K\6
MB6/J3KZKJSA$@LV[:_A#%.:O@5Q'#)$T]6->%EO>J>759V?>KYF8:?/:5JKN
MW].G$,%EWQ:J;]763_)>B$^^)/!1R+;@G^4!K""O?YG(3XLRP@>D_'JU2!A"
M<!95U. )+-:NE3(*=Y$HHM 7A!8BGPG8^EAB ZK:EGZC>ISX!*XZ%J:V,3?+
M45_0=(A[)H"QM6( 6/"B1+Z75G&^<+KIIM2[H6D6AW->L5U_:[D//R(<#%);
M46^#/_U6G3X.2"Z("$E$EJ>?]B)SV][JNXGS!;S.F !8U6<S/=A1=W*WUG9]
M7'MTDLT"7)(8[329+(>S92Z;HT2FJ>_*O\*[*78=K.9%W;L=*MMU+<SKN93B
M)Y"CZ-7JGR[9O]B?\S^Q_W/O))3]Y?\!4$L#!!0    (  R"8DD>5&R7IS
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M\ D+3A\8J(KT5 (D6%F5M$JA[] _:)&39\M+%Y."U$IN+]VGX6+-8^PG1$*
ML5U,ZBH=E/L0057?0W? 31DF$?. (%+ IA$HE_T5;6J$"EPX1D&$PHFUI9XT
M(37[NQ <84?9G)+^"A6J0B4I"QC #6R;AE9S>NE+G+:-8W2XC.)CJ#*&+)QP
M[*&ZA'HYG,@L\@--YTR^.5[<!_Z2'C[2XTBZ\"W\DY>IVFPDV<PB ":S,8\5
M^-3N##\C_!2$2/]][]VFZ&J[^^L7%V'"TVI[CYZ1)WCF1;(_C,W"T4(! FG
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MR);1B59*DV@"E9K!0$-*T\J@'#("8L94M&I_SLXI=L+OI3E!7QR-%^TG&3(
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M"  0              "  0    !C;'@M,C Q-C Y,S N>&UL4$L! A0#%
M  @ #()B2<A+4(^M#0  :G@  !               ( !VX8  &-L>"TR,#$V
M,#DS,"YX<V102P$"% ,4    "  ,@F))WT16<<\3   U^@  %
M    @ &VE   8VQX+3(P,38P.3,P7V-A;"YX;6Q02P$"% ,4    "  ,@F))
M@IYK[[T>  "(RP$ %               @ &WJ   8VQX+3(P,38P.3,P7V1E
M9BYX;6Q02P$"% ,4    "  ,@F))%MN%C]U.  !! 00 %
M@ &FQP  8VQX+3(P,38P.3,P7VQA8BYX;6Q02P$"% ,4    "  ,@F))'E1L
MEZ<P  #S 0, %               @ &U%@$ 8VQX+3(P,38P.3,P7W!R92YX
8;6Q02P4&      8 !@"$ 0  CD<!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
